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Abstract 
Following recent interest in the maintenance of health and wellbeing through dietary intervention, 
the acute cognitive benefits of wild blueberries were investigated in healthy young adults. 
Blueberries have shown promise in their ability to mediate postprandial cognition and mood; 
however the effects of dose, and potential mechanisms of action, are yet to be fully elucidated. My 
thesis, therefore, aimed to determine whether cognition and mood effects following wild blueberry 
supplementation were dose dependent, and whether modulation of postprandial glucose response 
was a likely mechanism of action, through increased availability of glucose to the brain. 
The cognitive and physiological effects of wild blueberry doses, containing 129mg-724mg 
anthocyanins, were investigated across three placebo controlled, crossover experiments. Data were 
analysed using linear mixed-effects modeling, and key findings were identified through pairwise 
comparisons. Observed dose-dependent cognitive benefits included the maintenance of immediate 
recall on a single-trial word list learning task, the improvement of working memory on a serial 
subtraction task, and the attenuation of negative affect using a self-report questionnaire. In 
addition, dose-dependent attenuation of postprandial heart rate decline was suggestive of increased 
glucose availability.  Further investigation revealed dose-dependent effects on postprandial blood 
glucose regulation, including attenuation of postprandial glucose peak, and extended availability of 
blood glucose. In all cases, the strongest effects were observed following blueberry doses containing 
517mg anthocyanins or higher. Few significant effects were observed following lower doses.  
With some statistical caveats, this programme of research is the first to demonstrate a dose-
dependent effect of anthocyanin-rich wild blueberries on episodic memory, working memory and 
mood. The research also indicates a dose-dependent glucoregulatory effect that may provide a 
plausible mechanism of action for observed cognitive benefits. Future research should consider the 
potential application of wild blueberries as a treatment or preventative intervention for metabolic 
disorders such as type 2 diabetes, where both cognition and glucoregulation are typically impaired. 
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Chapter 1  
Introduction 
An abridged version of this chapter has been published as Bell, L., Lamport, D. J., Butler, L. T., & 
Williams, C. M. (2015). A review of the cognitive effects observed in humans following acute 
supplementation with flavonoids, and their associated mechanisms of action. Nutrients, 7, 10290–
10306. 
1.1 General introduction 
Due to the rising cost of healthcare provision in the UK, there is increasing interest in the health 
benefits of natural foods. Government campaigns such as ‘5 A Day’ and ‘Change 4 Life’ have focused 
on the promotion of healthy eating throughout life, with a view to stemming observed rises in rates 
of obesity, type 2 diabetes, cardiovascular disease, stroke, and mental health problems including 
depression and dementia. As cognitive deficits have been associated with all of these health 
conditions, my research sought to investigate the cognitive, mood, and physiological health benefits 
of supplementation with anthocyanin-rich blueberries. Specifically, this thesis investigated the acute 
effects of blueberries, in the immediate postprandial period between 0-2 hours after consumption, 
in a young adult population. Effects were investigated across a range of doses as is recommended in 
clinical trials in order to gain insights into likely mechanisms of action. The longer term chronic 
effects of blueberries have already been the subject of much previous research and are not 
considered here. The thesis starts with a review of recent literature relating to acute intervention 
with flavonoid-rich food sources. Based on this review, specific research aims were identified and 
are reported at the end of this introductory chapter. Subsequent chapters report the methods and 
findings of a series of experiments designed to address each of these research questions. A final 
general discussion consolidates the findings of this programme of research and considers its impact. 
1.2 Introduction to flavonoids 
Flavonoids are a class of organic polyphenolic compounds found in varying concentrations in plant-
based whole foods such as berries, tea, cocoa, soybeans, and grains. Herbal extracts are also 
commonly prepared from the leaves, bark, or berries of these plants to provide a more concentrated 
flavonoid source. There are several subclasses of flavonoid, including flavanols, flavonols, 
anthocyanidins, flavones, flavanones and isoflavones. Flavonoids often naturally occur in polymer or 
conjugate form depending on the food type. A detailed overview of flavonoid structure is provided 
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by Beecher (Beecher, 2003), however a brief description of the main flavonoid forms relevant to this 
review are contained in Table 1.1. 
Table 1.1 Flavonoid subclasses and their naturally occurring forms 
Flavonoid subclass Food source Additional naturally occurring forms 
Anthocyanidins 
e.g. cyanidin, 
delphinidin 
 
Berries Anthocyanidins may occur in methylated form, e.g. malvidin. All 
anthocyanidins conjugate with saccharide (sugar) groups to form 
anthocyanins, e.g. chrysanthemin 
Flavanols 
e.g. catechin 
 
Tea, cocoa All flavanols are isomers, polymers or gallated conjugates of catechin, 
e.g. epicatechin, epigallocatechin gallate (EGCG) 
Flavonols 
e.g. kaempferol, 
quercetin 
 
Fruits, 
vegetables 
Flavonols may occur in methylated form, e.g. isorhamnetin and/or 
conjugate with saccharides 
Flavones 
e.g. apigenin, 
luteolin 
 
Cereals, herbs Flavones conjugate with saccharides 
Flavanones 
e.g. naringenin 
 
Citrus fruits Flavanones  may occur in methylated form e.g. hesperetin, and/ or 
conjugate with saccharides, e.g. hesperidin, narirutin 
 
Isoflavones 
e.g. daidzein, 
genistein 
Soya beans, 
peanuts 
Isoflavones may occur in methylated form and/or conjugate with 
saccharides 
 
Flavonoid-rich foods have been well documented to elicit health benefits by reducing the risk factors 
associated with cardiovascular disease, diabetes and stroke (Basu et al., 2010; Novotny, Baer, Khoo, 
Gebauer, & Charron, 2015). Over recent years interest has also grown in their ability to elicit 
cognitive benefits. As such, long term chronic supplementation with flavonoid-rich foods has been 
investigated extensively, particularly with respect to cognitive ageing and related neurodegenerative 
disorders, (Blumberg, Ding, Dixon, Pasinetti, & Villarreal, 2014; Cherniack, 2012; Lamport, Dye, 
Wightman, & Lawton, 2012; Lamport, Saunders, Butler, & Spencer, 2014; Lau, Shukitt-hale, & 
Joseph, 2006; Macready et al., 2009; Mecocci, Tinarelli, Schulz, & Polidori, 2014; Miller & Shukitt-
Hale, 2012; Poulose, Carey, & Shukitt-Hale, 2012; Rendeiro, Guerreiro, Williams, & Spencer, 2012; 
Scholey & Owen, 2013; Shukitt-Hale, 2012; Solanki, Parihar, Mansuri, & Parihar, 2015; Spencer, 
2008, 2010; Vauzour, 2014; R. J. Williams & Spencer, 2012). Less attention has been given to the 
acute effect of flavonoid-rich interventions on cognitive outcomes i.e. within the immediate 0-6 
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hours post ingestion. This review focuses on the limited, but increasing body of evidence for the 
cognitive benefits of acute flavonoid-rich supplementation. Immediate cognitive enhancement is 
often desirable in academic and work environments, such as during an exam or assessment. 
Flavonoid-rich foods may, therefore, be useful alternatives to stimulants such as caffeine in these 
situations. In addition to these potential practical benefits, acute studies are important in 
understanding the full range of effects that flavonoid-rich foods may elicit, and their mechanisms of 
action. A number of recent acute supplementation studies in humans are reviewed here. 
1.3 Method 
A search of Google Scholar, Pubmed, Web of Science and PsychInfo was performed using the 
keywords flavonoid, polyphenol, memory, and cognition (including truncated forms). The studies 
selected for inclusion have all been subject to peer and/or editorial review, or form part of a 
published doctoral thesis. For this reason, conference abstracts have been omitted. 
 Flavonoids are typically administered in food form rather than as pure compounds, therefore the 
studies reviewed here have been categorised according to the food source. As shown in Table 1.1 
and Table 1.2, the flavonoid subclass or subclasses present often differ according to the food source. 
This suggests the potential for differences in cognitive effect between food groups, and further 
supports this method of categorisation.  The subclass and dose of flavonoids administered, the 
cognitive domains affected, and the effect size of the response are discussed, along with associated 
physiological mechanisms of action. Where possible, Cohen’s d effect sizes have been calculated 
using the method described in Chapter 2.  In the majority of studies reviewed, post-intervention 
scores, or gain scores, have been compared with those obtained for a placebo or control (d), or if 
this information was not available then post-intervention scores were compared with baseline 
values (db). A summary of all cognitive effects reported in the literature review, including details of 
participants, intervention type, dose, cognitive domain, and effect size, is shown at the end of the 
review in Table 1.3. 
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Table 1.2 Average flavonoid compositions for different food types 
Food type Flavonoid composition (mg/100g) 
 Anthocyanidins Flavanols Flavanones Flavones Flavonols 
Apples (whole) 1.59 9.29 0.00 0.12 4.15 
Blackcurrants (whole) 157.78 1.17 - 0.00 11.46 
Blueberries (whole, 
cultivated) 
163.30 6.69 0.00 0.20 10.63 
Cherries (whole, red) 33.44 4.13 - 0.00 2.43 
Cocoa (powdered) - 52.73 - - 2.03 
Ginkgo biloba (EGb 761)* - - - - -  
Grapes (whole, Concord) 120.10 2.14 - - 3.11 
Green tea (brewed) - 132.81 - 0.30 4.82 
Oranges(whole) - 0.00 42.57 0.19 0.73 
Data were obtained from the USDA database for the flavonoid content of selected foods (Bhagwat, Haytowitz, 
& Holden, 2014).*Ginkgo biloba EGb 761 is a standardised extract that contains 24% flavonols in saccharide 
conjugate form (Clostre, 1999). 
 
1.4 Cognitive effects following acute flavonoid-rich food 
supplementation  
1.4.1 Fruit supplementation   
1.4.1.1 Berry anthocyanins (Blackcurrant, Blueberry, Cherry, Cranberry, Grape) 
As shown in Table 1.2, berries contain a range of different flavonoid subclasses, but they are typically 
richest in anthocyanins. Initial berry studies predominantly investigated the cognitive effects of 
whole fruit. For example, Dodd (2012) demonstrated improved accuracy on a letter memory task 
(measuring working memory) following freeze dried whole blueberries (200g fresh equivalent, 
631mg anthocyanidins), in 19 young adults at a postprandial time point of 5 hours  (d=0.57). The 
study employed a double blind, crossover design with an energy matched control condition. No 
effects were observed at an earlier time of 2 hours or for other measures of executive function, 
memory, or mood. For a subset of participants, blood samples taken 1 hour postprandially revealed 
a trend towards increased plasma levels of brain-derived neurotrophic factor (BDNF) in the 
blueberry condition. Unfortunately, cognition was not measured at this time point so it is impossible 
to say whether the neurochemical changes are related to the cognitive outcome. In the same study, 
older adults’ BDNF values decreased from baseline for both blueberry and placebo conditions, but 
the decrease at the 1 hour time point was attenuated in the blueberry condition. These older adults 
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(n=18) showed improved performance on an immediate word recognition task at both 2 hours 
(d=0.44) and 5 hours (d=0.69) postprandially, but no improvements in executive function or mood 
were observed. 
A later study by Whyte & Williams (2015), using fresh whole blueberries (200g, 143mg 
anthocyanins), investigated cognitive effects in children. They found no effects at 2 hours for a range 
of executive function tasks, but did observe a significant improvement in delayed word recall using 
the Rey auditory verbal learning task (RAVLT) (d=0.74). This was a small, crossover study with only 14 
participants. As no baseline measures were taken, variations in performance across test days may 
have reduced the statistical power. Nevertheless, the medium effect size for the RAVLT provides 
good evidence for positive effects of blueberry flavonoids in children. Whyte, Schafer & Williams 
(2016) conducted a larger (n=21) double-blind, placebo-controlled, crossover study investigating the 
cognitive effects of two separate blueberry doses (127mg & 253mg anthocyanins), again in children. 
The highest dose resulted in significant improvements in immediate word recall after 1.25 hours 
(d=0.80), and in delayed word recognition after 6 hours (d=0.78). Improved accuracy was observed 
during a flanker interference task after 3 hours, although only for cognitively demanding 
incongruent trials (d=0.78). However, reaction times for a Go-NoGo measure of inhibition revealed 
significantly faster performance following the placebo compared with the blueberry interventions. In 
a further blueberry study by Khalid et al. (2017) significant effects for mood were observed in similar 
aged children (7-10) and in young adults (18-21) following a drink made from freeze dried whole 
blueberry powder (253mg anthocyanins). Mood was measured 2 hours post-intervention using the 
Positive and Negative Affect Schedule (PANAS). In both age groups positive affect was significantly 
elevated following the blueberry intervention when compared with a control condition (d=0.28 and 
d= 0.61 for the children and young adults, respectively), while negative affect remained unchanged. 
The positive blueberry effects in older adults and children appear to be focussed on episodic 
memory, whereas improvements in executive function are more consistent in young adults. The 
differences in cognitive domains may be an artefact of the small sample sizes, but could also be 
indicative of age related differences in underlying neuronal structures that affect the capacity for 
improvement. For example, hippocampal function may be more receptive during development in 
childhood and decline in old age, whilst frontal regions associated with executive function may be 
more sensitive in young adulthood. It is noteworthy that neurochemical changes in BDNF were 
apparent after 1 hour, yet distinct time points for memory effects emerged at 1.25-2 hours and 5 
hours, but not at an intervening 3 hour time point. At this stage only BDNF trends have been 
observed, and not directly in association with cognitive changes. Although it is perhaps premature to 
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comment on the relationship between acute changes in cognition and BDNF, it has nevertheless 
been posited that flavonoid induced increases in BDNF may facilitate stronger memory encoding ( 
Whyte et al., 2016). Possible mechanisms of action are discussed later in this chapter. Overall, the 
timings of cognitive effects are likely to be related to the digestion, absorption and metabolism of 
flavonoids, but further mapping of cognitive and physiological observations is required in order to 
resolve inconsistencies within the current observations. 
The flavonoid content of blueberries is known to vary widely depending on growing, processing and 
storage conditions (Rodriguez-Mateos, Cifuentes-Gomez, Tabatabaee, Lecras, & Spencer, 2012; 
Rodriguez-Mateos, George, Heiss, & Spencer, 2014). The same 200g quantity of whole blueberries 
used in the first two studies described above (Dodd, 2012; Whyte & Williams, 2015) showed clear 
differences in flavonoid content (631mg anthocyanidins & 143mg anthocyanins respectively). This 
highlights the importance of analysing fresh fruits for their flavonoid content when conducting an 
intervention. It is also important to note that compositional analysis of anthocyanins typically (but 
not exclusively) involves the removal of saccharide conjugates prior to quantification; therefore 
anthocyanin content is often reported as anthocyanidin equivalent. This difference is critical when 
comparing doses between studies. For example, a berry intervention reported to contain 100mg 
cyanidin may actually contain 156mg chrysanthemin (a saccharide of cyanidin). Some studies 
reviewed here appear to use the terms anthocyanins and anthocyanidins interchangeably without 
acknowledging this distinction, making it unclear whether a reported anthocyanin dose is actually 
referring to an equivalent anthocyanidin dose. 
As with blueberries, blackcurrants are a rich source of anthocyanins. Watson et al. (2015) conducted 
a double-blind, controlled crossover trial of two blackcurrant extracts (cold-pressed juice or freeze-
dried powder). Improved attention compared with an energy-matched control was observed in 36 
young adults during a 70-minute-long, cognitively fatiguing battery, beginning 1 hour postprandially. 
Specifically, declining accuracy on a rapid visual information processing (RVIP) task was attenuated 
after taking the powdered extract (d=0.10, d=0.47, d=0.47, d=0.49, d=0.49, d=0.59, d=0.56, 
measured for seven task repetitions; once every 10 minutes). Similarly, a slowing of reaction time on 
a digit vigilance task was attenuated, relative to the control, after taking the juiced extract (d=0.60, 
d=0.73 & d=0.60 for the 1st, 4th and 7th repetitions of the task, respectively). No effects were 
observed for the Stroop task (a measure of inhibition and attention), or for subjective measures of 
mood and mental fatigue. The total polyphenol content of the two extracts were matched at 
525mg/60kg bodyweight. However, the anthocyanin content differed slightly; 483mg/60kg 
bodyweight for the powder and 467 mg/60 kg for the juice. This difference was also reflected in the 
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analysis of plasma anthocyanin levels, which were observed to be higher following consumption of 
the powdered extract compared with levels recorded following the juice. Interestingly, the juice but 
not the powder was observed to inhibit platelet monoamine oxidase (MAO) and to attenuate blood 
glucose decline over the duration of the 70-minute task battery. This study suggests that the way an 
extract is prepared may influence cognitive and physiological outcomes, however as different 
blackcurrant cultivars were used for each extract, the contrasting observations may simply represent 
compositional differences such as the ratio of flavonoid subclasses present. For the juiced 
blackcurrant extract, MAO inhibition and blood glucose regulation were observed providing 
evidence for additional mechanisms of action further to the neurochemical changes observed for 
blueberries. The significant cognitive effects were observed for tests of executive function (RVIP and 
to some extent vigilance) which is consistent with the executive function benefits reported in 
healthy young adults following blueberry anthocyanins. 
In a double-blind crossover intervention study, Hendrickson & Mattes (2008) investigated whether 
an acute dose of grape juice would mitigate deficits in mood and cognition that commonly occur 
following a large meal.  Approximately 600ml (10ml/kg), containing around 580mg anthocyanins, 
was administered to young adult smokers along with a standardised lunch. Smokers were selected 
on the rationale that this population have an increased propensity to oxidative stress, and because 
smoking abstinence can exaggerate the post-meal dip in cognitive or affective state, thus this 
population may be more sensitive to the effects of flavonoid-rich intervention than healthy non-
smokers. This was a large study (n=35) with considerable statistical power, yet no significant effects 
of grape juice were observed 1 hour postprandially when compared to an energy matched placebo 
condition. Mood ratings for positive mood states (pleasure, arousal & vigour) were observed to 
decline under both grape and placebo conditions, similarly ratings of negative mood states 
(confusion & fatigue) increased under both conditions. Although mood generally declined, word 
fragment completion task performance did not significantly change over time in either condition. It 
is unfortunate that performance was examined on only one cognitive domain (implicit memory), 
which is an area that has not previously been considered with respect to flavonoid-rich intervention. 
Studies have observed effects on traditional measures of explicit memory and executive function 
that were not measured here. Indeed, a more recent study by Haskell-Ramsay, Stuart, Okello, & 
Watson (2017) observed significant cognitive and mood effects following purple grape juice 
intervention in young adults (n=20), when compared to a sugar-matched white grape juice control. 
The purple grape juice contained only 27mg anthocyanins, but elicited a significant reduction in a 
composite measure of speed of attention (d=0.50) at 20 minutes postprandially. The same dose 
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concurrently increased composite ratings of calmness (d=0.57). Therefore improvements following 
flavonoid-rich interventions may be both temporally and cognitive-domain sensitive. 
Caldwell, Charlton, Roodenrys, & Jenner (2016) published their investigations into the effects of 
flavonoid-rich cherry. Following administration of 300ml cherry juice (55mg anthocyanins) to 
younger adults (n=6), older adults (n=5) and older adults with mild cognitive impairment (n=5), tests 
of executive function, speed of processing, and verbal learning and memory were performed at 
baseline and 6 hours postprandially. At 6 hours, the older adults displayed improved task switching 
performance compared to baseline (db=0.75). No other cognitive effects were observed. The authors 
attribute this single effect to type 1 error, citing attrition of participants in that group as a likely 
cause. However the small sample size in all groups suggests that the whole study is likely to be 
severely underpowered. The lack of an energy matched, low flavonoid control condition is also cause 
for concern; a second crossover condition only administered the same juice in three separate 100ml 
aliquots each consumed 1 hour apart. No cognitive effects were observed relative to baseline 
following consumption of the juice in these consecutive smaller doses. A further problem may be the 
intervention itself; the anthocyanin content of the cherry juice appears very low compared to some 
of the above studies. A considerably larger, controlled study is therefore needed to determine if 
anthocyanin-rich cherries elicit acute cognitive effects similar to those of other anthocyanin-rich 
fruits. Indeed more recently, Keane, George, et al. (2016) investigated the effects of 60ml cherry 
juice concentrate, containing 68mg anthocyanins, on 27 middle aged adults. No effects were 
observed on any of the cognitive or mood measures deployed at baseline, 1, 2, 3, or 5 hours 
postprandially, when compared to an energy matched control. Measures included digit vigilance, 
RVIP, Stroop, and mood scales. Cerebral blood flow (CBF) was measured concurrently using 
transcranial Doppler imaging. No changes in CBF were evident, although near-infrared spectroscopy 
(NIRS) revealed a significant increase in oxygenated haemoglobin at the 1 hour time point following 
the cherry intervention. Significant reductions in systolic blood pressure (SBP) were also observed at 
1 hour when compared with the control. It appears, then, that cherries are less effective than other 
fruits at impacting cognitive function despite evidence for cardiovascular effects. 
1.4.1.2 Citrus hesperidin (Orange) 
As with berries, citrus fruits contain several different flavonoids, but they are richest in the flavanone 
hesperidin. In a crossover intervention study, Lamport et al. (2016) supplemented 24 young adults 
with a commercially available flavanone-rich orange juice (70.5mg total flavonoids; 42.15mg 
hesperidin, 17.25mg naringin, 6.75mg narirutin) or an energy matched control. An extensive battery 
of tasks including measures of vision, episodic memory, processing speed, working memory, and 
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other executive functions were performed 2 hours postprandially. Significant improvements when 
compared to both control and baseline were observed only for the digit symbol substitution task 
(DSST), a measure of psychomotor processing speed (d=0.30). An additional group of participants 
underwent fMRI assessment using arterial spin labelling (ASL). Increased CBF was observed at 2 
hours but not 5 hours postprandially. However, as cognition was not measured directly in 
conjunction with CBF (and not at all at 5 hours) it remains unclear whether the observed 
improvements in processing speed are causally related to the CBF changes. The flavonoid dose used 
in this study was low, particularly when compared with the typical doses of other flavonoid 
subclasses reviewed here. If flavonoid effects are dose-dependent then a higher dose may have 
elicited increased cognitive benefit. Indeed, a subsequent study by Alharbi et al. (2016) used orange 
juice fortified with additional flavanone-rich orange pulp, to achieve a greater total flavonoid 
content (272mg; 220.46mg hesperidin, 34.54mg narirutin). Middle aged adults (n=24, 30-65 years) 
showed improved psychomotor performance on a finger tapping task at both 2 hours (d=0.87) and 6 
hours (d=0.62). Improvements in attention and general executive function, as measured by a 
continuous performance task (CPT), were observed at 6 hours (d=0.58). The orange juice was 
observed to attenuate a decline in subjective alertness throughout the testing period compared to a 
sugar-matched control. 
From this limited research, orange juice appears to benefit psychomotor performance across age 
groups at a time point also associated with increased CBF. Higher doses appear to elicit greater 
effect sizes for psychomotor performance and provide additional benefits in executive function, 
tentatively suggesting that flavanone effects may be dose-dependent. 
1.4.1.3 Quercetin & Epicatechin (Apple) 
Bondonno et al. (2014) conducted a crossover intervention study investigating the cognitive effects 
of whole fresh apple (184mg quercetin & 180mg epicatechin), spinach or a combination of the two. 
It was hypothesised that the nitrate content of spinach and the flavonoids in apple would both 
augment plasma nitric oxide (NO), although through distinct mechanisms. Increased NO status has 
been previously associated with vasodilatory related increases in blood flow, which the authors 
predicted would lead to a beneficial cognitive outcome following all three intervention conditions. 
Cognition and mood were measured 2.5 hours postprandially, using the Cognitive Drug Research 
(CDR) assessment battery and Bond-Lader mood scales. Even though significant increases in plasma 
NO were observed for the apple, spinach and combined conditions when compared with a control 
condition, all cognitive outcomes remained non-significant. This included factors for working 
memory and attention derived from the CDR results. This was a reasonably well powered study with 
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30 middle aged participants (mean age 47 years), so the lack of cognitive findings suggests that 
augmented NO status may not affect cognition. If alternative mechanisms are responsible for the 
previously observed cognitive effects of flavonoid-rich foods, then it may be that the flavonoids 
present in apple are not particularly effective, or that the peak time for observing apple flavonoid 
effects was missed by the study. The rationale for testing 2.5 hours postprandially is not given in the 
paper, but may relate to previous NO observations rather than the absorption and metabolism of 
flavonoid subclasses present in apples. 
1.4.2 Cocoa supplementation (Epicatechin)  
To date, much of the flavonoid-related literature has focussed on the effects of cocoa. Cocoa is a rich 
source of the flavanol epicatechin; however it also contains caffeine and theobromine that have 
known psychoactive properties. Not all of the cocoa studies reviewed here have matched for these 
potential confounds across experimental conditions. Scholey et al. (2010) carried out a double-blind 
crossover study of 30 young adults (age 18-35), comparing two acute doses of chocolate milk with a 
fully matched control. Beginning 90minutes postprandially, participants performed 6 consecutive 
repetitions of a 10minute task battery, designed to be cognitively fatiguing. A 520mg dose of cocoa 
flavanol resulted in significant improvements in working memory on a serial threes (3s) subtraction 
task at all six time points (d=0.57, d=0.71, d=0.50, d=0.64, d=0.50 and d=0.41 respectively) relative to 
the control.  A 994mg dose resulted in significant improvements for the first four repetitions on the 
same serial 3s task (d=0.44, d=0.52, d=0.41 and d=0.67 respectively). However, no improvements 
were observed whilst performing the more difficult serial sevens (7s) task. Only the high dose was 
reported to improve reaction time on an RVIP attention task, with significant improvements 
observed during the 3rd and 4th repetitions (d=0.35 for each repetition). Conversely, only the low 
dose improved self-reported levels of mental fatigue, with significant attenuation of fatigue across 
all but the 3rd repetition (d=0.39, d=0.37, d=0.30, d=0.27 and d=0.30 respectively). Overall the low 
dose was observed to be effective over more time points than the high dose for serial 3s and 
conveyed greater benefits in terms of counteracting mental fatigue. The high dose resulted in some 
additional reaction time benefits but also incurred cognitive costs with an increased error rate 
observed during the serial 7s task. The authors conclude that lower doses of cocoa flavanol may be 
more effective but do not offer an explanation as to why this might be the case. 
In contrast, a similar study of older adults by Pase et al. (2013) failed to observe any acute effects of 
a water based chocolate drink on cognition or mood. Doses containing 250mg and 500mg cocoa 
flavanol were compared with a fully matched control. The study used a broad spectrum of tasks 
from the CDR assessment battery and a range of Bond-Lader mood visual analogue scales. Testing 
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was performed at 1 hour, 2.5 hour, and 4 hour time points. The inconsistencies between the two 
studies in population, testing time point, and dose make it difficult to draw conclusions from the 
opposing outcomes. However, a notable methodological difference was that Pase et al. (2013) 
provided a light lunch 1.5 hours after the intervention. The effects of flavonoids may have been 
masked by stronger macronutrient effects, such as the neuronal energy provided by carbohydrate 
ingestion.  
In support of Scholey et al. (2010), Field, Williams, & Butler (2011) observed improved performance 
in visual spatial working memory (VSWM) (d=0.35) and choice reaction time (CRT) (d=0.16) in 30 
young adults (age 18-30), following a 773mg high dose of cocoa flavanols relative to a low flavanol 
white chocolate control. Testing was performed 2 hours postprandially. Visual function also 
benefited; significant improvements in visual contrast sensitivity and time to detect motion direction 
were observed following the high dose. However, caffeine and theobromine were not matched 
across the two conditions and baseline measurements were not recorded before administering 
either of the interventions. These methodological limitations are reflected in the lower effect sizes 
obtained relative to the previously reviewed flavanol-rich cocoa studies. Massee et al. (2015) 
investigated the effects of a cocoa extract containing 250mg cocoa flavanol in a between-subjects 
study of 40 young adults. At a postprandial time point of 2 hours, mental fatigue was observed to be 
significantly lower following the cocoa intervention when compared to a control (d=0.80). 
Improvement from baseline on a serial 7s subtraction task was also observed to be significantly 
improved at 2 hours for the cocoa condition when compared to the control (d=0.52). Again however, 
the control was not matched for caffeine so it is unclear whether the outcome was confounded by 
the small amounts of caffeine (5.56mg) also present.  
Most recently, Boolani, Lindheimer, Loy, Crozier, & O’Connor (2017) investigated the effects of 
cocoa and caffeine on mood and cognition in 23 young adults. Compared to placebo, fewer 
commission errors were observed on the Bakan task (similar to RVIP) at a postprandial time point of 
98 minutes (d=0.76), however the large effect size observed here may be due to the confounding 
influence of caffeine and theobromine that were not matched in the placebo. A significant lowering 
of anxiety was observed at the same time point when cocoa was compared with a caffeine-matched 
control (d=0.84). However no other cognitive effects were reported. The authors comment that an 
absence of calories compared with other cocoa research may have influenced the outcome; the 
cocoa interventions were sweetened using artificial sweetener in this case. 
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Findings following cocoa intervention appear mixed. However, when combined, these studies 
suggest that moderately high doses of cocoa flavanol provide benefits for cognition and mood up to 
two hours after ingestion in young adult populations. Enhanced visual functioning accompanied 
some of the cognitive improvements and as the majority of cognitive tasks are visual, it is possible 
that this concurrent effect may also play a role in the facilitation of cognitive improvement. Further 
cocoa flavanol studies are required to clarify the effects of dose, the effects on different populations, 
and the role of vision as a potential mechanism of action. 
1.4.3 Green tea supplementation (Epigallocatechin gallate)  
The main flavonoid constituent of green tea is the flavanol epigallocatechin gallate (EGCG). Dietz, 
Dekker, & Piqueras-Fiszman (2017) investigated the acute cognitive and mood effects of green tea 
using a tea powder intervention containing 280mg EGCG. Twenty-three young adults consumed the 
tea in drink and snack bar form. At a postprandial time point of 1 hour no significant changes in 
mood were observed compared with the drink or bar control conditions. Cognitive measures 
included immediate and delayed recall, simple and choice reaction tasks, digit vigilance, and spatial 
and numeric working memory tasks.  Choice reaction time was observed to be significantly faster 
following green tea when compared with performance following control conditions, irrespective of 
the delivery form of the intervention (drink or bar) (d=0.59). However, the authors attribute the 
finding to other active constituents in the intervention, including L-theanine (67mg), and caffeine 
(136mg) that were not matched in the control conditions. No other cognitive effects were observed. 
To avoid stimulant confounds, green tea is more typically administered in caffeine-free extract form. 
In a double-blind, placebo controlled crossover study, Wightman, Haskell, Forster, Veasey, & 
Kennedy (2012) administered 135mg and 270mg doses of EGCG extract, but observed no cognitive 
or mood effects for either dose. Cognitive tests included simple reaction time (SRT), serial 
subtraction, RVIP and Stroop, and were measured at baseline and 45 minutes after 
supplementation. Near-infrared spectroscopy (NIRS) revealed a lowering of CBF during cognitive 
testing following the lower dose. The authors attribute this CBF effect to previously observed 
vasoconstrictor properties of EGCG seen at low doses. This vasoconstrictor effect appears to 
contrast with vasodilatory properties previously observed for higher doses. In support of the latter, a 
study by Scholey et al. (2012) observed increased alpha, beta and theta electroencephalography 
(EEG) activity in the frontal gyrus 2 hours after a high dose of 300mg EGCG extract. This change in 
brain activity was accompanied by increased feelings of calm (d=0.55) and a reduction in ratings of 
stress (d=0.64). Scholey et al. (2012) reported that similar EEG activity has been observed in studies 
of meditation and mindfulness, suggesting a correlational link with mood. However, attention 
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outcomes measured using the RVIP task were reported as non-significant (in a separate publication; 
Camfield, Stough, Farrimond, & Scholey, 2014). The acute effects of EGCG therefore appear 
restricted to mood at this stage, and then only for higher doses. Some modulation of brain activity is 
apparent, but further investigation is needed to understand dose-related differences in 
vasoreactivity, and whether or not these are likely to lead to behavioural benefits on cognitive tasks. 
1.4.4 Ginkgo biloba supplementation (Quercetin, Kaempferol & Isorhamnetin)  
Ginkgo biloba is a flavonol-rich leaf extract that is typically standardised to contain 24% flavonols 
and 6% terpenoids (a group of bioactive plant lipids). A popular herbal supplement, it is reported 
anecdotally to improve blood circulation, relieve anxiety and enhance memory e.g. (Mahadevan & 
Park, 2008). Despite these claims, in a double-blind crossover trial, Warot et al. (1991) failed to 
observe any cognitive improvements in 12 young adults 1 hour after an acute dose of 600mg 
(containing approx. 144mg flavonols). The task battery included choice reaction time (CRT), picture 
recognition, the Sternberg memory scanning task, and critical flicker fusion frequency (CFF) – a 
measure of vigilance. However, the small sample size may have impacted the statistical power of the 
study. Similarly, Subhan & Hindmarch (1984) found no effect on either CFF or CRT at the same time 
point for doses of 120, 240 or 600mg (containing approx. 29, 58 & 144mg flavonols respectively). 
Significant improvements were however observed for the Sternberg task, with a decrease in reaction 
time observed after the 600mg dose, and decreases in memory scanning rates observed after the 
120mg and 600mg doses. These observations were in comparison with a placebo in a double-blind 
crossover design; however baseline measurements were not recorded prior to administering each 
intervention and only 8 participants were tested. Unfortunately there was insufficient data reported 
in the paper to allow calculation of effect size. Again, the small sample size may have impacted the 
statistical power of the study. 
Nathan et al. (2002) tested at the slightly later postprandial time of 90 minutes but found no 
significant improvements in older adults following 120mg supplementation (containing approx. 
29mg flavonols) using the CDR battery and RAVLT. Yet again this was a small study (n=11) with a 
small dose size and as such the conclusions may be statistically unreliable. A larger double-blind 
crossover study of young adults (n=20) conducted by Kennedy, Scholey, & Wesnes (2000) observed 
dose- and time-related improvements, in a ‘speed of attention’ factor derived from the CDR task 
battery. Effects were not apparent at 1 hour postprandially but became evident at 2.5, 4 and 6 
hours. Cohen’s d values were d=0.45, d=0.45 & d=0.50, respectively for a 240mg dose (containing 
approx. 58mg flavonols), and d=1.29, d=0.86 & d=0.80 for a 360mg dose (approx. 86mg flavonols) 
across the time period. No effect was observed for a lower 120mg dose (approx, 29mg flavonols).  
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The higher effect sizes for the 360mg dose compared with the 240mg dose, and the lack of any 
significant effect for the lowest 120mg dose, are indicative of a dose-related response for attention. 
This was not the case for memory; improvements in a ‘quality of memory’ factor were observed at 1 
hour and 4 hours for the 120mg dose only (d=0.57 & d=0.52), although trends were evident for the 
higher doses. A follow up study by the same authors (Kennedy, Scholey, & Wesnes, 2002) comparing 
ginkgo effects with panax ginseng (a plant extract rich in bioactive saponins) failed to replicate the 
‘speed of attention’ finding for an identical 360mg ginkgo biloba dose. This inconsistency was 
attributed to a procedural change in the second study. They did however observe serial 7s 
improvements at 4 hours (d=0.65) and 6 hours (d=0.28). Immediate recall (d=0.83) and delayed 
recall (d=0.67) were also observed to improve at 6 hours, as did a ‘Quality of memory’ factor 
(d=0.59).  
Elsabagh, Hartley, Ali, Williamson, & File (2005) administered a low dose of 120mg ginkgo biloba 
extract (containing approx. 29mg flavonols)  and after 4 hours observed improved attention relative 
to a placebo condition, using a paced auditory serial addition test (PASAT) (d=0.58). Improved 
pattern recognition (d=0.55) and a trend towards improved delayed recall were also observed. This 
was a well powered between-subjects study (n=52) but with only a single post-ingestion time point 
and no baseline. The two participant groups did not differ significantly in terms of age, gender, BMI, 
verbal IQ, or habitual caffeine and alcohol intake, however without cognitive baseline measures, the 
possibility remains that group differences in cognition may simply be due to differences in the 
participants. 
In order to consolidate the ginkgo biloba data from three smaller studies, Kennedy, Jackson, Haskell, 
& Scholey (2007) combined their data into a meta-analysis.  In young adults (combined n=78), a 
general decline in ‘quality of memory’ observed following the placebo was attenuated at 1 hour and 
4 hours following 120mg ginkgo biloba supplementation. However ‘speed of attention’ performance 
slowed at 1 hour and 6 hours relative to both baseline and placebo. The authors were unable to 
explain this unexpected outcome, particularly as higher doses have been shown to improve speed of 
attention relative to placebo. Such inconsistencies in the data highlight the need for further 
investigation. Overall, memory findings following ginkgo biloba supplementation appear to be 
relatively consistent across the larger, well powered crossover studies and mimic the timings of 
memory effects observed in the blueberry supplementation studies, occurring at 1 hour and 4-6 
hours postprandially. Attention effects following ginkgo biloba appear dose-dependent and seem to 
occur at later time points than some other flavonoid subclasses (from 2.5-6 hours). The effects of 
ginkgo biloba also appear to span several cognitive domains including attention, working memory, 
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and episodic memory. Some of the largest cognitive effect sizes, as summarised in Table 1.3, are 
observed following ginkgo biloba. This may reflect the additional effects of terpenoids also present 
in the extract. 
Table 1.3 Statistically significant cognitive outcomes in decreasing order of effect size 
Table 1.3 continued 
Study Age 
(years)
n 
Flavonoid dose 
(mg) 
Cognitive 
measure 
Postprandial 
time point 
Effect size (d) 
Kennedy et al. 
(2000) 
19-24
20 
ginkgo
360 
Speed of 
attention 
2.5-6h 
(Average)
0.98 
Boolani et al. 
(2017) 
20.3(2.2)
23 
cocoa
499 Mood 1.6h 0.84 
Kennedy et al. 
(2002) 
21.2(3.9)
20 
ginkgo
360 IR 6h 0.83 
Massee et al. 
(2015) 
24.1(4.5)
40 
cocoa
250 Mental fatigue 2h 0.80 
Whyte et al. (2016) 
7-10
21 
berry
253 IR 1.25h 0.80 
Whyte et al. (2016) 
7-10
21 
berry
253 Flanker 3h 0.78 
Whyte et al. (2016) 
7-10
21 
berry
253 
Word 
recognition 
6h 0.78 
Boolani et al. 
(2017) 
20.3(2.2)
23 
cocoa
499 Bakan 1.6h 0.76 
Alharbi et al. 
(2016) 
30-65
24 
citrus
272 Finger tapping 2-6h 
(Average)
0.75 
#Caldwell et al. 
(2016) 
74.1(7.9)
5 
berry
55 Task switching 6h (db)0.75 
*Whyte & Williams 
(2015) 
8-10
14 
berry
143 RAVLT 2h 0.74 
Kennedy et al. 
(2002) 
21.2(3.9)
20 
ginkgo
360 DR 6h 0.67 
Watson et al. 
(2015) 
18-34
36 
berry
467 Digit vigilance 1-2.5h 
(Average)
0.64 
Scholey et al. 
(2012) 
27.7(9.3)
31 
tea
300 Mood 2h 0.64 
Khalid et al. (2017) 
18-21
21 
berry
253 Mood 2h 0.61 
Dietz et al. (2017) 
20-35
23 
tea
280 CRT 1h 0.59 
Kennedy et al. 
(2002) 
21.2(3.9)
20 
ginkgo
360 
Quality of 
memory 
6h 0.59 
Alharbi et al. 
(2016) 
30-65
24 
citrus
272 CPT 6h 0.58 
*Elsabagh et al. 
(2005) 
18-26
52 
ginkgo
120 PASAT 4h 0.58 
Dodd (2012) 
18-25
19 
berry
631 Letter memory 5h 0.57 
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Table 1.3 continued 
Study Age 
(years)
n 
Flavonoid dose 
(mg) 
Cognitive 
measure 
Postprandial 
time point 
Effect size (d) 
Dodd (2012) 
62-73
18 
berry
631 
Word 
recognition 
2-5h 
(Average)
0.57 
Haskell-Ramsay 
et al. (2017) 
18-35
20 
berry
27 Mood 0.3h 0.57 
Scholey et al. 
(2010) 
18-35
30 
cocoa
520 Serial 3s 1.5-2.5h 
(Average)
0.56 
Kennedy et al. 
(2000) 
19-24
20 
ginkgo
120 
Quality of 
memory 
1-4h 
(Average)
0.55 
Scholey et al. 
(2012) 
27.7(9.3)
31 
tea
300 Mood 2h 0.55 
*Elsabagh et al. 
(2005) 
18-26
52 
ginkgo
120 
Pattern 
recognition 
4h 0.55 
Massee et al. 
(2015) 
24.1(4.5)
40 
cocoa
250 Serial 7s 2h 0.52 
Scholey et al. 
(2010) 
18-35
30 
cocoa
994 Serial 3s 1.5-2.5h 
(Average)
0.51 
Haskell-Ramsay 
et al. (2017) 
18-35
20 
berry
27 
Speed of 
attention 
0.3h 0.50 
Kennedy et al. 
(2000) 
19-24
20 
ginkgo
240 
Speed of 
attention 
2.5-6h 
(Average)
0.47 
Kennedy et al. 
(2002) 
21.2(3.9)
20 
ginkgo
360 Serial 7s 4-6h 
(Average)
0.47 
Watson et al. 
(2015) 
18-34
36 
berry
483 RVIP 1-2.5h 
(Average)
0.45 
Scholey et al. 
(2010) 
18-35
30 
cocoa
994 RVIP 1.5-2.5h 
(Average)
0.35 
*Field et al. (2011) 
18-25
30 
cocoa
773 VSWM 2h 0.35 
Scholey et al. 
(2010) 
18-35
30 
cocoa
520 Mental fatigue 1.5-2.5h 
(Average)
0.33 
Lamport et al. 
(2016) 
18-30
24 
citrus
71 DSST 2h 0.30 
Khalid et al. (2017) 
7-10
52 
berry
253 Mood 2h 0.28 
*Field et al. (2011) 
18-25
30 
cocoa
773 CRT 2h 0.16 
*Studies with no baseline measurements. 
#
Studies with no control condition. 
(Average)
Average of effect sizes for 
the same dose & cognitive measure recorded across multiple time points. 
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1.5 Mechanisms of action  
1.5.1 Absorption and metabolism  
In vitro and in vivo evidence suggests that flavonoids and their metabolites are readily absorbed into 
the blood stream and are able to cross the blood brain barrier (Jäger & Saaby, 2011; Youdim, 
Shukitt-Hale, & Joseph, 2004). Although it is not possible to directly measure flavonoid 
concentrations in the human brain, the timings of peak levels in blood plasma have been observed 
to correspond with the timings of cognitive effects. For example, whole anthocyanins are observed 
in plasma 1-4 hours postprandially (Mazza, Kay, Cottrell, & Holub, 2002), and their metabolites are 
observed to peak at 1-2 hours and 6 hours following berry supplementation (Kay, Mazza, Holub, & 
Wang, 2004; Rodriguez-Mateos et al., 2013), which seems to correspond with the two distinct 
timings of cognitive benefits observed for blueberry. Plasma flavanols following cocoa ingestion peak 
at 2 hours only (Holt et al., 2002; Rein et al., 2000; Schroeter et al., 2006; Wang et al., 2000), and this 
is reflected by a number of positive cognitive effects at 2 hours but an absence of cognitive effects at 
later time points. Conversely, the cognitive findings for ginkgo biloba are mainly observed between 
4-6 hours postprandially (Elsabagh et al., 2005; Kennedy et al., 2000, 2002). Bioavailability studies for 
ginkgo were not apparent in the literature, however bioavailability of some conjugates of quercetin, 
the main flavonoid present in ginkgo, have been observed to peak at 4-6 hours postprandially 
(Graefe et al., 2001). This may also explain the lack of cognitive findings for quercetin-rich apple 
where cognitive testing was carried out at 2.5 hours (Bondonno et al., 2014).  Similarly, late peak 
plasma timings have also been observed for the citrus flavonoid hesperidin (Manach, Williamson, 
Morand, Scalbet, & Remesy, 2005). The reviewed cognitive effects following orange juice 
consumption support this, but also show an earlier effect on psychomotor performance that may 
relate to mechanisms of action such as improved blood glucose regulation or increased 
cerebral/peripheral blood flow. In general however, the timings of cognitive effects appear closely 
related to the absorption and metabolism rates of the supplemented flavonoid compounds. 
Broad individual differences have been noted in the absorption profiles of a range of flavonoids and 
their associated metabolites (Bresciani et al., 2017; Mennen et al., 2008; Rodriguez-Mateos et al., 
2015); not only in the quantities of metabolites present, but also in the timings of their appearance 
(Bresciani et al., 2017). Intact flavonoids are generally only absorbed in very small quantities via the 
stomach and small intestine, large quantities therefore enter the colon where they are metabolised 
by gut microbiota before being absorbed into the blood stream. Specific bacteria have been 
identified that act on different flavonoids (Braune & Blaut, 2016), for example Bifidobacterium and 
Lactobacillus−Enterococcus catalyse the metabolism of anthocyanins (Aura et al., 2005; Hidalgo et 
 18 
 
al., 2012) and Eggerthella lenta and Flavonifractor plautii catalyse the metabolism of catechins (Jin & 
Hattori, 2012; Kutschera, Engst, Blaut, & Braune, 2011). Individuals have varying polyphenol 
metabolising phenotypes, largely dependent on their gut microbiota profile (Tomás-Barberán, 
Selma, & Espín, 2016). The effectiveness of a flavonoid intervention is therefore dependent on the 
phenotype of the subject which is typically unclear at the onset of testing. Interestingly, a diet 
habitually rich in flavonoids can have a positive impact on the profile of gut microbiota (Cardona, 
Andrés-Lacueva, Tulipani, Tinahones, & Queipo-Ortuño, 2013; M. Hidalgo et al., 2012; Valdés et al., 
2015), and so subjects who regularly consume flavonoids are likely to propagate a gut microbiota 
profile specifically suited to the metabolism of flavonoids. If cognitive health benefits observed 
following a single acute dose of flavonoids are dependent upon the metabolism of the flavonoid 
compounds by such gut microbiota, individuals who habitually consume greater quantities of 
flavonoids might therefore be expected to experience greater acute cognitive health benefits in the 
immediate postprandial period, particularly at later time points, due to the presence of greater 
quantities of flavonoid metabolising bacteria in the intestinal tract (Laparra & Sanz, 2010). This idea 
is contrary to the commonly posited theory that interventions are more effective in those with a low 
habitual intake of flavonoid-rich foods and requires further investigation. 
1.5.2 Endothelial function  
1.5.2.1 Vasodilation 
The vasoactive properties of flavonoid-rich foods as demonstrated by flow-mediated dilation of the 
brachial artery following ischemia (FMD) (Alexopoulos et al., 2008; Alqurashi, Galante, Rowland, 
Spencer, & Commane, 2016; Dohadwala et al., 2011; Monahan et al., 2011; Rendeiro et al., 2017; 
Rodriguez-Mateos et al., 2013; Schroeter et al., 2006; Widlansky et al., 2007), peripheral arterial 
tonometry (PAT)(Dohadwala et al., 2011), and Laser Doppler Flowmetry (LDF)(Morand et al., 2011), 
are known to result in increased peripheral blood flow. Peak vasodilatory effects have been 
observed at 1-2 hours and 6 hours postprandially for blueberry (Rodriguez-Mateos et al., 2013) and 
acai berry supplementation (Alqurashi et al., 2016), at 2 hours for cocoa (Monahan et al., 2011; 
Schroeter et al., 2006), at 30 minutes (Alexopoulos et al., 2008) and 2 hours (Widlansky et al., 2007) 
for green tea,  at 4 hours for cranberry (Dohadwala et al., 2011) and at 6 hours for orange juice 
(Morand et al., 2011), thereby covering the full range of time points at which cognitive effects have 
been observed. Meta-analysis of these FMD effects has revealed that they may be non-linearly dose-
dependent, following an inverted U shaped curve (Kay, Hooper, Kroon, Rimm, & Cassidy, 2012; 
Rodriguez-Mateos et al., 2013). Blood pressure reductions have also been associated with the 
consumption of flavonoid-rich foods, which may again be related to their vasoactive properties. 
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Although more commonly observed in chronic intervention studies (Kay et al., 2012), the effects 
have also been observed following acute supplementation. For example, acute reductions in systolic 
blood pressure (SBP) have been observed 1-3 hours following cherry juice concentrate (Keane, 
George, et al., 2016; Keane, Haskell-Ramsay, Veasey, & Howatson, 2016). 
These endothelial effects are not restricted to peripheral systems; flavonoids have also been 
observed to result in increased CBF 1 hour after acute blueberry supplementation (Dodd, 2012), and 
2 hours after cocoa (Francis, Head, Morris, & Macdonals, 2006) and orange juice supplementation 
(Lamport et al., 2016). Selective increases have been observed in the dorsolateral prefrontal cortex 
(DLPFC) following green tea supplementation (Borgwardt et al., 2012), however time of testing and 
exact dose of EGCG were not stated in the paper which makes interpretation of the observation 
difficult. It is likely that CBF increases will occur across the range of time points observed in 
peripheral blood flow studies, but currently there are insufficient published findings to support this 
fully. In particular, little work appears to have been reported regarding CBF modulation following 
acute ginkgo biloba supplementation in humans. However, CBF has been shown to be positively 
correlated with cognitive performance, particularly in epidemiological assessment of dementia risk, 
where CBF is reduced in patients with dementia, and greater CBF velocity is associated with a lower 
rate of cognitive decline and lower risk of dementia in healthy ageing  (Ruitenberg et al., 2005; 
Spencer, 2010). Cognitive training during healthy ageing has also been observed to increase both 
CBF and cognitive performance (Mozolic, Hayasaka, & Laurienti, 2010). Therefore, vasodilatory 
mechanisms of action may account for at least some of the cognitive improvements observed in 
acute supplementation studies. Similarly, increased CBF has been posited to account for cognitive 
benefits observed following acute exercise, although findings are not equivocal (McMorris, 2015). 
Cognitive improvements following flavonoid ingestion have yet to be directly matched with acute 
increases in CBF, making this an important area for further research. 
1.5.2.2 Nitric oxide synthesis 
There are a number of different chemical mediators for vasodilation including nitric oxide (NO). 
Flavonoids have been associated with acute augmentation of NO status. Bondonno et al. (2014) 
demonstrated a significant increase in plasma NO in response to flavonoid-rich apple, although no 
cognitive benefits were observed for a battery of tasks performed immediately after the blood 
samples were taken (2.5 hours postprandially). Similar enhancement of NO status has been 
observed at 1 hour for cocoa supplementation (Schroeter et al., 2006), and at 2 hours following pure 
epicatechin and quercetin (Loke et al., 2008).  In addition to its role in endothelial function, NO has 
also been implicated in the regulation of the transcription factor CREB; an important factor in 
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neuron survival and synaptic plasticity (Ciani, Guidi, Bartesaghi, & Contestabile, 2002). A proposed 
mechanism for flavonoid induced augmentation of NO status is through enhancing the expression or 
activity of endothelial nitric oxide synthase (eNOS) (Stoclet et al., 2004). eNOS itself has been 
implicated in the regulation of BDNF expression (Chen et al., 2005). This may account for the 
increased plasma BDNF levels observed after acute blueberry supplementation (Dodd, 2012), 
although this connection is speculative at this stage. Depending on the isoform present, NOS  has 
also been implicated as a causal agent in neurodegenerative disease (Cárdenas, Moro, Hurtado, 
Leza, & Lizasoain, 2005; Chung & David, 2010). Although eNOS is considered to be neuroprotective, 
neuronal and inducible isoforms (nNOS and iNOS) are thought to be neurotoxic through mechanisms 
of oxidative stress. So flavonoid regulatory effects on NO systems may be beneficial over long term 
supplementation, in addition to the acute mechanisms considered here. 
1.5.3 Blood glucose regulation  
Attenuation of peak postprandial plasma glucose followed by a more gradual post-peak decline 
observed following blackcurrant (Törrönen et al., 2010; Watson et al., 2015) and cranberry (Wilson 
et al., 2008) suggests that altered blood glucose regulation may provide an additional mechanism of 
action for the executive function effects observed in young adults. Irrespective of the presence of 
flavonoids, a postprandial glucose profile characterised by a low peak and gradual decline is 
associated with better cognitive function than a poor glucose profile with a high peak and rapid 
decline (Benton & Nabb, 2003; Sunram-Lea & Owen, 2017), thus this mechanism could account for 
cognitive benefits following consumption of flavonoid-rich foods. In particular, Watson et al. (2015) 
observed both higher blood glucose levels and improved attention 1 hour following blackcurrant 
supplementation relative to  a sugar matched control. There is some evidence to suggest that the 
absorption of sugar may be slowed when consumed in conjunction with flavonoids (Hanhineva et al., 
2010; Sancho & Pastore, 2012; Williamson, 2013); mechanisms of action are discussed in more detail 
in Chapter 5. Therefore a flavonoid-rich intervention may result in greater availability of glucose over 
a longer period relative to a low-flavonoid sugar-matched control. As glucose is necessary for all 
human cell function, and glucose supplementation has been directly linked to cognitive 
improvement (Benton, Owens, & Parker, 1994; Jones, Sünram-Lea, & Wesnes, 2012; Kennedy & 
Scholey, 2000), this mechanism offers a plausible explanation for the observed cognitive benefits of 
flavonoid-rich interventions (relative to sugar matched controls) in the immediate postprandial 
period. Here, reported effects are for sweet berry interventions. Similar effects may be observed 
following consumption of carbohydrate rich foods such as dark chocolate, or for low carbohydrate 
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drinks such as green tea if consumed alongside carbohydrate based foods, however further research 
is needed.   
1.5.4 Neuronal enhancement  
1.5.4.1 Monoamine oxidase inhibition 
Monoamines comprise a class of neurotransmitters that are responsible for the regulation of many 
cognitive processes. Monoamine levels, particularly for dopamine, have been observed to increase 
during working memory and attention tasks, correlating positively with task performance (Cox, 
Pipingas, & Scholey, 2015). Therefore inhibition of monoamine oxidase (MAO) ), an enzyme 
responsible for the breakdown of monoamines,  may be beneficial to monoaminergic 
neurotransmission during cognitive performance, through increased concentrations of monoamine 
neurotransmitters. Watson et al. (2015) observed MAO inhibition in association with improved 
attention after blackcurrant supplementation. None of the other studies reviewed here have 
measured MAO levels, but in vitro studies and animal studies using chronic supplementation have 
demonstrated MAO inhibitory effects for all flavonoid subclasses (Jäger & Saaby, 2011). 
Consideration should be given to the inclusion of such measures in future research. 
1.5.4.2 BDNF synthesis 
BDNF is a complex protein that has been implicated in the regulation of multiple neuronal processes 
including synaptic plasticity and neurogenesis.  Expression of BDNF is regulated by the transcription 
factor CREB. Trends towards increased plasma BDNF observed after 1 hour (Dodd, 2012) are a 
slightly unexpected finding in an acute study. BDNF regulated protein synthesis mechanisms of 
flavonoid action have been more consistently associated with chronic supplementation (Spencer, 
Vauzour, & Rendeiro, 2009). However as mentioned above, eNOS has been implicated in the 
regulation of BDNF expression (Chen et al., 2005). Acute exercise has been observed to result in 
rapid increase in BDNF (Szuhany, Bugatti, & Otto, 2015). Therefore, vasodilation following flavonoid 
ingestion might reasonably have a similarly rapid effect on BDNF availability. Assuming BDNF levels 
can increase over such short time periods following flavonoid ingestion, it seems unlikely that 
subsequent facilitation of neuronal functioning would occur in time to explain cognitive effects 
apparent at only 1-2 hours postprandially, but may provide a possible mechanism for the cognitive 
improvements observed at later time points. BDNF has been implicated in both short term memory 
formation and long term memory formation (Bekinschtein, Cammarota, Izquierdo, & Medina, 2008) 
through a permissive role in the facilitation of early long term potentiation (LTP) (Bramham & 
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Messaoudi, 2005), and so increases in BDNF might be responsible for acute enhancement of episodic 
memory. 
1.5.5 Visual function  
Flavonoids have been extensively associated with improvements in visual function both in vitro and 
in vivo (for a review see Kalt, Hanneken, Milbury, & Tremblay, 2010). Improvements in visual 
contrast sensitivity and detection of motion direction after acute cocoa flavanol supplementation in 
young adults have been described above (Field et al., 2011). Additionally, similar contrast sensitivity 
improvements have also been seen in older adults (Field, Bell, Mount, Willliams, & Butler, 2014). 
Flavonoids have also been shown to influence the focussing ability of the eyes; improvements in 
accommodative facility have been observed in young adults following acute cocoa, and 
improvements in convergence facility have been observed after acute blueberry supplementation 
(Field et al., 2014). Of the studies reviewed here only three have reported significant findings for 
non-visual tasks: RAVLT (Whyte & Williams, 2015), PASAT (Elsabagh et al., 2005), Simple & complex 
finger tapping (Alharbi et al., 2016). All other significant findings have been for visually presented 
tasks; therefore improved vision may account for at least some of these findings. The link between 
enhanced vision and improved cognitive performance following flavonoid supplementation is only 
speculative at this stage. However, epidemiological research has identified clear associations 
between visual acuity and cognitive performance across multiple age groups (Baltes & Lindenberger, 
1997). This is likely to reflect a common underlying variable such as general health. But as a possible 
mechanism, enhanced visual function warrants further investigation. 
1.6 Literature summary and Conclusions 
Table 1.3 summarises the cognitive effects observed across all reviewed studies. Acute flavonoid-
induced cognitive effects have been found across multiple cognitive domains. In particular, a 
number of studies report improvements for attention tasks and factors. Therefore, it is possible that 
improvements over a range of cognitive domains may be facilitated by general improvements in 
attention. The evidence suggests that the effects of flavonoids on cognitive outcomes are mediated 
by age. For example, executive function, working memory and psychomotor processing speed 
effects are apparent in young and middle aged adults. Episodic memory effects appear more 
prevalent in children and older adults, particularly following blueberry supplementation. This may 
reflect the relatively lower episodic memory performance generally observed in the very young or 
old when compared with adults in their cognitive prime. While the hippocampus has been shown to 
have the potential for improved neuronal connectivity and even neuronal growth throughout life, 
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those at critical developmental stages may simply have greater potential for episodic memory 
improvement. Conversely, developmental differences in the structure and functioning of the 
prefrontal cortex may mean that the potential for improvement in executive function is more limited 
in these extreme age groups.  
The studies reviewed have been primarily concerned with young adults and therefore more work is 
needed to determine true differences between age groups, ideally using mixed designs that allow 
direct comparison of different participant groups within the same study. Whatever the age group, 
cognitive effects are likely to be dose-dependent, as evidenced by the increasing cognitive effect 
sizes observed with increasing doses of ginkgo biloba (Kennedy et al., 2000) and the similar dose-
dependent vascular effects of blueberry (Rodriguez-Mateos et al., 2013).These potential effects of 
dose clearly need further investigation across all flavonoid subclasses and using a wider range of 
doses than those currently investigated.  
The timings of cognitive effects vary depending on the flavonoid-rich food source, which may reflect 
differences in rates of absorption and metabolism for individual flavonoid types, or simply for 
different food types. The majority of observed cognitive improvements match peaks in plasma 
metabolite concentrations and also peaks in peripheral and cerebral blood flow. Although 
vasodilation is often cited as the most likely mechanism for acute flavonoid induced improvements 
in cognition, cognitive improvements have not yet been observed directly in conjunction with 
vascular-related effects. This suggests a need for studies incorporating concomitant cognitive and 
vascular measurements. Cognitive improvements have been observed alongside other physiological 
changes such as altered rates of glucose absorption (Watson et al., 2015), inhibition of MOA 
(Watson et al., 2015), and improved vision (Field et al., 2011), suggesting that these factors may also 
be influential. 
Observed physiological responses to flavonoid-rich supplementation such as vasodilation have been 
consistently replicated, but cognitive findings are not as robust despite the number of moderate to 
large effect sizes apparent in Table 1.3. As discussed, methodological differences between studies 
are likely to partially explain the inconsistencies in cognitive observations. Comparisons between 
studies are often difficult due to differences in dose and flavonoid source. The design of a study may 
also impact on the size of any observed cognitive effects. For example, from Table 1.3 it can be seen 
that effect sizes in studies without a control (Caldwell et al., 2016) tend to be large, whereas those 
with no baseline measurements (Elsabagh et al., 2005; Field et al., 2011; Whyte & Williams, 2015) 
tend to exhibit small or moderate effect sizes or even no effects at all (Bondonno et al., 2014). From 
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Table 1.3 it can also be observed that studies with very small numbers of participants tend to exhibit 
greater effect sizes. This may be indicative of a type 1 error (false positive outcome) as such studies 
have a lower statistical power to determine a true cognitive effect, and other larger studies reviewed 
here have generally not observed similarly large effect sizes. In crossover studies, it is also important 
to reduce the impact of practice-related improvements in cognitive performance that is often 
associated with repeated testing. It is not always clear whether this has been adequately addressed 
in some of the studies reviewed here (Caldwell et al., 2016; Whyte & Williams, 2015). Additionally, 
extensive batteries of tasks are often deployed at several different time points, but often only one or 
two measures prove significant. This increases the potential for type 1 error considerably. Future 
studies therefore also need to address these methodological issues, to improve their statistical 
power to reliably observe small changes in cognition. Finally, it should be noted that many of these 
studies rely on whole foods as their source of flavonoids. While the flavonoid subclasses typically 
associated with each food type are the most abundant flavonoid forms within that food type, other 
flavonoids, and indeed other polyphenols may be present in varying concentrations. Therefore, any 
observed effects cannot be fully attributed to a single subclass. 
In conclusion, the evidence so far suggests that research into the cognitive benefits of flavonoid-rich 
foods is a promising area that demands further investigation. However, in terms of design, current 
studies are a long way from the large scale randomised controlled trials (RCTs) that are required to 
build a strong and robust evidence base supporting beneficial effects of flavonoid ingestion for 
cognitive outcomes in the immediate postprandial period. 
1.7 Thesis objective & research questions 
1.7.1 Objective 
From the literature review it is apparent that flavonoid-rich foods have the potential to elicit 
cognitive benefits following acute supplementation, however the findings of human studies remain 
mixed. There is some evidence to suggest that both cognitive and physiological effects may be dose-
dependent, and therefore differences in dose may be responsible for many of the inconsistencies 
between studies. Following this observation, the objective of my PhD thesis was to determine 
whether acute, dose-dependent cognitive effects were evident following anthocyanin-rich blueberry 
consumption. 
1.7.2 Research questions 
Specific research questions addressed in this thesis are: 
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 In crossover intervention studies, what is the best strategy for minimising the impact of 
repetition on cognitive task performance (addressed by Experiment 1, reported in 
Chapter 3)? 
Rationale & Hypotheses: In studies with repeated cognitive testing, practice-related 
improvements in performance may confound effects attributed to an intervention. Indeed it 
is unclear from the literature whether such practice effects have been taken into account in 
a number of flavonoid-rich intervention studies reporting significant effects. It is clearly 
important to minimise practice effects where possible in order to validate intervention 
research findings. Following a review of cognitive practice effects and strategies for their 
minimisation, a pilot study investigated practice effects for the cognitive tasks to be used in 
this thesis. It was hypothesised that practice effects would be evident for all cognitive tasks 
investigated, but that their impact would be attenuated through the provision of 
appropriate methodology, to be determined from the data collected in this study. 
 
 Following acute blueberry intervention in a young adult population, are cognitive or mood 
changes evident and, if so, are they dose-dependent (addressed by Experiments 2 & 4, 
reported in Chapters 4 & 6, respectively)? 
Rationale & Hypotheses: Evidence from the literature review suggested that acute blueberry 
intervention might elicit cognitive and mood benefits; however some of the flavonoid 
literature findings were mixed. Published studies typically varied in their choice of dose or 
population, making comparison between studies difficult. The evidence from Rodriguez-
Mateos et al. (2013) suggested that the metabolism and vasodilatory response to 
anthocyanin-rich blueberry may be dose-dependent in a young adult population. In a series 
of experiments, this thesis explored whether cognitive and mood outcomes followed a 
similar dose-dependent trajectory. It was hypothesised that the strongest cognition and 
mood effects would coincide with doses that elicited the greatest vasodilatory response in 
the previous work, through a mechanism of increased CBF. As with the Rodriguez-Mateos et 
al. (2013) study, these effects were investigated in a young adult population. 
A final research question addressed observations from Experiment 2: 
 Do blueberries impact postprandial blood glucose response in a young adult population, 
and is this a plausible mechanism of action for observed cognition or mood changes 
(addressed by Experiments 3 & 4, reported in Chapters 5 & 6, respectively)? 
Rationale & Hypotheses: Findings from the literature review, further supported by the 
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outcome of Experiment 2, suggested that blood glucose regulatory effects may play a 
significant role in cognitive outcome in blueberry intervention studies. The final two 
experiments of the thesis investigated changes in postprandial glucose response and 
cognition following varying doses of blueberry. The aim was to determine whether there 
was a dose-dependent effect of blueberry on postprandial glucose response, and whether 
there was a relationship between blood glucose level and cognitive outcome. It was 
hypothesised that dose-dependent changes to postprandial blood glucose regulation would 
be associated with similarly dose-dependent cognition and mood outcomes, through 
mechanisms of increased availability of glucose to the brain combined with vasodilatory 
increases in CBF. 
1.7.3 Methodological considerations 
Anthocyanin-rich blueberry was selected for investigation due to the strong evidence that the 
immediate postprandial vasodilatory response following blueberry is dose-dependent (Rodriguez-
Mateos et al., 2013). As data for metabolism and FMD response have already been reported for 
fixed doses of freeze-dried blueberry in previous work, identical doses were used here, after 
sourcing the same blueberry powder. In order to control for individual differences, a within-subjects 
design was used, whereby each participant took part in all experimental conditions, effectively 
acting as their own control. Within-subjects designs increase the statistical power of a study by 
eliminating between-subjects variance between conditions. This was considered particularly 
important in light of recent research indicating that individual responses to flavonoid-rich 
interventions may vary according to gut microbiota. The thesis also aimed to address some of the 
methodological issues previously identified in the literature review. Therefore, the design of all 
intervention experiments incorporated measures to improve statistical power such as testing 
sufficiently large numbers of participants, minimising the effects of repeated cognitive testing, 
incorporating baseline measurements, including a suitable control condition, and using appropriate 
statistical analyses. 
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Chapter 2  
Materials & methods 
 As highlighted in Chapter 1, a number of critical research questions were identified and used as the 
focus for my thesis. Firstly, what is the most effective methodology for investigating cognitive 
changes in response to multiple doses, whilst minimising practice-effects? Subsequently, are 
cognition and mood changes evident following acute blueberry supplementation, and are such 
effects dose-dependent? Finally, in relation to possible mechanisms of action, do blueberries 
influence postprandial glycaemic response, and might such glucoregulatory effects underlie 
observed changes to cognition and mood?  
2.1 Experimental design 
In order to answer these research questions a series of experiments were designed: 
 Experiment 1: Piloting of cognitive tasks and an examination of the effects of repeated 
cognitive testing on task performance (Chapter 3). 
 Experiment 2: A dose-response study of cognitive and blood pressure changes following 
acute anthocyanin-rich blueberry supplementation in healthy young adults (Chapter 4). 
 Experiment 3: A dose-response study of glycaemic response following acute anthocyanin-
rich blueberry supplementation in healthy young adults (Chapter 5). 
 Experiment 4: A dose-response study of cognitive and blood glucose changes following acute 
anthocyanin-rich blueberry supplementation in healthy young adults (Chapter 6). 
The majority of intervention studies reviewed in the previous chapter opted for a crossover design. 
In this type of design, a single group of participants take part in each experimental condition of the 
study. Participants effectively act as their own controls, thereby minimising the impact of between-
subjects variance and so improving statistical power. Similarly here, a crossover design was 
implemented for each blueberry intervention study. As cognitive practice effects are known to be an 
issue in experimental designs with a repeated testing component, the magnitude of these effects 
was fully investigated during the piloting of the cognitive tasks and appropriate methodology was 
implemented for reducing their impact (discussed in detail in Chapter 3). Methodological limitations, 
identified in several of the reviewed intervention studies, were their lack of an appropriate control 
condition or an omission of baseline testing. In each of the three intervention studies described in 
this thesis (Chapters 4, 5 & 6), appropriate matched control conditions were included alongside the 
 28 
 
blueberry interventions. Baseline measurements were recorded at each test visit before 
interventions were administered in order to control for random variations in performance across 
multiple test visits. In accordance with a further standard of good practice in intervention studies, all 
testing was performed double-blind in order to prevent potential experimenter effects or demand 
characteristics from influencing participant performance. 
2.1.1 Power analysis 
A priori power analysis was performed using GPower 3.1 to determine the minimum number of 
participants required for each experiment in order to achieve a statistical power of 0.8 with an alpha 
level of 0.05 (Cohen, 1992). For Experiment 1, assuming an effect size of d=0.47 (Bartels, Wegrzyn, 
Wiedl, Ackermann, & Ehrenreich, 2010; Donovan & Radosevich, 1999), 30 participants were 
determined as sufficient to detect an increase in cognitive performance between repeat test 
sessions. For Experiments 2 & 4, assuming an effect size of d=0.45 (Bell, Lamport, Butler, & Williams, 
2015), 32 participants were sufficient to detect an increase in cognitive performance between the 
control and blueberry conditions. For Experiment 3, assuming an effect size of d=0.71 (Törrönen et 
al., 2010), 14 participants were deemed sufficient to detect a reduction in peak glycaemic response 
between the control and blueberry conditions. Extra participants were recruited where possible to 
allow for attrition/drop outs throughout the course of testing. 
2.2 Ethical approval 
All studies were approved for ethical conduct by either the School of Psychology Research Ethics 
Committee (SREC), or the University of Reading Research Ethics Committee (UREC), in accordance 
with University of Reading guidelines. Evidence of ethical approval for all studies can be found in 
Appendix A. 
2.3 Participants 
2.3.1 Recruitment 
Participants were healthy young adults, aged 18 to 40, recruited from staff and student populations 
at the University of Reading. This population was selected as data outlining bioavailability 
(Rodriguez-Mateos, Feliciano, Cifuentes-Gomez, & Spencer, 2016) and vasoreactivity (Rodriguez-
Mateos et al., 2013) following acute doses of blueberry anthocyanins have already been published 
for this age group. Similarly, the literature review in Chapter 1, identified cognitive and mood effects 
in young adults following blueberry intervention. Recruitment was carried out via postings to group 
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email listings, campus notice boards, and the Psychology Department Undergraduate Research 
Panel. 
2.3.2 Screening 
Aside from smoking status, no screening restrictions were in place for Experiment 1. However, all 
participants were screened for suitability before inclusion in any of the blueberry intervention 
studies. Participants were required to be non-smokers, free from pregnancy, food allergies, diabetes 
mellitus (Type 1 & Type 2), and any conditions requiring hypotensive or anticoagulant medication. 
Full eligibility criteria are reported in Appendix B. A copy of the health questionnaire used for 
screening can be found in Appendix C. 
2.3.3 Participant demographic data 
Health and lifestyle demographic data comparing participants for all experiments are shown in Table 
2.1. The participant profile remained consistent between all experiments. 
2.3.4 Informed consent 
Before participation in any of the experiments reported here, prospective participants were emailed 
an information sheet providing detailed information about the study. If after reading the information 
participants were happy to continue, then they were required to sign a consent form at the 
beginning of their first test visit. Information sheets for all experiments can be found in Appendix D. 
Consent forms for all experiments can be found in Appendix E. 
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Table 2.1 Participant demographic data 
Demographic     Experiment 
    
 
1.1 
 
1.2 
 
2 
 
3 
 
4 
N 
  
29 
 
33 
 
45 
 
17 
 
41 
            Gender male 
 
9
 
3
 
12
 
4
 
11
 
female 
 
20 
 
30 
 
33 
 
13 
 
30 
            Age(years) Mean  
 
25.6
 
20.8
 
20.9
 
24.1
 
23.5
 
SD 
 
7.7 
 
4.9 
 
3.6 
 
4.9 
 
5.1 
            BMI (kg/m2) Mean 
 
N/R
 
N/R
 
N/R
 
23.8
 
23.4
 
SD 
       
3.6 
 
5.0 
            Fruit & veg (daily portions) Mean 
 
N/R
 
N/R
 
4.1
 
5.3
 
4.4
 
SD 
     
1.4 
 
2.3 
 
1.9 
            Tea & coffee (daily cups) Mean 
 
N/R
 
N/R
 
1.7
 
2.2
 
1.3
 
SD 
     
1.8 
 
1.5 
 
1.2 
            Alcohol (weekly units) Mean 
 
N/R
 
N/R
 
5.1
 
3.6
 
3.3
 
SD 
     
6.8 
 
5.0 
 
5.0 
            Exercise (weekly hours) Mean 
 
N/R
 
N/R
 
2.9
 
3.0
 
3.3
 
SD 
     
3.3 
 
2.3 
 
3.5 
                      
N/R Not recorded 
 
2.3.5 Low polyphenol diet 
Before participation in any of the blueberry intervention experiments reported here, participants 
were required to follow a low polyphenol diet for the 24 hours prior to each test visit. Similar 
methodology has been employed by studies investigating  bioavailability (Rodriguez-Mateos et al., 
2016),  vasodilatory response (Rodriguez-Mateos et al., 2013), cognition (Dodd, 2012), and mood 
(Khalid et al., 2017) following acute wild blueberry intervention. In addition to food and supplement 
restrictions, participants were asked to abstain from alcohol, fruit juices, and caffeine containing 
beverages such as energy drinks, cola, tea, coffee or cocoa. Participants were also asked to fast (no 
food or drink) for 2 hours immediately prior to attending each test visit. Participants were asked to 
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eat the same breakfast before each test visit and to ensure that breakfast was consumed before the 
2 hour fast, with baseline cognitive testing commencing at 9am. This methodology was introduced in 
order to minimise the interfering effects of habitual dietary polyphenols on each of the measured 
outcomes following blueberry intervention, and to minimise the impact of dietary changes on test 
performance between visits. The 2 hour fast ensured that participants were thirsty enough to 
consume the intervention beverage, whilst minimising the confounding effects of any breakfast food 
intake. A copy of the dietary requirements can be found in Appendix F. At each test visit participants 
retrospectively documented their 24 hour food intake using the record sheet found in Appendix G. 
Minor transgressions were noted and, where necessary, participants were asked to modify their pre-
test diet. 
2.3.6 Payment 
Participant payments were standardised in line with current University of Reading guidelines. 
Psychology undergraduates received 1 course credit per hour of testing completed. All other 
participants received expenses payments of £5 per visit. 
2.4 Blueberry interventions 
2.4.1 Freeze dried blueberry powder 
Rather than use fresh berries, which may vary in their composition according to growing and storage 
conditions, freeze dried wild blueberry powder derived from the Vaccinium angustifolium cultivar 
was used in all intervention experiments. This cultivar has been shown to have a high total 
polyphenol content and is a rich source of anthocyanins (Rodriguez-Mateos et al., 2012). 
Bioavailabilty data has similarly been published for this cultivar (Rodriguez-Mateos et al., 2013, 
2016). In freeze-dried form each batch of blueberry powder is homogenous; the anthocyanin 
content remains constant throughout the batch, and is reportedly stable when stored at -20 degrees 
Celsius (Lohachoompol, Srzednicki, & Craske, 2004). The powder was provided free of charge by the 
Wild Blueberry Association of North America (WBANA). Due to limited availability, two separate 
harvest batches were used during the course of this research. The second batch was derived from a 
harvest that had experienced more favourable ripening conditions and subsequently was found to 
contain higher anthocyanins levels than the initial batch. Adjustments were made to the quantities 
used in each experiment in order to match the anthocyanins content of the interventions. The 
composition of each batch can be found in Table 2.2. 
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Table 2.2 Wild blueberry powder composition 
Compound Batch 1
a
 
(Experiments 2 & 3)  
Batch 2
b
 
(Experiment 4)  
 
Total polyphenols (mg/100g) 2239 2900  
          Anthocyanins (mg/100g) 905 1900  
          Procyanidins (mg/100g) 400 Not quantified  
Vitamin C (mg/100g) 12 335  
Total sugars (g/100g) 50 70  
          Fructose (g/100g) 26 36  
          Glucose (g/100g) 24 34  
Dietary fibre (g/100g) Not quantified 16  
 
a
Polyphenol, vitamin and sugar analyses conducted by Food & Nutritional Sciences Department, University of 
Reading, UK 
b
Polyphenol analyses conducted by FutureCeuticals, Illinois, USA and vitamin, sugar and dietary fibre analyses 
conducted by RSSL, Reading, UK 
 
2.4.2 Drink preparation 
All blueberry intervention doses were administered in drink form by mixing appropriate quantities of 
blueberry powder with water. The exact doses are specified in each separate experimental chapter. 
Within each experiment, all blueberry doses, including a blueberry-free control, were matched for 
sugars and Vitamin C by the addition of food grade fructose, glucose, and Vitamin C powders (Sports 
Supplements Ltd, UK). All drink doses were blind-coded and prepared by a third party not involved 
with the testing component of the study. Drinks were served in opaque, lidded cups, and consumed 
through black straws. The participants and the researcher therefore remained blind to the 
intervention dose at any given test visit.  
2.4.3 Drink palatability 
In order to determine how well the different dose conditions were matched for taste, participants 
were asked to judge the palatability of each drink. Using the questionnaire found in Appendix H, 
participants rated their general liking for each drink as well as specific taste dimensions such as 
sweet or sour. Likert scale anchor points for each rating dimension were 1 ‘Not at all’ and 9 
‘Extremely.’ 
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2.4.4 Counterbalancing 
To reduce the confounding influence of order effects, the control and all blueberry doses were 
administered in counterbalanced order, determined using Williams matrices (Williams, 1949). 
2.4.5 Washout 
During each intervention study participants were required to attend multiple visits due to the 
crossover nature of the study design. The majority of participants attended regular weekly sessions 
with a 7 day washout period between visits. However in some instances adjustments to the testing 
schedule were required in order to accommodate participant availability. In previous research, after 
an acute blueberry anthocyanins dose of 348mg, anthocyanins were no longer detectable in plasma 
after a period of 24 hours (Del Bo’ et al., 2013). Similarly, metabolites of anthocyanins from 
elderberries showed no evidence of accumulation in plasma when comparing chronic daily 
supplementation with acute supplementation (de Ferrars, Cassidy, Curtis, & Kay, 2014). However, 
anthocyanin metabolites have been reported in urine after a five day anthocyanin-free diet 
preceded only by habitual consumption of anthocyanin-rich foods (Kalt, Liu, Mcdonald, Vinqvist-
tymchuk, & Fillmore, 2014). This observation suggests that baseline metabolite levels may persist for 
extended periods of time. Therefore any washout period following acute consumption will, at best, 
only minimise acutely elevated circulating metabolites. Metabolites may not be completely 
eliminated unless participants are restricted from following their habitual diet for the entire duration 
of a study. In light of the combined evidence, on the rare occasions that a 7 day washout was not 
possible, a minimum washout period of 3 days between test visits was considered sufficient for the 
minimisation of significantly elevated levels of anthocyanins or metabolites following an acute dose. 
It was acknowledged that circulating metabolites were likely to remain throughout the testing 
period; however these baseline levels were considered unlikely to significantly impact cognitive 
data. 
2.5 Cognitive measures 
2.5.1 Task selection & piloting 
The cognitive tests selected for inclusion in this thesis have all shown positive results in previous 
flavonoid or similar nutrition intervention studies. All tasks were programmed using E-Prime 2.0 
(Psychology Software Tools, Inc.). All tasks were piloted in Experiment 1 before being used in the 
later blueberry intervention studies. Piloting of the tasks served a multiple purpose; to identify any 
potential running problems with the tasks, to determine alternate form reliability, and to investigate 
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the occurrence of practice effects resulting from repeated cognitive testing. Issues with the tasks 
were rectified as they arose, and appropriate methodology was subsequently adopted in order to 
minimise the influence of cognitive practice effects in the later blueberry intervention experiments. 
Full descriptions of each task are given below. 
2.5.2 Neural correlates 
The selected cognitive tasks (described below) each contain an attention, working memory or 
episodic memory retrieval component, or a combination of the three. Neural correlates have been 
described individually for each of the cognitive tasks, and it is apparent from these descriptions that 
there is large degree of overlap between the neural correlates for each of these cognitive functions; 
an observation also confirmed by a previous review study (Naghavi & Nyberg, 2005). 
2.5.3 Sternberg memory scanning task  
This was a modified, computerised version of the original task developed by Sternberg (Sternberg, 
1966, 1969). This short term memory task is a measure of working memory and serial attention 
(Corbin & Marquer, 2013; Garavan, 1998). Successful performance on the task has been associated 
with activation in the dorsolateral prefrontal cortex (dPFC) (D’Esposito, Postle, & Rypma, 2000). The 
task measures how fast participants can scan through a list of items held in their short term 
memory. Previous research has shown this is a fixed time per item, therefore the task has been 
described as resistant to practice (Kristofferson, 1972, 1977; Sternberg, 1975); although underlying 
reaction times from which this measure is derived are still subject to practice related improvements.  
During the Sternberg task, participants were presented with a sequential series of one to six digits, 
the order of which they were required to memorise.  A new set of digits was randomly generated on 
each trial. The appearance of a fixation point indicated the end of the sequence. The digits and 
fixation were each presented for 1200ms at a rate of one every 1200ms. Participants were required 
to indicate as quickly as possible, with a labelled yes/no key press (‘b’ &’n’ respectively), whether or 
not a final digit, presented 2000ms after the fixation point, was present in the original memory set. 
Participants completed 12 familiarisation trials and 96 test trials at each test session. The dependent 
variables (DVs) were accuracy, scanning rate, and extrapolated RT. These latter variables were, 
respectively, the slope and intercept from the regression model for predicting RT from memory set 
size (Böcker et al., 2010; D’Esposito et al., 2000; Grattan-Miscio & Vogel-Sprott, 2005; Subhan & 
Hindmarch, 1984; Vinkhuyzen, van der Sluis, Boomsma, de Geus, & Posthuma, 2010). Accuracy rates 
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were important in order to provide sufficient power for the regression analysis, therefore 
performance feedback was given after each trial. 
2.5.4 Stroop task 
This was a modified, computerised version of the original executive function task (Stroop, 1935) and 
is a measure of inhibition, or selective attention . The words “Purple”, “Green”, “Blue”, and “Red” 
were displayed individually in randomised, counterbalanced order on a computer screen, with each 
word being displayed in either a congruent or an incongruent ink colour. The words were presented 
at a rate of one every 2000ms and each word remained on screen for 1250ms. Participants were 
instructed to respond to the ink colour as quickly as possible by pressing the corresponding coloured 
button on the keyboard (coloured stickers were placed over the keys ‘1’,’2’,’3’,&’4’ on the main 
keyboard). An equal number of congruent and incongruent trials were presented. Twelve 
familiarisation trials and 96 test trials were presented at each sitting of the task. DVs included 
accuracy and the interference effect of the semantic meaning of the word; calculated by subtracting 
the mean reaction times (for correct responses only) for congruent trials from incongruent trials. 
Neural correlates for this interference effect include the left posterior parietal cortex (PPC) (Galer et 
al., 2015). 
2.5.5 Serial 3s and 7s subtraction task 
Using a previously published method for this working memory task (Scholey et al., 2010, 2013; 
Scholey, Harper, & Kennedy, 2001), a random number between 800 and 999 was presented on 
screen and participants counted backwards, at first in 3s, entering their answers via the computer 
number pad as quickly as possible for a total of two minutes. The task was then repeated subtracting 
7s instead of 3s. A 20 second familiarisation trial was completed immediately before each 2 minute 
test. The DVs in both cases were the total number of correct responses, the total number of errors, 
and the mean reaction time for correct responses (ms). The accuracy of the response was 
determined relative to the previous response, irrespective of whether or not the previous response 
was correct. No studies have reported neural correlates for this task directly, but a meta-analysis of 
similar working memory tasks revealed the involvement of an extensive fronto-parietal network 
(Rottschy et al., 2012). 
2.5.6 Immediate & delayed word recall task 
This episodic memory task was a modified, computerised version of a single-trial word list learning 
task originally developed by Édouard Claparède (Boake, 2000; Lezak, Howieson, Bigler, & Tranel, 
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2012). For the immediate recall, 15 words were visually presented in sequence on a computer 
screen at a rate of one word every 2500ms. Each word remained on screen for 2000ms. Participants 
were instructed to read and remember each word. At the end of the presentation participants were 
asked to recall as many of the words as possible, writing them on a piece of paper. Participants were 
allowed as much time as they required to perform the recall. This task was the first task 
administered during each test session. After all other tasks had been completed, participants were 
again asked to recall the words. Delayed recall occurred approximately 30 minutes after the initial 
presentation of the word lists. Different word lists, matched for concreteness and familiarity, were 
used at each testing time point (Whyte et al., 2016). The full lists can be found in Appendix I. The 
DVs for each recall task were the total number of correct words and the total number of 
interference words recalled. Due to the crossover nature of the study design, multiple word lists 
were presented across different test sessions. Interference words were considered to be any words 
previously presented at an earlier test session. Neural correlates of episodic memory function 
involve complex interaction between the hippocampus and PFC areas during encoding and retrieval 
(Ranganath, Heller, Cohen, Brozinsky, & Rissman, 2005), and a large degree of overlap has been 
observed between the PFC correlates of working memory and long term memory (Ranganath, 
Cohen, & Brozinsky, 2005; Ranganath, Johnson, & D’Esposito, 2003). 
2.5.7 Rapid visual information processing task (RVIP) 
This working memory and sustained attention task correlates with both right and left fronto-parietal  
activation networks (Coull, Frith, Frackowiak, & Grasby, 1996; Lawrence, Ross, Hoffmann, Garavan, 
& Stein, 2003; Neale, Johnston, Hughes, & Scholey, 2015). Using a previously published method 
(Watson et al., 2015), participants were shown a continuous string of single digits, presented at a 
rate of 100 digits per minute in the centre of a computer screen. Participants were required to 
continuously monitor the digits for specific target strings of three consecutive odd or three 
consecutive even digits, pressing the space bar as quickly as possible when a target string was 
observed. A short familiarisation phase consisting of 30 single digits, including four target strings, 
was performed at each presentation of the task. The main test phase of the task lasted for 5 minutes 
with 501 single digits presented, including a total of 40 target strings. The dependant variables were 
accuracy score (correct out of 40), mean reaction time (ms) (for correct responses), and commission 
error score.  
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2.5.8 Digit vigilance task 
This task is a measure of sustained attention, a cognitive function which is reported to correlate with 
neural activation in right fronto-parietal brain regions (Sarter, Givens, & Bruno, 2001). Using a 
previously published method (Watson et al., 2015), a continuous string of single digits were 
displayed in the centre of a computer screen at a rate of 80 digits per minute. Participants were 
required to press the spacebar as quickly as possible when the digit matched a randomly selected, 
static, target digit, displayed to the right of the screen. A short familiarisation phase consisting of 25 
single digits, including 5 targets, was performed at each presentation of the task. The main test 
phase of the task lasted for 3 minutes, with 240 digits presented, including 45 target matches. The 
dependant variables were accuracy score (correct out of 45), mean reaction time (ms) (for correct 
responses), and commission error score.  
2.5.9 Positive & negative affect schedule (PANAS) & subjective mental fatigue 
The PANAS-Now (Watson, Clark, & Tellegen, 1988) mood questionnaire and a subjective Likert scale 
measure of mental fatigue (Scholey et al., 2010) were administered at the end of each cognitive test 
session. The PANAS questionnaire asked participants to rate their current mood in relation to a 
series of 20 mood related adjectives (10 positive & 10 negative items). The instrument was scored 
according to published criteria (Watson et al., 1988) by summing the Likert scale ratings (out of 5) for 
positive questionnaire items to create a Positive Affect score (out of 50). Similarly, ratings for 
negative questionnaire items were summed to create a Negative Affect score. The wording of the 
questionnaire asked participants to ‘Indicate to what extent you are feeling this way right now.’ 
Anchor points were 1 ‘Very slightly/Not at all’ and 5 ‘Extremely’. Therefore, high scores indicated a 
high level of positive or negative affect, respectively. The mental fatigue questionnaire asked 
participants ‘How mentally fatigued do you feel at this moment?’ Anchor points were 1 ’Not at all’ 
and 9 ‘Extremely.’ Therefore a high rating indicated a high level of mental fatigue. 
2.5.10 Subjective motivation & subjective perception of task difficulty 
During the piloting of the cognitive tasks in Experiment 1, measures of task difficulty and motivation 
were recorded using a nine point Likert scale questionnaire immediately after completing each 
cognitive task. The wording on each scale was as follows: ‘How difficult did you find the <task name> 
task?’ and ‘How motivated were you to do well during the <task name> task?’ Anchor points were 1 
‘Not at all’ and 9 ‘Extremely’. Therefore, high scores indicated a high level of difficulty or a high level 
of motivation respectively. These measures were repeated each time a particular task was 
performed. Example questionnaires can be found in Appendix J. 
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2.5.11 Alternate forms & counterbalancing 
All cognitive tasks used alternate forms for multiple presentations of the same task in order to 
minimise learning. In the case of the Sternberg, Stroop, serial subtraction, and digit vigilance tasks, 
new forms were randomly generated within E-Prime each time the task was run. For RVIP and word 
recall, separate versions of the tasks were created and presented in counterbalanced order. Within 
each cognitive test battery, the order of presentation of the different cognitive tasks was also 
counterbalanced, such that different participants experienced the cognitive battery in a different 
order. This was deemed appropriate as order effects have previously been reported within a 
cognitive test battery (Collie, Maruff, Darby, & McStephen, 2003). Williams matrices (Williams, 1949) 
were used for all counterbalancing. 
2.6 Other measures 
2.6.1 Fruit & vegetable consumption 
For Experiments 2, 3 & 4, participants were each asked to estimate their average daily consumption 
of fruits and vegetables. The measure was recorded using a questionnaire that gave portion size 
definitions for a range of different fruit and vegetable types, in an effort to standardise the 
responses between participants. A copy of the questionnaire can be found in Appendix K. 
2.6.2 Body mass index (BMI) 
For each participant in Experiments 3 & 4, weight (kg) and height (m) was measured. Body mass 
index was calculated using the formula:     
           
             
 
2.6.3 Blood pressure (BP) 
Blood pressure measurements were recorded in Experiment 2, using a clinically validated Omron M6 
Comfort automatic digital upper-arm blood pressure monitor (Omron Healthcare UK Ltd). Three 
repeat readings were taken at 2 minute intervals and average values recorded, in accordance with 
the manufacturer’s instructions.  To maintain consistency between repeat test sessions, blood 
pressure measurements were recorded in a seated position, with the cuff placed on the left arm, 
and with the arm resting on an adjacent desk throughout the measurement. 
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2.6.4 Blood glucose 
Blood glucose levels were recorded in Experiments 3 & 4 by capillary sampling using the clinically 
validated Accu-Chek Aviva Blood Glucose Meter System (Roche Diagnostics UK). The units of 
measurement were millimoles per litre (mmol/l). World Health Organisation guidelines on capillary 
sampling (World Health Organisation, 2010) were strictly adhered to. Blood was sampled from the 
edge of the finger pad. Prior to sampling, the area was cleansed using an alcohol wipe. Disposable 
lancets were used for each finger prick. For comfort, a different finger tip was used for successive 
sampling time points. All waste including alcohol wipes, lancets and test strips, were disposed of in 
appropriate contaminated waste containers.  
2.7 Testing procedure 
All testing was carried out at the Nutritional Psychology Unit at the University of Reading. On arrival 
at the unit, all baseline cognitive and physiological measures were recorded. Cognitive testing was 
performed in individual testing cubicles in order to minimise distraction; however cubicles were 
found not to be completely sound proof. In Experiment 4 participants were additionally required to 
wear noise cancelling headphones in order to reduce noise from adjacent offices; a problem that 
had been identified during Experiment 2. When baseline tests were complete, the appropriate 
intervention drink was administered (Experiments 2, 3, & 4). Participants were required to fully 
consume the drink within 10 minutes (Rodriguez-Mateos et al., 2013).  In order to maintain precise 
timings between interventions and testing time points, digital timers were used. Repeat 
physiological and cognitive testing occurred at fixed postprandial time points. These timings are 
specified in each separate experimental chapter. At the end of each visit, with the exception of the 
final visit, a return appointment date was confirmed. 
2.8 Data analysis 
All data cleaning and analysis procedures were performed using Microsoft Excel 2007 and IBM SPSS 
Statistics 21. 
2.8.1 Outlier procedures 
All raw data were systematically screened for outliers prior to statistical analysis using a published 
data cleaning protocol (Tabachnick & Fidell, 2013). For raw RT data collected across multiple test 
trials at each test session, only RT values for correct responses were included in subsequent 
analyses.  RTs less than 200 milliseconds were immediately removed. Z scores were calculated for all 
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remaining data points for each participant, and RTs with a corresponding z score of greater than 3.29 
were removed. This procedure was then repeated before calculating mean RTs for each participant 
at each test session. It was necessary to repeat the procedure due to the presence of some 
extremely slow RTs which biased the initial z distribution and prevented appropriate removal of all 
outliers. A similar procedure was followed to remove outlier means (RTs or test scores) across 
participants; Z scores were calculated according to session (Experiment 1) or dose (Experiments 2, 3, 
& 4), and mean values with a corresponding |z score| of greater than 3.29 were removed from the 
dataset. 
2.8.2 Sternberg regression analysis 
As described in the cognitive task section above, linear regression analysis of the Sternberg data was 
performed in order to obtain two of the DVs for the task. For each participant, and each repetition of 
the task, coefficients were determined for the regression line predicting RT from memory set size. 
The regression analysis was performed using data points for all correct responses, rather than using 
mean RTs obtained by averaging multiple trials with the same memory set size. A simulation of the 
analysis performed by Dr Kou Murayama (personal communication, February 13, 2015) at the 
University of Reading revealed that this method would better preserve statistical power. 
2.8.3 Repeated measures data 
On the recommendation of an independent statistician (University of Reading Statistical Services) all 
repeated measures data were analysed using Linear Mixed-effects Models (LMMs) in place of 
repeated-measures Analysis of Variance (repeated ANOVA). LMM analysis is based on a complex 
linear regression procedure. The technique  can be used to model variance relating to both fixed 
parameters such as experimental doses, and random parameters such as individual differences 
between subjects, within multiple layers of the same model (Hoffman & Rovine, 2007). LMM has a 
number of advantages over repeated ANOVA (Field, 2009; Hoffman & Rovine, 2007; Magezi, 2015; 
Shek & Ma, 2011). Repeated ANOVA requires the assumption that all data observations are 
independent, however in repeated designs this is generally not the case. In LMM the true covariance 
structure of the data can be more accurately modelled, increasing the power of the analysis. 
Additionally, LMM does not require balanced data, thereby further increasing the power of the 
analysis as subjects with missing data points need not be excluded. As with all regression analysis, 
there is no requirement for dependent variables to be normally distributed. In general, regression 
analysis does assume that regression residuals are normally distributed; however the distribution of 
residuals has been reported not to influence the outcome of LMM, making it a robust method 
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(Gelman & Hill, 2007). The method also permits the inclusion of repeated covariates within the 
model, not possible in repeated ANOVA. 
Throughout this thesis LMMs have been applied in a systematic way to retain consistency between 
analyses. In all analyses, subjects have been included as a random factor as a way of controlling for 
non-independence of data within subjects (Sweet & Grace-Martin, 2011). Additionally, a repeated 
factor has been included to control the covariance structure for each subject.  In LMM the 
covariance structure is modelled using a covariance matrix of all repeated data observations, with 
variances defined along the diagonal and covariances in off-diagonal positions. A selected structure 
can be imposed on relative positions within the matrix. In an unstructured matrix, as suggested by 
the name, the covariances are assumed to be unpredictable and not have any fixed underlying 
structure. This general matrix suits all data; however it has some practical limitations. In analyses 
with many repeated time points and a relatively small number of participants there can be 
insufficient degrees of freedom available to determine a solution for the model. In these 
circumstances alternative covariance structures that make some assumptions can be specified.  The 
most appropriate alternatives in respect of this doctoral research data were a heterogeneous, 
autoregressive structure (ARH1) or a diagonal structure. The ARH1 matrix assumes that variances are 
heterogeneous, and that covariances increase with greater proximity within the matrix i.e. repeated 
measurements are more closely correlated with an adjacent measurement than one recorded much 
earlier or later in the sequence of repeats. The diagonal matrix is a simpler model that assumes 
heterogeneous variances but a covariance of zero. This is the matrix assumed in repeated ANOVA. 
Where possible, an unstructured covariance matrix has been specified. LMM reports a measure 
proportional to the level of any variance not accounted for by the model. These ‘-2 log linear’ (-2LL) 
values may be compared across related models, with the smallest value indicating the best fit. 
Taking these values into consideration, the best available model has been used in all analyses and 
the exact model is clearly described in each set of reported results. 
2.8.4 Reporting of statistical results 
When reporting LMM outcomes a similar convention to the reporting of ANOVA has been used, with 
degrees of freedom, F value, and p value reported. However some of the terminology used is slightly 
different. In ANOVA outcomes are reported as significant (or non-significant) main effects and 
interactions of factors. LMM is a more complex regression procedure, therefore factors are 
described as significant (or non-significant) predictors of the dependent variable (Field, 2009). 
Where significant covariates have been identified, the LMM model has been extended to include 
covariate interactions. Regression coefficients have been reported for all significant covariates and 
 42 
 
covariate interactions. These beta values describe the slope of the regression line. Therefore 
participants displaying a single unit difference in their covariate measurement are predicted to 
display a difference in the dependant variable equal to the value of beta. 
Where significant fixed factors have been identified, and for all intervention interactions, pairwise 
comparisons have been used to further interpret the findings. Convention proscribes that pairwise 
comparisons should only be performed following a significant F-test outcome. However, if multiple 
pairwise comparisons are appropriately corrected for the increased likelihood of type 1 error (false 
positives) then a prior F test, significant or otherwise, is not required (Howell, 2010; Huck, 2015; 
Wilcox, 1987). The F-test is methodologically conservative, particularly in designs akin to those used 
in this thesis comparing multiple, highly similar means. Under such circumstances, non-significant 
interactions may still yield significant pairwise comparisons, therefore it is statistically appropriate to 
investigate these regardless of the F-test outcome (Huck, 2015). Pairwise comparisons, with 
correction for multiple comparisons, have therefore been applied in the interpretation of all 
intervention interactions throughout this thesis. Bonferroni correction was selected as the most 
appropriate correction method as it guarantees the greatest control over type 1 error (Field, 2009).  
For clarity, only significant findings have been reported in full in each experimental chapter. All other 
LMM results for each experiment have been tabulated in Appendix L. 
2.8.5 Cohen’s d effect sizes 
Cohen’s d effect sizes were calculated for literature findings reviewed in Chapter 1, and for 
significant effects observed in each of the experimental chapters. Cohen’s d is a standardised 
measure that describes effect size in terms of the number of standard deviations between group 
means.  Values of d equal to 0.2, 0.5 and 0.8 correspond to small, medium and large effect sizes, 
respectively (Cohen, 1988). A published meta-analysis method was used for all effect size 
calculations (Lipsey & Wilson, 2001). 
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Chapter 3  
Experiment 1: Piloting of cognitive tasks and an 
examination of the effects of repeated cognitive testing on 
task performance 
3.1 Introduction 
As an initial step, the cognitive tasks described in Chapter 2 were piloted before inclusion in any 
blueberry intervention work. Piloting was carried out in order to identify and rectify any technical 
problems with the tasks themselves, to determine alternate form reliability for each of the cognitive 
tasks deployed, and importantly to determine the most appropriate methodology for minimising the 
impact of cognitive practice effects, which are a known problem in studies involving repeated 
cognitive testing. Previous research on practice effects (described below) was not found to reflect 
the designs typically used in nutrition intervention studies, and so a new investigation was carried 
out. The findings are presented in this chapter. 
Repeated cognitive testing is often necessary in order to determine the efficacy of a nutrition 
intervention over time, particularly when determining a dose response curve. Equally this situation 
may arise in clinical drug trials or with other intervention types where repeated cognitive testing 
occurs over time. In such studies, multiple time points are used for comparing test values with 
baseline values and, in both acute and chronic crossover studies, testing may be performed multiple 
times by the same participant over a period of many weeks or months. However, the effects of 
repeatedly practising cognitive tasks are known to be problematic for studies using a repeated-
measures design (Bartels et al., 2010; Basso, Bornstein, & Lang, 1999; Collie et al., 2003; Falleti, 
Maruff, Collie, & Darby, 2006; Hausknecht, Halpert, Paolo, & Gerrard, 2007; Lamport et al., 2012; 
McCaffrey, Ortega, & Haase, 1993; McClelland, 1987). Each time a participant is asked to perform a 
task they become more familiar with both the procedure and stimuli presented, and a process of 
learning takes place, often leading to enhanced performance. This becomes increasingly problematic 
if performance approaches or reaches a ceiling. Additionally, practice may result in a change in the 
participant’s strategy for performing the task (Lowe & Rabbitt, 1998), which may in turn modify the 
brain network being utilised e.g. (Iaria, Petrides, Dagher, Pike, & Bohbot, 2003; Petersen, van Mier, 
Fiez, & Raichle, 1998), calling into question the validity of the result. Practice effects also add 
additional error variance that may impact on the statistical power of the study (McCaffrey, 2001). In 
order to ensure the validity of cognitive research, the European Food Safety Authority (EFSA) 
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guidelines on psychological health claims currently specify that practice effects must be addressed in 
behavioural intervention studies with a repeated testing component (EFSA, 2012). At least one 
methodological review paper (de Jager et al., 2014) has identified practice to be a problem for 
cognitive tasks across a number of cognitive domains. Many research groups adopt a range of 
strategies for dealing with practice; however there is no current consensus on the best methodology 
to address this issue.  
Conceptually, very few cognitive tasks were developed with repeated-measures testing specifically 
in mind. Instead of seeking practice-resistant tasks, which are likely to be difficult or even impossible 
to create due to human adaptive behaviour, it has become almost standard practice for studies 
using multiple testing points to adopt the use of alternative forms of a task. Using this method, the 
same task is used but different equivalent forms of stimuli are presented across the multiple testing 
points. However although this strategy has previously been shown to be effective at attenuating 
practice effects, for some tasks significant residual practice effects may still be evident (Beglinger et 
al., 2005); it is thought that for many tasks participants are able to develop strategies to enhance 
their performance over time irrespective of the specific stimuli presented. The use of alternate 
forms cannot fully counteract this procedural learning process (Roebuck-Spencer, Sun, Cernich, 
Farmer, & Bleiberg, 2007). A number of studies attempt to reduce practice effects by incorporating 
an additional task familiarisation session before the test sessions, where participants familiarise 
themselves with the tasks, either on a prior visit or immediately before data collection, with a view 
to raising performance to a more stable level before beginning data collection. Indeed, this 
technique was historically advocated by McClelland (McClelland, 1987), who recommended a 
minimum of four familiarisation sessions prior to data collection for some tasks, although it is 
unclear from the paper whether these four sessions should be spread across one or more visits. The 
addition of this number of sessions has significant time and cost implications and has not been 
adopted due to its impracticality. Typically, many studies include upwards of one familiarisation 
session e.g. (Alharbi et al., 2016; Cox et al., 2015; Kennedy et al., 2002; Rigney, Kimber, & 
Hindmarch, 1999; Wightman et al., 2012), but it has been acknowledged that others entirely forgo 
adequate training (Wesnes & Pincock, 2002). The effectiveness of different strategies, including the 
most appropriate time for conducting familiarisation sessions (separate visit or immediately before 
testing) have not been fully investigated. 
The effect of practice on performance has previously been investigated for short term repeated 
testing on a single visit e.g. (Collie et al., 2003; Falleti et al., 2006), where participants performed 
four repetitions of a battery of tasks at 10 minute intervals, and for repeated testing over a longer 
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term with single performances of a task across multiple visits e.g. (Bartels et al., 2010; Basso et al., 
1999; Beglinger et al., 2005; Lemay, Bedard, Rouleau, & Tremblay, 2004; McCaffrey, 2001; McCaffrey 
et al., 1993). A few studies have combined within visit and multiple visit sessions of testing e.g. 
(McClelland, 1987); however in this example the majority of tasks were conducted using pencil and 
paper and were observed to be relatively unaffected by practice. Subsequent studies suggest that 
significant practice effects are observed for most modern computerised tasks, with the strongest 
practice effects typically observed between the first and second testing time points (Bartels et al., 
2010; Collie et al., 2003; Falleti et al., 2006), although significant practice related improvements have 
been observed beyond a second session of testing (Bartels et al., 2010; Beglinger et al., 2005; Lemay 
et al., 2004). Practice effects have also been observed both within individual tasks, and within a test 
battery depending on the temporal positioning of individual tasks (Collie et al., 2003). Overall there 
is some suggestion that the rate of practice-related improvement may slow after two or more 
sessions irrespective of the testing interval. However, the timing of the repeated sessions used by 
these studies generally do not reflect those typically used in crossover nutrition studies or similar 
clinical intervention trials, where it is common to measure performance at baseline and again at one 
or more post- intervention time points at each visit, over a number of weekly visits e.g. (Alharbi et 
al., 2016; Cox et al., 2015; Kennedy et al., 2002; Nathan et al., 2002; Rigney et al., 1999; Watson et 
al., 2015; Wightman et al., 2012). This is important as practice effects have been observed to differ 
depending on the testing interval (Dikmen, Heaton, Grant, & Temkin, 1999). Similarly, in the parallel 
field of learning and memory, the timing of practice sessions is known to be important, as 
distributed practice spread across days, weeks or months has been observed to facilitate differential 
learning compared with massed practice performed multiple times on a single occasion (Anderson, 
1992). 
This experiment aimed to investigate practice effects for the cognitive tasks to be used in later 
blueberry crossover intervention work; such crossover designs incorporate a larger repeated testing 
component than parallel designs as participants are actively involved in all control and intervention 
arms of the study. Practice effects were examined within this crossover design framework; in 
Experiment 1.1 the design included three test days and two testing points within each day (a 3x2, 
Visit x Session design); in Experiment 1.2 the design included three test days and three testing points 
within each day (a 3x3, Visit x Session design). In line with current standard practice, alternate forms 
of all cognitive tasks were used, and familiarisation trials immediately prior to data collection were 
also incorporated in the study design. The intention was to identify the extent of practice effects 
within the cognitive batteries used in this thesis. This data was used to elucidate an effective 
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strategy for minimising the impact of practice effects in the later blueberry intervention 
experiments, as required by EFSA. 
3.2 Methods 
Methodological detail common to all experiments in this thesis can be found in Chapter 2. 
Methodology specific to the piloting of the cognitive tasks is reported here. 
3.2.1 Participants 
The participants in Experiment 1.1 were 29 young adults, aged 18-42 years (M 25.6, SD 7.7, 9 male). 
Thirty participants were recruited, however one participant failed to attend any test visits. The 
participants in Experiment 1.2 were 33 young adults aged 19-44 years (M 20.8, SD 4.9, 3 male). One 
participant attended only the first test visit. All participants were apparently healthy, non-smokers. 
3.2.2 Design 
The study design is illustrated in Figure 3.1. In Experiment 1.1, each participant completed the 
cognitive test battery six times following a crossover design. The six test sessions were split over 
three visits, with each visit separated by approximately one week (M 7.02, SD 1.12, Range 3-11 
days). Within each visit there were two test sessions which were separated by 1 hour. The cognitive 
battery lasted 40 minutes. In Experiment 1.2, each participant completed a shorter 15 minute 
cognitive battery a total of nine times. Within each of the three visits there were three test sessions 
which were all separated by 1 hour breaks. Again, each visit was approximately one week apart (M 
7.09, SD 0.39, Range 6-8 days). In both experiments participants were tested at the same time of day 
on each visit to minimise diurnal effects. Exceptions were two participants (one participant in each 
experiment) who attended both morning and afternoon sessions as their circumstances changed 
after testing had begun.  
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Experiment 1.1 Experiment 1.2 
 
 
Figure 3.1 Study design for Experiments 1.1 & 1.2 
Each pilot experiment was structured to mimic a shortened version of the design used in later blueberry 
experiments. 
 
3.2.3 Procedure 
In both experiments, participants attended the lab for a total of three visits. On arrival they 
immediately completed the battery of cognitive tasks and subjective measures of mood outlined 
below. Participants then waited in the lab for 1 hour before repeating the testing. In Experiment 1.2 
a further repeat of the test battery was performed after another hour.  During all breaks participants 
were supplied with magazines to read. Participants tested in the morning were asked to record their 
breakfast intake on the first visit, and were asked to eat the same breakfast prior to all subsequent 
visits. Participants tested in the afternoon were asked to eat the same lunch before all visits. The 
two participants who attended both morning and afternoon sessions ate the same meal before 
attending each visit, regardless of time of day. During all visits only consumption of water was 
permitted. After testing had been completed a return appointment was arranged for the following 
week. Participants spent a total of 2 ½ hours in the lab at each visit. All were informed from the 
outset that the aim of the study was to investigate the effects of repeated practice on cognitive task 
performance. 
3.2.4 Cognitive & subjective measures 
The cognitive tasks used in Experiment 1.1 were broadly representative of three main cognitive 
domains: working memory (serial 3s & 7s subtraction; Sternberg memory scanning), executive 
function (Stroop) and episodic memory (immediate & delayed recall), all tasks also required varying 
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degrees of attentional processing. The cognitive tasks used in Experiment 1.2 focussed on working 
memory (serial 3s & 7s subtraction; RVIP) and sustained attention (RVIP & digit vigilance).  Full task 
descriptions can be found in Chapter 2. In Experiment 1.1, with the exception of the immediate and 
delayed recall tasks, which were respectively presented first and last, the order of the remaining 
three cognitive tasks was counterbalanced between participants. In Experiment 1.2 the order of all 
cognitive tasks was similarly counterbalanced. Short practice trials were incorporated at the 
beginning of each of the executive function, working memory and sustained attention tasks, for 
which data was not collected. This was to ensure that participants had fully familiarised themselves 
with the task directly before each administration. Alternate forms were used at each repeat 
presentation of any given task. 
Subjective measures of task difficulty and motivation were recorded each time a particular task was 
performed (Chapter 2). In addition, the PANAS-Now (Watson et al., 1988) mood questionnaire and a 
measure of mental fatigue (Scholey et al., 2010) were administered at the end of each session of 
cognitive tasks. 
3.3 Data analysis 
3.3.1 Sternberg regression analysis 
Regression analysis was performed on all raw Sternberg data in accordance with the procedure 
outlined in Chapter 2. Coefficient of determination values were low (R2<0.380), but were similar to 
those observed in previous studies e.g. (Corbin & Marquer, 2009), and were typical of behavioural 
data. 
3.3.2 Linear mixed models 
LMM using a first-order autoregressive heterogeneous covariance structure (ARH1) to model 
successive repeat test sessions was used to analyse data for all cognitive tasks. Visit, Session and the 
Visit x Session interaction were included as fixed factors in the model, and subjects were included as 
random effects (Model 1.1). Motivation was subsequently included in the model as a repeated 
covariate (Model 1.2). In order to confirm the validity of motivation as a covariate -2 Log Likelihood 
(-2LL) values for Model 1.2 were compared with corresponding values for Model 1.1. The addition of 
motivation improved the fit of the model as evidenced by a reduction in -2LL (Shek & Ma, 2011). The 
analysis aim was to determine whether practice related improvements in cognitive performance 
were evident following the use of same day familiarisation trials and alternate forms of cognitive 
tasks, whilst accounting for potentially confounding changes in motivation. Pairwise comparisons 
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were used to investigate any significant effects of Visit, Session, or any Visit x Session interaction. A 
Bonferroni correction was applied to all multiple comparisons. The same LMM procedure (Model 
1.1) was used to determine the effects of repeated testing on mood and mental fatigue.  
For the analysis of the interference errors DV for the immediate and delayed recall tasks, the 
random effects component was removed from the LMM procedure (Model 1.3). This modification 
was necessary in order to counter the large number of zero scores present in the data set. Some 
participants showed no variation at all in their scores, causing an error in the modelling of the 
covariance matrix when including random effects (West, Welch, & Galecki, 2015). Motivation was 
also excluded as a covariate. It was judged impossible for motivation to consistently influence the 
number of interference errors across all test sessions. By definition, the possibility of making such an 
error increases with increasing presentations of the task. 
Difficulty ratings recorded at each time point and for each cognitive task were analysed using a 
separate LMM (Model 1.4). ARH1 covariance structure was used to model successive repeat test 
sessions. Visit, Session, Cognitive Task, and Task x Visit, Task x Session, Visit x Session, and Task x 
Visit x Session interactions were included as fixed factors in the model. Subjects were included as 
random effects. The same model was also applied to the motivation ratings recorded at each time 
point for each cognitive task. 
Serial 3s & 7s, positive & negative affect, and mental fatigue data obtained during Experiments 1 & 2 
were subsequently combined. This larger dataset was analysed to determine whether time of testing 
(am or pm) played a significant role in predicting performance. The same LMM procedure was used 
as for the individual experiment analyses, but with the addition of a Time of Day factor, and all 
interactions between Time of Day, Visit and Session (Model 1.5). Motivation was again included as a 
repeated covariate for cognitive outcomes (Model 1.6). 
3.3.3 Cohen’s d effect sizes 
Cohen’s d values were calculated to compare cognitive practice effect sizes between all visits and 
sessions, with a view to determining whether the introduction of a familiarisation visit on a separate 
day prior to data collection would reduce practice effects in a typical nutrition intervention study 
design. 
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3.3.4 Intraclass correlation coefficients 
Alternate-form reliability was determined for each of the cognitive tasks through the calculation of 
Intraclass Correlation Coefficients (ICCs). ICC scores for consistency between alternate test forms 
were calculated using a two-way mixed effects model. Scores between 0.4-0.75 were judged to be 
adequate and scores greater than 0.75 were considered good, according to published criteria 
(Cicchetti, 1994; Weintraub et al., 2014). 
3.4 Results 
All raw data collected during these experiments are included in the supplementary Excel files 
‘Experiment 1.1.xls’ and ‘Experiment 1.2.xls’ on the accompanying CD. Means and standard 
deviations for all recorded variables are tabulated under the relevant sections of the chapter. The 
findings of Experiments 1.1 and 1.2 are reported individually under each section heading. All LMM 
results are presented in full in Appendix L. For clarity, only statistically significant effects are 
reported in the text. 
3.4.1 LMM analysis of the changes in cognitive performance across all task 
repetitions 
3.4.1.1 Experiment 1.1 
Means and standard deviations for all cognitive variables recorded in Experiment 1.1 are shown in 
Table 3.1. 
Table 3.1 Cognitive data for Experiment 1.1 (n=29) 
Table 3.1 continued 
         Testing time point 
Cognitive variable 
 
Visit 
 
Session 1 
 
Session 2 
  
 
  
 
Mean SD 
 
Mean SD 
    
  
 
  
Immediate recall score (correct/15) 
 
Visit 1 
 
7.52 2.01 
 
8.00 2.27 
  
Visit 2 
 
9.03 1.97 
 
8.59 2.11 
  
Visit 3 
 
10.21 2.51 
 
9.24 2.61 
         Immediate recall interference errors 
 
Visit 1 
 
0.03 0.19
 
0.07 0.26
  
Visit 2 
 
0.07 0.26 
 
0.03 0.19 
  
Visit 3 
 
0.10 0.41 
 
0.03 0.19 
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Table 3.1 continued 
         Testing time point 
Cognitive variable 
 
Visit 
 
Session 1 
 
Session 2 
  
 
  
 
Mean SD 
 
Mean SD 
Delayed recall score (correct/15) 
 
Visit 1 
 
6.00 2.38 
 
5.45 2.64 
  
Visit 2 
 
6.69 2.38 
 
5.41 2.95 
  
Visit 3 
 
7.90 2.94 
 
5.79 4.14 
         Delayed recall interference errors 
 
Visit 1 
 
0.03 0.19
 
0.31 0.66
  
Visit 2 
 
0.14 0.44 
 
1.41 1.50 
  
Visit 3 
 
0.07 0.26 
 
1.45 1.74 
         Serial 3s score (correct in 2 minutes) 
 
Visit 1 
 
32.79 14.37
 
40.07 16.23
  
Visit 2 
 
41.62 18.45 
 
46.72 16.78 
  
Visit 3 
 
49.59 19.31 
 
51.21 18.80 
         Serial 3s RT (ms) 
 
Visit 1 
 
3515.13 1457.62
 
3094.01 1412.59
  
Visit 2 
 
2935.73 1165.08 
 
2512.30 997.39 
  
Visit 3 
 
2621.67 1229.22 
 
2446.37 1120.99 
         Serial 3s errors (incorrect in 2 minutes) 
 
Visit 1 
 
2.24 2.44
 
2.36 2.33
  
Visit 2 
 
2.62 2.01 
 
2.33 1.98 
  
Visit 3 
 
2.10 1.45 
 
2.86 2.50 
         Serial 7s score (correct in 2 minutes) 
 
Visit 1 
 
20.28 11.59
 
22.45 10.56
  
Visit 2 
 
23.97 13.68 
 
25.10 12.66 
  
Visit 3 
 
26.72 13.76 
 
28.10 13.89 
         Serial 7s RT (ms) 
 
Visit 1 
 
5644.86 2609.60
 
5086.12 2157.89
  
Visit 2 
 
4910.95 2413.92 
 
4484.32 1670.49 
  
Visit 3 
 
4601.17 2085.15 
 
4505.79 2017.93 
    
  
 
  
Serial 7s errors (incorrect in 2 minutes) 
 
Visit 1 
 
3.14 2.47 
 
3.34 3.14 
  
Visit 2 
 
2.57 2.39 
 
3.17 2.90 
  
Visit 3 
 
2.86 2.31 
 
2.69 2.59 
         
         Sternberg accuracy (correct/96) 
 
Visit 1 
 
91.38 3.52
 
91.24 3.57
  
Visit 2 
 
91.50 3.39 
 
89.66 4.70 
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Table 3.1 continued 
         Testing time point 
Cognitive variable 
 
Visit 
 
Session 1 
 
Session 2 
  
 
  
 
Mean SD 
 
Mean SD 
  
Visit 3 
 
89.90 5.23 
 
90.68 4.42 
         Sternberg scanning rate (ms/item) 
 
Visit 1 
 
37.67 15.17
 
35.59 26.13
  
Visit 2 
 
26.98 18.15 
 
28.42 14.62 
  
Visit 3 
 
27.05 21.30 
 
25.55 21.65 
         Sternberg extrapolated RT (ms) 
 
Visit 1 
 
668.81 189.31 
 
595.49 180.10 
  
Visit 2 
 
616.15 169.75 
 
583.18 153.24 
  
Visit 3 
 
538.86 147.41 
 
561.33 162.40 
    
  
 
  
Stroop accuracy (correct/96) 
 
Visit 1 
 
90.82 3.27 
 
90.55 4.64 
  
Visit 2 
 
91.52 4.08 
 
91.14 3.85 
  
Visit 3 
 
89.86 4.47 
 
90.90 3.30 
    
  
 
  
Stroop incongruent RT (ms) 
 
Visit 1 
 
783.37 90.70 
 
729.09 93.62 
  
Visit 2 
 
743.47 93.88 
 
734.31 97.31 
  
Visit 3 
 
725.15 109.73 
 
715.61 89.13 
    
  
 
  
Stroop congruent RT (ms) 
 
Visit 1 
 
714.54 97.83 
 
661.10 101.75 
  
Visit 2 
 
681.62 99.68 
 
663.20 109.07 
  
Visit 3 
 
673.58 119.38 
 
640.12 96.09 
         Stroop interference effect (ms) 
 
Visit 1 
 
68.84 46.16
 
62.39 38.26
  
Visit 2 
 
61.85 51.41 
 
71.11 44.20 
  
Visit 3 
 
51.56 47.76 
 
75.48 44.19 
               
 
3.4.1.1.1 Motivation 
As a repeated covariate in the model, Motivation significantly predicted IR score [F(1,136.77)=13.56, 
p<0.001, beta=0.400], DR score [F(1,127.22)=7.64, p=0.007, beta=0.364], serial 7s score 
[F(1,135.85)=19.05, p<0.001, beta=1.186], serial 7s errors [F(1,82.72)=16.49, p<0.001, beta=-0.433], 
Sternberg accuracy [F(1,131.06)=44.25, p<0.001, beta=0.949], Stroop accuracy [F(1,102.34)=6.35, 
p=0.013, beta=0.477], and Stroop RT for congruent trials [F(1,140.24)=5.82, p=0.017, beta=-6.734], 
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such that higher motivation was associated with better performance in all cases. Means and 
standard deviations for all motivation ratings collected during Experiment 1.1 are shown in Table 
3.2. 
3.4.1.1.2 Visit 
Fixed effects of Visit were significant for IR score [F(2,54.20)=16.82, p<0.001], serial 3s score 
[F(2,49.95)=70.48, p<0.001], serial 3s RT [F(2,53.89)=35.30, p<0.001], serial 7s score 
[F(2,46.26)=32.86, p<0.001], serial 7s RT [F(2,66.14)=11.43, p<0.001], Sternberg scanning 
rate[F(2,60.89)=6.87, p=0.002], and both incongruent [F(2,52.41)=13.62, p<0.001] and congruent 
RTs on the Stroop task. 
Pairwise comparisons showed performance improvements between Visits 1 & 2 for IR score 
[p=0.004], serial 3s score [p<0.001], serial 3s RT [p=0.001], serial 7s score [p<0.001], Sternberg 
scanning rate [p=0.010], and Stroop incongruent RT [p=0.018]. Continued improvements between 
Visits 2 & 3 were observed for IR score [p=0.010], serial 3s score [p<0.001], serial 7s score [p=0.020], 
and Stroop incongruent RT [p=0.029]. Therefore, 8 of 15 DVs were predicted by the Visit factor, with 
6 DVs showing significant improvements between Visits 1 & 2 but only 4 showing significant 
improvements between Visits 2 & 3. Accuracy and error scores were observed to remain stable 
across repeated visits, irrespective of the type of cognitive task. 
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Table 3.2 Motivation data for Experiment 1.1 (n=29) 
 
        Testing time point 
Motivation rating (out of 9) 
 
Visit 
 
Session 1 
 
Session 2 
  
 
  
 
Mean SD 
 
Mean SD 
    
  
 
  
Immediate recall rating 
 
Visit 1 
 
6.76 1.57 
 
5.72 2.05 
  
Visit 2 
 
6.62 1.63 
 
6.03 2.18 
  
Visit 3 
 
6.55 1.94 
 
6.10 2.09 
         Delayed recall rating 
 
Visit 1 
 
6.24 1.77
 
5.97 2.13
  
Visit 2 
 
6.00 2.00 
 
5.83 2.05 
  
Visit 3 
 
6.31 2.09 
 
6.14 2.33 
         Serial 3s rating 
 
Visit 1 
 
6.10 1.95
 
6.31 1.91
  
Visit 2 
 
5.69 2.16 
 
5.69 2.38 
  
Visit 3 
 
6.38 1.90 
 
5.97 2.11 
         Serial 7s rating 
 
Visit 1 
 
6.03 2.13
 
5.76 2.12
  
Visit 2 
 
5.38 2.23 
 
5.45 2.35 
  
Visit 3 
 
5.86 2.13 
 
5.79 2.38 
         Sternberg rating 
 
Visit 1 
 
5.45 1.97
 
5.45 2.16
  
Visit 2 
 
5.14 2.00 
 
5.05 2.10 
  
Visit 3 
 
5.72 2.25 
 
5.48 2.15 
         Stroop rating 
 
Visit 1 
 
6.34 1.74
 
6.14 1.68
  
Visit 2 
 
6.14 1.85 
 
5.97 1.90 
  
Visit 3 
 
6.24 1.94 
 
6.07 2.17 
              
 
3.4.1.1.3 Session 
Fixed effects of Session were significant for DR score, serial 3s score, serial 3s RT, serial 7s score, 
serial 7s RT, Sternberg extrapolated RT, Stroop incongruent RT, Stroop congruent RT, and Stroop 
interference effect. Significant improvements between Sessions 1 & 2 were observed for serial 3s 
score [F(1,76.87)=42.98, p<0.001], serial 3s RT F(1,86.05)=16.59, p<0.001], serial 7s score 
[F(1,69.02)=10.74, p=0.002], serial 7s RT [F(1,67.33)=17.04, p<0.001], Sternberg extrapolated RT 
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[F(1,55.60)=9.37, p=0.003], Stroop incongruent RT [F(1,57.19)=24.57, p<0.001], and Stroop 
congruent RT [F(1,42.89)=50.08, p<0.001]. Conversely, significant decreases in performance 
between Sessions 1 & 2 were observed for DR [F(1,71.43)=17.08, p<0.001], and Stroop interference 
effect [F(1,61.19)=6.50, p=0.013]. Therefore, 9 of 15 DVs were predicted by the Session factor, with 
7 DVs showing improvement, and 2 DVs showing a decline in performance. Accuracy and error 
scores were observed to remain stable across repeated sessions, irrespective of the type of cognitive 
task. 
3.4.1.1.4 Visit x Session interactions 
A significant Visit x Session interaction observed for IR score [F(2,81.91)=4.36, p=0.016] was 
explained by a significant increase in performance between Sessions 1 & 2 at Visit 1 [p=0.041], but 
not at any other visits. For Serial 3s score [F(2,76.20)=3.87, p=0.025] improvements were observed 
between Sessions 1 & 2 on Visit 1 [p<0.001] and Visit 2 [p<0.001], but not on Visit 3 [p=0.179]. 
Similarly for Serial 7s RT [F(2,73.47)=4.39, p=0.016] the significant interaction was explained by 
improvement in performance between Sessions 1 & 2 at Visit 1 [p=0.001] and Visit 2 [p=0.029], but 
not at Visit 3 [p=0.503]. A significant interaction for Stroop incongruent RT [F(2,74.68)=8.70, 
p<0.001] was explained by improvements between Sessions 1 & 2 on Visit 1 only [p<0.001]. For 
Stroop congruent RT [F(2,83.05)=3.52, p=0.034], larger improvements were observed between 
Sessions 1 & 2 on Visit 1 [p<0.001], although moderate improvements remained evident between 
Sessions on Visit 2 [p=0.016] and Visit 3 [p=0.001]. In all interaction cases, therefore, practice effects 
between Sessions 1 & 2 were attenuated or eliminated altogether at later visits. 
3.4.1.2 Experiment 1.2 
Means and standard deviations for all cognitive variables recorded in Experiment 1.2 are shown in 
Table 3.3. 
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Table 3.3 Cognitive data for Experiment 1.2 (n=33) 
 
Table 3.3 continued 
         Testing time point 
Cognitive 
variable 
 
Visit 
 
Session 1 
 
Session 2 
 
Session 3 
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
 
           Digit vigilance 
score 
(correct/45)  
 
Visit 1 
 
43.52 1.68 
 
42.91 2.79
 
43.25 2.71
 
Visit 2 
 
43.29 2.72 
 
42.22 4.12 
 
41.97 3.50 
 
Visit 3 
 
43.03 3.35 
 
42.35 3.33 
 
42.40 4.01 
            Digit vigilance 
RT (ms) 
 
Visit 1 
 
425.65 36.69
 
436.72 39.38
 
434.76 39.11
 
Visit 2 
 
429.53 39.19 
 
430.89 36.03 
 
440.81 40.71 
 
Visit 3 
 
433.35 39.38 
 
438.05 38.57 
 
441.21 43.72 
            Digit vigilance 
commission 
errors 
 
Visit 1 
 
1.48 1.68
 
1.56 1.32
 
1.64 1.90
 
Visit 2 
 
1.48 1.75 
 
1.75 1.59 
 
2.16 1.92 
 
Visit 3 
 
2.23 1.89 
 
2.34 1.84 
 
2.00 1.60 
            RVIP score 
(correct/40) 
 
Visit 1 
 
17.91 7.65
 
19.64 6.61
 
20.18 7.09
 
Visit 2 
 
21.59 7.49 
 
24.34 7.04 
 
22.97 7.25 
 
Visit 3 
 
24.45 7.47 
 
24.13 7.64 
 
24.50 7.56 
            RVIP RT (ms) 
 
Visit 1 
 
395.26 39.03
 
384.65 46.28
 
375.48 35.28
  
Visit 2 
 
377.91 44.34 
 
378.06 46.89 
 
372.67 44.82 
  
Visit 3 
 
386.77 47.20 
 
381.23 41.81 
 
379.42 45.54 
    
        
RVIP 
commission 
errors 
 
Visit 1 
 
23.39 17.09 
 
19.27 17.56 
 
17.91 17.59 
 
Visit 2 
 
18.25 18.14 
 
17.94 18.88 
 
19.50 20.04 
 
Visit 3 
 
19.81 21.60 
 
18.69 19.18 
 
20.22 22.47 
            Serial 3s score 
(correct in 2 
minutes) 
 
Visit 1 
 
26.12 12.62
 
31.39 12.35
 
35.03 14.82
 
Visit 2 
 
39.32 14.22 
 
40.35 16.83 
 
42.32 16.92 
 
Visit 3 
 
43.72 16.35 
 
45.19 19.09 
 
46.41 17.69 
            
Serial 3s RT (ms) 
 
Visit 1 
 
3935.75 1490.55 
 
3612.64 1393.70 
 
3444.88 1505.46 
  
Visit 2 
 
3031.82 1119.44 
 
3045.28 1248.74 
 
2766.70 1056.58 
  
Visit 3 
 
2900.23 1285.32 
 
2771.11 1174.39 
 
2709.68 1202.84 
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Table 3.3 continued 
         Testing time point 
Cognitive 
variable 
 
Visit 
 
Session 1 
 
Session 2 
 
Session 3 
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
Serial 3s errors 
(incorrect in 2 
minutes) 
 
Visit 1 
 
2.97 2.38 
 
2.97 2.35 
 
2.48 2.43 
 
Visit 2 
 
2.35 2.46 
 
2.29 2.33 
 
2.90 2.26 
 
Visit 3 
 
1.66 2.74 
 
2.31 2.12 
 
2.06 2.23 
            Serial 7s score 
(correct in 2 
minutes) 
 
Visit 1 
 
15.38 7.25
 
17.79 6.41
 
19.44 7.49
 
Visit 2 
 
21.38 9.54 
 
23.28 9.85 
 
23.74 9.91 
 
Visit 3 
 
23.74 10.63 
 
24.56 11.05 
 
24.39 8.85 
            
Serial 7s RT (ms) 
 
Visit 1 
 
6844.93 2861.18 
 
6170.24 2859.86 
 
5428.16 2394.88 
  
Visit 2 
 
5637.11 2751.33 
 
5376.46 2555.78 
 
5156.44 2277.00 
  
Visit 3 
 
5339.91 2348.87 
 
4852.81 2305.07 
 
4864.63 2005.26 
            Serial 7s errors 
(incorrect in 2 
minutes) 
 
Visit 1 
 
2.03 1.45
 
2.31 1.86
 
2.69 2.35
 
Visit 2 
 
1.72 1.46 
 
2.42 2.39 
 
2.23 2.05 
 
Visit 3 
 
1.33 1.71 
 
2.69 1.96 
 
2.19 2.06 
                    
 
3.4.1.2.1 Motivation 
As a repeated covariate in the model, Motivation significantly predicted RVIP score 
[F(1,243.60)=9.49, p=0.002, beta=0.584], digit vigilance score [F(1,172.34)=6.54, p=0.011, 
beta=0.236], digit vigilance RT [F(1,237.80)=8.14, p=0.005, beta=-2.736], digit vigilance commission 
errors [F(1,224.24)=10.48, p=0.001, beta=-0.186], serial 3s score [F(1,197.14)=17.64, p<0.001, 
beta=1.311], serial 7s score [F(1,209.03)=11.28, p=0.001, beta=0.705], and serial 7s RT 
[F(1,219.22)=4.45, p=0.036, beta=-92.460], such that higher motivation was associated with better 
performance. Means and standard deviations for all motivation ratings collected during Experiment 
1.2 are shown in Table 3.4.  
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Table 3.4 Motivation data for Experiment 1.2 (n=33) 
 
        Testing time point 
Motivation 
 
Visit 
 
Session 1 
 
Session 2 
 
Session 3 
rating (out of 9) 
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
Digit vigilance rating 
 
Visit 1 
 
5.58 2.02 
 
5.03 1.93 
 
4.52 2.22 
  
Visit 2 
 
5.38 2.01 
 
4.88 2.25 
 
4.53 2.29 
  
Visit 3 
 
4.70 2.14 
 
4.41 2.01 
 
4.34 1.68 
            RVIP rating 
 
Visit 1 
 
5.03 2.02 
 
4.94 1.84 
 
4.38 2.15 
  
Visit 2 
 
4.87 2.00 
 
4.47 2.16 
 
4.26 2.32 
  
Visit 3 
 
4.84 2.03 
 
3.94 2.03 
 
3.91 1.94 
            
Serial 3s rating 
 
Visit 1 
 
5.67 1.73 
 
5.39 1.85 
 
5.36 1.78 
  
Visit 2 
 
5.69 1.58 
 
5.47 2.06 
 
5.41 2.11 
  
Visit 3 
 
5.97 1.96 
 
5.50 2.02 
 
5.50 1.97 
            
Serial 7s rating 
 
Visit 1 
 
5.97 1.79 
 
5.64 1.60 
 
5.27 1.84 
  
Visit 2 
 
5.53 1.57 
 
5.06 1.81 
 
5.00 2.21 
  
Visit 3 
 
5.58 1.71 
 
5.03 2.01 
 
5.06 1.81 
                   
 
3.4.1.2.2 Visit 
The Visit factor was a significant predictor of RVIP score [F(2,71.74)=26.88, p<0.001], RVIP RT 
[F(2,82.56)=3.59, p=0.032], digit vigilance commission errors [F(2,93.92)=4.94, p=0.009], serial 3s 
score [F(2,35.86)=49.65, p<0.001] and serial 3s RT [F(2,64.06)=30.25, p<0.001], serial 7s score 
[F(2,63.84)=32.34, p<0.001], and serial 7s RT [F(2,79.61)=44.95, p<0.001]. 
Pairwise comparisons showed performance improvements between Visits 1 & 2 for RVIP score 
[p<0.001], RVIP RT [p=0.026], serial 3s score [p<0.001], serial 3s RT [p<0.001], serial 7s score 
[p<0.001], and serial 7s RT [p<0.001]. Significant improvements between Visits 2 & 3 were only 
observed for serial 3s score [p=0.002], serial 3s RT [p=0.012], and serial 7s RT [p=0.002]. Therefore, 6 
of 12 DVs showed practice effects across test visits with 6 DVs showing significant changes between 
Visits 1 & 2 but only 3 showing significant changes between Visits 2 & 3. Error scores were generally 
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observed to remain stable across visits, irrespective of the type of cognitive task. The only exception 
was for commission errors produced during the digit vigilance task, where an increase in errors was 
observed between Visits 1 & 3 [p=0.007]. 
3.4.1.2.3 Session 
The Session factor was a significant predictor of performance for the majority of DVs. Performance 
improvements across sessions were observed for RVIP score [F(2,138.85)=5.51, p=0.005], RVIP RT 
F(2,133.46)=5.38, p=0.006], RVIP commission errors [F(2,116.65)=3.06, p=0.050], serial 3s score 
[F(2,105.34)=22.49, p<0.001], serial 3s RT [F(2,104.83)=12.12, p<0.001], serial 7s score 
[F(2,114.35)=16.54, p<0.001], and serial 7s RT [F(2,110.43)=28.16, p<0.001]. Conversely, significant 
decreases in performance across sessions were observed for digit vigilance score [F(2,117.55)=5.87, 
p=0.004], digit vigilance RT [F(2,127.82)=4.21, p=0.017], and serial 7s errors [F(2,133.11)=8.63, 
p<0.001]. 
Pairwise comparisons showed performance improvements between Sessions 1 & 2 for RVIP score 
[p=0.009], serial 3s score [p<0.001], serial 3s RT [p=0.008], serial 7s score [p=0.001], and serial 7s RT 
[p<0.001]. Significant improvements between Sessions 2 & 3 were only observed for serial 3s score 
[p=0.019], serial 3s RT [p=0.037], and serial 7s RT [p=0.020]. Therefore, 7 of 12 DVs showed practice 
effects across test sessions with 5 DVs showing significant performance improvements between 
Sessions 1 & 2 but only 3 showing continued improvements between Sessions 2 & 3. Decreases in 
performance between Sessions 1 & 2 were evident for digit vigilance score [p=0.019], and serial 7s 
errors [p=0.001], however this decline did not persist between Sessions 2 & 3 [p=0.996 & p>0.999 
respectively].  With the exception of serial 7s then, error scores were observed to remain stable 
across repeat sessions, irrespective of the type of cognitive task. Practice effects were more likely to 
persist across all repeat test sessions for the serial subtraction tasks, compared with RVIP and digit 
vigilance. 
3.4.1.2.4 Visit  x Session interactions 
A significant Visit x Session interaction observed for RVIP commission errors [F(4,86.94)=3.22, 
p=0.016] was explained by a significant increase in the number of errors between Sessions 1 & 3 at 
Visit 2 [p=0.012], but not at any other visits. For serial 3s score [F(4,82.51)=2.87, p=0.028] 
improvements were observed between Sessions 1 & 3 on Visit 1 [p<0.001] but not at any other 
visits, suggesting an attenuation of practice related improvement. 
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3.4.2 LMM analysis of the incidence of interference errors in the immediate & 
delayed recall tasks (Experiment 1.1 only) 
Mean interference errors with standard deviations, recorded at each time point, are presented in 
Table 3.1. IR interference errors were not predicted by any of the factors included in the model: Visit 
[F(2,73.11)=0.07, p=0.934]; Session [F(1,61.39)=0.38, p=0.538]; Visit x Session [F(2,71.07)=0.67, 
p=0.517], indeed the incidence of interference errors remained consistently low for the IR task 
throughout repeated testing. Conversely, DR interference errors were significantly predicted by all 
factors: Visit [F(2,54.91)=11.31, p<0.001]; Session [F(1,67.05)=44.29, p<0.001]; Visit x Session 
[F(2,71.07)=9.16, p<0.001]. Pairwise comparisons revealed a significant increase in the number of 
errors between Visits 1 & 2 [p=0.001] and Visits 1 & 3 [p=0.005], but not between Visits 2 & 3 
[p>0.999]. Increases in the number of errors at Session 2 relative to Session 1 were marginally 
significant at Visit 1 [p=0.032] and highly significant at Visits 2 & 3 [both p<0.001]. As expected by 
their nature, interference errors for the DR task were less prevalent at Visit 1 compared with later 
visits and occurred more often at the second session of testing on any given visit.  
3.4.3 Comparison of Cohen’s d effect sizes between visits and sessions for all 
cognitive tasks 
3.4.3.1 Experiment 1.1 
Cohen’s d effect sizes for cognitive changes observed in Experiment 1.1 are presented in Table 3.5. 
By comparing Cohen’s d effect sizes between visits, it can be seen that practice effect sizes between 
Visits 2 & 3 were reduced for 11 of 15 DVs when compared with effect sizes between Visits 1 & 2. 
The only exceptions were DR score, Serial 3s errors, Sternberg accuracy, and Stroop interference, 
where slight increases in practice effect sizes were observed. Between visit effect sizes for accuracy 
and error rates were typically lower than for other DVs reflecting overall stability in these measures. 
Practice effect sizes between same-day Sessions 1 & 2 were reduced when comparing Visits 2 & 3 
with Visit 1. For IR score, DR score and Stroop interference, where overall performance decreases 
were observed between same-day sessions, the magnitude of these negative Cohen’s d values 
increased at subsequent visits. 
3.4.3.2 Experiment 1.2 
Cohen’s d effect sizes for cognitive changes observed in Experiment 1.2 are presented in Table 3.6. 
By comparing Cohen’s d effect sizes between visits, it can be seen that practice effect sizes between 
Visits 2 & 3 were reduced for 8 of 12 DVs when compared with effect sizes between Visits 1 & 2. The 
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only exceptions were Serial 3s errors, where a slight increase in practice effect size was observed; 
and all of the digit vigilance DVs, where consistent decreases in performance were observed across 
visits. Between-visit effect sizes for error rates were typically lower than for other DVs reflecting 
overall stability in these measures. Practice effect sizes between same-day test sessions were 
typically reduced when comparing performance increases between Sessions 2 & 3 with increases 
between Sessions 1 & 2. Similarly, practice effect sizes between sessions were typically attenuated 
at Visits 2 & 3 relative to Visit 1. For RVIP, serial 3s, and serial 7s error scores, overall performance 
decreases were observed between same-day sessions. Similarly, consistent decreases in 
performance were observed between test sessions for all of the digit vigilance DVs. 
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Table 3.5 Cohen's d effect sizes for cognitive changes in Experiment 1.1 
 
    Mean practice effect size between Visits 
 
Mean practice effect size between Sessions 
Cognitive Measure 
       
Visit1 
 
Visit2 
 
Visit3 
  
 
Visit1-Visit2 
 
Visit2-Visit3 
 
Visit1-Visit3 
 
Session1-Session2 
 
Session1-Session2 
 
Session1-Session2 
Immediate recall score 
 
0.368 
 
0.333 
 
0.686 
 
0.395 
 
-0.104 
 
-0.354 
Delayed recall score 
 
0.117 
 
0.188 
 
0.304 
 
-0.173 
 
-0.440 
 
-0.650 
Serial 3s score 
 
0.351 
 
0.258 
 
0.608 
 
0.434 
 
0.311 
 
0.113 
Serial 3s RT 
 
0.273 
 
0.149 
 
0.450 
 
0.324 
 
0.150 
 
0.167 
Serial 3s errors 
 
-0.051 
 
-0.013 
 
-0.063 
 
-0.091 
 
0.116 
 
-0.238 
Serial 7s score 
 
0.250 
 
0.157 
 
0.409 
 
0.236 
 
0.097 
 
0.133 
Serial 7s RT 
 
0.198 
 
0.100 
 
0.321 
 
0.371 
 
0.305 
 
0.048 
Serial 7s errors 
 
0.183 
 
-0.018 
 
0.166 
 
-0.034 
 
-0.246 
 
0.087 
Sternberg accuracy 
 
-0.160 
 
-0.133 
 
-0.322 
 
-0.046 
 
-0.153 
 
0.043 
Sternberg scanning rate 
 
0.382 
 
0.081 
 
0.438 
 
0.100 
 
-0.088 
 
0.069 
Sternberg extrapolated RT 
 
0.159 
 
0.117 
 
0.259 
 
0.395 
 
0.221 
 
0.091 
Stroop accuracy 
 
0.053 
 
-0.036 
 
0.020 
 
0.131 
 
-0.269 
 
0.250 
Stroop incongruent RT 
 
0.148 
 
0.146 
 
0.293 
 
0.619 
 
0.112 
 
0.114 
Stroop congruent RT 
 
0.125 
 
0.112 
 
0.235 
 
0.557 
 
0.208 
 
0.356 
Stroop interference effect 
 
0.022 
 
0.058 
 
0.080 
 
0.002 
 
-0.217 
 
-0.528 
                    
Decreases in performance are prefixed with a minus sign 
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Table 3.6 Cohen's d effect sizes for cognitive changes in Experiment 1.2 
 
    
Mean practice effect size 
between Visits   Mean practice effect size between Sessions 
Cognitive measure 
     
Visit1 
 
Visit2 
 
Visit3 
  
 
Visit1-Visit2 
 
Visit2-Visit3  
 
S1-S2 
 
S2-S3 
 
S1-S2 
 
S2-S3 
 
S1-S2 
 
S2-S3 
RVIP score 
 
0.346 
 
0.136 
 
0.226 
 
0.106 
 
0.380 
 
0.183 
 
0.006 
 
0.054 
RVIP RT 
 
0.160 
 
0.069 
 
0.243 
 
0.239 
 
0.040 
 
0.114 
 
0.124 
 
0.047 
RVIP commission errors 
 
0.045 
 
-0.009 
 
0.213 
 
0.032 
 
-0.019 
 
-0.226 
 
0.012 
 
-0.086 
Digit vigilance score 
 
-0.097 
 
-0.045 
 
-0.136 
 
-0.086 
 
-0.239 
 
-0.049 
 
-0.305 
 
-0.128 
Digit vigilance RT 
 
-0.059 
 
-0.030 
 
-0.255 
 
-0.035 
 
0.012 
 
-0.249 
 
-0.132 
 
-0.032 
Digit vigilance commission errors 
 
-0.141 
 
-0.141 
 
0.037 
 
-0.011 
 
-0.077 
 
-0.218 
 
-0.022 
 
0.141 
Serial 3s score 
 
0.389 
 
0.190 
 
0.408 
 
0.260 
 
0.133 
 
0.076 
 
0.139 
 
0.08 
Serial 3s RT 
 
0.317 
 
0.091 
 
0.297 
 
0.129 
 
0.018 
 
0.128 
 
0.119 
 
0.052 
Serial 3s errors 
 
0.078 
 
0.177 
 
0.017 
 
0.186 
 
0.061 
 
-0.359 
 
-0.254 
 
0.11 
Serial 7s score 
 
0.370 
 
0.092 
 
0.274 
 
0.173 
 
0.250 
 
0.139 
 
0.116 
 
0.039 
Serial 7s RT 
 
0.196 
 
0.109 
 
0.361 
 
0.233 
 
0.201 
 
0.120 
 
0.210 
 
0.023 
Serial 7s errors 
 
0.123 
 
0.040 
 
-0.188 
 
-0.130 
 
-0.349 
 
0.103 
 
-0.859 
 
0.266 
                           
Decreases in performance are prefixed with a minus sign 
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3.4.4 LMM analysis of the changes in subjective mood across all test sessions 
3.4.4.1 Experiment 1.1 
Mental fatigue was significantly predicted by the factor Visit [F(2,58.82)=5.18, p=0.008] with 
pairwise comparisons revealing decreased ratings of fatigue at Visit 3 compared with both Visit 1 
[p=0.077] and Visit 2 [p=0.008]. Session number was also a significant predictor of mental fatigue 
[F(1,69.09)=7.24, p=0.009], with increased mental fatigue observed at Session 2 relative to Session 1. 
Positive affect was significantly predicted by Visit [F(2,53.70)=5.18, p=0.009], with pairwise 
comparisons revealing decreased positive affect at Visit 2 compared with Visit 1 [p=0.006]. 
Significant decreases in positive affect across same-day sessions were also evident 
[F(1,61.90)=13.24, p=0.001]. Moreover, the interaction between Visit x Session was also marginally 
significant [F(2,71.46)=3.13, p=0.050]. Significant decreases in positive affect between sessions were 
found at Visit 1 [p=0.001] and Visit 2 [p<0.001] only. Expected decreases in positive affect at the 
second session of testing on the final visit were likely to have been negated by positive feelings 
associated with completing the study. Reassuringly, no significant changes in negative affect were 
observed throughout testing.  
Means and standard deviations for all mood ratings recorded during Experiment 1.1 are shown in 
Table 3.7. 
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Table 3.7 Mood data for Experiment 1.1 (n=29) 
 
        Testing time point 
Mood variable 
 
Visit 
 
Session 1 
 
Session 2 
  
 
  
 
Mean SD 
 
Mean SD 
    
    
 
    
Mental fatigue (rating/9) 
 
Visit 1 
 
5.31 1.91 
 
6.10 1.74 
  
Visit 2  
 
5.48 1.70 
 
6.00 2.04 
  
Visit 3 
 
4.79 2.19 
 
5.03 2.04 
         
Positive affect (score/50) 
 
Visit 1 
 
24.66 7.59 
 
21.97 8.35 
  
Visit 2  
 
23.24 9.28 
 
19.55 7.55 
  
Visit 3 
 
22.76 7.86 
 
23.00 8.50 
Negative affect (score/50) 
 
Visit 1 
 
13.34 3.87 
 
12.72 4.10 
  
Visit 2  
 
12.86 4.56 
 
12.76 5.12 
  
Visit 3 
 
12.72 5.65 
 
12.38 2.88 
              
 
3.4.4.2 Experiment 1.2 
Mental fatigue was not significantly predicted by any of the factors. Positive affect was significantly 
predicted by the Visit factor [F(2,73.67)=3.48, p=0.036], with pairwise comparisons revealing 
decreased positive affect at Visit 2 compared with Visit 1 [p=0.039]. Significant decreases in positive 
affect across same day test sessions were predicted by the Session factor [F(2,126.73)=8.93, 
p<0.001]. Significant decreases in positive affect were found between Sessions 1 & 2 only [p<0.001]. 
Unexpectedly, negative affect was also significantly predicted by Session [F(2,136.12)=6.35, 
p=0.002]. Post hoc comparisons revealed a reduction in negative affect between Sessions 1 & 2 
[p=0.012].  
Means and standard deviations for all mood ratings recorded during Experiment 1.2 are shown in 
Table.3.8. 
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Table 3.8 Mood data for Experiment 1.2 (n=33) 
 
        Testing time point 
Mood variable 
 
Visit 
 
Session 1 
 
Session 2 
 
Session 3 
  
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
    
    
 
    
   Mental fatigue 
(rating/9) 
 
Visit 1 
 
5.00 1.94 
 
4.55 1.87 
 
5.10 2.04
 
Visit 2  
 
5.00 2.05 
 
4.28 2.23 
 
4.81 2.26 
 
Visit 3 
 
4.56 2.26 
 
4.81 2.26 
 
4.91 2.32 
            Positive affect 
(score/50) 
 
Visit 1 
 
24.76 7.07
 
22.30 7.92
 
22.13 9.27
 
Visit 2  
 
22.59 7.25 
 
20.34 7.29 
 
20.77 6.85 
 
Visit 3 
 
22.06 7.11 
 
20.47 6.69 
 
21.09 7.71 
 
           Negative affect 
(score/50) 
 
Visit 1 
 
13.38 3.97
 
12.31 3.82
 
12.27 3.23
 
Visit 2  
 
13.59 4.17 
 
12.31 3.24 
 
11.74 2.44 
 
Visit 3 
 
13.26 3.69 
 
13.03 3.61 
 
13.09 3.97 
                    
 
3.4.5 LMM analysis of the changes in perception of task difficulty for all cognitive 
tasks across all task repetitions 
3.4.5.1 Experiment 1.1 
Cognitive task type was a significant factor in predicting difficulty ratings [F(5,186.29)=20.12, 
p<0.001]. In task order, serial 7s was rated the most difficult (M 6.49, SD 1.89), followed by DR (M 
6.24, SD 1.79), IR (M 5.61, SD 1.64), serial 3s (M 5.17, SD 2.12), Sternberg (M 4.76, SD 2.06) and 
Stroop (M 4.26, SD 1.62). Difficulty ratings were also predicted by the Visit factor [F(2,595.30)=7.38, 
p=0.001], although not by Session [F(1,602.72)<0.01, p=0.947]. Tasks were perceived to become 
significantly easier between Visits 1 & 2 [p=0.030] and Visits 1 & 3 [p<0.001], but not between Visits 
2 & 3 [p=0.069]. Variations in ratings of difficulty were indicated by significant interactions: Session x 
Cognitive Task [F(5,602.72)=7.22, p<0.001]; Visit x Session [F(2,54.08)=6.54, p=0.002]; Visit x Session 
x Cognitive Task [F(10,544.08)=1.87, p=0.047]. The Visit x Cognitive Task interaction was not 
significant [F(10,595.30)=1.07, p=0.387]. Due to their complex nature, these interactions have not 
been fully interpreted here but are shown in Figure 3.2. 
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3.4.5.2 Experiment 1.2 
Cognitive task type was a significant factor in predicting difficulty ratings [F(3,204.29)=142.51, 
p<0.001]. In task order, RVIP was rated the most difficult (M 5.77, SD 2.03), followed by serial 7s (M 
5.72, SD 1.89), serial 3s (M 4.22, SD 1.86), and digit vigilance (M 2.84, SD 1.73). Difficulty ratings 
were also predicted by Visit [F(2,452.45)=22.98, p<0.001], and by Session [F(2,586.29)=37.75, 
p<0.001]. Tasks were perceived to become significantly easier between Visits 1 & 2 [p<0.001], and 
continued to do so between Visits 2 & 3 [p=0.003]. Similarly, tasks were perceived to become 
significantly easier between Sessions 1 & 2 [p<0.001], and this trend continued between Sessions 2 
& 3 [p=0.001]. Variations in difficulty rating patterns across cognitive tasks were indicated by 
significant interactions: Visit x Cognitive Task [F(6,585.91)=2.83, p=0.010]; Session x Cognitive Task 
[F(6,449.48)=2.72, p=0.013], and Visit x Session x Cognitive Task [F(16,447.23)=3.11, p<0.001]. Due 
to their complex nature, these interactions have not been fully reported here but are evident in 
Figure 3.2. 
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Figure 3.2 Subjective ratings of task difficulty for each cognitive task in Experiments 1.1 & 1.2 
Reported values are estimated marginal means. Error bars represent standard error of the mean 
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3.4.6 LMM analysis of the changes in motivation for all cognitive tasks across all 
task repetitions 
Mean motivation ratings for all cognitive tasks used in Experiments 1.1 & 1.2 can be found in Table 
3.3 and Table3.4, respectively. 
3.4.6.1 Experiment 1.1 
Cognitive task type was a significant factor in predicting motivation ratings [F(5,262.17)=10.42, 
p<0.001]. In task order, motivation was rated highest for IR (M 6.30, SD 1.93), followed by Stroop (M 
6.15, SD 1.86), DR (M 6.08, SD 2.04), serial 3s (M 6.02, SD 2.06), serial 7s (M 5.71, SD2.21) and finally 
Sternberg (M 5.38, SD 2.09). Motivation ratings were also predicted by Visit [F(2,537.87)=8.03, 
p<0.001], and by Session [F(1,481.32)=15.14, p<0.001]. Motivation dropped significantly between 
Visits 1 & 2 [p=0.007], but increased again between Visits 2 & 3 [p=0.001]. Motivation also dropped 
between Sessions 1 & 2 [p<0.001]. Variations in motivation patterns across cognitive tasks were 
indicated by a significant interaction between Session x Cognitive Task [F(5,481.32)=2.72, p=0.019]; 
motivational differences apparent between cognitive tasks at Session 1 were less apparent at 
Session 2.  No other significant interactions were evident. 
3.4.6.2 Experiment 1.2 
Cognitive task type was a significant factor in predicting motivation ratings [F(3,225.84)=21.04, 
p<0.001]. In task order, motivation was rated highest for serial 3s (M 5.55, SD 1.88), followed by 
serial 7s (M 5.35, SD 1.83), digit vigilance (M 4.82, SD 2.08), and RVIP (M 4.52, SD 2.07). Motivation 
ratings were also predicted by Visit [F(2,414.59)=5.28, p=0.005], and by Session [F(2,558.39)=27.76, 
p<0.001]. Motivation significantly decreased between Visits 1 & 3 [p=0.004]. Similarly, motivation 
decreased between Sessions 1 & 2 [p<0.001], and this trend continued between Sessions 2 & 3 
[p=0.048]. There were no significant interactions between Cognitive task, Visit or Session. 
3.4.7 LMM analysis of time of day effects 
After combining serial subtraction and mood data from Experiments 1.1 & 1.2 in order to increase 
statistical power, LMM analysis revealed that Time of Day was a significant predictor of serial 3s 
errors [F(1,71.49)=6.66, p=0.012]. More errors were made in the morning (M 2.92, SE 0.24) 
compared with the afternoon (M 2.07, SE 0.23). For serial 7s score, the Time of Day x Visit 
interaction was significant [F(2,111.67)=5.80, p=0.004]; at Visit 2 participants scored higher in the 
morning (M 25.92, SE 1.64) compared with the afternoon (M22.47, SE 1.60), however statistical 
significance of this pairwise comparison was not maintained following Bonferroni correction 
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[p=0.087]. For positive affect, the Time of Day x Visit interaction was similarly significant 
[F(2,107.87)=4.32, p=0.016]. At Visit 1 [p=0.053] & Visit 2 [p=0.056] participants rated positive affect 
higher in the mornings (MV1 24.79 SEV1 1.15; MV2 22.66, SEV2 1.13) than in the afternoons (MV1 21.93 
SEV1 1.12; MV2 19.89, SEV2 1.10). Time of day was not a significant predictor of performance for any 
other DV included in the analysis. 
3.4.8 Intraclass correlation coefficients for the determination of alternate-form 
reliability 
ICCs for all cognitive tasks are reported in Table 3.9. 
Alternate-form reliability was acceptable for all cognitive DVs with the exception of error scores for 
the serial 3s & 7s and digit vigilance tasks, and the accuracy score for the Stroop task. However, in 
light of the good scores for the other DVs determined for each of these tasks, the poor ICC scores 
were more likely due to low between-subjects variability in the data rather than an indication that 
alternate forms were not suitably equivalent (Weir, 2005). 
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Table 3.9 ICC values for all cognitive tasks in Experiment 1.1 & Experiment 1.2 
 
      
Cognitive Measure 
 
ICC 
  
 
  
Experiment 1.1: 
  Immediate recall score 
 
0.44 
Delayed recall score 
 
0.42 
Serial 3s score 
 
0.90 
Serial 3s RT 
 
0.83 
Serial 3s errors 
 
0.25 
Serial 7s score 
 
0.90 
Serial 7s RT 
 
0.77 
Serial 7s errors 
 
0.38 
Sternberg accuracy 
 
0.53 
Sternberg scanning rate 
 
0.41 
Sternberg extrapolated RT 
 
0.67 
Stroop accuracy 
 
0.27 
Stroop incongruent RT 
 
0.86 
Stroop congruent RT 
 
0.86 
Stroop interference effect 
 
0.54 
   Experiment 1.2: 
  Serial 3s score 
 
0.83 
Serial 3s RT 
 
0.88 
Serial 3s errors 
 
0.05 
Serial 7s score 
 
0.77 
Serial 7s RT 
 
0.89 
Serial 7s errors 
 
0.35 
Digit Vigilance correct 
 
0.56 
Digit Vigilance RT 
 
0.60 
Digit Vigilance commission errors 0.31 
RVIP correct 
 
0.67 
RVIP RT 
 
0.61 
RVIP commission errors  0.82 
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3.5 Discussion 
The purpose of this experimental chapter was to pilot the selected cognitive tasks before including 
them in subsequent blueberry intervention work; in particular, the aim was to investigate the effects 
of repeated exposure to a task on cognitive performance, within and between multiple test days. By 
gaining a better understanding of the patterns of cognitive practice effects it was hoped to reduce 
this confound by adopting appropriate methodology. Practice effects were evident for all cognitive 
tasks investigated in Experiment 1.1 and Experiment 1.2, either across weekly visits or between 
same-day sessions despite the use of alternate forms of each task and familiarisation trials 
immediately before the start of each test performance. However, in accordance with previous 
findings (Bartels et al., 2010; Collie et al., 2003; Falleti et al., 2006) the strongest practice effects 
appeared between Visits 1 & 2, such that Cohen’s d effect sizes would be attenuated in all cases by 
discarding data from the first visit. Specifically, significant practice effects remained evident between 
visits 2 & 3 for IR score, serial 3s score, serial 7s score and Stroop incongruent RT in Experiment 1.1; 
and for serial 3s score and RT, and serial 7s RT in Experiment 1.2. But effect sizes were attenuated in 
all cases when compared with performance increases observed between Visits 1 & 2. Therefore a 
separate familiarisation visit followed by a period of consolidation before data collection, is likely to 
aid in addressing the impact of practice related improvements on test performance between visits. 
In both experiments, practice effect sizes between same day sessions were similarly reduced at Visits 
2 & 3 compared with Visit 1. In Experiment 1.1 significant improvements evident between Sessions 1 
& 2 at Visit 1 for IR score, serial 3s score, serial 7s RT, and Stroop congruent & incongruent RT, were 
greatly attenuated by Visit 3. Interestingly in Experiment 1.2, where three test sessions were 
performed per visit, it was evident that performance increases were also attenuated between 
Sessions 2 & 3, when compared with increases observed between Sessions 1 & 2. However 
significant increases in performance across Sessions 2 & 3 still remained evident for serial 3s score & 
RT, and serial 7s RT. The results suggest that familiarisation trials, whether on a separate visit or 
immediately prior to data collection, are likely to be ineffective at actually eliminating practice 
effects between same day test sessions. A similar observation was made by Lemay et al (Lemay et 
al., 2004). Indeed, the lack of a Visit x Session interaction for the majority of the DVs reported here 
suggests that performance increases across multiple testing points on a single day remain relatively 
constant between visits, with only slight attenuation of effect sizes at subsequent visits. After 
excluding Visit 1, residual between-session practice effects were evident only as small Cohen’s d 
effect sizes (d=0.01-0.35). Nevertheless in nutrition intervention studies, nutrient effect sizes 
typically range from small to moderate. For example, effect sizes following acute flavonoid 
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intervention have been reported to range upwards from d=0.16 (Bell et al., 2015). Therefore even 
small practice effect sizes may impact statistical power in a nutrition intervention study. Future 
consideration of how to take practice effects into account in a priori power calculations may provide 
a solution to the problem of underpowered nutrition intervention studies. 
The statistically significant improvements in task performance between test days shown here 
remained apparent when the variance accounted for by motivation was included in the model. By 
including motivation, this supports the notion that the observed effects are likely related to practice, 
although other variables such as mood or fatigue cannot be ruled out. As a covariate, motivation 
was found to significantly predict episodic memory (IR and DR) recall, Stroop, RVIP, digit vigilance 
and serial 7s task performance. With the exceptions of Stroop and digit vigilance, these tasks were 
also rated to be the most difficult tasks overall. Therefore, when tasks were particularly difficult 
motivation was a strong predictor of performance, independently of practice effects. Motivation was 
reported retrospectively and so it is possible that participants reported high motivation when they 
felt they had performed well during the task, even though direct feedback was not given. However if 
this was the case, motivation might be expected to have been a significant predictor of performance 
for all of the cognitive tasks investigated. Fatigue is also likely to be a major contributing factor to 
task performance. As expected following an extended period of cognitive testing, mental fatigue was 
observed to increase at session 2 relative to session 1 and may also have impacted on subjective 
ratings of motivation. Perceptions of task difficulty were observed to decrease over time for all 
cognitive tasks, suggestive of a general practice effect. After repetition, the tasks were rated as 
becoming easier and performance on the tasks improved. Minor fluctuations in this downward trend 
in perceived difficulty are again likely to result from the impact of fatigue on participants’ 
retrospective, subjective ratings. Interestingly, accuracy or error scores were observed to remain 
relatively unaffected by repeat performance for the Stroop, Sternberg, RVIP, digit vigilance and serial 
subtraction tasks. With the exception of the RVIP task, participants were performing near ceiling 
levels on each of these measures. Although appearing resistant to practice, these measures may 
have little practical application in nutrition intervention work as high accuracy scores leave little 
room for cognitive improvement following an intervention. Nevertheless, task parameters were not 
altered at this stage as the tasks were designed to replicate those used in previous research (Chapter 
2) and RT measures are more commonly reported for these tasks. 
Depending on the cognitive task, different performance related effects of repeated exposure were 
observed. It has been demonstrated that practice related effects are evident across separate visits 
and same day sessions of testing, particularly for tasks measuring working memory (RVIP, serial 
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subtraction). For attention based DVs including Stroop interference effect and digit vigilance score & 
RT, and episodic memory DVs such as immediate and delayed recall score, practice-related 
improvements observed across visits were slight or not present at all, but apparent decreases in 
performance were observed between same day test sessions. For the IR & DR episodic memory tasks 
there is some suggestion of interference at the second session of each visit, that counters practice 
related improvements. The LMM analysis revealed that motivation significantly predicted memory 
performance and so motivational decreases are likely to account for some of the observed decreases 
in performance between these same day sessions, although as discussed above, motivation may be 
confounded with mental fatigue. Word list interference from the previous session is also likely to be 
a major contributing factor here (Greenberg & Underwood, 1950; Underwood, 1957). Indeed, 
analysis of the interference error scores revealed the stable presence of low level interference for 
the IR task, and significant increases in interference across Visits and Sessions for the DR task. 
Performance decreases on the Stroop interference measure are more complex. In fact, overall 
reaction times decreased between sessions, but more so for the congruent trials, resulting in an 
increased interference effect. This is a potentially interesting observation that warrants further 
investigation, particularly as previous research has often, though not always, shown the Stroop 
interference effect to be reduced by practice (Macleod, 1991).Therefore, it is important to interpret 
Stroop interference effect changes with reference to the underlying reaction times. For the digit 
vigilance task, where sustained attention was required for a sustained period on a relatively simple 
task, decreases in performance appear simply to reflect increased fatigue. Interestingly, where 
interference related performance decreases were observed between same day sessions (Stroop, IR, 
DR), Cohen’s d effect sizes increased at all subsequent visits. This appears consistent with the notion 
that practice related improvements had been attenuated and therefore interfering effects now 
demonstrated greater magnitude in the opposing direction. 
The Sternberg task appears relatively robust to practice compared to the other cognitive tasks 
investigated here; an observation shared by previous research (Kristofferson, 1972, 1977; Sternberg, 
1975). Overall, extrapolated RT performance did speed up slightly due to practice, which may be 
explained by faster visual processing, decision making or motor output. However the main DV for 
the task measures how fast participants can scan items in their STM, and the above cited research 
shows this to be a fixed time per item that cannot be changed by practice, reflecting a fundamental 
cognitive process. Despite this, the observational data here suggest some practice related 
improvement between visits 1 & 2 but performance appeared to stabilise after this. Similarly, task 
performance appeared to stabilise after Visit 1 for the RVIP task, although this is likely to reflect the 
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attainment of a ceiling level of performance imposed by task parameters rather than a cognitive 
process. 
For the subjectively reported mood measures, as might reasonably be expected after an extended 
period of cognitive testing, higher ratings of mental fatigue were observed at Session 2 relative to 
Session 1, within visits. However this effect was observed in Experiment 1.1 only, possibly due to the 
longer duration of the cognitive battery in this experiment. A decrease in positive mood was also 
observed at Session 2, this time in both experiments. However it was evident from Experiment 1.2 
that no further decreases in positive mood occurred between Sessions 2 & 3. In general, positive 
affect scores remained just below mid-range. No corresponding increases in negative affect were 
observed, in fact negative affect actually decreased between Sessions 1 & 2 in Experiment 1.2. This 
may reflect a reduction in anxiety initially present when facing the prospect of an extended period of 
cognitive testing. Together, these measures imply no serious negative consequences for participants 
in terms of fatigue, or mood over prolonged periods of repeated testing. 
Times of day effects were limited to serial 3s errors, serial 7s score, and positive affect. With the 
exception of serial 3s errors, performance was generally better in the mornings. However, any 
observed differences were minimal and no longer reached statistical significance following 
corrections for multiple comparisons. This suggests that diurnal effects may have little impact on 
cognition or mood. However, the cognitive findings were based on serial subtraction data only and 
may not generalise to other cognitive domains. Regardless of time of day or cognitive domain, 
alternate-forms reliability analysis revealed acceptable consistency between the different forms of 
each task used at successive time points. 
There are some shortcomings to this study. The effects of practice have not been investigated 
beyond a period of three weeks; the findings are exclusive to the tests examined; and the effects of 
including dual baselines (McCaffrey, Ortega, Orsillo, Nelles, & Haase, 1992), such as those used by 
Scholey et al. (Scholey et al., 2010), have not been investigated.  Dual baseline designs discard the 
first session of data collected on each visit. The findings of Experiment 1.2 support the theory that 
between session practice effects may be attenuated, but not eliminated by this method. The findings 
of the study demonstrate that practice cannot be assumed to have been adequately addressed 
through the use of alternate forms of stimuli or familiarisation trials immediately prior to data 
collection, and suggest that dual baseline designs may be an effective addition to crossover study 
methodology in their ability to attenuate practice effects. But the method is likely to be better suited 
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to short cognitive test batteries, and the optimal length of time between the first and second 
performance of the test battery needs further investigation. 
Contrary to previous findings (Bartels et al., 2010; Falleti et al., 2006) but consistent with theories of 
learning and memory, within a nutrition intervention design framework the effects of practice have 
been observed to persist well past the first two repeat sessions of cognitive testing on the majority 
of tasks investigated here. The only exceptions were the Sternberg memory scanning task and RVIP 
task that appeared to become relatively resistant to practice-related improvements after an initial 
test visit. Practice can interact with a nutrition intervention such that more learning takes place in 
the active condition and then what is learned is retained and causes elevated performance in the 
control condition, masking intervention effects for half the participants in a typical counterbalanced 
crossover design. Conversely, care must be taken to ensure that improvements in performance 
arising from repeated practice of the task when the control condition is performed first are not 
confused with those associated with the intervention. Therefore the use of practice resistant tasks 
or appropriate methodology, as outlined below, for minimising the influence of practice effects is 
paramount. Motivation and fatigue clearly also contribute to cognitive performance, particularly for 
more difficult cognitive tasks. The relationship between motivation, fatigue and practice requires 
further investigation. 
The findings of this experiment are likely to generalise as similar memory, reaction time and 
accuracy components are inherent in all commonly used cognitive tasks. In future intervention 
studies, whether that be nutritional or pharmacological, it is recommended that methodologies take 
practice effects into account; a summary of recommendations is included in the final paragraph. For 
studies which have already reported effects of nutrition interventions, care should be taken when 
retrospectively calculating effect sizes. For example in the absence of an appropriate control 
condition, effect size may be inflated by practice. On the other hand, a study may be underpowered 
as a result of the additional variance introduced by practice (McCaffrey, 2001). In the absence of 
good design and/or replication, effect sizes for nutrition interventions should be accepted with 
caution (Bell et al., 2015). 
3.5.1 Conclusion 
Methodological recommendations emerging from the experiment include the importance of an 
initial familiarisation visit which is on a separate day to subsequent testing. Indeed, further 
investigation is required to determine the impact of the length of time between familiarisation and 
test days. The inclusion of at least one baseline at each visit within a counterbalanced framework 
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including the control, and the use of tasks with a reduced susceptibility to practice such as RVIP and 
Sternberg is also recommended. Alternate forms and familiarisation trials are also recommended at 
each task performance, along with a between participants counterbalanced order of tasks within a 
battery. As these measures will only minimise, not eliminate practice effects, residual practice 
effects should always be taken into account in the design stage when selecting the number of 
participants required to adequately power a crossover intervention study. Additionally practice 
effects may be taken into account in the data analysis stage. For example, using LMM analysis it is 
possible to include testing order as a factor within the analysis model. Parallel designs, with a 
separate control group of participants, may be used to mitigate practice effects, but will add 
between-subjects error variance and increase the number of participants needed. An active 
intervention may also interact with practice, for example through improved strategy selection. 
Therefore it is still recommended to address practice effects in a parallel design if there is a repeated 
testing component, such as with longitudinal designs.  In combination, these measures will aid in 
improving the reliability and validity of repeated cognitive testing in nutritional intervention designs 
and, as such, have been included in the methodology of all blueberry experiments in this thesis. 
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Chapter 4  
Experiment 2: A dose-response study of cognitive and 
blood pressure effects following acute anthocyanin-rich 
blueberry supplementation in healthy young adults 
4.1 Introduction 
In order to fully understand the acute effects of anthocyanin-rich blueberries on human cognition, it 
is critical to determine the most effective doses and their mode of action. Preclinical trials carried 
out in animal models have clearly demonstrated cognitive benefits from berry flavonoids e.g. (Carey, 
Gomes, & Shukitt-hale, 2014; Kumar, Arora, Kuhad, & Chopra, 2012; Rendeiro et al., 2013; Shukitt-
Hale et al., 2015). However, human data is more mixed. Indeed, as shown in Chapter 1, acute studies 
are often not consistent in their choice of flavonoid-rich food type, population, cognitive outcome or 
dose, making direct comparison between studies difficult. 
Some studies have sought to directly link cognitive outcomes following flavonoid-rich intervention 
with concurrently measured physiological changes in order to determine a likely mode of action. 
Francis et al. (2006) observed increased cerebral blood flow (CBF) in healthy females one to two 
hours after acute supplementation with 450mg cocoa flavanol. However, no corresponding 
behavioural improvements were observed using a cognitive switching task paradigm. The study 
tested only four participants, so it may have been lacking the statistical power necessary to observe 
such behavioural effects. A larger, more recent study by Brickman et al. (2014) developed a pattern 
recognition task that demonstrated functional localisation to the dentate gyrus region of the 
hippocampus. After a 3 month period of daily supplementation with 900mg cocoa flavanol, 19 older 
adults showed significant improvements in both task performance and regional BOLD activation 
compared to a control group of 18 participants that consumed a lower daily dose of 10mg cocoa 
flavanol. However, although the study provides strong, domain-specific evidence for a connection 
between increased CBF and cognitive task performance, the study did not investigate acute 
intervention and it is also unclear from the paper whether cognitive performance and CBF were 
measured concurrently.  
The above studies relate only to flavanol-rich cocoa. Dodd (2012) reported an acute effect of 
blueberries on human cognitive performance in young adults in a task measuring executive function 
after administering a freeze-dried blueberry powder containing 631mg anthocyanins. The observed 
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improvement in cognitive performance was also accompanied by a trend towards increased plasma 
BDNF levels. And the same dose of anthocyanin-rich blueberry was also found to increase cerebral 
blood flow to the precentral and middle frontal gyrus in the frontal lobe, and the angular gyrus in the 
parietal lobe, 1 hour post-consumption, when compared to a control. The study provides evidence 
that anthocyanin-rich blueberries are associated with acute changes in cognition and CBF, although 
again these were not observed concurrently. The study also suggests that acute supplementation 
may result in chemical changes in the brain normally associated with longer term supplementation. 
A similar acute intervention study (Watson et al., 2015) observed  cognitive improvements following 
acute blackcurrant supplementation that were accompanied by significant inhibition of monoamine 
oxidase (MAO) activity and sustained elevation of plasma glucose levels. 
It is likely, then, that increases in cognitive performance after acute supplementation with 
blueberries are, at least in part, due to cerebral blood flow increases, although this has only been 
demonstrated indirectly, but other mechanisms including BDNF synthesis, MAO inhibition and blood 
glucose regulation may play a role. However, the limited aforementioned evidence demonstrates 
that it is difficult to directly match behavioural effects with physiological changes such as increases in 
cerebral blood flow; these measures often involve expensive, complex or lengthy procedures that 
cannot be easily combined with cognitive testing at the same time points, or for a large sample of 
participants.  
With regard to the effects of dose, as identified in Chapter 1, few studies have investigated the 
impact of dose on cognition and those that do typically investigate only two or three doses e.g. 
(Kennedy et al., 2000; Pase et al., 2013; Scholey et al., 2010; Whyte et al., 2016; Wightman et al., 
2012). The majority of these studies investigated cocoa and ginkgo biloba effects. The cognitive 
effects of dose are therefore yet to be fully elucidated, particularly following anthocyanin-rich berry 
intervention. However, dose-dependent vascular effects following acute blueberry supplementation 
have been observed; Rodriguez-Mateos et al (2013) measured changes in flow mediated dilation 
(FMD) of the brachial artery over time and in response to five doses of blueberry and a control. FMD 
measures the level of naturally occurring dilation by an artery in response to shear stress, and is a 
measure of cardiovascular health. Maximum increases in FMD were observed 1-2 hours after 
ingestion. Significant dose-dependent increases in FMD response were observed across doses 
ranging from 319-766mg of total polyphenols (129-310mg anthocyanins). Peak FMD response was 
observed following a polyphenol dose of 766mg (310mg anthocyanins). At higher doses, up to 
1791mg total polyphenols (724mg anthocyanins) the FMD response was observed to plateaux. FMD 
and CBF responses are likely to be synonymous as evidenced by a correlation found between FMD 
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and coronary blood flow (Teragawa et al., 2005), and a correlation found between FMD and BOLD 
response for a working memory task (Gonzales et al., 2010). As reported in Chapter 1, the timings of 
observed FMD, CBF and cognitive effects following acute supplementation with flavonoid-rich foods 
appear similar. Timings, of course, vary according to the flavonoid subclasses present in the food 
source; however following anthocyanin-rich berry interventions FMD, CBF and cognitive effects have 
each been independently observed around 1-2 hours postprandially. As FMD effects have been 
shown to be dose-dependent (Rodriguez-Mateos et al., 2013), beneficial cognitive effects may also 
be dose-related. 
The current experiment aimed to determine a dose-response for the cognitive effects of blueberry 
flavonoids, using doses matched exactly to those used by Rodriguez-Mateos et al. (2013) for which 
vascular changes have already been documented. In this way, it was hoped to link dose-related 
cognitive effects with known dose-related vascular effects whilst avoiding the inherent difficulty of 
measuring the two concurrently. Blood pressure measurements were included in the design as an 
alternative indicator of vasoreactivity. As described in Chapter 1, a lowering of blood pressure has 
been observed following both acute and chronic flavonoid supplementation, likely due to their 
vasodilatory properties. Blood pressure measurements and cognitive testing were performed pre- 
and 1 hour post-intervention in order to coincide with the maximum increases in FMD observed by 
Rodriguez-Mateos et al. (2013). The tasks incorporated into this study were those previously 
identified in the literature review as sensitive to flavonoid-rich intervention, and that were 
subsequently investigated for practice effects in the previous chapter. The methodology used here 
reflected the findings of that study, in order to comply with EFSA guidelines on addressing practice 
effects in studies utilising repeated cognitive testing. 
4.2 Methods 
Methodological detail common to all experiments in this thesis can be found in Chapter 2. 
Methodology specific to this intervention study is reported here. 
4.2.1 Participants 
The participants were 45 healthy adults, aged 18-36 years (M 20.87, SD 3.63 years). All participants 
were screened according to criteria outlined in Chapter 2. 
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4.2.2 Design 
A double-blind crossover intervention study design was used. Independent variables were blueberry 
dose (6 levels; 5 doses and a matched control) and test session (2 levels; pre- and 1 hour post-
intervention). All testing took place in the morning. Participants attended a total of 7 regularly 
spaced visits. The mean number of days between visits was 7, but ranged from a minimum of 3 days 
to a maximum of 14 days where occasional rescheduling was required to compensate for missed 
appointments.  In order to minimise the impact of practice on cognitive task performance, in 
accordance with the findings of Chapter 3, the first visit was treated as a familiarisation visit. 
Cognitive and physiological data collected during this visit were not included in subsequent analyses. 
Participants were not made aware of this and followed the same procedure as for all other visits, 
with the exception that participants were permitted as much practice as they required in order to 
feel comfortable with the cognitive tasks. The cognitive battery lasted 40 minutes. The different 
blueberry doses were administered in drink form. The drink consumed at the familiarisation visit was 
identical to the control. At subsequent visits, the control and all blueberry doses were administered 
in counterbalanced order, determined using Williams matrices (Williams, 1949).  
4.2.3 Procedure 
At each visit participants arrived 2 hours fasted having previously followed the prescribed 24 hour 
low polyphenol diet (Chapter 2). They completed a pre-intervention battery of cognitive tasks and 
blood pressure measurements. Participants then consumed a blueberry or control drink. Participants 
were required to finish the drink within a ten minute time period (Rodriguez-Mateos et al., 2013), 
after which they were asked to remain in the lab waiting room. During this time participants 
completed a 24 hour retrospective food diary to check for compliance with the low polyphenol diet. 
A post-drink palatability questionnaire was also completed to determine opinions on the drinks and 
to establish whether participants were remaining blind to the intervention. Participants resumed 
testing, repeating the cognitive task battery and blood pressure measurements, at the post-
intervention time point of 1 hour. A return appointment was then booked for the following week, at 
the same start time. Participants were asked to eat the same breakfast prior to fasting before each 
attendance. 
4.2.4 Blueberry intervention drinks 
The blueberry doses were aligned with those used in the previous vascular study (Rodriguez-Mateos 
et al., 2013). In the vascular study the drinks were not matched for sugars or vitamin C. In the 
current study they were matched to the highest dose on these constituents to avoid potential 
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confounding effects on cognition. As the same source/batch of freeze-dried wild blueberry powder 
was used for both studies, the compositional analysis of the drinks was taken from the previous 
study and is shown in Table 4.1. The drinks were prepared immediately prior to consumption by 
adding the appropriate amounts of freeze-dried blueberry powder, sugars and vitamin C to 500ml of 
water. These were mixed until smooth using opaque coloured protein shaker cups commonly used 
in sports nutrition. Participants consumed the drinks through a black straw, before completing a 
palatability questionnaire. 
Table 4.1. Compositional analysis of the control and blueberry drinks in Experiment 2 
   
  Freeze-dried wild blueberry powder (g) 
Composition Control 14 28 34 57 80 
Anthocyanins (mg) 0 129 258 310 517 724 
Procyanidins (mg) 0 57 114 137 228 320 
Total polyphenols (mg) 0 319 639 766 1278 1791 
Vitamin C (mg) 9.5 9.5 9.5 9.5 9.5 9.5 
Fructose (g) 21 21 21 21 21 21 
Glucose (g) 19 19 19 19 19 19 
 
4.2.5 Cognitive & subjective measures 
Full details of the selected cognitive tasks are given in Chapter 2. The order of the tasks was: 
immediate word recall (IR);  Stroop task, Sternberg memory scanning task, and serial 3s & 7s 
subtraction tasks, in between-subjects counterbalanced order; delayed word recall (DR); PANAS Now 
mood questionnaire. 
4.2.6 Physiological measures 
Blood pressure and resting heart rate were measured after all cognitive tasks had been completed. 
Participants had therefore been seated for a minimum of 30 minutes prior to the measurements. 
Equipment details and measuring procedure are reported in Chapter 2. 
4.3 Data analysis 
Data collected during Visit 1 were discarded prior to analysis and any outliers were removed from 
the remaining data for Visits 2-7 according to criteria previously described in Chapter 2. 
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4.3.1 Linear mixed models 
All cognitive and mood data were analysed by LMM using an unstructured covariance matrix to 
model successive repeat measurements. Visit, Session, Dose, and Session x Dose interaction were 
included as fixed factors in the model. The factor Visit was included in the LMM model for each 
dependent variable in order to identify and account for the presence of any order effects. Subjects 
were included as random effects (Model 2.1). The analysis aim was to determine whether blueberry 
dose was a significant predictor of cognition or mood performance. However, for the analysis of the 
interference errors DV for the immediate and delayed recall tasks, the random effects component 
was removed from the LMM procedure (Model 2.2). This modification was necessary in order to 
counter the large number of zero scores present in the data set. Some participants showed no 
variation at all in their scores, causing an error in the modelling of the covariance matrix when 
including random effects (West et al., 2015). Pairwise comparisons were used to investigate 
significant effects and all interactions (see Chapter 2 for rationale). A Bonferroni correction was 
applied to all multiple comparisons. 
Blood pressure measurements were analysed using the same model as above (Model 2.1). The 
analysis aim was to determine whether blueberry dose had a mediating effect on postprandial blood 
pressure and heart rate. Palatability ratings for the intervention drinks were analysed by LMM using 
an unstructured covariance matrix to model successive ratings. Dose was the only fixed factor in the 
model (Model 2.3). The analysis aim was to determine whether the intervention drinks were 
adequately matched for flavour across a number of different taste dimensions. 
4.3.2 Cohen’s d effect sizes 
Cohen’s d effect sizes (see Chapter 2 for calculation method) were determined where pairwise 
comparisons revealed significant changes from baseline at 1 hour postprandially following blueberry 
intervention, but not following the control intervention (or vice versa). 
4.4 Results 
Raw data for all measured variables can be found in the supplementary data accompanying this 
thesis. Means and standard deviations for all recorded variables are tabulated under the relevant 
sections of the chapter. Tabulated LMM results can be found in Appendix L. For clarity, only 
significant F-statistics are reported in full in the text. 
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4.4.1 Cognitive analysis 
4.4.1.1 Order effects and baseline differences 
For the episodic memory tasks, Visit was a significant predictor of delayed recall score 
[F(5,219.14)=2.98, p=0.013] and a trend was evident for immediate recall score [F(5,219.21)=1.88, 
p=0.098]. Pairwise comparisons revealed a significant improvement in delayed recall score between 
Visit 2 (M 5.91, SE 0.43) and Visit 7 (M 6.93, SE 0.44) [p=0.006]. Slight improvements in immediate 
recall score were found not to be statistically significant [p>0.1]. 
For the serial subtraction tasks, Visit was a significant predictor of 3s score [F(5,219.20)=80.02, 
p<0.001], 3s RT [F(5,218.15)=109.92, p<0.001], 7s score [F(5,218.11)=27.62, p<0.001], and 7s RT 
[F(5,192.26)=20.45, p<0.001]. Pairwise comparisons revealed a significant increase in 3s score 
between Visit 2 (M 38.74, SE 2.74) and Visit 7 (M 55.90, SE 2.74) [p<0.001]. Significant 3s score 
improvements were maintained between consecutive Visits 2 & 3, 4 & 5, and 5 & 6 [p<0.05]. 
Similarly, for 3s RT, a significant improvement was observed between Visit 2 (M 2878.72, SE 102.52) 
and Visit 7 (M 2050.25, SE 102.77) [p<0.001]. Significant improvements were observed between all 
consecutive, intermediate test visits up to Visit 6 [p<0.05].  Pairwise comparisons for 7s score 
revealed a significant increase between Visit 2 (M 21.97, SE 1.70) and Visit 7 (M 29.78, SE 1.71) 
[p<0.001]. However, consecutive improvements were observed between Visits 6 & 7 only [p=0.002]. 
For 7s RT, a significant improvement was again observed between Visit 2 (M 5226.32, SE 245.47) and 
Visit 7 (M 4164.13, SE 246.60) [p<0.001]. Marginally significant gains were observed between Visits 2 
& 3 [p=0.065], however no further significant gains were observed between later consecutive test 
visits. 
For the Sternberg task, Visit was a significant predictor of accuracy [F(5,206.40)=5.67, p<0.001], 
scanning rate [F(5,219.80)=7.69, p<0.001], and extrapolated RT [F(5,219.23)=3.79, p=0.003]. Again, 
significant differences were apparent between Visit 2 and Visit 7 for all DVs. Specifically, Sternberg 
accuracy decreased between Visit 2 (M 90.68, SE 0.82) and Visit 7 (M 88.36, SE 0.83) [p<0.001], 
although significant decreases were not evident between consecutive intermediate visits. Sternberg 
scanning rate improved between the Visit 2 (M 33.25, SE 2.05) and Visit 7 (M 23.80, SE 2.08) 
[p<0.001], however significant gains were only evident between consecutive Visits 2 & 3 [p=0.003]. 
Sternberg RT improved between Visit 2 (M 574.93, SE 17.30) and Visit 7 (M 541.39, SE 17.39) 
[p=0.026], although significant improvements were not evident between consecutive, intermediate 
visits. 
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Finally, for the Stroop task, Visit predicted interference effect [F(5,219.28)=4.24, p=0.001] and a 
trend was evident for incongruent RT [F(5,218.94)=1.97, p=0.083]. Pairwise comparisons revealed a 
decrease in interference effect between Visit 2 (M 60.34, SE 4.68) and Visit 7 (M 42.03, SE 4.73) 
[p=0.007], however significant improvements were not evident between consecutive, intermediate 
visits. Marginally significant improvements in incongruent RT were observed between Visit 2 (M 
716.61, SE 13.54) and Visit 7 (M 694.93, SE 13.60) [p=0.055] but again significant improvements 
were not evident between consecutive, intermediate visits. 
Order effects, therefore, remained apparent for the majority of cognitive tasks. However, although 
significant differences were evident between measurements recorded at the beginning and end of 
the experiment, there were few significant differences between consecutive, intermediate test 
visits. This suggests that the methodological measures identified in Chapter 3 were moderately 
successful at minimising order effects. Following the counterbalancing of the order in which all doses 
were presented to participants, pairwise comparisons revealed no significant baseline differences 
for any of the cognitive tasks, under any of the individual dose conditions [p>0.1]. 
4.4.1.2 Immediate & delayed recall 
Tabulated means for the immediate and delayed recall tasks can be found in Table 4.2. 
For the immediate recall task, Session was a significant predictor of score F(1,264.00)=30.95, 
p<0.001] and interference errors F(1,264.01)=11.24, p=0.001]. Pairwise comparisons revealed a 
significant decrease in score between baseline and 1 hour [p<0.001], accompanied by an increase in 
interference errors [p=0.001]. Similarly, for the delayed recall task, Session was a significant 
predictor of score F(1,264.00)=100.36, p<0.001] and interference errors F(1,263.06)=58.79, 
p<0.001]. Again pairwise comparisons revealed a significant decrease in score between baseline and 
1 hour [p<0.001], accompanied by an increase in interference errors [p<0.001]. 
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Table 4.2 Episodic memory data for Experiment 2 (n=45) 
         Test session 
Recall 
 
Dose 
 
Baseline 
 
1 hr 
variable 
 
  
 
Mean SD 
 
Mean SD 
IR score 
(correct/15) 
 
0mg 
 
9.31 2.70 
 
8.16 2.72 
 
129mg 
 
9.02 2.97 
 
8.48 3.41 
  
258mg 
 
9.28 2.69 
 
7.86 2.90 
  
310mg 
 
9.02 2.72 
 
8.29 3.25 
  
517mg 
 
8.82 2.60 
 
8.34 3.07 
  
724mg 
 
9.12 2.32 
 
8.63 2.92 
         IR interference 
errors 
 
0mg 
 
0.02 0.15
 
0.04 0.21
 
129mg 
 
0.00 0.00 
 
0.07 0.33 
  
258mg 
 
0.00 0.00 
 
0.05 0.21 
  
310mg 
 
0.00 0.00 
 
0.09 0.36 
  
517mg 
 
0.00 0.00 
 
0.05 0.21 
  
724mg 
 
0.00 0.00 
 
0.07 0.26 
         DR score 
(correct/15) 
 
0mg 
 
7.38 2.76 
 
5.62 3.26 
 
129mg 
 
7.34 3.37 
 
6.00 3.65 
  
258mg 
 
7.56 3.45 
 
5.40 3.30 
  
310mg 
 
6.87 2.87 
 
5.40 3.34 
  
517mg 
 
6.86 2.83 
 
6.00 3.72 
  
724mg 
 
7.07 3.01 
 
5.67 3.16 
         DR interference 
errors 
 
0mg 
 
0.02 0.15 
 
0.60 1.07 
 
129mg 
 
0.00 0.00 
 
0.53 1.32 
  
258mg 
 
0.02 0.15 
 
0.37 0.87 
  
310mg 
 
0.00 0.00 
 
0.44 0.92 
  
517mg 
 
0.00 0.00 
 
0.27 0.66 
  
724mg 
 
0.00 0.00 
 
0.70 1.26 
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Neither Dose, nor Session x Dose interaction were found to be significant factors in predicting any of 
the recall DVs. However, more detailed interpretation of pairwise comparisons for the interaction 
revealed a significant decline in immediate recall score between baseline and 1 hour for the control 
[p=0.001], 258mg [p<0.001] and 310mg [p=0.037] doses, but not for the 129mg [p=0.124], 517mg 
[p=0.178], and 724mg [p=0.173] doses. This interaction is shown in Figure 4.1. Immediate recall 
interference errors increased between baseline and 1 hour for the 310mg dose only [0.031], 
although a non-significant trend was observed for the 724mg dose [p=0.098]. For delayed recall 
score and delayed recall interference, pairwise comparisons for the interaction simply revealed a 
significant decrease in performance over time regardless of dose [p<0.1]. 
 
Figure 4.1 The interaction between session and dose for immediate recall score 
Values are estimated marginal means. Error bars represent standard error of the mean. Difference from 
baseline is indicated above the column, ** (p<0.01), * (p<0.05), † (p<0.1). 
 
4.4.1.3 Serial 3s & 7s 
Tabulated means for the serial 3s & 7s tasks can be found in Table 4.3 and Table 4.4, respectively. 
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Table 4.3 Serial 3s data for Experiment 2 (n=45) 
         Test session 
Serial 3s 
 
Dose 
 
Baseline 
 
1 hr 
variable 
 
  
 
Mean SD 
 
Mean SD 
Score 
(correct in 2 mins) 
 
0mg 
 
47.20 19.93 
 
49.29 23.07 
 
129mg 
 
47.45 20.54 
 
49.93 19.63 
  
258mg 
 
46.79 16.91 
 
49.60 19.07 
  
310mg 
 
49.13 22.02 
 
51.27 23.97 
  
517mg 
 
47.32 17.93 
 
48.98 20.75 
  
724mg 
 
46.58 18.29 
 
50.12 19.15 
         Errors 
(incorrect in 2 mins) 
 
0mg 
 
2.09 1.71
 
2.44 1.84
 
129mg 
 
1.82 2.22 
 
2.02 2.18 
  
258mg 
 
1.93 2.44 
 
2.07 1.88 
  
310mg 
 
1.96 1.94 
 
2.50 2.10 
  
517mg 
 
2.14 2.58 
 
2.16 2.43 
  
724mg 
 
1.62 1.89 
 
1.95 1.80 
         RT (ms) 
 
0mg 
 
2464.88 848.23
 
2330.63 779.69
  
129mg 
 
2489.71 867.89 
 
2323.42 748.16 
  
258mg 
 
2402.68 702.03 
 
2292.59 715.97 
  
310mg 
 
2443.99 929.38 
 
2277.70 851.01 
  
517mg 
 
2406.99 691.37 
 
2316.97 715.66 
  
724mg 
 
2390.97 694.71 
 
2252.78 666.62 
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Table 4.4 Serial 7s data for Experiment 2 (n=45) 
         Test session 
Serial 7s 
 
Dose 
 
Baseline 
 
1 hr 
variable 
 
  
 
Mean SD 
 
Mean SD 
Score 
(correct in 2 mins) 
 
0mg 
 
25.62 11.64 
 
26.24 12.71 
 
129mg 
 
25.61 12.77 
 
25.65 11.01 
  
258mg 
 
24.91 10.89 
 
25.56 12.06 
  
310mg 
 
24.82 13.11 
 
25.20 10.97 
  
517mg 
 
25.50 11.67 
 
27.23 12.95 
  
724mg 
 
24.30 11.91 
 
27.14 12.55 
         Errors 
(incorrect in 2 mins) 
 
0mg 
 
2.13 1.82
 
2.02 1.63
 
129mg 
 
1.89 1.69 
 
1.86 1.64 
  
258mg 
 
1.95 1.94 
 
2.56 1.68 
  
310mg 
 
2.27 1.71 
 
2.23 1.51 
  
517mg 
 
1.98 1.77 
 
2.20 1.72 
  
724mg 
 
2.05 1.83 
 
2.37 2.32 
         RT (ms) 
 
0mg 
 
4641.95 1595.72
 
4583.39 1770.62
  
129mg 
 
4660.56 1652.82 
 
4437.11 1511.59 
  
258mg 
 
4514.64 1445.50 
 
4527.53 1624.32 
  
310mg 
 
4828.93 2035.04 
 
4480.39 1561.91 
  
517mg 
 
4713.68 1558.86 
 
4325.14 1552.65 
  
724mg 
 
4791.82 1787.96 
 
4427.62 1941.27 
              
 
For the serial subtraction tasks, Session was a significant predictor of 3s score [F(1,263.94)=22.98, 
p<0.001], 3s RT [F(1,261.91)=63.60, p<0.001], 7s score [F(1,261.55)=16.52, p<0.001], and 7s RT 
[F(1,237.18)=14.59, p<0.001].  A non-significant trend was observed for serial 3s errors 
[F(1,254.27)=3.37, p=0.067]. All scores and RTs significantly improved between baseline and 1 hour 
[p<0.001]. Serial 3s errors increased between baseline and 1 hour [p=0.067]. Neither Dose, nor 
Session x Dose interaction were found to be significant factors in predicting any of the serial 
subtraction variables. For serial 3s score and RT, pairwise comparisons for the interaction simply 
revealed a significant improvement in performance over time regardless of dose [p<0.1]. The only 
exception was for 3s score following the 517mg dose where no significant change was observed 
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[p=0.194]. No significant changes were observed for 3s errors. However, significant improvements in 
serial 7s score and RT were apparent between baseline and 1 hour following the two highest 
blueberry doses (517mg & 724mg) only [p<0.05] with a non-significant trend for 7s RT following the 
310mg dose [p=0.091]. No significant improvements were observed following the control or any of 
the lower doses [p>0.10]. These interactions are shown in Figure 4.2 and Figure 4.3. For serial 7s 
errors there was a non-significant trend towards increased errors following the 258mg dose only 
[p=0.065]. 
 
 
Figure 4.2 The interaction between test session and dose for serial 7s scores 
Values are estimated marginal means. Error bars represent standard error of the mean. Difference from 
baseline is indicated above the column, ** (p<0.01), * (p<0.05), † (p<0.1). 
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Figure 4.3 The interaction between test session and dose for serial 7s RT 
Values are estimated marginal means. Error bars represent standard error of the mean. Difference from 
baseline is indicated above the column, ** (p<0.01), * (p<0.05), † (p<0.1). 
 
 
4.4.1.4 Sternberg task 
Tabulated means for the Sternberg task can be found in Table 4.5. 
For the Sternberg task, Session was a significant predictor of extrapolated RT only F(1,264.00)=17.37, 
p<0.001], with faster RTs observed at 1 hour compared with baseline. Neither Dose, nor Session x 
Dose interaction were predictive of any of the Sternberg variables. Pairwise comparisons for the 
interaction revealed a significant decrease in extrapolated RT for the control [p=0.035], 258mg 
[p=0.051], 310mg [p=0.010], and 724mg [p=0.013] doses, but not for the 129mg or 517mg doses 
[p>0.1].  
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Table 4.5 Sternberg data for Experiment 2 (n=45) 
         Test session 
Sternberg 
 
Dose 
 
Baseline 
 
1 hr 
variable 
 
  
 
Mean SD 
 
Mean SD 
Accuracy 
(correct/96) 
 
0mg 
 
89.31 7.32 
 
90.37 5.13 
 
129mg 
 
89.72 5.01 
 
89.02 5.12 
  
258mg 
 
89.36 6.34 
 
90.15 4.27 
  
310mg 
 
89.50 5.59 
 
89.42 5.11 
  
517mg 
 
90.63 4.96 
 
90.40 3.04 
  
724mg 
 
90.05 4.83 
 
90.12 5.04 
         Scanning rate 
(ms/item) 
 
0mg 
 
27.26 20.89
 
24.83 18.10
 
129mg 
 
27.11 13.91 
 
25.48 14.62 
  
258mg 
 
29.44 16.53 
 
28.80 17.73 
  
310mg 
 
23.41 14.17 
 
24.50 16.08 
  
517mg 
 
28.96 15.52 
 
25.22 18.99 
  
724mg 
 
28.16 14.40 
 
26.90 17.55 
         Extrapolated RT (ms) 
 
0mg 
 
574.13 140.45
 
550.17 129.78
  
129mg 
 
551.15 126.87 
 
542.37 119.34 
  
258mg 
 
558.30 107.50 
 
535.69 114.17 
  
310mg 
 
576.62 134.04 
 
547.38 133.67 
  
517mg 
 
562.18 127.80 
 
558.98 122.43 
  
724mg 
 
564.06 118.56 
 
535.20 116.71 
              
 
4.4.1.5 Stroop task 
Tabulated means for the Stroop task can be found in Table 4.6. 
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Table 4.6 Stroop data for Experiment 2 (n=45) 
         Test session 
Stroop 
 
Dose 
 
Baseline 
 
1 hr 
variable 
 
  
 
Mean SD 
 
Mean SD 
Accuracy 
(correct/96) 
 
0mg 
 
91.75 2.89 
 
91.91 3.06 
 
129mg 
 
91.82 2.90 
 
91.77 3.20 
  
258mg 
 
91.39 3.71 
 
91.84 2.75 
  
310mg 
 
91.57 2.85 
 
90.96 3.54 
  
517mg 
 
91.89 2.91 
 
91.63 3.53 
  
724mg 
 
92.07 2.98 
 
92.02 2.64 
         Incongruent RT (ms) 
 
0mg 
 
719.67 97.68
 
701.96 95.28
  
129mg 
 
705.95 98.63 
 
695.75 94.23 
  
258mg 
 
708.38 95.58 
 
692.47 93.00 
  
310mg 
 
719.17 102.27 
 
702.26 103.12 
  
517mg 
 
708.43 86.58 
 
692.83 86.27 
  
724mg 
 
691.89 88.15 
 
685.34 89.56 
         Congruent RT (ms) 
 
0mg 
 
667.61 100.22
 
648.51 105.60
  
129mg 
 
651.65 94.87 
 
646.12 93.67 
  
258mg 
 
662.90 100.78 
 
647.49 94.29 
  
310mg 
 
667.15 103.65 
 
649.02 100.77 
  
517mg 
 
646.58 85.72 
 
635.79 88.16 
  
724mg 
 
645.51 78.03 
 
631.19 83.92 
         Interference effect 
(ms) 
 
0mg 
 
52.06 35.22
 
53.45 31.60
 
129mg 
 
54.31 37.69 
 
49.63 35.58 
  
258mg 
 
45.49 38.71 
 
44.98 39.33 
  
310mg 
 
52.02 42.48 
 
53.25 43.10 
  
517mg 
 
61.85 44.64 
 
52.98 39.55 
  
724mg 
 
46.37 29.94 
 
51.45 30.27 
              
 
Session was a significant predictor of both congruent RT [F(1,264.00)=21.99, p<0.001] and 
incongruent RT [F(1,264.00)=19.54, p<0.001], but not of accuracy or interference effect [p>0.1]. RTs 
were faster at 1 hour compared with baseline [p<0.001]. Dose was a marginally significant predictor 
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of congruent RT [F(5,218.71)=2.12, p=0.064]; RTs for the 724mg condition were faster than for all 
other conditions, however statistical significance was not maintained following pairwise comparison. 
No other significant Dose or Dose x Session interactions were evident from the model. However, 
pairwise comparisons for the interaction revealed significant improvements in congruent RT 
between baseline and 1 hour following the control [p=0.008], 258mg [p=0.038], 310mg [p=0.012], 
and 724mg [p=0.052] doses, but not following the 129mg or 517mg doses [p>0.1]. Significant 
improvements in incongruent RT were observed between baseline and 1 hour for the control 
[p=0.020], 258mg [p=0.041], 310mg [0.026], and 517mg [p=0.043] doses, but not for the 129mg or 
724mg doses [p>0.1].  
4.4.2 Mood analysis 
Tabulated means for the self-reported mood measures can be found in Table 4.7 
Visit was found to be a significant predictor of mental fatigue only [F(5,219.63)=3.40, p=0.006]. 
Pairwise comparisons revealed a significant decrease in ratings of mental fatigue between Visit 2 (M 
5.12, SE 0.26) and Visit 7 (M 4.20, SE 0.26) [p=0.023]. Significant decreases between consecutive, 
intermediate visits were observed between Visits 2 & 3 only [p=0.006]. These findings suggest that 
participants found the tasks particularly mentally challenging at the beginning of the experiment, but 
quickly became more comfortable with the level of cognitive testing. No similar order effects were 
apparent for measures of affect [p>0.1]. Pairwise comparisons indicated no significant baseline 
differences for any of the counterbalanced dose conditions, for any of the mood measures [p>0.1]. 
Session was found to be a significant predictor of mental fatigue [F(1,264.00)=10.51, p=0.001] and 
negative affect [F(1,259.58)=4.55, p=0.034], and approached significance for positive affect 
[F(1,264.00)=3.37, p=0.067]. Mental fatigue decreased between baseline and 1 hour, positive affect 
increased, and negative affect decreased. These Session effects are most likely attributable to the 
consumption of a sugary drink, irrespective of dose condition.  
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Table 4.7 Mood data for Experiment 2 (n=45) 
         Test session 
Mood 
 
Dose 
 
Baseline 
 
1 hr 
variable 
 
  
 
Mean SD 
 
Mean SD 
Mental fatigue 
(rating/9) 
 
0mg 
 
4.53 2.14 
 
4.09 2.00 
 
129mg 
 
4.32 1.96 
 
4.41 1.98 
  
258mg 
 
4.84 2.00 
 
4.21 2.17 
  
310mg 
 
4.91 2.11 
 
4.18 1.72 
  
517mg 
 
4.48 2.10 
 
3.89 1.85 
  
724mg 
 
4.42 2.33 
 
4.28 2.35 
         Positive affect 
(score/50) 
 
0mg 
 
21.29 8.70
 
21.38 8.86
 
129mg 
 
21.68 7.91 
 
22.57 8.21 
  
258mg 
 
20.33 7.25 
 
22.00 7.76 
  
310mg 
 
20.76 7.44 
 
22.16 7.91 
  
517mg 
 
21.20 8.14 
 
22.30 7.83 
  
724mg 
 
22.26 7.74 
 
21.72 8.73 
         Negative affect 
(score/50) 
 
0mg 
 
13.42 4.14
 
13.11 4.25
 
129mg 
 
13.00 3.59 
 
13.05 3.95 
  
258mg 
 
13.17 3.51 
 
12.79 4.28 
  
310mg 
 
13.27 4.30 
 
12.16 2.96 
  
517mg 
 
12.95 3.46 
 
13.00 3.95 
  
724mg 
 
12.98 3.69 
 
12.57 3.12 
              
 
Dose and Session x Dose interaction were not significant for any of the mood measures [p>0.1]. 
However, more detailed interpretation of pairwise comparisons for the Session x Dose interaction 
revealed a significant reduction in mental fatigue between baseline and 1 hour following the 258mg 
[p=0.045] and 310mg [p=0.017] doses, and non-significant trend following the 517mg dose 
[p=0.056]. No significant changes were observed for the control, 129mg or 724 mg conditions 
[p>0.1]. A significant decrease in negative affect was observed following the 310mg dose only 
[p=0.013]. These interactions are shown in Figure 4.4 and Figure 4.5. 
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Figure 4.4 The interaction between session and dose for ratings of mental fatigue 
Values are estimated marginal means. Error bars represent standard error of the mean. Difference from 
baseline is indicated above the column, ** (p<0.01), * (p<0.05), † (p<0.1). 
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Figure 4.5 The interaction between session and dose for ratings of negative affect 
Values are estimated marginal means. Error bars represent standard error of the mean. Difference from 
baseline is indicated above the column, ** (p<0.01), * (p<0.05), † (p<0.1). 
 
 
4.4.3 Blood pressure analysis 
Tabulated means for all blood pressure data can be found in Table 4.8. 
Unexpectedly, Visit was found to be a significant factor in predicting both systolic (SBP) 
[F(5,219.10)=2.80, p=0.018] and diastolic (DBP) blood pressure [F(5,217.05)=3.90, p=0.002]. Pairwise 
comparisons revealed a significant increase in SBP between Visit 3 (M 102.79, SE 1.59) and Visit 7 (M 
105.15, SE 1.59) [p=0.028]. Similarly, DBP increased significantly at Visit 7 (M 69.80, SE 0.82) when 
compared with both Visit 2 (M 67.98, SE 0.81) [p=0.043] and Visit 3 (M 67.67, SE 0.81) [p=0.007]. 
This gradual increase in blood pressure observed over the duration of the experiment remains 
unexplained. No similar changes in heart rate were evident. However, the impact of this order effect 
was minimal due to the counterbalancing of the doses; no baseline differences in blood pressure or 
heart rate were evident between any of the dose conditions [p>0.1]. 
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Table 4.8 Blood pressure data for Experiment 2 (n=45) 
         Test session 
Blood pressure 
 
Dose 
 
Baseline 
 
1 hr 
Variable 
 
  
 
Mean SD 
 
Mean SD 
Systolic BP (mmHg) 
 
0mg 
 
102.62 11.35 
 
105.73 12.16 
  
129mg 
 
101.18 9.79 
 
104.20 11.58 
  
258mg 
 
102.65 10.77 
 
105.93 11.14 
  
310mg 
 
101.69 10.24 
 
105.51 11.63 
  
517mg 
 
101.89 11.80 
 
105.34 11.93 
  
724mg 
 
101.16 10.60 
 
104.79 10.86 
         Diastolic BP (mmHg) 
 
0mg 
 
67.93 5.41
 
69.70 5.22
  
129mg 
 
67.34 5.22 
 
69.57 6.91 
  
258mg 
 
66.62 4.83 
 
69.14 5.18 
  
310mg 
 
67.47 6.32 
 
69.93 5.80 
  
517mg 
 
66.59 5.22 
 
69.09 5.23 
  
724mg 
 
67.77 6.16 
 
69.62 5.14 
         Heart rate (bpm) 
 
0mg 
 
72.00 7.20
 
68.73 8.30
  
129mg 
 
71.91 9.60 
 
70.45 8.64 
  
258mg 
 
72.26 10.24 
 
69.63 8.86 
  
310mg 
 
71.04 8.84 
 
69.58 9.60 
  
517mg 
 
72.59 9.92 
 
71.98 9.88 
  
724mg 
 
72.70 11.27 
 
71.28 8.92 
              
 
Session was observed to be a significant predictor of SBP [F(1,264.00)=153.18, p<0.001], DBP 
[F(1,259.02)=107.86, p<0.001] and heart rate [F(1,263.40)=28.60, p<0.001]. Both SBP and DBP 
increased significantly after consuming the intervention drinks, whereas heart rate decreased. 
Although Dose and Session x Dose interaction were not significant for any of the physiological 
measures [p>0.1]; more detailed investigation of pairwise comparisons for the interaction revealed 
that significant postprandial reductions in heart rate were observed following the control and lower 
doses, however these were attenuated in the higher dose conditions. Specifically, a significant 
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difference between baseline and 1 hour was observed following the control [p<0.001] and 258mg 
dose [p=0.002] but not following the 517mg dose [p=0.465]. Non-significant trends were observed 
following the 129mg, 310mg, and 724mg doses, [p=0.084], [p=0.078], and [p=0.096] respectively. At 
the 1 hour test session heart rate was significantly lower in the control condition compared with the 
517mg condition [p=0.021], indeed this was the only between-condition effect observed during this 
experiment. All other reported effects were within-condition only. This dose dependent interaction 
is shown in Figure 4.6. 
 
Figure 4.6 The interaction between test session and dose for measurements of heart rate 
Values are estimated marginal means. Error bars represent standard error of the mean. Difference from 
baseline is indicated above the column, difference between conditions is indicated by a horizontal bar, ** 
(p<0.01), * (p<0.05), † (p<0.1). 
 
4.4.4 Palatability analysis 
LMM analysis of the palatability data revealed a significant effect of dose for ‘bland’ 
[F(5,44.52)=2.82, p=0.027], ‘tasty’[F(5,44.54)=10.07, p<0.001] , ‘pleasant’ [F(5,44.36)=10.26, 
p=<0.001], ‘sour’ [F(5,44.21)=3.97, p=0.005], ‘satisfying’ [F(5,44.29)=5.10, p=0.001], ‘how much 
more could you consume?’ [F(5,43.24)=6.82, p<0.001] , and ‘how easy was it to consume?’ 
[F(5,43.75)=10.61, p<0.001] rating dimensions, but not for ‘sweet’ ratings [F(5,44.23)=1.57, 
p=0.190]. The effect of dose on each rating dimension is shown in Figure 4.7. The 310mg dose was 
rated most ‘tasty’; ratings were significantly higher than the control [p=0.006], 517mg [p=0.073] and 
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724mg [p<0.001] doses. The 310mg dose was also rated most ‘pleasant’ and most ‘satisfying’; 
significantly more so than the 724mg dose, [p<0.001] and [p=0.001] respectively. The 724mg dose 
was rated more ‘sour’ than the control [p=0.082], 129mg [p=0.001], 258mg [p=0.011], and 310mg 
[p=0.009] doses. The 724mg was also rated the least ‘easy’ to drink and was similarly rated worst in 
terms of how much more participants felt they could consume. The control drink was rated most 
‘bland’; approaching significance when compared with the 129mg [p=0.060] and 517mg [p=0.059] 
doses. Therefore, although the intervention drinks appeared well-matched for sweetness, noticeable 
differences were evident for all other taste dimensions. 
 
Figure 4.7 Palatability ratings for all intervention doses 
Values are estimated marginal means. Error bars represent standard error of the mean. 
 
4.4.5 Cohen’s d effect sizes 
Cohen’s d effect sizes for all significant interactions (identified by pairwise comparisons) are shown 
in Table 4.9. Effect sizes were calculated from estimated marginal means and standard error values 
using the method described in Chapter 2. For cognition, mood and heart rate effects, difference 
from baseline following blueberry intervention was compared with difference from baseline 
following the control. Positive values indicate performance improvements compared to the control. 
Negative values indicate detriments to performance.   
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Table 4.9 Cohen's d effect sizes for Experiment 2 
Table 4.9 continued 
    Variable  Dose  Cohen's d
Cognition: 
    Immediate recall score 
 
129mg
 
(**)0.297
  
517mg 
 
(**)0.291 
  
724mg 
 
(**)0.285 
Immediate recall interference errors 
 
310mg 
 
*-0.247 
  
724mg 
 
†-0.174 
     Serial 3s score 
 
517mg
 
(†)-0.082
  
724mg 
 
**0.14 
     Serial 7s score 
 
517mg
 
*0.213
  
724mg 
 
**0.423 
     Serial 7s RT 
 
310mg
 
†0.055
  
517mg 
 
*0.106 
  
724mg 
 
**0.344 
     Serial 7s errors 
 
258mg
 
†-0.325
     Sternberg RT 
 
129mg
 
(*)-0.201
  
517mg 
 
(*)-0.275 
     Stroop congruent RT 
 
129mg
 
(**)-0.284
  
517mg 
 
(**)-0.174 
     Stroop incongruent RT 
 
129mg
 
(*)-0.149
  
724mg 
 
(*)-0.220 
Mood: 
    Mental fatigue 
 
258mg
 
*0.090
  
310mg 
 
*0.143 
  
517mg 
 
†0.072 
     Negative affect 
 
310mg
 
*0.318
     Physiology: 
    Heart rate 
 
517mg
 
(**)0.506
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Table 4.9 continued 
    Variable  Dose  Cohen's d
  
724mg 
 
(**)0.359 
     Cohen’s d values represent small (d=0.2), medium (d=0.5), and large (d=0.8) effect sizes, respectively. Positive 
values indicate performance improvements, and negative values indicate detriments to performance, 
compared to the control.  Significance of the underlying pairwise comparison with baseline is indicated, 
**(p<0.01), *(p<0.05), †(p<0.1). The use of brackets, (**), (*), (†) indicates an effect derived through a change 
from baseline for the control condition, attenuated for the blueberry condition. 
 
4.5 Discussion 
The lack of a LMM Session x Dose interaction for any of the DVs suggests that, in this experiment, 
anthocyanin-rich blueberry had no effect on the cognition, mood or blood pressure of a healthy 
young adult population, at any dose, when compared with a matched control condition. However, 
when employing statistically less conservative pairwise comparisons, as recommended by Huck 
(2015), significant dose-dependent effects on episodic memory, working memory, mood, and heart 
rate became evident. These pairwise effects were corrected for multiple comparisons, and so have 
been reported despite the non-significance of the LMM interaction. Possible reasons for this lack of 
a significant LMM interaction are considered later in this section.  
Where consistent effects have been observed for specific doses, across two or more DVs for the 
same cognitive task, and in line with previous literature findings, it seems likely that the results are 
not simply a result of type I error.  In particular, consumption of the highest doses (517mg & 724mg) 
appeared to convey small to medium benefits for the maintenance of constant heart rate and 
immediate recall memory score, and improvements in serial 7s performance for both score and 
reaction time. The 310mg dose elicited small to medium benefits in mental fatigue and mood. 
However the lower (129mg & 258mg) doses showed no consistent domain specific effects. 
Immediate recall and serial 7s benefits were evident following the 517mg and 724mg blueberry 
doses, findings which are consistent with previous literature following supplementation with varying 
flavonoid-rich food sources and in varying populations e.g. (Dodd, 2012; Kennedy et al., 2002; 
Massee et al., 2015; Whyte & Williams, 2015). Indeed the serial subtraction benefits were 
successfully replicated later in this thesis (Chapter 6). However it is unclear how these observations 
relate to the underlying FMD response previously published for the same doses (Rodriguez-Mateos 
et al., 2013). The FMD data predicted the greatest benefit to cognition following the 310mg dose. 
Therefore, alternative mechanisms of action may be relevant here. As reported in the literature 
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review, a difference in postprandial blood glucose response has previously been observed 
concurrently with cognitive benefits when an anthocyanin-rich berry intervention was compared 
with a sugar-matched control (Watson et al., 2015). Therefore, a similar mechanism may be 
responsible for cognitive improvements here. The link showing that glucose influences cognitive 
performance is well supported. For example, a study by Benton, Owens, & Parker, (1994) 
investigating the effects of glucose on cognition in healthy young adults found that immediate and 
delayed recall memory performance was  correlated with individual changes in blood sugar levels at 
the time of testing. The authors suggest that it is the ability to process a glucose load that influences 
cognition. The same effect has been demonstrated in older adults (Craft, Zallen, & Baker, 1992). 
Similar studies have revealed a significant effect of glucose on serial 7s subtraction tasks (Kennedy & 
Scholey, 2000; Scholey et al., 2001). It has been theorised that increased glucose supply to the brain 
is a physiological response to a cognitively demanding task, but that individual differences in heart 
rate and glucose response may influence cognitive outcome (Kennedy & Scholey, 2000).  Blood 
glucose may therefore have influenced memory and serial 7s performance in the current study 
through a mechanism of altered glucose regulation in the blueberry conditions but not the control 
condition. Possible mechanisms of action are considered in Chapters 5 and 6. 
The lack of a beneficial effect for the Sternberg and Stroop tasks suggests that these tasks were not 
sensitive to blueberry intervention. The 129mg & 517mg doses were observed to elicit a moderate 
negative effect on performance during each of these tasks when compared to the control. However, 
it seems likely that these effects may be attributable to type 1 error as the remaining doses, of both 
intermediate and higher anthocyanin strength, showed no similar negative outcome. In addition, the 
previous literature has shown performance on these tasks to be improved by similar nutritional 
interventions e.g. flavonoid-rich ginkgo biloba (Subhan & Hindmarch, 1984).  In the previous chapter, 
the piloting of these tasks revealed that they were rated amongst the least difficult, and so it may be 
that a more demanding cognitive load is needed before blueberry benefits become apparent in 
healthy young adults. This theory is consistent with the serial subtraction task data, where moderate 
cognitive benefits were observed for the serial 7s task but effect size was far smaller for the less 
demanding serial 3s. The theory is also compatible with the glucose mechanism proposed above, as 
increased availability of glucose may only be beneficial during particularly cognitively demanding 
tasks. As there was a great deal of overlap between the neural correlates for all of the cognitive 
tasks (Chapter 2), it appears likely that it is cognitive load, particularly working memory demand, 
that is responsible for these differences in cognitive outcome.  Additionally, the computerised serial 
subtraction tasks used here had a high psychomotor processing component. The extra physical costs 
of these tasks may therefore contribute to extra demand for glucose. 
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The observed negative affect and mental fatigue benefits observed following the 310mg dose were 
consistent with both the FMD data and the previous literature e.g. (Khalid et al., 2017; Scholey et al., 
2010, 2012). However, palatability data for the intervention drinks revealed that this dose was rated 
more pleasant, tasty, and satisfying than all other doses and therefore these mood effects may 
simply have been due to the influence of positive taste dimensions rather than the anthocyanin-rich 
blueberry content of the intervention. However, it may also be the case that these were genuine 
blueberry effects on mood that were also present following the 517mg and 724mg doses but, for 
these higher dose conditions, subjective ratings were negatively influenced by the poor taste of the 
intervention drink. Palatability has previously been shown to impact mood (Benton, 2002), in 
particular negative affect (Macht & Mueller, 2007). In future work it is therefore important to pay 
greater attention to palatability differences between intervention conditions. 
The physiological measure of blood pressure was included in the study as an indirect measure of 
vasoreactivity, with a lowering of blood pressure expected following anthocyanin-rich berry 
supplementation (Keane, George, et al., 2016; Keane, Haskell-Ramsay, et al., 2016).  However, in this 
experiment, no significant differences were observed between the control and blueberry doses for 
measures of systolic or diastolic blood pressure.  A significant main effect of Session revealed an 
increase in blood pressure (SBP & DBP) between pre- and post- intervention time points, irrespective 
of intervention condition. This is likely attributable to circadian changes in blood pressure 
approaching a mid-morning peak (Millar-Craig, Bishop, & Raftery, 1978). Blood pressure 
measurements appeared not to be sensitive to any additional blueberry induced vasodilatory 
response. However, heart rate results were more interesting. Although the LMM interaction was not 
statistically significant, pairwise comparisons revealed that consumption of the highest doses 
(517mg & 724mg) conveyed small to medium protective benefits for the maintenance of a constant 
heart rate.  Conversely, a marked decrease in heart rate was observed following the control and 
258mg doses. As with the cognitive observations, glucose effects may similarly be responsible for 
the observed heart rate effects. Heart rate is known to be highly correlated with blood glucose e.g. 
(Ostrander & Weinstein, 1964; Valensi et al., 2011), and so the attenuation of postprandial decline in 
heart rate following these doses is suggestive of a dose-dependent glucoregulatory effect. This 
observation may point to an interaction between anthocyanins and sugars in the intervention drinks, 
influencing the postprandial glucose profile. In vitro and in vivo studies have linked polyphenols such 
as anthocyanins with the modulation of glucose digestion, absorption, and distribution to insulin-
sensitive tissue (Cazarolli et al., 2008). Effects on postprandial glucose response have also been 
previously observed in human studies following anthocyanin-rich berry intervention (Törrönen et al., 
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2010; Watson et al., 2015; Wilson et al., 2008). Blood glucose measurements were not recorded 
during this experiment, but clearly warrant further investigation. 
Despite the small to moderate effects on cognition, mood, and physiology described above, LMM 
analysis found no significant interactions between dose and session for any of the measured DVs. 
Huck (2015) suggests that having similar means across multiple conditions will negatively impact the 
statistical outcome of an F test interaction. In addition, a number of potential methodological factors 
were identified which may further account for the LMM null effects. It was inferred that FMD and 
CBF timings were likely to be synonymous (Teragawa et al., 2005; Gonzales et al., 2010). In addition, 
both Francis et al. (2006) and Dodd (2012) observed increased CBF at similar time points for cocoa 
and blueberry polyphenols respectively. But it is possible that that peak CBF did not occur at the 
time of testing or that the dose-dependent vasodilatory response was somehow altered. For 
example, extracellular glucose has been demonstrated in vitro to facilitate vasodilation through a 
mechanism of insulin-induced endothelial nitric oxide production (Taubert, Rosenkranz, Berkels, 
Roesen, & Schömig, 2004). While not evident in the published findings for the control drink used in 
the Rodriguez-Mateos et al. (2013) study, the control was only matched to the second highest dose 
and contained 28 g total sugars compared to the 40g used in this experiment. Taubert et al. (2004) 
demonstrated the mechanism to be concentration-dependent, so enhanced nitric oxide production 
induced by sugar ingestion may have confounded the outcome of the current study by eliciting a 
vasodilatory response following the control condition, thus reducing the expected difference 
between the control and blueberry conditions. A further study (Kawano et al., 1999) revealed that 
hyperglycaemia  suppressed endothelium dependant vasodilation, therefore the vasodilatory 
response in the blueberry conditions may have been attenuated; though this was not evident in the 
Rodriguez-Mateos et al. (2013) study where the FMD data for the highest dose showed a clear 
vascular response. A repeat FMD study would be necessary to confirm whether the timings of the 
cognitive study still coincided with peak vasodilation. Regrettably, this was beyond the timescale and 
resources of the current thesis. However, it is also unlikely that such an affect would reduce the 
statistical power of the LMM analysis but not the pairwise comparisons. 
A more plausible explanation for the lack of LMM interaction despite significant pairwise 
comparisons is that, despite methodological efforts to keep them to a minimum, the order effects 
resulting from the length of study were of greater magnitude than the expected blueberry effects. 
As a result of the sizeable order effects, the necessary counterbalancing of doses over the six week 
period may have increased within-dose variance sufficiently to impact the statistical power of the 
LMM analysis. Additionally, main effects of session revealed order effects of greater magnitude than 
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those observed during the piloting of the tasks. In Chapter 3 participants received no intervention 
drink between the baseline and test sessions. This suggests that the intervention drink itself may 
have been an additional confound. The control and blueberry drinks were matched to the highest 
dose in terms of sugars (21g fructose and 19g glucose) and vitamin C (9.5mg) content. As previously 
discussed, glucose is the main fuel for brain function and is highly correlated with cognitive 
performance, so the high sugar content of the drinks may have boosted cognitive performance to a 
ceiling following both the control and blueberry doses. There was no evidence that participants were 
operating at ceiling for any of the cognitive tasks deployed, however it is possible that following the 
sugary intervention drink participants may have achieved a cognitive ceiling in terms of their 
individual potential for improvement, particularly on the tasks where no significant pairwise 
comparisons were observed. 
In conclusion, only limited dose-dependent cognition and mood effects were apparent. Small mood 
benefits following the 310mg dose, while consistent with the literature, may have been confounded 
by the poorly matched flavour of the intervention drink. It is possible that subjective mood may have 
been positively influenced by the taste of the intervention rather than the blueberry content. 
Conversely, blueberry induced mood effects following the higher doses may have been negated by 
their poor taste. The pattern of results for cognition appeared inconsistent with the previous FMD 
data. The two highest doses (517mg & 724mg) conveyed the strongest cognitive benefits rather than 
the expected 310mg dose. However, heart rate data following the same two highest doses 
suggested that blood glucose effects may, at least in part, have been responsible for these findings. 
From these results it was considered necessary to investigate the postprandial glycaemic response 
for the control and blueberry drinks used in the study. A more detailed literature review of flavonoid 
effects on postprandial glucose regulation is reported in the next chapter along with the findings of 
the glycaemic response experiment. 
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Chapter 5  
Experiment 3: A study of glycaemic effects following acute 
anthocyanin-rich blueberry supplementation in healthy 
young adults; implications for cognition and type 2 
diabetes 
An abridged version of this chapter has been published as Bell, L., Lamport, D. J., Butler, L. T., & 
Williams, C. M. (2017). A study of glycaemic effects following acute anthocyanin-rich blueberry 
supplementation in healthy young adults. Food & Function, 8, 3104-3110. 
5.1 Introduction 
In the previous chapter, protection against postprandial heart rate decline was observed in 
conjunction with benefits to episodic memory, working memory and mood, particularly following 
the higher doses of anthocyanin-rich blueberry. Specifically, pairwise comparisons revealed that 
consumption of the highest doses (517mg & 724mg) conveyed benefits for the maintenance of a 
constant heart rate and maintenance of immediate recall memory score. Additionally, the same two 
doses elicited improvements to serial 7s performance for measures of both score and reaction time. 
The 310mg dose was observed to benefit mental fatigue and mood. However the lower (129mg & 
258mg) doses showed no consistent cognitive effects. Irrespective of dose, blueberry intervention 
failed to impact Stroop or Sternberg task performance.  It was posited that the high sugar content of 
the intervention drinks may have influenced the experimental outcome, through a dose-dependent 
modulation of postprandial glucoregulation. Therefore, it was deemed important to investigate the 
postprandial glucose response for the doses of blueberry administered during the previous 
experiment.  
Flavonoid-rich foods have been previously observed to influence blood glucose and glucose 
homeostasis. For example, key mechanisms have been identified in vitro including inhibition of 
carbohydrate digestion and glucose absorption, facilitation of insulin synthesis and secretion, and 
facilitation of glucose uptake by cells (Cazarolli et al., 2008; Hanhineva et al., 2010; Norberto et al., 
2013; Sancho & Pastore, 2012; Williamson, 2013; Zia Ul Haq, Riaz, & Saad, 2016). In vivo animal 
models have demonstrated that these mechanisms can impact upon the immediate postprandial 
period in addition to longer term glucoregulatory health (Hanamura, Mayama, Aoki, Hirayama, & 
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Shimizu, 2006). Epidemiological data support these findings (Jennings, Welch, Spector, Macgregor, & 
Cassidy, 2014; Wedick et al., 2012); in particular, this epidemiological evidence suggests that higher 
intake of the flavonoid subclass anthocyanins is associated with lower incidence of type 2 diabetes 
and increased insulin sensitivity. However few research trials have been conducted in humans that 
investigate modulation of the glycaemic response following anthocyanin-rich foods (Burton-
Freeman, 2010), or have considered how these effects may impact on cognitive function.  
Research to date has produced mixed findings. Attenuated and/or delayed postprandial blood 
glucose concentrations have been observed in healthy adults in a number of studies. Following a 
480ml serving of cranberry juice, Wilson et al., (2008) observed attenuated and delayed postprandial 
plasma glucose concentrations when compared with a sugar matched control. 187 participants took 
part in this between-subjects study investigating six different control and active conditions. The 
outcome reported here was for the normal calorie juice. Anthocyanins levels were reportedly 
quantified however were not documented in the paper. The authors attributed the findings to the 
proanthocyanidin content of the juice rather than the anthocyanins that were also present. Other 
studies have similarly linked proanthocyanidins (oligomers of the subgroup of flavonoids known as 
flavanols) with altered glycaemic response e.g. (Sulaiman, 2014). Torronen et al (2010) investigated 
the postprandial glucose response, in 12 healthy adults, following sucrose consumption (35g) either 
with or without a mixed berry puree (bilberry, blackcurrant, cranberry & strawberry) containing an 
estimated 300mg anthocyanins. This crossover study found that the mixed berry condition was 
associated with a delayed and attenuated glucose peak relative to the sugar-matched control. 
Additionally, after 150 minutes blood glucose levels remained significantly elevated in the mixed 
berry condition relative to the control condition. Nyambe-Silavwe & Williamson (2016) observed 
significant lowering of peak postprandial glucose and insulin, in a dose-dependent manner, when 
white bread was consumed with a flavonoid-rich intervention combining green tea and a mixture of 
freeze-dried fruits. This was a crossover intervention study with 16 participants.  Incremental area-
under-the-curve (iAUC) values for glucose were reduced following both high and low flavonoid 
doses, when compared with sugar-matched controls. Insulin iAUC was reduced for the high dose 
only. The exact flavonoid content of the intervention, again, was not stated. Based on tabulated 
values supplied for the individual fruits, the total flavonoid content of the high dose was estimated 
to be 690mg, of which an estimated 250mg were anthocyanins.  
In a study of eight middle aged males (Kay & Holub, 2002), significant postprandial glucose effects 
were observed following a wild blueberry intervention consumed with a high fat, high carbohydrate 
fast food meal that included potatoes and white bread. Glucose levels were observed to remain 
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significantly elevated at 3 & 4 hours postprandially when compared with a blueberry-free control 
condition. Interestingly though, the glucose effect was attributed to the fructose content of the 
blueberry rather than the 1160mg anthocyanins present in the intervention; the rationale being that 
fructose consumption has been associated with a delayed appearance of glucose in blood serum 
following the conversion of fructose to glucose in the liver. The control condition in the study had 
not been matched for fructose content, making it impossible to differentiate anthocyanins and 
fructose effects in this case. The above studies were all conducted in healthy adults, however effects 
have also been observed in clinical populations. For example, in 10 glucose intolerant subjects (J. 
Hidalgo et al., 2014), attenuation of peak glucose was observed in the immediate 60 minute 
postprandial period following boiled rice when consumed with a maqui berry extract containing 
20mg anthocyanins.  
Despite these positive findings, other similar studies have failed to replicate anthocyanin-rich 
intervention effects on glycaemic response. For example, in eight healthy adults, Cao, Russell, 
Lischner, & Prior, (1998) observed no significant effect of a 240g fresh strawberry intervention on 
postprandial glucose, when consumed with a breakfast meal. Vinson, Bose, Proch, Al Kharrat, & 
Samman, (2008) investigated the effect of cranberry juice on postprandial glucose response in 10 
healthy adults following consumption of high fructose corn syrup. The intervention containing 24mg 
anthocyanins was observed to blunt the initial glucose peak and reduce AUC; however statistical 
significance was not achieved. The authors suggest that the true peak for the control condition may 
have been missed due to individual differences in the response profiles for different subjects that 
failed to coincide with the timing of blood samples. Clegg, Pratt, Meade, & Henry, (2011) 
investigated the postprandial glucose response in 12 healthy subjects following a starchy 
carbohydrate intervention of pancakes fortified with 100g blueberries or 100g raspberries. However, 
no differences in iAUC were observed for either of the berry conditions when compared to pancakes 
alone. Again, the anthocyanins content of the berry interventions were not quantified. In other 
studies, even though glucose effects were not observed, insulin effects were evident. For example, 
in 24 overweight adults, freeze-dried strawberry powder containing 39mg anthocyanins taken with a 
high carbohydrate meal, significantly attenuated postprandial plasma insulin concentrations when 
compared with a control beverage containing no strawberry (Edirisinghe et al., 2011). Alqurashi, 
Galante, Rowland, Spencer, & Commane, (2016) investigated postprandial glucose and insulin 
response in 23 mildly obese subjects following an acai fruit and banana smoothie consumed with a 
high fat breakfast. The intervention contained 493mg anthocyanins. No significant differences in 
postprandial blood glucose were observed compared with a control condition, although mean 
insulin peak was found to be greater in the acai condition. But in this study, blood sampling only 
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occurred at hourly intervals, so it is possible that glucose differences in the immediate 60 minute 
postprandial period may have been missed. Most recently, the postprandial glucose and insulin 
effects of freeze-dried strawberry powder were measured in 21 obese adults with insulin resistance 
(Park et al., 2016). Four doses containing 0mg, 42mg, 88mg, & 155mg anthocyanins, matched for 
energy and fibre, were administered in drink form with a high fat, high carbohydrate meal. Although 
the glucose response following the highest dose appeared to show an attenuated peak, and 
extended availability of glucose at later postprandial time points, measurements were not 
statistically different from the control. However, postprandial insulin concentrations were 
significantly lower than control between baseline and 2 hours following the same dose. Interestingly, 
a significant inverse correlation was observed between plasma concentrations of anthocyanin 
metabolites and both glucose and insulin levels, indicative of a possible mechanism of action. 
As reviewed above, there were many methodological differences between previous studies, not 
least the variability in the anthocyanin content of the berry interventions investigated (ranging from 
20mg up to 1160mg). Significant methodological limitations were evident in a number of these 
studies. For example: low anthocyanins dose (Edirisinghe et al., 2011; Vinson et al., 2008), no 
quantification of anthocyanins dose (Cao et al., 1998; Clegg et al., 2011; Nyambe-Silavwe & 
Williamson, 2016; Wilson et al., 2008), infrequent blood sampling time points (Alqurashi et al., 
2016), and an inadequately matched control condition (Kay & Holub, 2002). Whilst findings are not 
conclusive, there remains enough supporting evidence to suggest that anthocyanin consumption can 
modulate the postprandial glycaemic response. The degree of this response and the associated 
implications for cognitive outcomes in humans remain to be determined. A major shortcoming of 
the current literature is the absence of clearly defined flavonoid concentrations and subclasses. 
Therefore, not surprisingly, knowledge of the specific impact of anthocyanins on blood glucose 
remains limited (Zia Ul Haq et al., 2016). In light of this, the aim of the current study was to 
determine postprandial blood glucose profiles following known doses of anthocyanin-rich blueberry 
in healthy adults. Two blueberry doses, containing 310mg & 724mg anthocyanins, were selected 
from the previous experimental chapter. These doses represented the upper and lower limits of the 
range for which changes in heart rate, cognition and mood were observed. Blueberry doses were 
investigated with and without added sugar in order to better understand the impact of sugar-
matching on postprandial glucose response. Therefore blueberry effects were compared with both 
sugar-matched and no-added-sugar controls. The aims of the study were twofold.  First, the aim was 
to determine likely blood glucose status of participants at the time of cognitive testing in the 
previous thesis chapter. Second, the study aimed to determine whether anthocyanin-rich blueberry 
evoked a dose-dependent effect on postprandial glucose response that might provide a plausible 
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mechanism of action for the cognitive benefits observed during Experiment 2, and in the previous 
cognitive literature.  
5.2 Methods 
Methodological detail common to all experiments in this thesis can be found in Chapter 2. 
Methodology specific to this intervention study is reported here. 
5.2.1 Participants 
Seventeen young adults, 4 male, with a mean age of 24.12 years (SD 4.85) and a mean BMI of 23.82 
kg/m2 (SD 3.56) were recruited for the study. The participants were of similar demographic to those 
who took part in the previous experiment. Full participant details are reported in Chapter 2 
5.2.2 Design 
The study was a double-blind, five-condition, counterbalanced, crossover design comparing doses of 
anthocyanin-rich blueberry powder containing 0mg, 310mg and 724mg anthocyanins in both sugar-
matched and no-added-sugar conditions (see Table 1). All testing took place in the morning. 
Participants attended a total of five regularly spaced visits. The minimum number of days between 
visits was 4, (M 7.69, SD 2.80). Blood glucose measurements were recorded at regular intervals 
(specified below) for 2 ½ hours post intervention. Equipment details and measuring procedure are 
reported in Chapter 2. 
 
Table 5.1 Composition of each experimental condition in Experiment 3 
Condition Anthocyanins (mg) Vitamin C (mg) Fructose (g) Glucose (g) 
No-added-sugar control 0 9.5 0 0 
Sugar-matched control 0 9.5 21 19 
No-added-sugar low dose 310 9.5 9 8 
Sugar-matched low dose 310 9.5 21 19 
Sugar-matched high dose 724 9.5 21 19 
All conditions were prepared by dissolving the required quantities of freeze dried blueberry powder, sugars 
and ascorbic acid in 500ml water. Sugar-matched conditions were matched to the naturally occurring sugar 
content of the highest blueberry dose. 
 
5.2.3 Procedure 
Participants were required to follow the low polyphenol diet (Chapter 2) for 24 hours prior to each 
visit and were asked to fast for 2 hours immediately prior to attending the laboratory. On arrival, 
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baseline blood glucose was recorded. Participants then consumed one of five test condition drinks. 
Drink order was counterbalanced. Participants were asked to consume the drink as quickly as 
possible within a maximum 10 minute period (Alqurashi et al., 2016; Rodriguez-Mateos et al., 2013). 
Blood glucose measurements were recorded at pre-consumption, 15, 30, 45, 60, 90, 120 and 150 
minutes postprandially. Equipment and procedural details for the sampling of blood glucose can be 
found in Chapter 2. 
5.3 Data analysis 
Data were analysed with a linear mixed model (LMM), using an unstructured covariance matrix for 
repeated blood glucose measurements. Time, Dose and Time x Dose interaction were included as 
fixed factors in the model. Subjects were included as random effects and BMI was included as a 
covariate (Model 3.1). Pairwise comparisons with Bonferroni corrections were applied to investigate 
any significant effects. The analysis aim was to determine whether blueberry dose had a mediating 
effect on postprandial glucose response. 
 iAUC was subsequently calculated, from the glucose response curve for each dose, using the 
trapezoid rule (Le Floch, Escuyer, Baudin, Baudon, & Perlemuter, 1990). Incremental analysis, 
determined by excluding the area below baseline, has been shown to be a more representative 
measure of rapid postprandial changes in glycaemic status than total AUC analysis which is strongly 
correlated with basal blood glucose level (Le Floch et al., 1990). Between-subjects differences in 
baseline glucose were taken into account during the calculation. LMM analysis was used to 
determine the effect of dose on iAUC, again using an unstructured covariance matrix for repeat 
doses. Dose was included as a fixed factor in the model, and BMI was included as a covariate (Model 
3.2). The aim of this analysis was to determine whether blueberry dose had a mediating effect on 
postprandial iAUC. 
5.4 Results 
Raw glucose results can be found in the supplementary data accompanying this thesis. All LMM 
results are presented in Appendix L. For clarity, only statistically significant effects are reported in 
full within the text below. 
5.4.1 Blood Glucose Effects 
Mean blood glucose concentrations are summarised in Figure 5.1. All factors were statistically 
significant: Time [F(7,84.00)=45.17, p<0.001], Dose [F(4,59.06)=15.12, p<0.001], Time x Dose 
[F(28,84.00)=4.53, p<0.001]. BMI was a significant covariate [F(1,15.99)=5.64, p=0.030] with higher 
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BMI predicting higher glucose levels (beta=0.047). Pairwise comparisons for the three sugar-
matched conditions revealed that the highest anthocyanin dose (724mg) extended the glycaemic 
response such that blood glucose remained significantly elevated at 120 minutes compared with 
baseline levels [p=0.008]. Blood glucose remained significantly elevated compared with baseline at 
90 minutes [p=0.016] following the sugar-matched low dose (310mg), and at 45 minutes [p<0.001] 
following the sugar-matched control. As observed in Figure 5.1, the sugar-matched blueberry doses 
produced non-significant reductions in mean peak compared with the sugar-matched control 
condition at postprandial time points of 15 minutes (p>0.999) and 30 minutes (p>0.999). The no-
added-sugar control condition profile confirmed that there was no significant blood glucose effect 
(hyper- or hypoglycaemic) associated with simply consuming a 500ml sugar-free beverage. 
 
 
Figure 5.1 Mean blood glucose concentration recorded at baseline and following each dose at fixed 
postprandial time points 
All sugar-matched doses contained the same quantity of sugars naturally present in the highest dose (40g total 
sugars). The 310mg no-added-sugar dose contained 17g total sugars. Values are estimated marginal means 
adjusted for BMI. Error bars represent standard error of the mean. Horizontal bars indicate the final time point 
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at which blood glucose remained significantly elevated compared with baseline for each dose, 
**(p<0.01),*(p<0.05). 
 
5.4.2 iAUC 
Mean iAUC values are summarised in Table 5.2. Dose was observed to be a significant predictor of 
iAUC [F(4,17.12)=14.02, p<0.001]. BMI did not reach significance as a covariate [F(1,17.88)=0.07, 
p=0.795]. Post hoc comparisons revealed no significant difference in iAUC between any of the three 
sugar-matched conditions [p>0.1]. Other comparisons are summarised in Table 5.2. 
Table 5.2 Mean iAUC values for each intervention condition in Experiment 3 (n=17) 
  
Condition iAUC (mmol.min/l) 
 Mean SE 
No-added-sugar control (0mg) 34.38
a
 8.66 
No-added-sugar low dose (310mg) 78.47
ab
 15.73 
Sugar-matched control (0mg) 119.00
b
 17.38 
Sugar-matched low dose (310mg) 140.03
b
 16.73 
Sugar-matched high dose (724mg) 138.14
b
 16.34 
   
Values are estimated marginal means adjusted for BMI. Means not sharing a common superscript are 
significantly different from each other (p<0.05). 
 
5.5 Discussion 
The results show that anthocyanin-rich blueberry significantly extended the postprandial glycaemic 
response compared to the equivalent sugar dose in the absence of blueberry. Indeed, blood glucose 
levels remained significantly elevated above baseline for 2 hours following a blueberry dose 
containing 724mg anthocyanins, and for 1.5 hours following a lower 310mg dose. These post-peak 
elevations were in the range of 0.5-1.5mmol/l above fasting baseline which is well within the healthy 
postprandial blood glucose range (American Diabetes Association, 2014) and is metabolically 
beneficial through the avoidance of reactive hypoglycaemic episodes (Willett, Manson, & Liu, 2002) 
where glucose level falls close to, or below, fasting levels. 
In addition, the results demonstrate that at the time of cognitive testing used in Chapter 4 (60 
minutes postprandially), glucose levels were already in decline, but still remained significantly 
elevated following the 724mg and 310mg sugar-matched blueberry doses (and by inference the 
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517mg dose). Following the sugar-matched control dose, while glucose levels appeared to remain 
elevated at 60 minutes (Figure 5.1), the difference from baseline was not found to be statistically 
significant at this time point. Indeed, it is possible that the limited cognitive effects observed in 
Chapter 4 may, at least in part, have been due to differences in blood glucose at the time of testing. 
The cognitive benefits were of small effect size when compared with the control, which might be 
explained by marginally elevated blood glucose levels in the control condition at the time of 
cognitive testing. The potential impact of improved blood glucose regulation on cognition is 
discussed in more detail later in this chapter. 
The findings of the current study are consistent with previous human research (Törrönen et al., 
2010; Wilson et al., 2008) where extension of the postprandial glycaemic response was observed for 
mixed berry and cranberry interventions respectively. Here we have demonstrated an effect for 
blueberries, and have shown that the effect is not due to the presence of fructose as previously 
reported (Kay & Holub, 2002), but is likely related to anthocyanin content. However unlike many 
previous studies (Hidalgo et al., 2014; Nyambe-Silavwe & Williamson, 2016; Törrönen et al., 2010; 
Wilson et al., 2008), we did not observe a statistically significant attenuation of peak glucose during 
the immediate postprandial period of 15-30 minutes, despite the apparent differences in peak 
height shown in Figure 5.1. A possible explanation is that the intervention drinks were consumed 
after a 2 hour fast period in the absence of any starchy food. Previous studies included additional 
food items, therefore attenuation of peak glucose may be more noticeable in the presence of a high 
sucrose (Törrönen et al., 2010) or more complex carbohydrate load (Hidalgo et al., 2014; Nyambe-
Silavwe & Williamson, 2016). 
The findings may, in part, also be due to the mediating effect of BMI on postprandial glucose 
response, as reflected by the significance of BMI as a covariate in this analysis. Postprandial glucose 
response has been shown to be associated with BMI (Carroll, Kaiser, Franks, Deere, & Caffrey, 2007; 
Hopper, Koch, & Koch, 2013) and the issue of individual variability in glucose response has been 
previously highlighted (Carroll et al., 2007; Vinson et al., 2008). It is of particular interest here that 
BMI predicted blood glucose even in a group of young adults with a healthy BMI range, an effect not 
apparent in the current literature. Future studies should consider whether the effects of 
anthocyanin-rich foods on postprandial metabolism are mediated by BMI; it is possible that 
overweight adults with high levels of subcutaneous fat may show a greater reduction in peak glucose 
following an anthocyanin-rich intervention relative to healthy normal weight adults; however this 
hypothesis could not be tested in our small sample of healthy young adults. Additionally, individual 
differences in the time taken to consume the drink may also have influenced the outcome. Ten 
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minutes were allowed, but some participants consumed the drinks considerably faster than this 
(range 0.5-10 minutes). Peak glucose may have occurred prior to the onset of postprandial testing, 
or between the earlier testing time points for some of the participants, particularly following rapid 
absorption of glucose in the sugar-matched control which contained free sugars not bound with 
other nutrients. Thus, mean glucose peak may not have accurately reflected the true value for the 
control condition. Future studies should impose tighter control over the time taken to consume an 
intervention, and consider the use of continuous glucose monitoring to identify true peaks. 
Another important consideration here is that the drinks were not matched for fibre content. Fibre is 
known to influence postprandial glucose response. For example, guar gum and sugar beet fibre 
(both non-starch polysaccharides) have been observed to attenuate peak postprandial blood glucose 
levels and reduce overall glucose AUC (Morgan, Tredger, Wright, & Marks, 1990). However, the 
maintenance of raised glucose over a longer postprandial period, as observed in the current study, 
has not been previously associated with a high fibre intervention. It has been posited that it is 
predominantly soluble fibre that attenuates postprandial glucose through viscosity effects (Törrönen 
et al., 2010). As berries are typically low in soluble fibre and no significant attenuation of peak 
glucose was observed, the extended postprandial response following blueberry supplementation 
observed here is unlikely due to fibre confounds. Indeed, insulin regulatory effects of anthocyanin-
rich berries have previously been observed where control and experimental conditions were 
matched for fibre (although apparent glucose effects were not found to be statistically significant) 
(Park et al., 2016). As an alternative mechanism of action, anthocyanins have been observed to 
inhibit intestinal alpha-amylase and alpha-glucosidase activity (Hanamura et al., 2006; McDougall et 
al., 2005; Nyambe-Silavwe & Williamson, 2016; Tadera, Minami, Takamatsu, & Matsuoka, 2006), 
thereby slowing the rate of carbohydrate digestion. Furthermore, anthocyanins and other berry 
polyphenols have also been associated with inhibition of glucose transport from the intestine to 
blood plasma (Hanamura et al., 2006). Specific mechanisms include delayed intestinal absorption of 
glucose through inhibition of the sodium glucose co-transporter SGLT1 (Hidalgo et al., 2014; 
Johnston, Sharp, Clifford, & Morgan, 2005), and the glucose transporter GLUT2 (Kwon et al., 2007; 
Song et al., 2002). Therefore, any combination of these mechanisms is likely to underlie the 
immediate postprandial effects observed here and these potential mechanisms of action warrant 
further investigation in future studies.  
There are a number of important implications for this work. Numerous cognitive benefits of 
flavonoid-rich foods, including foods rich in anthocyanins, have been previously documented 
including reduced risk of neurodegenerative disease, and short term improvements to cognition 
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during the immediate postprandial period. It is possible that previously observed cognitive effects, 
following acute intervention with anthocyanin-rich foods, are mediated by variations in blood 
glucose levels rather than, or in addition to, other hypothesised mechanisms of actions associated 
with flavonoid intake, such as increased cerebral blood flow (Rendeiro, Rhodes, & Spencer, 2015). 
Increased glucose availability in the late postprandial period following ingestion of anthocyanin-rich 
foods may convey a cognitive advantage, given that low circulating glucose levels are often 
correlated with cognitive deficits. Indeed, it has been demonstrated that foods which elicit a 
favourable glycaemic response are beneficial for cognition (Lamport, Lawton, Mansfield, Moulin, & 
Dye, 2014), and such effects may even extend beyond the first postprandial response period, 
continuing to influence cognition after subsequent food intake (Lamport, Hoyle, Lawton, Mansfield, 
& Dye, 2011). Therefore, it is possible that circulating anthocyanin metabolites may also induce 
‘second meal’ effects (Lamport et al., 2011), which is an important consideration for flavonoid 
intervention studies where a standardised meal is provided prior to extended cognitive testing time 
points. Further work is needed to confirm whether effects on glycaemic response, such as the 
effects following anthocyanin-rich blueberry observed here, correlate with changes in cognitive 
performance. However, it is possible that cognitive benefits may be limited in a metabolically 
healthy population such as the young adults investigated here. 
The postprandial response to ingested carbohydrate is also recognised as a marker of metabolic 
health. For example, postprandial hyperglycaemia is observed in type 2 diabetes mellitus and has 
been shown to be a risk factor for cardiovascular disease (Bonora & Muggeo, 2001). Cognitive 
deficits including neurodegenerative disease are also associated with type 2 diabetes (Chung et al., 
2015; Lamport, Lawton, Mansfield, & Dye, 2009) and hypertension (Muela et al., 2017). Therefore, 
interventions which moderate postprandial glucose by limiting periods of hyper- or hypoglycaemia 
are desirable. Indeed, although not directly relevant to the aims of this thesis, the present data may 
also have implications for type 2 diabetes where regulation of postprandial glucose response is 
important in the prevention and treatment of the disease, and in the reduction of associated risk 
factors such as cardiovascular disease (Bonora & Muggeo, 2001). Glucoregulatory effects similar to 
the current study have been reported following the consumption of low glycaemic index foods, 
which are reported to reduce incidence of hypoglycaemia and type 2 diabetes (Willett et al., 2002). 
It should be noted, however, that no hypoglycaemic episodes were observed following the control 
intervention in the current study, suggesting that these benefits may only be relevant in subjects 
with pre- or type 2 diabetes, rather than in healthy young adults. Nevertheless, anthocyanin-rich 
blueberries have been positively associated with multiple health outcomes including enhanced 
cognition (Bell et al., 2015; Lamport et al., 2012), decreased blood pressure (Basu et al., 2010), and 
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improved vasoreactivity (Rodriguez-Mateos et al., 2013), all of which are compromised in type 2 
diabetes (Chung et al., 2015; Lamport et al., 2009). Furthermore, anthocyanins, and particularly 
blueberry consumption, are significantly associated with lower type 2 diabetes mellitus risk 
(Jennings et al., 2014; Wedick et al., 2012). In addition to the regulatory mechanisms described 
previously, anthocyanins have also been reported to further inhibit alpha-glucosidase activity in 
synergy with acarbose (Akkarachiyasit, Charoenlertkul, Yibchok-Anun, & Adisakwattana, 2010), a 
common anti-diabetic drug. Other reviewed blueberry effects on metabolic syndrome include 
evidence of a lowering of leptin concentrations thereby decreasing the tendency towards obesity, 
improved pancreatic beta cell function facilitating insulin secretion (Martineau et al., 2006), and 
subsequent improved insulin sensitivity (Norberto et al., 2013). Other flavonoid subclasses have also 
been observed to regulate tissue and cell specific isoforms of glucose transporters (GLUTs1-5) 
(Cazarolli et al., 2008), the rate determining step for glucose uptake by all cells including transport of 
glucose across the blood-brain barrier (Vannucci, Maher, & Simpson, 1997). Additional evidence also 
suggests that berry anthocyanins may inhibit glycative activity, where glucose interacts with proteins 
and lipids in both exogenous food sources and endogenous body tissue (Thangthaeng, Poulose, 
Miller, & Shukitt-Hale, 2016). The reactive products of such activity (AGEs) have been linked with 
both hyperglycaemia and cognitive decline. Cognitive outcomes have not been assessed in the 
current study, however these mechanisms would support enhancement of cognition in type 2 
diabetes following anthocyanin-rich intervention. The combined evidence suggests there is clear 
potential for a diet-based blueberry intervention to benefit the risk factors and co-morbidities 
associated with type 2 diabetes. 
In conclusion, blood glucose levels were found to be significantly elevated at the time of cognitive 
testing utilised in Chapter 4 following the sugar-matched blueberry doses, but not following the 
sugar-matched control. It is unclear at this stage whether the sugar levels in the intervention drinks 
confounded the previous experiment, or provided an additional mechanism of action for observed 
cognitive benefits. In the current glycaemic experiment, anthocyanin-rich blueberry also influenced 
the postprandial glucose response such that blood glucose availability was extended, in a dose-
dependent manner, for up to 2 hours postprandially. The potential impact of this experimental 
outcome has been discussed with reference to cognition and metabolic health.  In relation to the 
current thesis, it was decided to design a follow-up experiment, incorporating blood glucose 
measurements and cognitive testing at baseline, 1 hour and 2 hour postprandial time points. The 
aim was to determine whether cognitive benefits following blueberry intervention were directly 
related to blood glucose levels at the time of cognitive testing and whether extended availability of 
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blood glucose conveyed cognitive benefits at a slightly later time point. The outcome of this follow-
up study is reported in the next chapter.
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Chapter 6  
Experiment 4: A dose-response study of cognitive and 
blood glucose effects following acute anthocyanin-rich 
blueberry supplementation in healthy young adults 
6.1 Introduction 
As with Experiment 2 (Chapter 4), this study aimed to determine a dose-response for the cognitive 
effects of blueberry flavonoids, using doses matched to those used by Rodriguez-Mateos et al. 
(2013). This time cognitive testing was performed pre-, 1 hour, and 2 hours post-intervention in 
order to monitor changes in cognition at time points with and without expected differences in blood 
glucose concentration, as identified in the previous chapter. Blood glucose measurements were 
included in the current study in order to confirm glucose status at the time of cognitive testing. The 
cognitive tasks previously used in Experiment 2 were identified as sensitive to flavonoid intervention 
in the literature review, but for this experiment the task battery was modified to place greater 
emphasis on mood, working memory and attention. There were a number of reasons for this; newly 
published research showed marked effects in these domains following berry intervention (Khalid et 
al., 2017; Watson et al., 2015); as a possible mechanism, glucose has previously been linked with 
improved attention and working memory (Benton, Brett, & Brain, 1987; Benton et al., 1994; 
Kennedy & Scholey, 2000; Scholey et al., 2001); a shortened cognitive test battery was needed to 
maintain two distinct post-intervention time points. In particular, the shortened battery ruled out 
the testing of episodic memory. The tasks were all investigated for practice effects prior to use, as 
reported in Chapter 3. Again, the methodology used here reflects the findings of that study. 
6.2 Methods 
6.2.1 Participants 
The participants were 41 healthy adults, aged 18-36 years (M 23.54, SD 5.14 years), 11 male, BMI (M 
23.44, SD 4.99). The participants were of similar demographic to those who took part in all previous 
experiments. Full participant details are reported in Chapter 2. 
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6.2.2 Design 
A double-blind crossover intervention study design was used. Independent variables were blueberry 
dose (4 levels; 3 doses and a matched control) and time (3 levels; pre-, 1 hour, and 2 hours post-
intervention). Additional postprandial time points of 15 minutes and 30 minutes were included for 
blood glucose measurement only. Participants attended a total of 5 regularly spaced visits. The 
minimum number of days between visits was 3 (M 6.97, SD 4.27).  Again, in order to minimise the 
impact of practice on cognitive task performance, the first visit was treated as a familiarisation visit. 
Cognitive and blood glucose data collected during this visit were not included in subsequent 
analyses. Participants were not made aware of this and followed the same procedure as for all other 
visits, with the exception that participants were permitted as much practice as they required in 
order to feel comfortable with the cognitive tasks. The different blueberry doses were administered 
in drink form. The drink consumed at the familiarisation visit was identical to the control. At 
subsequent visits, the control and all blueberry doses were administered in counterbalanced order, 
determined using Williams matrices (Williams, 1949).  
6.2.3 Procedure 
At each visit participants arrived 2 hours fasted having previously followed a 24 hour low polyphenol 
diet (Chapter 2). They completed a pre-intervention battery of cognitive tasks and blood glucose 
measurements. Participants then consumed a blueberry or control drink. In order to minimise drink 
consumption rate variability, participants were required to finish the drink within a 5 minute time 
period, after which they were asked to remain in the lab waiting room. As in Experiment 2, 
participants completed a 24 hour retrospective food diary and a post-drink palatability questionnaire 
(Chapter 2). Further blood glucose measurements were recorded 15 minutes and 30 minutes after 
consuming the intervention. Participants resumed testing, repeating the cognitive task battery and 
blood glucose measurements at the post-intervention time points of 1 and 2 hours. A return 
appointment was then booked for the following week. 
6.2.4 Blueberry intervention drinks 
The blueberry doses used in the drinks were again aligned with those used in a previous vascular 
study (Rodriguez-Mateos et al., 2013), however in this case two of the previous doses (129mg and 
258mg) were omitted. Thus, three blueberry doses, containing 310mg, 517mg & 724mg 
anthocyanins, were selected as these doses represented the range for which heart rate, cognition 
and mood effects were observed in Experiment 2.  Additionally, as described in Chapter 2, a new 
batch of freeze-dried blueberry powder was used in this experiment. The anthocyanin content of 
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this new batch was proportionally greater than the powder used in previous experiments. Indeed, by 
matching the anthocyanin content of the doses between experiments, the overall polyphenol 
content of each dose was greatly reduced in the current experiment when compared with 
Experiments 2 & 3. Therefore, the total polyphenol content of the lower, 129mg & 258mg, doses fell 
below that observed to elicit a vasodilatory response in the vascular study (Rodriguez-Mateos et al., 
2013), giving further justification for the omission of these doses. Similarly, the total sugar content of 
the highest dose was reduced compared with Experiments 2 & 3. All doses were sugar-matched to 
this new value. The compositional analyses of all intervention drinks are shown in Table 6.1. The 
drinks were again prepared immediately prior to consumption by adding the appropriate amounts of 
freeze-dried blueberry powder, sugars and vitamin C to water. However, this time a lower volume of 
300ml water was used. Lower amounts of powder were needed to achieve the doses and so the 
corresponding amount of water was reduced to maintain taste and consistency of the drinks. As a 
result the drinks were also easier to consume within the reduced time limit.  
Table 6.1. Composition of blueberry and control doses in Experiment 4 
   
  Freeze-dried wild blueberry powder (g) 
Composition Control 16.3 27.2 38.1 
Anthocyanins (mg) 0 310 517 724 
Procyanidins (mg) 0 Not 
quantified 
Not 
quantified 
Not 
quantified 
Total polyphenols (mg) 0 473 789 1105 
Vitamin C (mg) 128 128 128 128 
Fructose (g) 13.7 13.7 13.7 13.7 
Glucose (g) 13.0 13.0 13.0 13.0 
 
6.2.5 Cognitive & subjective measures 
Full details of the selected cognitive tasks are given in Chapter 2. The order of the tasks was as 
follows: serial 3s & 7s subtraction tasks, RVIP, and digit vigilance, presented in between-subjects 
counterbalanced order; PANAS Now mood questionnaire. 
6.2.6 Physiological measures 
Blood glucose was measured at baseline and at 15, 30, 60 and 120 minutes. At each time point that 
coincided with a cognitive test session (baseline, 1 hour, 2 hours), measurements were recorded 
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prior to cognitive testing. Blood sampling equipment details and measuring procedure are reported 
in Chapter 2. 
6.3 Data analysis 
Data collected during Visit 1 were discarded prior to analysis and any outliers were removed 
according to criteria previously described in Chapter 2.  
Blood glucose data were analysed by LMM using an unstructured covariance matrix to model 
successive repeat measurements. Visit, Time, Dose, and Time x Dose interaction were included as 
fixed factors in the model. Subjects were included as random effects. BMI was included as a 
covariate (Model 4.1). Where the covariate was found to be a significant predictor of performance, 
the analysis was performed with the further addition of covariate interactions (Model 4.2).The 
analysis aim was to determine whether blueberry dose had a mediating effect on postprandial 
glycaemic response. Pairwise comparisons were used to investigate significant effects and all 
interactions. A Bonferroni correction was applied to all multiple comparisons. iAUC values were 
calculated for each dose using the trapezoid rule. iAUC data were analysed by LMM, again using an 
unstructured covariance matrix. Visit and Dose were included as fixed factors in the model and BMI 
was included as a covariate (Model 4.3). The analysis aim was to determine whether blueberry dose 
had a mediating effect on the total amount of glucose absorbed into the blood stream post 
ingestion. Pairwise comparisons with Bonferroni correction were again used to investigate any 
significant effects and all interactions.  
All cognitive and mood data were similarly analysed by LMM, also using an unstructured covariance 
matrix to model successive repeat measurements. Visit, Session, Dose, and Session x Dose 
interaction were included as fixed factors in the model. Subjects were included as random effects. 
The analysis aim was to determine whether blueberry dose was a significant predictor of cognitive or 
mood performance. In order to determine whether blood glucose concentration was also a 
significant predictor of cognition or mood, the analysis was performed both without (Model 4.4) and 
with the addition of this repeated covariate (Model 4.5). Where the covariate was found to be a 
significant predictor of performance, the analysis was performed with the further addition of 
covariate interactions (Model 4.6). Pairwise comparisons with Bonferroni correction were used to 
investigate any significant effects and all interactions for each of the models. 
Palatability ratings for the intervention drinks were analysed by LMM using an unstructured 
covariance matrix to model successive ratings. Dose was the only fixed factor in the model (Model 
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4.7). The analysis aim was to determine whether the intervention drinks were adequately matched 
for flavour across a number of different taste dimensions. 
6.4 Results 
Raw data for all measured variables can be found in the supplementary data accompanying this 
thesis. Tabulated LMM results can be found in Appendix L. For clarity, only significant F-statistics are 
reported in full in the text. 
6.4.1 Glucose analysis 
LMM analysis revealed that Time [F(4,164.00)=215.62, p<0.001], Dose [F(3,90.27)=4.81, p=0.004], 
and Time x Dose interaction [F(12,164.00)=3.36, p<0.001] were all statistically significant factors in 
the prediction of blood glucose concentration. Visit was not observed to be a significant factor 
[F(3,120.95)=2.03, p=0.113], indicating that order effects were not present in the data. BMI was a 
significant covariate [F(1,39.01)=9.96, p=0.003]; higher BMI was predictive of higher glucose 
[beta=0.043]. When added to the model, no covariate interactions were observed to be significant. 
The interaction between blueberry dose and postprandial glucose response is shown in Figure 6.1. 
For all doses, blood glucose levels were significantly elevated compared to baseline at 15minutes 
[p<0.001] and 30minutes [p<0.001], but were no longer elevated at 1 hour [p>0.1]. At 2 hours, 
glucose levels were significantly reduced for all doses compared with baseline values [p<0.001]. 
Significant differences in peak glucose concentration were observed between 15 minutes and 30 
minutes postprandially: at 15 minutes the 724mg dose was significantly lower than both the 310mg 
[p=0.011] and 0mg [p<0.001] doses, and the 517mg dose was significantly lower than the 0mg dose 
[p=0.009]; at 30 minutes the 724mg dose was significantly lower than both the 517mg [p=0.048] and 
0mg [p=0.001] doses. No significant differences were found between doses at baseline, or at 1 and 2 
hours postprandially, despite apparent differences at 1 hour seen in Figure 6.1 . 
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Figure 6.1 The interaction between blueberry dose and postprandial blood glucose concentration 
All doses were sugar-matched to contain the same quantity of sugars naturally present in the highest dose 
(26.7g total sugars). Values are estimated marginal means adjusted for BMI. Error bars represent standard 
error of the mean. Coloured asterisks indicate a significant difference between the corresponding blueberry 
dose and the 0mg control condition at that time point, ** (p<0.01).  
 
Analysis of iAUC data revealed that neither Visit [F(3,40.03)=0.09, p=0.965] nor Dose 
[F(3,92.64)=2.15, p=0.100] significantly predicted iAUC. BMI was not a significant covariate 
[F(1,39.86)=0.33, p=0.569]. Therefore iAUC did not significantly differ between conditions. 
Table 6.2 Mean iAUC values for each intervention condition in Experiment 4 (n=41) 
  
Anthocyanins dose iAUC (mmol.min/l) 
 Mean SE 
0mg 63.98 6.97 
310mg 68.17 7.01 
517mg 70.26 6.98 
724mg 55.43 6.99 
Values are estimated marginal means adjusted for BMI 
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6.4.2 Cognitive analysis 
Tabulated means for cognitive data can be found under each individual task subheading. LMM 
results for the analyses of all cognitive variables are reported in full in Appendix M. In the text 
significant F-statistics are reported in full. Non-significant effects are reported as p values only. 
6.4.2.1 Order effects and baseline differences 
The factor Visit was included in the LMM model for each cognitive dependent variable in order to 
determine the nature of any residual order effects. For the digit vigilance task, Visit was a significant 
predictor of both score [F(3,113.74)=3.42, p=0.020] and commission errors [F(3,121.23)=2.83, 
p=0.041] , but not RT [p=0.082]. Pairwise comparisons revealed a significant decrease in digit 
vigilance score between Visits 2 & 5 [p=0.025]. A corresponding trend for increased commission 
errors was evident over the same period [p=0.094]. For the RVIP task, Visit was a significant 
predictor of RT only [F(3,122.19)=2.86, p=0.040]. Pairwise comparisons revealed a significant slowing 
of RT between Visits 3 & 5 [p=0.045]. No other significant order effects were evident for this task. 
Visit was a significant predictor of 3s score [F(3,120.61)=97.76, p<0.001], 3s RT [F(3,116.29)=31.53, 
p<0.001], 7s score [F(3,118.96)=35.01, p<0.001], and 7s RT [F(3,114.31)=24.56, p<0.001]. Post hoc 
comparisons revealed a significant increase in both 3s and 7s scores between all consecutive visits 
[p<0.05]. Significant decreases for 3s RT occurred up to Visit 3 [p<0.05], however for 7s RT significant 
improvements continued between all visits [p<0.05] apart from between Visits 3 & 4 where 
apparent improvements were non-significant [p=0.281]. Therefore significant order effects were 
evident for both serial 3s and 7s tasks. In general, order effects therefore remained apparent despite 
methodological measures employed to keep them to a minimum. However, following the successful 
counterbalancing of the order in which all doses were presented to participants, no significant 
baseline differences were evident for any of the cognitive tasks, under any of the individual dose 
conditions [p>0.1]. 
6.4.2.2 Digit vigilance 
Tabulated means for the digit vigilance task can be found in Table 6.3. 
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Table 6.3 Digit vigilance data for Experiment 4 (n=41) 
         Test session 
Digit vigilance 
 
Dose 
 
Baseline 
 
1 hr 
 
2 hr 
 variable 
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
Score 
(correct/45) 
 
0mg 
 
42.85 2.89 
 
42.75 2.36 
 
42.31 2.92 
 
310mg 
 
42.41 2.87 
 
42.20 3.16 
 
43.05 2.16 
  
517mg 
 
42.66 3.41 
 
42.83 2.65 
 
42.74 2.62 
  
724mg 
 
42.80 2.76 
 
42.41 2.95 
 
42.15 3.43 
            Commission 
errors 
 
0mg 
 
1.53 1.58
 
1.63 1.80
 
1.93 1.80
 
310mg 
 
1.56 1.19 
 
1.95 1.92 
 
1.45 1.57 
  
517mg 
 
1.76 1.76 
 
1.40 1.32 
 
1.83 1.89 
  
724mg 
 
1.56 1.45 
 
2.07 1.89 
 
2.08 1.61 
    
        
RT (ms) 
 
0mg 
 
442.05 40.82 
 
448.92 45.89 
 
451.65 48.35 
  
310mg 
 
446.50 50.20 
 
449.34 44.21 
 
448.66 47.40 
  
517mg 
 
436.76 38.72 
 
449.19 46.51 
 
446.44 41.90 
  
724mg 
 
440.31 48.30 
 
449.64 51.73 
 
451.08 48.91 
                   
 
For the digit vigilance task, Session was a significant predictor of RT [F(2,163.68)=7.59, p=0.001], but 
not of score or errors [p>0.1]. RTs slowed significantly between baseline and 1 hour [p=0.002]. 
Neither Dose, nor Session x Dose interaction was found to be a significant factor in predicting any of 
the digit vigilance variables. However, more detailed interpretation of pairwise comparisons for the 
interaction revealed a significant slowing of RT between baseline & 1 hour [p=0.016] and a trend 
towards a slowing of RT between baseline & 2 hours [p=0.085] following the 517mg dose, however 
no corresponding changes in score or errors were observed. When added to the model as covariate, 
glucose concentration was not found to be a significant factor [p>0.1]. 
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6.4.2.3 RVIP 
Tabulated means for the RVIP task can be found in Table 6.4. 
Table 6.4 RVIP data for Experiment 4 (n=41) 
         Test session 
RVIP variable 
 
Dose 
 
Baseline 
 
1 hr 
 
2 hr 
  
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
Score 
(correct/40) 
 
0mg 
 
23.20 8.89 
 
25.00 9.44 
 
23.93 9.43 
 
310mg 
 
22.93 8.68 
 
23.66 9.72 
 
23.44 9.59 
  
517mg 
 
23.63 9.36 
 
25.02 9.51 
 
23.98 10.16 
  
724mg 
 
23.88 9.67 
 
23.85 9.32 
 
23.08 9.58 
            Commission 
errors 
 
0mg 
 
12.07 13.17
 
11.20 12.47
 
11.35 13.68
 
310mg 
 
11.39 12.15 
 
12.46 13.40 
 
12.41 14.00 
  
517mg 
 
12.76 14.26 
 
11.54 14.02 
 
12.17 14.67 
  
724mg 
 
12.56 14.23 
 
11.51 14.73 
 
11.13 13.07 
    
        
RT (ms) 
 
0mg 
 
388.39 39.45 
 
394.62 48.28 
 
384.37 46.21 
  
310mg 
 
398.26 47.75 
 
391.45 45.06 
 
392.79 43.00 
  
517mg 
 
395.01 47.16 
 
386.69 40.57 
 
391.24 44.84 
  
724mg 
 
387.76 48.96 
 
392.33 46.48 
 
388.51 38.74 
                   
 
For the RVIP task, Session was a significant predictor of score [F(2,163.61)=4.54, p=0.012], but not of 
RT or errors [p>0.1]. Scores significantly increased between baseline and 1 hour [p=0.038]. Neither 
Dose, nor Session x Dose interaction were found to be significant factors in predicting any of the 
RVIP variables, however pairwise comparisons for the interaction revealed a trend towards 
increased score between baseline & 1 hour following the control intervention [p=0.063]. No 
corresponding changes in RT or error rate were observed. When added to the model as covariate, 
glucose concentration was not found to be a significant factor [p>0.1]. 
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6.4.2.4 Serial 3s & 7s 
Tabulated means for the serial 3s & 7s tasks can be found in Table 6.5 & Table 6.6, respectively. 
Table 6.5 Serial 3s data for Experiment 4 (n=41) 
 
        Test session 
Serial 3s 
variable 
 
Dose 
 
Baseline 
 
1 hr 
 
2 hr 
  
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
Score 
(correct 
in 2 mins) 
 
0mg 
 
53.08 19.33 
 
55.93 19.73 
 
55.47 18.43 
 
310mg 
 
50.79 19.50 
 
53.00 19.64 
 
53.05 18.89 
 
517mg 
 
51.73 20.84 
 
55.63 20.88 
 
57.28 20.76 
  
724mg 
 
52.53 18.32 
 
55.60 19.41 
 
56.13 16.15 
            Errors 
(incorrect 
in 2 mins) 
 
0mg 
 
1.15 1.49
 
1.63 1.64
 
1.92 1.92
 
310mg 
 
1.44 2.01 
 
1.82 1.76 
 
1.88 2.05 
 
517mg 
 
1.39 1.36 
 
1.90 2.01 
 
1.51 1.80 
  
724mg 
 
1.63 1.71 
 
1.71 1.68 
 
1.62 1.95 
    
        
RT (ms) 
 
0mg 
 
2283.43 957.26 
 
2170.61 1017.07 
 
2085.89 869.50 
  
310mg 
 
2428.45 1171.80 
 
2258.22 1102.35 
 
2249.03 1029.78 
  
517mg 
 
2361.19 1005.97 
 
2125.26 874.77 
 
2128.29 863.73 
  
724mg 
 
2315.17 1094.88 
 
2025.87 862.48 
 
2139.95 873.66 
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Table 6.6 Serial 7s data for Experiment 4 (n=41) 
 
        Test session 
Serial 7s 
variable 
 
Dose 
 
Baseline 
 
1 hr 
 
2 hr 
  
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
Score 
(correct 
in 2 mins) 
 
0mg 
 
26.18 8.64 
 
26.18 10.85 
 
28.92 13.94 
 
310mg 
 
25.30 11.24 
 
26.93 11.05 
 
26.82 12.96 
 
517mg 
 
26.30 13.26 
 
28.33 14.89 
 
27.95 10.57 
  
724mg 
 
26.23 13.27 
 
26.77 11.14 
 
27.31 11.21 
            Errors 
(incorrect 
in 2 mins) 
 
0mg 
 
1.68 1.68
 
2.32 1.89
 
1.56 1.74
 
310mg 
 
1.88 1.93 
 
2.05 2.28 
 
2.46 2.05 
 
517mg 
 
1.98 2.04 
 
2.27 1.95 
 
2.39 2.38 
  
724mg 
 
1.93 1.57 
 
1.95 2.05 
 
2.25 2.15 
    
        
RT (ms) 
 
0mg 
 
4332.43 1907.26 
 
3953.11 1626.98 
 
4257.97 1993.81 
  
310mg 
 
4513.37 1906.53 
 
4471.30 2036.34 
 
4380.48 2058.33 
  
517mg 
 
4302.26 1619.31 
 
4156.56 1729.86 
 
4070.61 1740.44 
  
724mg 
 
4403.49 1772.28 
 
4105.09 1636.97 
 
4420.54 2112.45 
                     
 
For the serial subtraction tasks, Session was a significant predictor of 3s score [F(2,158.32)=18.62, 
p<0.001], 3s RT [F(2,156.34)=31.24, p<0.001], 7s score [F(2,156.55)=11.62, p<0.001],  and 7s RT 
[F(2,145.93)=10.99, p<0.001].  All scores and RTs significantly improved between baseline and 1 hour 
[p<0.001] but no further improvements were observed between 1hour and 2 hours [p>0.1]. Error 
scores remained stable between all visits and sessions. Neither Dose, nor Session x Dose interaction 
were found to be significant factors in predicting any of the serial subtraction variables. However, 
pairwise comparisons for the interaction revealed significant improvements in serial 3s score and RT 
between baseline & 1 hour, and between baseline & 2 hours following the control, 517mg and 
724mg conditions [p<0.05], but not the 310mg condition [p>0.10]. For the control condition, these 
improvements were accompanied by a trend towards an increase in error rate [p=0.052] that was 
not observed for any of the blueberry doses, shown in Figure 6.2.  
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Figure 6.2 The interaction between test session and dose for serial 3s errors 
Values are estimated marginal means. Error bars represent standard error of the mean. A significant difference 
from baseline is indicated above the column, † (p<0.10). 
 
Pairwise comparisons for the serial 7s interaction revealed significant improvements in score and RT 
between baseline & 1 hour, and between baseline & 2 hours following the two highest blueberry 
doses (517mg & 724mg) only [p<0.05]. No significant improvements were observed following the 
control or 310mg dose [p>0.10]. These interactions are shown in Figure 6.3 & Figure 6.4. 
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Figure 6.3 The interaction between test session and dose for serial 7s score 
Values are estimated marginal means. Error bars represent standard error of the mean. A significant difference 
from baseline is indicated above the column, *(p<0.05), †(p<0.10). 
 
 
Figure 6.4 The interaction between test session and dose for serial 7s RT 
Values are estimated marginal means. Error bars represent standard error of the mean. A significant difference 
from baseline is indicated above the column, *(p<0.05). 
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When added to the model as covariate, glucose concentration was found to be a significant 
predictor of serial 3s score only [F(1,345.39)=6.81, p=0.009]; higher glucose levels were predictive of 
better cognitive performance [beta=1.406]. In order to further investigate the relationship between 
glucose and serial 3s task performance, covariate interactions with the fixed factors Session & Dose 
were added to the LMM model. Glucose x Session [F(2,208.96)=5.16, p=0.006], and Glucose x Dose 
[F(3,308.62)=4.81, p=0.003] were found to be statistically significant, however Glucose x Session x 
Dose was not [F(6,241.69)=1.69, p=0.125]. For the Glucose x Session interaction, beta coefficients 
were: baseline [beta=1.748]; 1 hour [beta=1.831]; 2 hours [beta=2.841]. Therefore, at later time 
points a greater proportional difference in serial 3s performance was observed for each unit 
difference in blood glucose i.e. blood glucose level showed greatest impact on cognitive 
performance at 2 hours postprandially. For the Glucose x Dose interaction, beta coefficients were: 
0mg [beta=2.841]; 310mg [beta=0.308]; 517mg [beta=6.497]; 724mg [beta=5.063]. Therefore, 
differences in blood glucose showed the greatest impact on cognitive performance following the 
two highest blueberry doses. 
6.4.3 Mood analysis 
Tabulated means for all mood data can be found in Table 6.7. LMM results for the analyses of 
positive affect, negative affect and mental fatigue can be found in Appendix L. For clarity, only 
significant F-statistics are reported in full in the text.  
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Table 6.7 Mood data for Experiment 4 (n=41) 
         Test session 
Mood measure 
 
Dose 
 
Baseline 
 
1 hr 
 
2 hr 
  
 
  
 
Mean SD 
 
Mean SD 
 
Mean SD 
    
    
 
    
   Mental fatigue 
(rating/9) 
 
0mg 
 
4.17 2.10 
 
3.83 2.17 
 
4.00 2.22
 
310mg 
 
4.54 2.27 
 
4.34 2.27 
 
4.27 2.11 
  
517mg 
 
4.34 2.15 
 
3.88 1.82 
 
3.59 1.72 
  
724mg 
 
4.56 2.26 
 
4.49 2.05 
 
4.05 1.96 
            Positive affect 
(score/50) 
 
0mg 
 
23.90 8.52
 
21.93 7.47
 
23.67 8.13
 
310mg 
 
21.95 8.01 
 
21.51 8.03 
 
23.20 8.35 
  
517mg 
 
22.78 7.44 
 
23.71 7.77 
 
24.76 9.19 
  
724mg 
 
22.41 8.39 
 
22.41 7.49 
 
23.73 7.84 
           Negative affect 
(score/50) 
 
0mg 
 
12.49 2.70
 
11.90 3.13
 
11.97 2.99
 
310mg 
 
12.63 4.04 
 
12.51 3.49 
 
12.32 2.71 
  
517mg 
 
12.76 3.71 
 
12.27 3.32 
 
12.00 2.74 
  
724mg 
 
13.54 4.15 
 
12.37 3.48 
 
11.98 2.58 
                    
 
For all subjective mood measures Visit was not a significant factor [p>0.1], indicating no order 
effects for these measures. Subsequently, pairwise comparisons revealed there were no significant 
baseline differences for any of the counterbalanced dose conditions [p>0.1]. Dose and Session x 
Dose interaction were not significant for any of the mood measures [p>0.1]. Session, however, was 
observed to be a significant predictor of positive affect [F(2,161.97)=4.99, p=0.008], negative affect 
[F(2,161.93)=4.63, p=0.011], and mental fatigue [F(2,163.32)=3.45, p=0.034]. Pairwise comparisons 
revealed: a significant increase in positive affect between the 1 & 2 hour test sessions [p=0.007]; a 
significant reduction in negative affect between baseline & 1 hour [p=0.038], and baseline & 2 hours 
[p=0.009]; and a significant reduction in mental fatigue between baseline & 2 hours [p=0.028]. These 
Session effects are most likely attributable to the consumption of an energy-containing drink, 
irrespective of dose condition.  
More detailed interpretation of pairwise comparisons for the Session x Dose interaction revealed a 
trend towards decreased positive affect between baseline & 1hour following the control condition 
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[p=0.091]; no similar trends were observed following any of the blueberry conditions. A trend 
towards reduced mental fatigue between baseline & 2 hours was observed following the 517mg 
dose [p=0.076]. The highest (724mg) dose elicited significant reductions in negative affect between 
baseline & 1hr [p=0.041], and between baseline & 2hrs [p=0.010], as shown in Figure 6.5.  When 
added to the model as a repeated covariate, blood glucose concentration approached significance as 
a predictor of mental fatigue [F(1,364.76)=3.12, p=0.078]; higher glucose levels were predictive of 
lower levels of mental fatigue [beta=-0.227]. Following their addition to the model, no covariate 
interactions were observed to be significant. 
 
Figure 6.5 The interaction between session and dose for negative affect 
Values are estimated marginal means. Error bars represent standard error of the mean.  A significant 
difference from baseline is indicated above the column, **(p<0.05), *(p<0.05).  
 
6.4.4 Cohen’s d effect sizes  
Cohen’s d effect sizes for all significant interactions (identified by pairwise comparisons) are shown 
in Table 6.8. Effect sizes were calculated from estimated marginal means and standard error values 
using the method described in Chapter 2. For cognition and mood effects, difference from baseline 
following blueberry intervention was compared with difference from baseline following the control. 
Glucose effect sizes indicate the difference compared to control at the stated postprandial time 
point.   
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Table 6.8 Cohen's d effect sizes for Experiment 4 
Table 6.8 continued   
    Variable  Dose  Time point  Cohen's d 
Physiology:   
    Blood glucose  517mg 
 
15 mins 
 
**0.647 
 
 724mg 
 
15 mins 
 
**0.876 
 
  
 
30 mins 
 
**0.789 
Cognition:   
    Digit vigilance RT  517mg 
 
1h 
 
*-0.200
 
  
 
2h 
 
†-0.023 
 
  
    RVIP score  310mg 
 
1h 
 
(†)-0.219
 
 517mg 
 
1h 
 
(†)-0.085 
 
 724mg 
 
1h 
 
(†)-0.373 
 
  
    Serial 3s score  310mg 
 
1h 
 
(*)-0.119
 
  
 
2h 
 
(*)-0.178 
 
 517mg 
 
1h 
 
**0.143 
 
  
 
2h 
 
**0.258 
 
 724mg 
 
1h 
 
*0.031 
 
  
 
2h 
 
*0.021 
 
  
    Serial 3s errors  310mg 
 
2h 
 
(†)0.187
 
 517mg 
 
2h 
 
(†)0.330 
 
 724mg 
 
2h 
 
(†)0.378 
 
  
    Serial 3s RT  310mg 
 
1h 
 
(*)-0.295
 
  
 
2h 
 
(*)-0.434 
 
 517mg 
 
1h 
 
**0.167 
 
  
 
2h 
 
**0.633 
 
 724mg 
 
1h 
 
*0.062 
 
  
 
2h 
 
**0.362 
 
  
    Serial 7s score  517mg 
 
1h 
 
†0.362
 
  
 
2h 
 
*0.248 
 
 724mg 
 
2h 
 
*0.116 
 
  
    Serial 7s RT  517mg 
 
1h 
 
*0.116
 
 137 
 
Table 6.8 continued   
    Variable  Dose  Time point  Cohen's d 
 
  
 
2h 
 
*0.297 
 
 724mg 
 
1h 
 
*0.142 
Mood:   
    Mental fatigue  517mg 
 
2h 
 
†0.241
 
  
    Positive affect  310mg 
 
1h 
 
(†)0.294
 
 517mg 
 
1h 
 
(†)0.507 
 
 724mg 
 
1h 
 
(†)0.345 
 
  
    Negative affect  724mg 
 
1 h 
 
*0.197
 
  
 
2h 
 
**0.305 
   
    Cohen’s d values represent small (d=0.2), medium (d=0.5), and large (d=0.8) effect sizes, respectively. Positive 
values indicate performance improvements, and negative values indicate detriments to performance, 
compared to the control.  Significance of the underlying pairwise comparison is indicated, **(p<0.01), 
*(p<0.05), †(p<0.1). The use of brackets, (*), (†), indicates a change from baseline for the control condition, 
which was attenuated for the blueberry condition. 
 
6.4.5 Palatability analysis 
LMM analysis of the palatability data revealed a significant effect of dose for ‘sweet’ 
[F(3,40.81)=15.76, p<0.001], ‘bland’[F(3,40.94)=6.79, p=0.001], and ‘sour’ [F(3,40.63)=8.82, 
p<0.001]rating dimensions, but nor for ‘tasty’[p=0.114], ‘pleasant’[p=0.112], ‘satisfying’[p=0.382], 
‘how much more could you consume?’[p=0.429], and ‘how easy was it to consume?’ [p=0.714] 
ratings. The effect of dose on each rating dimension is shown in Figure 6.6. The 0mg control drink 
was rated as tasting significantly sweeter than all of the blueberry doses [p<0.001]. The 517mg and 
724mg doses were rated significantly more sour than the control [<0.001], and were each rated 
marginally more sour than the 310mg dose, [p=0.093] and [p=0.058], respectively. However, 
although there were noticeable differences between interventions for specific taste dimensions 
(sweet, bland, sour), they appeared well-matched in terms of overall taste, pleasantness and 
satisfaction ratings. 
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Figure 6.6 Palatability ratings for all intervention doses in Experiment 4 
Values are estimated marginal means. Error bars represent standard error of the mean. 
 
6.5 Discussion 
LMM analysis revealed a significant dose-dependent effect of anthocyanin-rich blueberry on 
postprandial glucose response. Specifically, the 724mg and 517mg doses, but not the 310mg dose, 
significantly attenuated peak postprandial glucose compared to the control condition. Observed 
effect sizes were large following the 724mg dose and moderate following the 517mg dose. However, 
unlike my previous results in Experiment 3 (Chapter 5), no extended elevation of blood glucose was 
observed following any of the blueberry doses.  
The lack of a LMM Dose x Session interaction for any of the cognitive or mood DVs suggests that, in 
this experiment, blueberry anthocyanins had no effect on mood or cognition at any dose when 
compared with the matched control condition. However, when employing statistically less 
conservative pairwise comparisons, as recommended by Huck (2015), significant effects on mood 
and working memory became evident. In particular, the 724mg dose elicited a significant reduction 
in negative affect between baseline and 1 & 2hrs, while positive affect decreased at 1 hour following 
the control but not following any of the blueberry doses. Improvements in serial 3s score & RT, at 1 
& 2 hour time points, were evident following the two highest (517mg & 724mg) blueberry doses but 
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not the lowest 310mg dose. In this case, similar score & RT improvements were also observed 
following the matched control, although here the improvements were accompanied by an increase 
in errors that approached significance at 2 hours. No such increased error rate was observed for any 
of the blueberry conditions. Improvements in serial 7s score & RT were evident at 1 & 2 hours 
following the 516mg & 724mg doses only.  
No cognitive benefits were observed for the digit vigilance or RVIP tasks suggesting that they were 
not sensitive to flavonoid-rich intervention in this study. During the piloting of the tasks (Chapter 3), 
the digit vigilance task was rated the easiest of all the tasks in the cognitive battery so it may be that 
a more demanding cognitive load is needed before blueberry effects become apparent. Indeed, a 
similar observation has been made in a study of executive function in children following blueberry 
intervention (Whyte, Shafer, & Williams, 2017). However, the RVIP task was rated at a similar level 
of difficulty as the serial 7s task. It is unclear why intervention with anthocyanin-rich blueberry 
should elicit improvement in serial 7s but not RVIP, as the tasks were well matched for cognitive 
load, with some overlap in cognitive domain. The RVIP task has previously shown sensitivity to 
flavonoid-rich intervention in young adult populations (Scholey et al., 2010; Watson et al., 2015). 
While Scholey et al. (2010) investigated flavanol-rich cocoa, Watson et al. (2015) observed 
maintenance of RVIP accuracy compared to control following a freeze-dried blackcurrant extract rich 
in anthocyanins. However in the same study, a juiced extract from a different cultivar did not elicit 
the same effect. Conversely, significant improvements in digit vigilance RT were observed following 
the juice but not the freeze-dried extract. Therefore it may be that different profiles of anthocyanins 
or other polyphenols also present, or indeed other components of the food matrix, may impact very 
specific cognitive domains via different mechanisms of action. For example, in the same experiment, 
the juice elicited altered postprandial glucose response and inhibited monoamine oxidase, whereas 
the freeze-dried extract showed neither effect. Due to cost implications, the exact polyphenol and 
anthocyanin profiles for the freeze-dried powder used here were not determined, but such analyses 
should be considered in future work. 
The improvements to working memory following the highest doses of anthocyanin-rich blueberry 
are similar to the effects observed in Experiment 2 (Chapter 4); the observed small to moderate 
effect sizes compare favourably between the two thesis chapters and are in agreement with 
literature values. Similar effects on serial subtraction performance have been observed following 
flavonoid-rich intervention e.g. (Kennedy et al., 2002; Massee et al., 2015; Scholey et al., 2010) and 
are reported in Chapter 1. No significant differences in blood glucose were evident at the time of 
cognitive testing in the current study, suggesting that elevated glucose could not be a cause of the 
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observed cognitive effects. However, the two highest doses were observed to significantly attenuate 
the peak postprandial glucose response. Therefore, changes to blood glucose regulation may still, at 
least in part, underlie these working memory effects through other related mechanisms of action, 
for example through insulin effects. The co-regulation of insulin and glucose is particularly important 
when considering the impact of carbohydrate on cognitive function as it is insulin that facilitates the  
uptake of glucose to the brain e.g.(Gibson, 2007; Kullmann et al., 2016). Indeed, acute increases in 
insulin have been observed to improve cognition and vasoreactivity (Novak et al., 2014). Insulin was 
not measured for this thesis but should be included in future work. As discussed in the previous 
chapter, it has been demonstrated that foods which elicit a favourable postprandial glycaemic 
response are beneficial for cognition (Lamport, Lawton, et al., 2014), even at later time points where 
no blood glucose differences are apparent (Benton & Nabb, 2003; Lamport et al., 2011).  Therefore 
the overall glucose (or insulin) profile may be important, not just the plasma glucose level at the 
time of cognitive testing. Indeed, at the 2 hour time point, where mean blood glucose fell below 
baseline for all dose conditions, effect sizes for improvements in serial 3s RT following the 517mg 
and 724mg doses were at their greatest. Further, irrespective of dose condition or time point, blood 
glucose concentration was observed to be a significant predictor of serial 3s score and approached 
significance as a predictor of mental fatigue in the current experiment. As marginal decreases in 
mental fatigue were also observed following the 517mg dose, there is some suggestion that 
increases in task performance may be facilitated by immediate availability of plasma glucose, 
perhaps affording protection against mental fatigue. Such a mechanism may be particularly relevant 
in cognitively demanding working memory tasks that are combined with a rapid speed of processing 
component, such as in the serial subtraction tasks used here.  Indeed similar observations have been 
made in the literature (Massee et al., 2015; Scholey et al., 2010). 
When considering the original hypothesis that cognitive benefits following blueberry intervention 
might be related to CBF increases, the results of this experiment echo my observations in 
Experiment 2 (Chapter 4) and do not appear compatible with the findings of Rodriguez-Mateos et al. 
(2013), where peak vasodilatory effects occurred following the 310mg anthocyanins dose. Therefore 
the outcome of this study casts further doubt on whether increased CBF following flavonoid-rich 
intervention may be the main mechanism for acute cognitive enhancement. In light of the discussed 
evidence relating to anthocyanin-facilitated improvements to blood glucose regulation (Chapter 5), 
it seems more likely that cognitive effects may arise from a synergy between increased CBF and 
improved glucoregulation. A well-powered intervention study similar to the one performed here, 
manipulating both flavonoid dose and glucose dose, and combining postprandial cognition and 
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blood glucose testing with FMD or fMRI analysis in a subset of participants, may help to confirm this 
hypothesis. 
The observed mood effects, again identified through pairwise comparisons, compare favourably 
with the literature.  For example, Khalid et al. (2017) observed improvements in positive affect, in 
young adults, 2 hours after a consumption of a blueberry dose containing 253mg anthocyanins. 
Increases in ratings of calmness have also been reported following anthocyanin-rich grape 
intervention (Haskell-Ramsay et al., 2017). Studies investigating interventions rich in other flavonoid 
subgroups have also shown similar effects on self-reported ratings of mood and mental fatigue e.g. 
(Boolani et al., 2017; Massee et al., 2015; Scholey et al., 2012). In the current study, a marginal 
reduction in positive affect, at 1 hour following the control condition, was attenuated following all 
three blueberry doses. The 517mg dose reduced mental fatigue, and interestingly, the highest 
(724mg) dose also significantly reduced negative affect; an effect not observed by Khalid et al. 
(2017). While a similar reduction in negative affect, following the 310mg dose in Chapter 4, may 
have been confounded by differences in the pleasantness of the doses, in this experiment no such 
differences were evident. Therefore it is unlikely that the observed effects on positive, or negative, 
affect here are simply due to the consumption of a pleasant beverage. 
Positive and negative affect, as determined by PANAS, are distinct facets of mood. Low positive 
affect is an indicator of depression, whereas high negative affect is an indicator of anxiety (D. 
Watson et al., 1988), therefore different flavonoid mechanisms may be responsible for observed 
changes in either scale. Here, it has been posited that acute cognitive improvements following 
flavonoid-rich intervention are likely due to an interaction between improvements in blood glucose 
regulation and CBF. However, the underlying mechanisms for acute mood improvements may be 
more complex. Khalid et al. (2017) posit that glucose consumption may enhance uptake of 
tryptophan, a precursor of serotonin, to the brain. This insulin driven mechanism of action requires 
competing large neutral amino acids to be selectively transported into peripheral tissue, increasing 
the ratio of circulating tryptophan available for transport across the blood brain barrier. However 
this has been reported not to occur if glucose is consumed with even small levels of plant or animal 
protein, which are naturally low in tryptophan compared with other amino acids and thereby 
oppose any increase in the ratio of circulating tryptophan (Benton & Donohoe, 1999; Benton & 
Nabb, 2003; Gibson & Green, 2002).  Therefore this mechanism is unlikely to be responsible for the 
blueberry influence on negative affect observed here. Increased availability of glucose has also been 
associated with a reduction in self-reported tension (Benton & Owens, 1993). The mechanism 
remains unclear but is again suggestive of an impact on negative affect. Falling glucose levels during 
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cognitively demanding tasks have been associated with increases in mental fatigue (Owens, Parker, 
& Benton, 1997), therefore flavonoid induced improvements in glucoregulation may afford 
protection against mental fatigue, thereby attenuating a dip in mood. Blood glucose effects are 
likely, then, to contribute to flavonoid induced mood effects. But other flavonoid related mood 
mechanisms have been observed. For example, anxiolytic effects have been observed via flavonoid 
interaction with GABA receptors, leading to the upregulation of the inhibitory neurotransmitter 
GABA (Hanrahan, Chebib, & Johnston, 2011; Wasowski & Marder, 2012). Anthocyanins have also 
been observed to inhibit monoamine oxidase (MAO) (Watson et al., 2015), resulting in the 
upregulation of monoamine type neurotransmitters such as serotonin and dopamine. These 
mechanisms were not tested in the current study, but may have contributed to the observed mood 
effects, and therefore warrant further investigation.  
When considering the varying physiological, cognitive and mood effects observed in this experiment 
following different blueberry doses, it should be noted that the doses administered were from a 
batch of blueberry powder different from that used previously, both in earlier chapters of this thesis 
and in the Rodriguez-Mateos et al (2013) study. The lowest blueberry dose containing 310mg 
anthocyanins elicited no glucose, mood or cognitive effects in the current study. Although the dose 
contained a level of anthocyanins comparable to previous research, which has shown significant 
cognition or mood effects (Khalid et al., 2017; Whyte & Williams, 2015; Whyte et al., 2016), the total 
polyphenol content of this dose (473mg total polyphenols) was lower than that found in the 
equivalent dose (766mg polyphenols) for which a peak vasodilatory response had been previously 
observed (Rodriguez-Mateos et al., 2013). It is possible that anthocyanins may not be effective in 
isolation; other polyphenols also present may be a contributory factor in improvements to 
vasodilation, cognition and mood. However, the 310mg dose did not elicit any cognitive effects in 
Experiment 2 (Chapter 4) either, when the previous batch of powder was used. Negative affect was 
reduced following this dose in Chapter 4, but this outcome may have been influenced by taste 
differences rather than flavonoid effects. Therefore, irrespective of total polyphenol content, the 
310mg dose appeared relatively ineffective in the current research. Studies using extracts of 
anthocyanins may be more helpful in isolating their specific benefits, in the absence of other 
polyphenol confounds. 
In the previous investigation of glycaemic response (Chapter 5), extended availability of blood 
glucose was observed up to 2 hours postprandially following the 724mg dose and up to 90 minutes 
following the 310mg dose. In that experiment the sugar matched doses and control all contained 
40g sugar; substantially higher than the 26.7g in the current experiment. Indeed, an additional 
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difference between this study and the previous literature is the considerably lower availability of 
sugars or more complex forms of carbohydrate. In similar flavonoid-rich intervention studies 
reviewed in Chapter 1 (Dodd, 2012; Field, Williams, & Butler, 2011; Haskell-Ramsay et al., 2017; 
Khalid et al., 2017; Lamport et al., 2016; Scholey et al., 2010; Watson et al., 2015), this value ranged 
from 19.9g-55g, and in all cases further forms of carbohydrate were introduced through the 
provision of standardised breakfasts and lunches or the addition of cordials to improve intervention 
taste. Therefore the overall carbohydrate consumption in these studies was much greater than in 
the current study. Given the known effects of flavonoid-rich foods on postprandial blood glucose 
response, it is possible that in all of these studies blood glucose levels remained elevated for longer 
periods in the flavonoid-rich conditions compared with the control conditions, due to the abundant 
availability of glucose. Indeed this was evident in the Watson et al (2015) study, where blood glucose 
remained significantly elevated up to 2.5 hours after a blackcurrant juice extract. In Experiment 2 
(Chapter 4) cognitive testing did not take place at the later time point when differential glucose 
concentrations were subsequently observed (Chapter 5). However, it is possible that cognitive 
effects at later time points may be more likely to occur when flavonoid-rich foods are consumed 
with higher amounts of glucose, due to increased availability combined with facilitated uptake of 
glucose. None of the other studies reviewed in Chapter 1 recorded blood glucose during cognitive 
test sessions so this cannot be confirmed as a potential mechanism of action, but nevertheless, 
warrants further investigation.  
When interpreting the cognitive data presented here, it is important to recognise that the 
dependent variables for each cognitive task (score, errors, RT) are intrinsically related. A limitation of 
the type of analysis performed here is that each dependent variable is analysed separately. 
Therefore greater weight should be given to the findings that extend across two or more of these 
variables. Where only one variable is affected, there may be a greater likelihood of type 1 error. 
Some of the isolated cognitive effects observed here, such as the worsening performance for RVIP 
and digit vigilance, may indeed be false positives and should be interpreted with caution. 
Nevertheless, the effects on working memory appear consistent across scores, errors and RTs, and 
are in line with previous research.  Future research should seek to develop ways of combining 
related dependent variables in their analyses. Currently available methods such as hits minus false 
alarms, summation of z scores, or inverse efficiency scores (expressing accuracy as a function of RT) 
often suffer from a lack of statistical power due to increased variance in the combined data (Bruyer 
& Brysbaert, 2011). Such methods were, therefore, considered inappropriate for the current work in 
light of the already considerable variance within the data that resulted from the within-subjects 
design incorporating multiple conditions and time points. 
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In conclusion, only limited dose-dependent cognition and mood effects were apparent, as identified 
through Bonferroni corrected pairwise comparisons. With respect to the research questions, the 
highest blueberry dose (containing 724mg anthocyanins) has shown a small modulating effect on 
mood and cognition, and the second highest dose (517mg) has shown effects on cognition, whereas 
the lowest dose (310mg) has not impacted either domain. This is clearly suggestive of a dose 
dependent effect that may be related to the concurrently observed effects on blood glucose 
regulation, and may also relate to the previously observed effects on vasodilation (Rodriguez-
Mateos et al., 2013). Indeed a synergy of the two effects offers a plausible mechanism for improved 
cognition as discussed in Chapter 5. Mood effects may be less straightforward. As discussed above, 
other potential mechanisms of action such as monoamine oxidase inhibition and GABA upregulation 
have not been investigated here but may be responsible for observed mood effects. Finally, although 
dose-dependent effects were evident, it remains unclear whether the anthocyanin dose or the total 
polyphenol dose was the determining factor for the observed effects on either cognition or mood. 
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Chapter 7  
Final Discussion 
7.1 Summary of findings 
Following recent interest in the maintenance of health and wellbeing through dietary intervention, 
the acute cognitive and mood benefits of wild blueberries were investigated in a young adult 
population. The main thesis aims were to determine whether cognition and mood effects following 
wild blueberry supplementation were dose dependent, and whether modulation of blood glucose 
regulation was a likely mechanism of action. The cognitive, mood, blood pressure, and blood glucose 
effects of various wild blueberry doses, with known postprandial metabolite and FMD response 
profiles, were investigated across three separate experiments, each using a crossover design. Key 
findings included dose-dependent cognitive benefits to episodic memory, working memory, and 
mood. In addition, dose-dependent effects on postprandial blood glucose regulation were observed, 
providing evidence for a possible mechanism of action. Indeed, in the case of working memory, 
blood glucose at the time of cognitive testing was found to be a significant predictor of performance. 
The outcome of each experiment is discussed in more detail below. 
7.1.1 Experiment 1 
All cognitive tasks were first piloted in Experiment 1 in order to determine appropriate design 
strategies for minimizing cognitive practice effects. Methodological recommendations following the 
outcome of Experiment 1 were that participants should attend a familiarization visit on a separate 
occasion prior to data collection, and that well-correlated alternate task forms should be used at 
each test point, with familiarization trials also included immediately before each period of data 
collection. Visit order was also included as a factor in the subsequent analysis of all cognitive data in 
order to statistically model any residual practice effects, thereby accounting for some of the variance 
in the data that may otherwise have been attributed to intervention effects. 
7.1.2 Experiment 2 
Following on from Experiment 1, an investigation into the effects of wild blueberry on cognitive 
function was performed using the previously piloted cognitive tasks. In Experiment 2, a double-blind, 
crossover intervention study compared the effects of five separate wild blueberry doses (containing 
129mg, 258mg, 310mg, 517mg, and 724mg anthocyanins) with a sugar-matched control. Measures 
included cognition, mood, blood pressure and heart rate. Testing was performed at baseline, and 1 
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hour postprandially.  No significant blood pressure effects were observed for any of the doses when 
compared with the control. However, consumption of the highest doses (517mg & 724mg) appeared 
to convey small to medium protective benefits for the maintenance of a constant heart rate. 
Following the control and 258mg blueberry dose heart rate was observed to drop significantly. Heart 
rate is strongly correlated with blood glucose and so the attenuation of postprandial decline in heart 
rate following these doses is suggestive of a dose-dependent glucoregulatory effect. The same doses 
similarly showed maintenance of immediate recall memory score, and improvements in serial 7s 
performance for both score and reaction time. The 310mg dose elicited small to medium benefits in 
mental fatigue and mood, although these findings may have been confounded by taste differences 
between the intervention doses. The lower (129mg & 258mg) doses showed no consistent domain 
specific effects for cognition or mood.  
7.1.3 Experiment 3 
Based on the physiological and cognitive observations from Experiment 2, and the probable link 
between postprandial heart rate and blood glucose availability, it was deemed necessary to 
investigate the underlying glucose response for the doses that elicited heart rate, cognition and 
mood effects. Therefore in Experiment 3, the impact of anthocyanin-rich wild blueberry on 
postprandial glucose response was investigated for two of the doses used in Experiment 2. Blueberry 
doses containing 310mg and 724mg anthocyanins were administered to participants, in both sugar-
matched and no-added-sugar conditions. Plasma glucose was determined by a capillary sampling 
method at baseline and at regular intervals up to 2.5 hours postprandially. The results demonstrated 
that wild blueberry significantly extended the postprandial glycaemic response compared with the 
equivalent sugar dose in the absence of blueberry. Indeed, blood glucose levels remained 
significantly elevated above baseline for 2 hours following a blueberry dose containing 724mg 
anthocyanins, and for 1.5 hours following a lower 310mg dose. These post-peak elevations were in 
the range of 0.5-1.5mmol/l above fasting baseline which is well within the healthy postprandial 
blood glucose range (American Diabetes Association, 2014) and is metabolically beneficial through 
the avoidance of reactive hypoglycaemic episodes (Willett et al., 2002) where glucose level falls 
close to or below fasting levels. Furthermore, blueberry was observed to reduce peak postprandial 
glucose levels, although statistical significance was not achieved.  The results were suggestive of a 
possible glucoregulatory mechanism of action for the observed heart rate, cognition, and mood 
effects in Experiment 2, through extended availability of blood glucose in the blueberry conditions. 
Indeed, at the time of cognitive testing in the previous experiment (1 hour postprandially), blood 
glucose remained significantly elevated above baseline following the 310mg and 724mg sugar-
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matched doses, but not following the sugar–matched control. However, apparent blood glucose 
differences between each of these three matched conditions did not reach statistical significance at 
the 1 hour time point. This may be due to a lack of statistical power as this was a small study, but 
also suggests that anthocyanin-rich blueberries may not facilitate improvements to cognition solely 
through availability of glucose, but also through other related mechanisms such as insulin regulation 
leading to increased efficiency of glucose uptake. Clear differences in glucose availability were 
evident at later time points providing a rationale for the investigation of cognitive effects beyond 1 
hour. 
7.1.4 Experiment 4 
As Experiment 3 revealed extended availability of blood glucose following anthocyanin-rich 
blueberry, a repeat of the cognitive investigation performed in Experiment 2 was carried out, but 
with the addition of a later testing time point at 2 hours postprandially. A modified cognitive task 
battery was also administered to investigate whether glucose differences at this later time point 
would elicit effects not previously measured by the cognitive battery from Experiment 2. Specifically, 
a greater emphasis was placed on attention as both glucose and flavonoid interventions have been 
independently reported to impact attention.  Therefore in Experiment 4, a double-blind, crossover 
intervention study compared the effects of three separate wild blueberry doses (containing 310mg, 
517mg, and 724mg anthocyanins) with a sugar-matched control. Measures included cognition, 
mood, and postprandial glucose response. Testing was performed at baseline, and 1 and 2 hours 
postprandially. The wild blueberry doses containing 517mg and 724mg anthocyanins elicited 
significant improvements in working memory at 1 and 2 hours, as measured by the serial subtraction 
task. Following the 724mg dose, participants also reported a significant reduction in negative affect. 
Both the 517mg and 724mg doses significantly attenuated the peak postprandial glucose response, 
when compared to the control, at a time point of 15 minutes. However, blood glucose levels 
following wild blueberry intervention were not found to be significantly different from those 
observed following the control at either time of cognition and mood testing. The 310mg dose 
produced no significant cognitive, mood or glucose effects. Interestingly, this dose was previously 
observed to elicit the greatest vasodilatory response when measured for the same range of wild 
blueberry doses. The findings suggest that benefits to cognition and mood following wild blueberry 
supplementation may be related to concurrent alterations in blood glucose regulation. Indeed, 
irrespective of experimental condition, blood glucose level was observed to be a significant predictor 
of serial subtraction performance. A similar observation was made by Kennedy & Scholey (2000) 
during a glucose intervention, where serial 7s performance correlated with blood glucose level.  
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7.2 General discussion 
In this section the cognitive and physiological effects of anthocyanin-rich blueberries reported above 
are compared with the literature. Potential mechanisms of action are discussed in relation to the 
thesis hypotheses. 
7.2.1 Cognitive effects 
The episodic memory effects observed in Experiment 2 are consistent with the findings of Whyte et 
al. (2016), where increased immediate recall was observed at 1.25 hours postprandially in children. 
Here the same effect has been demonstrated in young adults. The effect size appears somewhat 
diminished in the young adults (d=0.29) compared with the children (d=0.80). Indeed, in the children 
immediate recall improved between baseline and test following blueberry intervention, whereas in 
the young adults blueberry merely attenuated a decline in performance. The differences in effect 
may reflect developmental differences in the capacity for improvement. Interestingly, in the child 
study it was the higher of two blueberry doses (253mg anthocyanins) that elicited a significant 
effect. In young adults, effects were similarly observed following the higher blueberry doses (517mg 
and 724mg), although the 129mg dose did also elicit an immediate recall effect. In general however, 
there is some evidence for dose-dependency with higher doses being more effective. Differences in 
the effective dose sizes between the two studies may simply reflect body mass differences between 
the different age groups. Indeed, for an average child weighing 27.5kg (based on NHS growth curve 
data), the effective dose in Whyte et al. (2016) was calculated to be 9.2mg/kg body weight. For a 
60kg young adult this equates to an anthocyanin dose of 552mg, which is comparable to the 517mg 
and 724mg doses that were observed to elicit significant effects in Experiment 2. 
The working memory effects observed in Experiments 2 and 4 are consistent with the findings of 
Scholey et al. (2010), Massee et al. (2015), and Kennedy et al. (2002), who observed serial 3s and 
serial 7s improvements following acute doses of cocoa and ginkgo in young adults. However this is 
the first study to demonstrate a similar effect following anthocyanin-rich blueberry. Again, the effect 
sizes are smaller in this thesis (d=0.02-0.42) compared with the previous work (d=0.47-0.56). As with 
cocoa, significant effects following blueberry were evident at 1 - 2 hours postprandially, whereas 
ginkgo effects occurred at a later time point of 6 hours, reflecting differences in the absorption and 
metabolism rates of the different flavonoid subclasses present. A notable difference between the 
previous and current work is that effect sizes for blueberry were clearly dose dependent; in 
Experiment 2 effect sizes were largest following the 724mg dose and no significant effects were 
observed for doses of 310mg or lower. In Experiment 4 the largest effect sizes were observed 
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following the 517mg dose, but were still evident following the 724mg dose. Again, no significant 
performance improvements were evident following the 310mg dose. However, fewer doses were 
investigated in the previous literature and the flavonoid profiles of cocoa and ginkgo are very 
different to blueberry, making direct dose comparisons difficult. 
Previous literature on acute mood changes following flavonoid-rich intervention is limited. However 
the effects on positive and negative affect observed in Experiments 2 and 4 are broadly in 
agreement with recent published data. Khalid et al. (2017) observed significant improvements in 
positive affect following a single blueberry dose containing 253mg anthocyanins in both children and 
young adults, and Boolani et al. (2017) observed a reduction in anxiety in young adults following 
cocoa. The outcomes of these two studies suggest that flavonoid-rich interventions can impact 
different facets of mood; depression or anxiety. In the current thesis the findings of Experiment 2 
revealed a reduction in negative affect following the 310mg dose only. This observation may have 
been confounded by significant taste differences between doses, but in Experiment 4, where taste 
differences were minimal, maintenance of positive affect was observed for all blueberry conditions 
when compared with a marginally significant drop in the control condition, and a significant 
reduction in negative affect was observed following the 517mg and 724mg doses. The findings 
suggest that, at varying doses, anthocyanin-rich blueberries may exert effects on both anxiety and 
depression scales of mood. 
7.2.2 Physiological effects 
Experiment 2 failed to replicate the reductions in blood pressure observed following acute 
supplementation with cherry juice (Keane et al 2016). Therefore, it may be that different flavonoid-
rich fruits elicit different cardiovascular effects due to differences in their flavonoid profile. 
Differences in flavonoid composition are considered in the limitations section below. However 
despite the lack of a blood pressure effect, constant heart rate was maintained following the 517mg 
blueberry dose, despite a significant drop following the control. To a lesser degree this decline in 
heart rate was also attenuated following the 129mg, 310mg and 724mg blueberry doses. This effect 
was unexpected as similar findings have not been previously reported in the literature, but is 
suggestive of a glucoregulatory effect as heart rate is correlated with glucose availability (Valensi et 
al., 2011). Indeed, when postprandial glucose response was subsequently investigated in 
Experiments 3 and 4, significant differences in glucose profile were observed between the control 
and blueberry conditions. Similar glucoregulatory effects have been previously observed for a 
number of different anthocyanin-rich berry interventions e.g. (Törrönen et al., 2010; Watson et al., 
2015; Wilson et al., 2008). Heart rate and blood glucose were not recorded concurrently during any 
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of the experiments carried out during this thesis. On reflection it may have been helpful to do so in 
Experiment 4. Nevertheless, evidence of the interaction between glucose, heart rate and cognition 
has previously been reported following direct supplementation with glucose (Kennedy & Scholey, 
2000). 
7.2.3 Mechanisms of action 
Combined, the cognitive findings of each of the blueberry intervention experiments reported in this 
thesis support the hypothesis that wild blueberry effects on cognition are dose-dependent, with 
doses containing 517mg and 724mg anthocyanins eliciting the greatest cognitive effects. However, 
contrary to expectation, the most effective doses were higher than the 310mg dose previously 
observed to elicit the greatest vasodilatory response by Rodriguez-Mateos et al. (2013). No 
vasodilatory measures were recorded during any of the current experiments; vasodilatory response 
was inferred from the previous research, using the same source of blueberry powder in participants 
of a similar age. Nevertheless, the results suggest that other mechanism(s) may play a role in 
improvements to cognition. Indeed, it was hypothesised that dose-dependent blood glucose effects 
would likely contribute to the cognitive outcome of the study through a mechanism of increased 
availability of glucose to the brain. Few cognitive studies have measured blood glucose to date, 
however Watson et al. (2015) demonstrated enhanced cognition and concurrently elevated blood 
glucose following an anthocyanin-rich berry intervention. As reported in Chapter 5 there are a 
number of mechanisms whereby flavonoid interventions, and in particular those rich in 
anthocyanins, have been shown to impact glucoregulation, supporting the idea that flavonoid 
intervention may improve availability or efficiency of glucose uptake by the brain during cognitive 
exertion. This hypothesis was supported in Experiment 4, where cognitive performance and blood 
glucose were measured concurrently, and the 517mg and 724mg doses elicited significant 
modulation of the postprandial blood glucose profile and significant improvements to working 
memory and mood, whereas the 310mg dose did neither. In the same experiment, blood glucose 
level was also observed to be a significant predictor of working memory performance irrespective of 
dose condition, providing further evidence that cognitive outcome is dependent on the availability of 
glucose. Improved glucoregulation did not appear to facilitate global increases in cognition as there 
were no significant effects observed for the RVIP or digit vigilance tasks. Observed effects were 
clearly domain specific, relating to episodic memory, working memory, and mood. The availability of 
extracellular glucose and improved glucoregulation have  been associated with improved episodic 
memory and working memory (for a comprehensive review see Smith, Riby, Eekelen, & Foster, 
2011). There is some evidence that hippocampus function may be selectively enhanced by glucose, 
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possibly due to the increased number of insulin receptors in this area of the brain (Smith et al., 
2011). There is also some evidence that glucose facilitates the synthesis of acetylcholine and 
influences the action of other neurotransmitters including dopamine and serotonin (Benton & Nabb, 
2003; Benton et al., 1994). These neurotransmitter effects have the potential to facilitate global 
cognition and mood improvements such as the serial subtraction and PANAS effects observed in this 
thesis. However, it remains unclear why such mechanisms should not also impact attention. No 
consistent attention effects were observed on any of the tasks deployed in this work, although other 
authors have reported such actions e.g. (Haskell-Ramsay et al., 2017; Kennedy et al., 2000; Scholey 
et al., 2010; Watson et al., 2015). A possible explanation may be that the task versions used here 
were not cognitively demanding enough; the most robust effects of glucose have been observed 
during divided attention or at times of high cognitive demand (Benton & Nabb, 2003; Scholey et al., 
2001; Smith et al., 2011). Although improved glucoregulation appears a viable mechanism of action 
for the cognition and mood effects observed throughout this thesis, it is possible that such a 
glucoregulatory mechanism of action may occur in synergy with increased cerebral blood flow. 
Increased CBF is a much posited mechanism for cognitive improvements following flavonoid-rich 
interventions. However, it should be noted that neither CBF nor other potential mechanisms of 
action, such as MAO inhibition or BDNF synthesis, have been directly investigated here, and require 
further study.  
7.3 Limitations of the research 
7.3.1 Experimental confounds 
7.3.1.1 Practice effects 
Methodology was specifically tailored to minimise cognitive practice effects after an investigation of 
the size and distribution of these effects was carried out in Experiment 1. However previous 
research suggests that it is impossible to completely eradicate practice effects and so a low level of 
confound is still likely to have remained during the two blueberry intervention studies. Indeed 
practice related improvements were evident in all experiments, as identified by the significance of 
visit number as a predictor of cognitive performance for the majority of tasks. Residual practice 
effects are likely to have increased the variance in each counterbalanced dose condition, thus 
reducing the statistical power of each experiment to detect small changes in cognition and mood. 
Therefore, residual practice effects are likely to have impacted the statistical significance of the 
session x dose interaction term when employing conservative LMM analyses of cognition and mood 
in Experiments 2 and 4. The problem was overcome by employing Bonferroni corrected pairwise 
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comparisons as a less conservative alternative to the F test interaction (Huck, 2015).  Previously 
published crossover studies with multiple conditions appear to have adopted a similar analysis 
strategy e.g. Kennedy et al. (2000) and Kennedy et al. (2002). Replication is important when judging 
the validity and reliability of a statistical approach (Keppel, 1991). Working memory and mood 
effects evident in Experiment 2 were replicated in Experiment 4, further demonstrating the 
suitability of this statistical strategy. 
7.3.1.2 Habitual diet 
The interfering effects of habitual diet were addressed by asking participants to follow a low 
polyphenol diet for 24 hours before participation, to eat the same breakfast on each visit date, and 
fast for 2 hours immediately prior to baseline testing. Compliance was recorded using self-report. 
The presence of a few minor misdemeanours in these reports suggests that participants were honest 
in their recording of dietary intake. No attempt was made to quantify differences in the intake of any 
prohibited items between participants or between visits; rather any deviance from the diet was 
immediately discussed with the participant to ensure that they would not repeat the mistake, and 
therefore further minimise any interference from polyphenol consumption other than the test 
intervention. Tighter controls on diet could have been implemented. For example a standardised 
evening meal could have been provided for all participants on the day before testing, along with a 
standardised breakfast across all participants (rather than within-participants) on the morning of 
testing. This may have further reduced any dietary confound. Standardisation of food intake may 
therefore have helped to reduce variance in the data. However, if such measures are required to 
detect the acute cognitive effects of flavonoids, then observed effects may arguably have little real 
world relevance. As such, there is a counter argument for conducting studies with no dietary 
restrictions.  
7.3.1.3 Taste matching of doses 
An additional confound was that the intervention drinks were not always well matched in terms of 
taste. Variations in pleasantness may have influenced mood ratings in Experiment 2 in particular, as 
palatability has previously been observed to influence negative affect (Benton, 2002; Macht & 
Mueller, 2007). Drink ratings were more similar in Experiment 4 following the use of a different 
batch of wild blueberry powder, but further improvements could be made, for example through the 
addition of flavourings and thickeners to better match both taste and texture of all interventions. 
There were also notable hydration differences between the two cognitive studies. In Experiment 2, 
drinks were mixed using 500ml water, whereas in Experiment 4 this volume was reduced to 300ml in 
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order to make the drinks easier to consume within a shorter time period. Hydration has been 
previously shown to influence cognition and mood (Masento, Golightly, Field, Butler, & van Reekum, 
2014) and so minor differences between the study outcomes could, at least in part, be due to 
hydration differences. However, the task batteries for the two studies were different making direct 
comparison difficult. 
7.3.1.4 Presence of other polyphenols 
In this thesis, wild blueberry doses were quantified in terms of their anthocyanin content. 
Anthocyanins form the largest group of flavonoids, and indeed polyphenols, in wild blueberries. It 
was considered appropriate to quantify the doses in this way as anthocyanins consumption has 
specifically been linked to vasodilatory (Bell & Gochenaur, 2006) and glucoregulatory (Cazarolli et al., 
2008; Hanhineva et al., 2010; Sancho & Pastore, 2012) mechanisms of action in vitro, and has been 
linked with improved cognition in vivo (Rendeiro et al., 2013). Epidemiological studies have also 
linked anthocyanins to reduced incidence of type 2 diabetes (Jennings et al., 2014; Wedick et al., 
2012).  The Oxygen Radical Absorbance Capacity (ORAC) of blueberry also correlates strongly with 
anthocyanins (Howard, Clark, & Brownmiller, 2003; Lohachoompol et al., 2004; Zheng & Wang, 
2003). However, it should be noted that other polyphenols are also present in moderate quantities 
and so the effects observed in this thesis cannot solely be attributed to anthocyanins and should be 
considered as blueberry effects. Human supplementation with pure extracts would be needed to 
confirm if acute benefits to cognition and mood were attributable to anthocyanins in isolation. 
However, pure extracts are costly and arguably unnecessary given that blueberries provide a 
relatively cheap and convenient way to consume beneficial quantities of anthocyanins and other 
polyphenols within a normal healthy diet. 
7.3.1.5 The role of gut microbiota in the biotransformation & metabolism of polyphenols  
As described in Chapter 1, notable individual differences have been observed in the absorption 
profiles of a range of flavonoids and their associated metabolites (Bresciani et al., 2017; Mennen et 
al., 2008; Rodriguez-Mateos et al., 2015); not only in the types and quantities of metabolites 
present, but also in the timings of their appearance (Bresciani et al., 2017). Recent research has 
attributed many of these individual differences to gut microbiota; specific bacteria have been 
identified that act on different flavonoids (Braune & Blaut, 2016). Individuals have varying 
polyphenol metabolising phenotypes, largely dependent on their gut microbiota profile (Tomás-
Barberán et al., 2016). The effectiveness of a flavonoid intervention is therefore dependent on the 
phenotype of the subject; polyphenol biotransformation and metabolism by microbiota in the gut is 
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pivotal to the subsequent biological activity of an intervention. If the relevant bacteria are not 
present then the intervention may show little or no effect at postprandial time points where the 
ingested intervention has reached the large intestine. Interestingly, a flavonoid-rich diet can have a 
positive impact on the profile of gut microbiota (Cardona et al., 2013; Hidalgo et al., 2012; Valdés et 
al., 2015), and so subjects who regularly consume flavonoids are likely to produce greater quantities 
of biologically active metabolites, and may therefore experience greater cognitive health benefits in 
the immediate postprandial period following their consumption, although this has not yet been 
investigated. Therefore it is important to identify the gut microbiota phenotype of participants. 
Small effect sizes may simply be due to the diluting effect of participants with a mismatched 
phenotype, for whom little or no flavonoid effects are likely to be observed. The young adult student 
participants in this research reportedly consumed around 4-5 daily portions of fruit and vegetables, 
suggesting a relatively healthy lifestyle. However, this was a self-report measure and appears very 
close to the ‘5-a-day’ Government target, so reporting may have been influenced by demand 
characteristics. If participants routinely consumed below this level, then this may explain the small 
cognitive and mood effect sizes observed here. All of the experiments in this thesis used a within-
subjects design in order to minimise the impact of individual differences such as gut microbiota, but 
phenotypes were not determined. In future research, studies may benefit from the assessment of 
gut micriobiota phenotype so that its impact can be systematically investigated.  
7.3.2 Methodology 
7.3.2.1 Population 
The data collected throughout this thesis relate to healthy young adults. The data cannot therefore 
be generalised to older or younger populations, or those with clinical conditions. In order to fully 
understand the acute effects of anthocyanin-rich blueberries it is recommended to extend this work 
to other age ranges and clinical populations who may further benefit from acute blueberry 
supplementation. 
7.3.2.2 Physiological measures 
Physiological measures that were recorded during this research were limited to blood pressure and 
blood glucose. The absorption, metabolism, and vasodilatory response profiles following varying 
doses of wild blueberry were not measured directly but were inferred from previous research 
conducted by Rodriguez-Mateos et al. (2013); therefore the study would have been strengthened by 
the inclusion of these measures. Similarly, cerebral blood flow was not measured; again, peripheral 
and cerebral vasodilation was assumed from the published observations of Rodriguez-Mateos et al. 
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(2015) and Dodd (2012). A methodological strength of Experiments 2 and 3 was that the 
intervention drinks were prepared using the same batch of freeze-dried blueberry powder as used 
by Rodriguez-Mateos and colleagues, so metabolism and vasodilation profiles were likely to be 
similar. However in Experiment 4 a new batch, still from the same cultivar, was used. Therefore, it is 
unknown whether the same underlying response occurred in this final experiment.  It should also be 
noted that individual differences, for example in gut microbiota, may have altered absorption, 
metabolism and vasodilatory response profiles or effect sizes throughout this research, when 
compared with previous work. Any differences may potentially have reduced the statistical power of 
this series of experiments to observe cognitive changes resulting from direct or indirect metabolite 
effects.  
With respect to the measurement of glucose regulation, only blood glucose values were recorded. 
However, blueberry-induced changes to the corresponding insulin response may also have 
influenced the availability of glucose in these experiments, for example through facilitated uptake of 
glucose by cells. Indeed, as described in Chapter 5, insulin effects have previously been observed 
following anthocyanins-rich berry interventions (Alqurashi et al., 2016; Edirisinghe et al., 2011; 
Nyambe-Silavwe & Williamson, 2016). Future flavonoid research should consider the interaction 
between postprandial glucose and insulin response, and how this relationship may influence 
cognitive outcome. 
7.3.2.3 Cognitive measures 
Although a range of cognition, mood and memory tasks were deployed in Experiments 2 and 4, it 
should be noted that significant outcomes relate only to performance on those specific tasks. It is 
not valid to generalise these effects to other related tasks or domains.  
7.3.2.4 Compositional differences between blueberry powder batches 
Two different batches of freeze dried blueberry powder were used during the course of this 
research. The total anthocyanin content was matched between studies; however there remained 
considerable differences in the total polyphenol content. There were also considerable differences in 
the vitamin C content of the two batches. It is unclear whether vitamin C differences arose from 
actual differences between the batches or differences in the analytical techniques used for each 
assay. The analysis of the second batch (used in Experiment 4) was carried out using a reducing 
agent to convert dehydroascorbic acid (DHA), the oxidised form of ascorbic acid, into ascorbic acid 
prior to determination. This method is commonly used for the determination of vitamin C in fruits 
and vegetables (Campos, Ribeiro, Della Lucia, Pinheiro-Sant’Ana, & Stringheta, 2009) as DHA is 
 156 
 
known to be a biologically available and active form of vitamin C (Wilson, 2002). However the same 
method was not used in the analysis of the first batch (used in Experiments 2 & 3). This may have 
resulted in inconsistencies in the vitamin C matching of blueberry and control drinks. Regrettably, 
fibre was not quantified for the first batch of blueberry powder making direct comparison between 
batches impossible. It is unlikely that the total fibre content differed greatly between the two 
batches; however after anthocyanin-matching between experiments, differences in the total fibre 
content of the intervention drinks may have been introduced. 
Anthocyanin profiling was not performed for either batch of blueberry powder used in this thesis. 
Anthocyanins are a group of compounds with similar structural properties. There are reportedly 
more than 600 unmodified anthocyanidin and modified anthocyanin compounds (Babu, Liu, & 
Gilbert, 2013). It is possible that these compounds may exert different physiological and cognitive 
effects. For example, in vitro glucose stimulation of insulin secretion was reported to be augmented 
by pelargonidin-3-galctoside, cyanidin -3-glucoside, delphinidin-3-glucoside, and marginally by 
delphinidin, whereas cyanidin, pelargonidin, malvidin and petunidin showed no effect 
(Jayaprakasam, Vareed, Olson, & Nair, 2005). Additionally, as described in Chapter 1, Watson et al. 
(2015) observed different cognitive and physiological outcomes following two blackcurrant cultivars 
with different polyphenol and anthocyanin profiles. Therefore anthocyanin profiles for a particular 
intervention may be important in determining cognitive and/or physiological outcomes. 
Observed differences in the outcomes of Experiment 2 and Experiment 4 in this thesis reflect 
differences in the study design, such as changes to the task battery and the addition of an extra 
testing time point. For the cognition and mood tasks in common between the two experiments, the 
outcome was very similar. Blood glucose response profiles were quite different between Experiment 
3 and Experiment 4, but as identical cultivars were used for all experiments it is likely that these 
differences were due to variation in sugar content rather than anthocyanin profile. Nevertheless, 
polyphenol, vitamin C and fibre differences between the experiments, as described above, may have 
contributed to the outcome. With hindsight, it may have been methodologically preferable to match 
the sugar, fibre and vitamin C content across studies in order to better control for these differences. 
Future work should seek to better define the full compositional profile, including anthocyanin 
subclasses present in any intervention, and control for as many compositional elements as possible.  
7.4 Future work 
Now that this work has identified that higher doses of anthocyanin-rich blueberry (517mg & 724mg) 
appear the most effective doses in terms of mood and working memory outcomes, the natural 
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progression would be an acute intervention trial focussing on a single similar dose, with the aim of 
obtaining sufficient statistical power to confirm a significant dose x session interaction when 
comparing the blueberry dose with a well-matched control (e.g. matched for flavour, colour, 
viscosity, sugars, protein, vitamin C and fibre) at pre- and post-intervention time points. It would also 
be desirable to concurrently measure postprandial blood glucose and insulin, and to profile 
participants’ gut microbiota. Measurement of vasodilatory response should also be considered, but 
may require testing of a subgroup of participants as there are inherent methodological difficulties in 
recording cognition and vasodilation simultaneously. A series of such studies might further 
investigate the impact of age, gender, health status, cognitive domain, or cognitive load with respect 
to acute wild blueberry intervention. Well-powered studies, such as those described, may provide a 
fuller understanding of the acute cognitive benefits of wild blueberry and their likely mechanisms of 
action. 
The observed effects on blood glucose regulation strongly suggest that wild blueberry may have a 
clinical application in the prevention or treatment of metabolic disorders such as type 2 diabetes. As 
discussed in Chapter 5, the postprandial response to ingested carbohydrate is recognised as a 
marker of metabolic health. Interventions such as wild blueberry which modulate postprandial 
glucose by limiting periods of hyper- or hypoglycaemia are desirable. In type 2 diabetes, regulation 
of postprandial glucose response is important not only in the prevention and treatment of the 
disease, but also in the reduction of associated risk factors such as cardiovascular disease (Bonora & 
Muggeo, 2001). Cognition, blood pressure and vasoreactivity are all reportedly compromised in type 
2 diabetes (Chung et al., 2015; Lamport et al., 2009) and, as reviewed in Chapter 1, these areas have 
all shown  improvement following acute anthocyanins-rich interventions. Furthermore, habitual 
diets rich in anthocyanins, and particularly blueberry consumption, are significantly associated with 
lower type 2 diabetes mellitus risk (Jennings et al., 2014; Wedick et al., 2012). The combined 
evidence suggests there is clear potential for a diet-based blueberry intervention to benefit the risk 
factors and co-morbidities associated with type 2 diabetes. This should be further investigated 
through intervention trials on a clinical population of type 2 diabetes patients, or those with pre-
diabetes. 
7.5 Final conclusions 
With some statistical caveats, this programme of research is the first to demonstrate a dose-
dependent effect of anthocyanin-rich wild blueberries on episodic memory, working memory and 
mood. In particular effects appear strongest for the maintenance of immediate recall on a single-trial 
word list learning task, the attenuation of negative affect using a self-report questionnaire, and the 
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improvement of working memory on a serial subtraction task combining a high cognitive load with a 
psychomotor component. However, in order to increase the statistical power, allowing future 
studies to detect these small cognitive changes following flavonoid-rich intervention, additional 
controls for the reduction of variance in collected data may be needed. In particular, research is 
recommended into the mediating effect of gut microbiota on the effectiveness of acute wild 
blueberry supplementation. 
This research is also the first to indentify a dose-dependent glucoregulatory effect of wild 
blueberries that may provide a plausible mechanism of action for observed cognitive and mood 
benefits, through extended glucose availability and/or facilitated uptake of glucose to the brain. 
Therefore, future research should consider the potential application of wild blueberry as a treatment 
or preventative intervention for metabolic disorders such as type 2 diabetes, where both cognition 
and glucoregulation are typically impaired. 
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Appendix A Ethical approval for Experiments 1-4 
A.1 SREC Ethics committee approval for Experiment 1.1 
From: Philip T. Smith [p.t.smith@reading.ac.uk] 
Sent: 19 March 2014 12:28 
To: claire.williams@reading.ac.uk 
Cc: l.a.forrest@reading.ac.uk 
Subject: Ethics 2014/033/CW 
 
Dear Claire 
 
Ethics proposal: Examination of the occurrence of practice effects in the Sternberg task and other 
cognitive tasks commonly used in crossover dietary intervention studies. 
 
I have been asked to look at this proposal. This project is in line with University of Reading ethics 
guidelines, and may proceed. 
 
Regards 
 
 
  
 184 
 
A.2 SREC Ethics committee approval for Experiment 1.2 
From: Philip T. Smith <p.t.smith@reading.ac.uk> 
Date: Thu, Dec 3, 2015 at 10:41 AM 
Subject: Ethics 2014/033/CW 
To: Lynne Bell <l.bell@pgr.reading.ac.uk>, Claire Michelle Williams <claire.williams@reading.ac.uk> 
Cc: PCLS Ethics <pclsethics@reading.ac.uk> 
 
Dear Claire and Lynne 
Thank you for the request to revise this project. This project is in line with University of Reading 
ethics guidelines, and may proceed. 
There is just one detail: it is not clear to me whether Emma and Nasser are undergraduates, and 
whether they will conduct any of the testing without any more senior member of the School being 
present. If so, they need to sign the consent form, beneath each participant’s signature. But I can 
rely on you to make these adjustments, if they are necessary: I don’t need to see the application 
again. 
Regards 
Philip 
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A.3 UREC Ethics committee approval for Experiment 2 
 
Coordinator for Quality Assurance in 
Research  
Dr Mike Proven, BSc(Hons), PhD  
Office of the University Secretary  
Whiteknights House  
Whiteknights, PO Box 217   
Reading RG6 6AH  
phone +44 (0)118 378 7119  
fax  +44 (0)118 378 8979  
email m.j.proven@reading.ac.uk  
 
 Dr Claire Williams  
School of Psychology and Clinical Language  
Sciences  
University of Reading  
RG6 6AL  
 
10 July 2014 
 
 Dear Claire  
UREC 14/28: A dose-response study of the acute effects of blueberry juice on cognitive performance 
in healthy young adults. Provisional opinion  
 
Thank you for your revised application (your email, including attachment, dated 10 July 2014  
refers) addressing the minor issues raised by the UREC Sub-committee at its June meeting. On  
the basis of these revisions, I can confirm that the Chair is pleased to confirm a favourable  
ethical opinion.  
 
Please note that the Committee will monitor the progress of projects to which it has given  
favourable ethical opinion approximately one year after such agreement, and then on a regular  
basis until its completion.  
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Please also find attached Safety Note 59: Incident Reporting in Human Interventional Studies at  
the University of Reading, to be followed should there be an incident arising from the conduct  
of this research.  
 
 The University Board for Research and Innovation has also asked that recipients of favourable  
ethical opinions from UREC be reminded of the provisions of the University Code of Good  
Practice in Research. A copy is attached and further information may be obtained here:  
http://www.reading.ac.uk/internal/res/QualityAssuranceInResearch/reas-RSqar.aspx.   
  
Yours sincerely  
  
Dr M J Proven  
Coordinator for Quality Assurance in Research (UREC Secretary)  
cc: Dr John Wright (Chair); Dr Laurie Butler, Head of School 
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A.4 SREC Ethics committee approval for Experiment 3 
2015-053-CW - An investigation of the glycaemic response following blueberry drink ingestion in 
healthy young adults: a dose response study – Claire Williams, Laurie Butler, Daniel Lamport, & 
Lynne Bell 
11th May 2015 
In my opinion, this study meets the requirements for ethical approval, and I am happy for it to 
proceed 
 
John Harris 
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A.5 SREC Ethics committee approval for Experiment 4 
From: PCLS Ethics <pclsethics@reading.ac.uk> 
Date: Mon, Jan 25, 2016 at 12:45 PM 
Subject: FW: 2014-047-CW - A dose-response study of the acute effects of blueberry juice on 
cognitive performance in healthy young adults 
To: "claire.williams@reading.ac.uk" <claire.williams@reading.ac.uk>, Lynne Bell 
<l.bell@pgr.reading.ac.uk> 
 
From: Anastasia Christakou [mailto:a.christakou@reading.ac.uk]  
Sent: 25 January 2016 12:43 
To: PCLS Ethics 
Subject: Re: 2014-047-CW - A dose-response study of the acute effects of blueberry juice on 
cognitive performance in healthy young adults 
These amendments have SREC approval. 
Anastasia 
[sent from a mobile device] 
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Appendix B Intervention study eligibility criteria 
 
Age 18-40 years 
Non-smoker 
Not pregnant 
Able to consume the beverages 
No significant vision, hearing or language difficulties 
Should not suffer from any of the following diseases: 
 Major mental illness 
 Liver disease 
 Diabetes mellitus (Type 1 and 2) 
 Heart disease 
 Renal or gastrointestinal disorders 
Should not be taking blood pressure lowering or anticoagulant medication 
Should not be consuming more than the Government recommended units of alcohol per week 
Should not be vigorous exercisers (restricted to < 4 hours per week for the duration of the study) 
Should not be taking nutritional supplements (for the duration of the study) 
Should not be taking recreational drugs (either illegal or legal for the duration of the study) 
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Appendix C Health screening questionnaire 
*** Please answer the following questions as accurately as possible.  All information 
provided will remain confidential *** 
Demographic Information: 
Age      ________ 
Gender ________ 
Questions about health and lifestyle: (Circle the relevant answer) 
Do you smoke?  Yes / No 
If ‘Yes’, please state how many per day ________. 
Do you drink alcohol?  Yes/No 
If ‘Yes’, approximately how many units per week? ________________ 
Do you drink tea? Yes / No 
If ‘Yes’, approximately how many cups of tea per day? ________________ 
Do you drink coffee? Yes / No 
If ‘Yes’, approximately how many cups of coffee per day? ________________ 
Are you currently on a weight-reducing or other special diet?  Yes/No 
If ‘Yes’, please give details. 
_________________________________________________________________________
_________________________________________________________________________
_______________________________________________________ 
Do you exercise regularly?  Yes/No  
If ‘Yes’, please give an estimate of the number of hours you spend exercising per week. 
___________________________________________________________________ 
Do you have allergies to any foods?  In particular, any fruits or cocoa, nut, milk or gluten 
based products?  Yes/No 
If ‘Yes’, please list foods you have an allergy to below: 
_________________________________________________________________________
_________________________________________________________________________
_______________________________________________________ 
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Are you pregnant?  Yes/No/Not applicable 
Please indicate if you had or have any if the following conditions:  (place a tick next to 
any relevant conditions) 
[  ] Diabetes – if yes, please circle: Type I / Type II 
[  ] Heart disease – if yes, have you had open heart/bypass surgery? Yes / No 
[  ] High blood pressure – if yes, are you currently taking medication to control your 
blood pressure? Yes / No 
Did you start taking medication immediately after diagnosis?  Yes / No 
How long have you been taking medication for?__________________ 
[  ] Nervous system disease / Degenerative disorder (e.g. Multiple Sclerosis)  
[  ] Stroke or Transient Ischaemic Attack 
[  ] Chronic kidney disease/impaired kidney function 
[  ] Chronic liver disease/impaired liver function 
[  ] Chronic thyroid disease/impaired thyroid function 
[  ] Mental or emotional problems for which you were admitted to hospital  
[  ] Renal or Gastrointestinal disorders – if yes, please give details  
_________________________________________________________________  
[  ] Any other serious illnesses – if yes, please give details 
_________________________________________________________________ 
Are you currently, or have you been within the last month, on any of the following 
medication? 
[  ]  Warfarin 
[  ] Heparin 
[  ] Rivaroxaban 
[  ]  Dabigatran 
[  ] Apixaban 
[  ] Aspirin 
[  ] Plavix (Clopidogrel) 
[  ] Persantin 
[  ] Other anticoagulant medication- if yes, please give details 
_______________________________________________________________ 
[  ] Any other medication – if yes, please give details 
_________________________________________________________________ 
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Appendix D Information sheets 
D.1 Participant information sheet for Experiment 1.1 
Title of Study: A comparison of practice effects for the Sternberg task and other 
cognitive tasks commonly used in crossover intervention studies 
 
Information Sheet 
 
Supervisors:   Email:      Phone: 
Dr Claire M. Williams claire.williams@reading.ac.uk  0118 378 7540 
Dr Laurie T. Butler  l.t.butler@reading.ac.uk   0 118 378 7543 
 
Experimenter:    
Lynne Bell                  l.bell@pgr.rdg.ac.uk       
 
 
We would be grateful if you could please assist us by participating in our study exploring 
practice effects for the Sternberg task. Specifically we are interested to find out whether 
prolonged practice on this task improves performance and whether or not the level of 
observed improvement differs from other commonly used cognitive tasks.  
 
Your participation will take approximately 2.5 hours, on each of 3 separate visits, with 1 
week between each visit. During each visit you will perform a range of cognitive tasks, 
measuring episodic memory, working memory and executive function. At each visit the 
complete set of tasks will be performed twice with a one hour break between each set. During 
the break you may spend the time as you wish, but you are requested not to consume any 
food and to only drink water. At your first visit you will also be asked to record what you 
consumed for your last meal (breakfast for morning participants and lunch for afternoon 
participants). For your subsequent visits you will be asked to eat the same meal (or as close as 
possible) before attending. 
 
Your data will be kept confidential and securely stored, with only an anonymous number 
identifying it. Information linking that number to your name will be stored securely and 
separately from the data you provide us. All information collected for the project will be 
destroyed after a period of 5 years from the completion of the project. Taking part in this 
study is completely voluntary; you may withdraw at any time without having to give any 
reason. Please feel free to ask any questions that you may have about this study at any point.  
 
This application has been reviewed by the University Research Ethics Committee and has 
been given a favourable ethical opinion for conduct 
 
Thank you for your help. 
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D.2 Participant information sheet for Experiment 1.2 
Title of Study: Examination of the occurrence of practice effects in cognitive tasks 
commonly used in crossover dietary intervention studies 
 
Information Sheet 
 
Supervisors:   Email:      Phone: 
Dr Claire M. Williams claire.williams@reading.ac.uk  0118 378 7540 
Dr Daniel J. Lamport  d.j.lamport@reading.ac.uk   0118 378 7937 
Dr Laurie T. Butler  l.t.butler@reading.ac.uk   0 118 378 7543 
 
Experimenter:    
Lynne Bell                  l.bell@pgr.rdg.ac.uk         0118 378 7928 
Emma Coleman  e.coleman2@student.reading.ac.uk 
Nasser Al-Farhan  Nasser.s.al.farhan@gmail.com 
 
We would be grateful if you could please assist us by participating in our study exploring 
practice effects in cognitive testing. Specifically we are interested to find out whether 
prolonged practice on cognitive tasks improves performance and whether or not the level of 
observed improvement differs between different cognitive domains.  
 
Your participation will take approximately 2.5 hours, on each of 3 separate visits, with 1 
week between each visit. During each visit you will perform a range of cognitive tasks. Each 
task will be performed 3 times on each visit, with a one hour break between each set of tasks. 
During the break you may spend the time as you wish, but you are requested not to consume 
any food and to only drink water. At your first visit you will also be asked to record what you 
consumed for your last meal (breakfast for morning participants and lunch for afternoon 
participants). For your subsequent visits you will be asked to eat the same meal (or as close as 
possible) before attending. 
 
Your data will be kept confidential and securely stored, with only an anonymous number 
identifying it. Information linking that number to your name will be stored securely and 
separately from the data you provide us. All information collected for the project will be 
destroyed after a period of 5 years from the completion of the project. Taking part in this 
study is completely voluntary; you may withdraw at any time without having to give any 
reason. Please feel free to ask any questions that you may have about this study at any point.  
 
This application has been reviewed by the University Research Ethics Committee and has 
been given a favourable ethical opinion for conduct 
 
Thank you for your help. 
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D.3 Participant information sheet for Experiment 2 
Title of study: A dose-response study of the acute effects of blueberry juice on cognitive 
performance in healthy young adults  
Participant Information Sheet 
Supervisors:    
Name:    E mail:    Telephone: 
Dr L.T. Butler    l.t.butler@reading.ac.uk +44 (0)118 378 7543 
School of Psychology and Clinical Language Sciences. 
 
Name:    E mail:    Telephone: 
Dr C.M.Williams   claire.williams@reading.ac.uk +44 (0)118 378 7540 
School of Psychology and Clinical Language Sciences. 
 
Experimenter: 
Name:    E mail:    Telephone: 
Lynne Bell    l.bell@pgr.reading.ac.uk  PCLS Office: +44 (0)118 378 8523 
School of Psychology and Clinical Language Sciences. 
  
Introduction 
Flavonoids are dietary polyphenols (plant chemicals found in certain foods such as fruit and vegetables) 
and previous studies have shown both cognitive and cardiovascular benefits of these compounds. This 
research project is looking at the short-term effects of a range of doses of flavonoid-rich blueberry on 
measures of cognition, which will be administered in the form of juice drinks. To avoid interference you 
will be asked to restrict your intake of flavonoid-rich foods prior to participating in the study and to fast 
for 2 hours prior to each test session. During the study you will undergo a range of cognitive tests. You 
will also be asked to give permission for blood pressure measurements to be taken. This is in order to 
determine the effects of flavonoids on vascular reactivity. 
Project Description 
The following is a brief description of the procedure for this research project.  If you have any additional 
questions or require further explanation, please do not hesitate to ask.  
Participation in this research project will require you to be available to attend the Psychology 
department on seven separate days and times that will be agreed with you in advance. Please let the 
Experimenter know if you cannot attend for any reason and the appointment can be rearranged. 
Screening 
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Before participating in the study you are asked to fill in a short health questionnaire and return this to 
the experimenter via email. 
All visits - Test sessions 
For the 24 hours preceding all visits we ask that you follow a restricted diet, and do not partake in any 
vigorous physical activities. Please also refrain from eating or drinking for 2 hours immediately prior to 
each test visit. During the first half of each visit you will have your blood pressure recorded and 
complete a battery of computerised cognitive tasks. You will then be given a 600ml drink that may have 
a thick smoothie-like texture and will be asked to complete a food consumption questionnaire. You will 
then have one hour of free time but we ask that you stay within the Department and do not eat or drink 
anything else other than water.  After the one hour break you will complete a second set of computer 
based cognitive tasks and further blood pressure measurements will be taken. The whole visit should 
take no longer than 2 3/4 hours. Before leaving we will also confirm your next visit date which will be one 
week later. The procedure will be exactly the same for all test visits, with the exception that you will be 
given a different drink.  
All of your data throughout the study will be kept confidential by the use of an identification code 
and therefore your name will not be attached to any of the data collected.  Data will be securely 
stored and retained for 5 years then destroyed. Please note that participation in this study is entirely 
voluntary and you have the right to withdraw from the study at any time without having to give a 
reason.  The juice drinks are safe for human consumption and no negative side-effects are expected. 
This application has been reviewed by the University Research Ethics Committee and has been given 
a favourable ethical opinion for conduct.  This research will be carried out by a PhD student from the 
University of Reading.  
Thank you for your help. 
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D.4 Participant information sheet for Experiment 3 
Title of study: An investigation of the glycaemic response following blueberry drink 
ingestion in healthy young adults: a dose response study 
Participant Information Sheet 
Supervisors:    
Name:    E mail:     Telephone: 
Prof C.M.Williams   claire.williams@reading.ac.uk +44 (0)118 378 7540 
School of Psychology and Clinical Language Sciences. 
 
Name:    E mail:     Telephone: 
Dr D.J.Lamport    d.j.lamport@reading.ac.uk +44 (0)118 378 7937 
School of Psychology and Clinical Language Sciences. 
 
Name:    E mail:     Telephone: 
Prof L.T. Butler    l.t.butler@reading.ac.uk +44 (0)118 378 7543 
School of Psychology and Clinical Language Sciences. 
 
Experimenter: 
Name:    E mail:     Telephone: 
Lynne Bell    l.bell@pgr.reading.ac.uk  +44 (0)118 378 7924 
School of Psychology and Clinical Language Sciences. 
  
Introduction 
This research project is looking at the short-term effects of a range of doses of blueberry on blood 
glucose. Blueberries are a rich source of flavonoids (plant chemicals found in certain foods such as fruit 
and vegetables) and will be administered in the form of a smoothie-like drink. To avoid interference you 
will be asked to restrict your intake of flavonoid-rich foods prior to participating in the study and to fast 
for 2 hours prior to each test session.  
Blood glucose measurement 
During this study you will be required to give a finger prick sample which is used to measure your blood 
glucose level. This is a relatively painless procedure which will cause you minimal distress. If you would 
like to experience giving a finger prick sample before consenting to take part in this research please tell 
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the experimenter. If during the experiment you decide that you do not want to give a finger prick 
sample then you can withdraw from the experiment without giving a reason. Unusually low or high 
glucose levels can be indicative of abnormalities in glucose regulation. We will inform you verbally if we 
observe unusual glucose levels and in such cases we recommend that you contact your GP and ask for 
an official glucose assessment. If you prefer we can contact your GP directly and pass on your readings. 
This finger prick procedure has been has been reviewed by the University Research Ethics Committee 
and has been given a favourable ethical opinion for conduct. 
Procedure 
The following is a brief description of the procedure for this research project.  If you have any additional 
questions or require further explanation, please do not hesitate to ask.  
Participation in this research project will require you to be available to attend the Psychology 
department on five separate days and times that will be agreed with you in advance. Please let the 
Experimenter know if you cannot attend for any reason and the appointment can be rearranged. 
Initial screening 
A short medical questionnaire has been emailed to you along with this information sheet. Please 
complete and return by email to the experimenter. You will then be given a date for your first test 
session. At this session you will be asked to sign a consent form before commencing the study.  
Test sessions 
For the 24 hours preceding these sessions we ask that you follow a restricted diet (see attached), and do 
not partake in any vigorous physical activities. Please also refrain from eating or drinking for 2 hours 
immediately prior to each test session. You may eat a light breakfast (still following the restricted diet) 
before the 2 hour fasting period. If you choose to do so, you are kindly asked to eat an identical 
breakfast before all subsequent visits. At the start of each session you will complete a food consumption 
questionnaire, before having your baseline blood glucose level recorded. You will then be given a 600ml 
drink that may have a thick smoothie-like texture. The drink must be fully consumed within 10 minutes. 
After this you will remain in the lab for a period of 2 ½ hours, during which further blood glucose 
measurements will be recorded at intervals of 15 minutes. The whole visit should take no longer than 3 
hours. Before leaving we will also confirm your next session date which will be one week later. The 
procedure will be exactly the same for all test sessions, with the exception that you will be given a 
different drink.   
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Data protection and ethical conduct 
All of your data throughout the study will be kept confidential by the use of an identification code 
and therefore your name will not be attached to any of the data collected.  Data will be securely 
stored and retained for 5 years then destroyed. Please note that participation in this study is entirely 
voluntary and you have the right to withdraw from the study at any time without having to give a 
reason.  The blueberry drinks are safe for human consumption and no negative side-effects are 
expected. This application has been reviewed by the University Research Ethics Committee and has 
been given a favourable ethical opinion for conduct.  This research will be carried out by a PhD 
student from the University of Reading.  
Thank you for your help. 
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D.5 Participant information sheet for Experiment 4 
Title of study: A dose-response study of the acute effects of blueberry juice oncognitive 
performance in healthy young adults  
Participant Information Sheet 
Supervisors:    
Name:    E mail:     Telephone: 
Dr D.J.Lamport    d.j.lamport@reading.ac.uk +44 (0)118 378 7937 
School of Psychology and Clinical Language Sciences. 
 
Name:    E mail:     Telephone: 
Dr L.T. Butler    l.t.butler@reading.ac.uk +44 (0)118 378 7543 
School of Psychology and Clinical Language Sciences. 
 
Name:    E mail:     Telephone: 
Dr C.M.Williams   claire.williams@reading.ac.uk +44 (0)118 378 7540 
School of Psychology and Clinical Language Sciences. 
 
Experimenter: 
Name:    E mail:     Telephone: 
Lynne Bell    pf008864@pgr.reading.ac.uk  +44 (0)118 378 7928 
School of Psychology and Clinical Language Sciences. 
  
Introduction 
This research project is looking at the short-term effects of a range of doses of blueberry on measures of 
cognition. Flavonoids are dietary polyphenols (plant chemicals found in certain foods such as fruit and 
vegetables) and will be administered in the form of a juice drink. To avoid interference you will be asked 
to restrict your intake of flavonoid-rich foods prior to participating in the study and to fast for 2 hours 
prior to each test session. During the study you will undergo a range of cognitive tests. You will also be 
asked to give permission for blood glucose measurements to be taken. This is in order to determine the 
effects of flavonoids on blood glucose regulation. 
Blood glucose measurement is a relatively painless procedure involving a finger prick which will cause 
you minimal distress. If you would like to experience giving a finger prick sample before consenting to 
take part in this research please tell the experimenter. If during the experiment you decide that you do 
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not want to give a finger prick sample then you can withdraw from the experiment without giving a 
reason. Unusually low or high glucose levels can be indicative of abnormalities in glucose regulation. We 
will inform you verbally if we observe unusual glucose levels and in such cases we recommend that you 
contact your GP and ask for an official glucose assessment. If you prefer we can contact your GP directly 
and pass on your readings. This finger prick procedure has been has been reviewed by the University 
Research Ethics Committee and has been given a favourable ethical opinion for conduct. 
Project Description 
The following is a brief description of the procedure for this research project.  If you have any additional 
questions or require further explanation, please do not hesitate to ask.  
Participation in this research project will require you to be available to attend the Psychology 
department on five separate days and times that will be agreed with you in advance. Please let the 
Experimenter know if you cannot attend for any reason and the appointment can be rearranged. 
Screening 
Before participating in the study you are asked to fill in a short health questionnaire and return this to 
the experimenter via email. 
All visits - Test sessions 
For the 24 hours preceding these visits we ask that you follow a restricted diet, and do not partake in 
any vigorous physical activities. Please also refrain from eating or drinking for 2 hours immediately prior 
to each test session. At the start of each session you will complete a food consumption questionnaire, 
before having your blood glucose level recorded and completing a short battery of computerised 
cognitive tasks. You will then be given a 300ml drink that may have a thick smoothie-like texture. After 
this you will have your blood glucose re-measured at 15 mins and 30 mins followed by a further 30 mins 
of free time. We ask that you stay within the Department and do not eat or drink anything else other 
than water.  After the break you will complete a second set of computer based cognitive tasks.  After a 
further break of around 45 minutes you will complete the cognitive tasks for a third time. Blood glucose 
measurements will also be taken each time you resume cognitive testing (5 finger pricks in total per 
visit). The whole visit should take no longer than 2 3/4 hours. Before leaving we will also confirm your 
next visit date which will be one week later. The procedure will be exactly the same for all test visits, 
with the exception that you will be given a different drink.  
All of your data throughout the study will be kept confidential by the use of an identification code 
and therefore your name will not be attached to any of the data collected.  Data will be securely 
stored and retained for 5 years then destroyed. Please note that participation in this study is entirely 
voluntary and you have the right to withdraw from the study at any time without having to give a 
reason.  The juice drinks are safe for human consumption and no negative side-effects are expected. 
This application has been reviewed by the University Research Ethics Committee and has been given 
a favourable ethical opinion for conduct.  This research will be carried out by a PhD student from the 
University of Reading.  
Thank you for your help. 
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Appendix E Consent forms 
E.1 Consent form for Experiment 1.1 
 
Title of Study: Examination of the occurrence of practice effects in the Sternberg task and other 
cognitive tasks commonly used in crossover dietary intervention studies 
CONSENT FORM 
 
I, ……………………………………… agree to participate in the study ‘Examination of the occurrence of 
practice effects in the Sternberg task and other cognitive tasks commonly used in crossover 
dietary intervention studies’, being conducted by Lynne Bell at The University of Reading. I have 
seen and read a copy of the Participants Information Sheet and have been given the opportunity to 
ask questions about the study and these have been answered to my satisfaction. I understand that 
all personal information will remain confidential to the Investigator and arrangements for the 
storage and eventual disposal of any identifiable material have been made clear to me. I understand 
that participation in this study is voluntary and that I can withdraw at any time without having to 
give an explanation. 
 
I am happy to proceed with my participation. 
 
Signature  ------------------------------------------------------------ 
 
Name (in capitals) ------------------------------------------------------------- 
 
Date     ------------------------------------------------------------- 
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E.2 Consent form for Experiment 1.2 
Title of Study: Examination of the occurrence of practice effects in cognitive tasks commonly used 
in crossover dietary intervention studies 
CONSENT FORM 
 
I, ……………………………………… agree to participate in the study ‘Examination of the occurrence of 
practice effects in cognitive tasks commonly used in crossover dietary intervention studies’, being 
conducted by Lynne Bell, Emma Coleman & Nasser Al-Farhan at The University of Reading. I have 
seen and read a copy of the Participants Information Sheet and have been given the opportunity to 
ask questions about the study and these have been answered to my satisfaction. I understand that 
all personal information will remain confidential to the Investigator and arrangements for the 
storage and eventual disposal of any identifiable material have been made clear to me. I understand 
that participation in this study is voluntary and that I can withdraw at any time without having to 
give an explanation. 
 
I am happy to proceed with my participation. 
 
Signature  ------------------------------------------------------------ 
Name (in capitals) ------------------------------------------------------------- 
Date     ------------------------------------------------------------- 
 
Researcher signature ------------------------------------------------------------ 
Name (in capitals) ------------------------------------------------------------- 
Date     ------------------------------------------------------------- 
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E.3 Consent form for Experiment 2 
A dose-response study of the acute effects of blueberry juice on 
cognitive performance in healthy young adults 
Consent Form 
When you have read each statement below, please put your initials in the box next to it to 
show that you understand and agree with the statement 
 
1. I agree to participate in the project ‘A dose-response study of the acute effects of blueberry 
juice on 
cognitive performance in healthy young adults’, being conducted by the Nutrition and 
Cognition Research Group at the University of Reading. 
 
2. I have read and been given a copy of the Participant’s Information Sheet and this consent 
form.  I have had the opportunity to ask any questions about the project and these have 
been answered to my satisfaction.  I agree to the arrangements described in the Information 
Sheet in so far as they relate to my participation.  
 
3. I am aware that this application has been reviewed by the University Research Ethics 
Committee and has been given a favourable ethical opinion for conduct. 
 
4. I understand that participation is entirely voluntary and that I have the right to withdraw 
from the project at any time, without giving a reason, and that this will be without detriment 
to any care or services I may be receiving or may receive in the future. 
 
5. I understand that all personal information will remain confidential to the Investigator and 
arrangements for the storage and eventual disposal of any identifiable material have been 
made clear to me. 
 
6. I am happy to proceed with my participation. 
 
        In the presence of: 
Name:.........................................(Volunteer)  Name:........................................(Researcher) 
Signed:........................................(Volunteer)  Signed:......................................(Researcher) 
Date:...........................................(Volunteer)   Date:……….............................(Researcher) 
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E.4 Consent form for Experiment 3 
An investigation of the glycaemic response following blueberry drink 
ingestion in healthy young adults: a dose response study 
Consent Form 
When you have read each statement below, please put your initials in the box next to it to 
show that you understand and agree with the statement 
 
1. I agree to participate in the project ‘An investigation of the glycaemic response to varying 
doses of blueberry in healthy young adults’, being conducted by the Nutrition and Cognition 
Research Group at the University of Reading. 
 
2.  I have read the information sheet and I have been told the reasons why a finger prick blood 
sample is required. I have had the opportunity to ask any questions about the project and 
these have been answered to my satisfaction.  I agree to the arrangements described in the 
Information Sheet in so far as they relate to my participation. 
 
3. I consent to a series of finger prick samples being taken. 
 
4. I authorise the Investigator to consult my General Practitioner if abnormal glucose readings 
are observed. 
 
5. I am aware that the finger prick procedure has been reviewed by the University Research 
Ethics Committee and has been given a favourable ethical opinion for conduct. 
 
6. I understand that participation is entirely voluntary and that I have the right to withdraw 
from the project at any time, without giving a reason, and that this will be without detriment 
to any care or services I may be receiving or may receive in the future. 
 
7. I understand that all personal information will remain confidential to the Investigator and 
arrangements for the storage and eventual disposal of any identifiable material have been 
made clear to me. 
 
8. I am happy to proceed with my participation. 
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        In the presence of: 
Name:.........................................(Volunteer)    Name:........................................(Researcher) 
Signed:........................................(Volunteer)    Signed:......................................(Researcher) 
Date of birth:..............................(Volunteer)   Date:……….............................(Researcher) 
Name and address of GP:.............(Volunteer) 
..................................................................... 
...................................................................... 
...................................................................... 
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E.5 Consent form for Experiment 4 
A dose-response study of the acute effects of blueberry juice on 
cognitive performance in healthy young adults 
Consent Form 
When you have read each statement below, please put your initials in the box next to it to 
show that you understand and agree with the statement 
 
1. I agree to participate in the project ‘A dose-response study of the acute effects of blueberry 
juice on 
cognitive performance in healthy young adults’, being conducted by the Nutrition and 
Cognition Research Group at the University of Reading. 
 
2. I have read the information sheet and I have been told the reasons why a finger prick blood 
sample is required. I have had the opportunity to ask any questions about the project and 
these have been answered to my satisfaction.  I agree to the arrangements described in the 
Information Sheet in so far as they relate to my participation. 
 
3. I consent to a series of finger prick samples being taken 
 
4. I authorise the Investigator to consult my General Practitioner if abnormal glucose readings 
are observed 
 
5. I am aware that the finger prick procedure has been reviewed by the University Research 
Ethics Committee and has been given a favourable ethical opinion for conduct. 
 
6. I am aware that this application has been reviewed by the University Research Ethics 
Committee and has been given a favourable ethical opinion for conduct. 
 
7. I understand that participation is entirely voluntary and that I have the right to withdraw 
from the project at any time, without giving a reason, and that this will be without detriment 
to any care or services I may be receiving or may receive in the future. 
 
8. I understand that all personal information will remain confidential to the Investigator and 
arrangements for the storage and eventual disposal of any identifiable material have been 
made clear to me. 
 
9. I am happy to proceed with my participation. 
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       In the presence of: 
Name:.........................................(Volunteer)  Name:........................................(Researcher) 
Signed:........................................(Volunteer)  Signed:......................................(Researcher) 
Date:...........................................(Volunteer)   Date:……….............................(Researcher) 
Name and address of GP:.............(Volunteer) 
..................................................................... 
...................................................................... 
...................................................................... 
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Appendix F Low polyphenol diet 
 
Please avoid alcohol or other recreational drugs for 48 hours before each visit 
to the Nutritional Psychology Unit and for the duration of each study day. 
Please avoid eating foods shown below for 24 hours before each visit to the 
Nutritional Psychology Unit and for the duration of each study day. 
 All berries 
 Fruit and vegetables (except potatoes) 
 Fruit juices 
 Jams and preserves 
 Red wine 
 Fruit teas 
 Soy products 
 Chocolate/cocoa 
 Tea (black, green. earl grey etc) 
 Coffee  
 All high energy and/or caffeinated drinks, eg: Coca-Cola, 
Red Bull, Lucozade.  
 All dietary supplements 
 Alcohol or other recreational drugs (avoid for 48 hours) 
 
Foods you may eat include those shown below. 
 Potatoes 
 Rice 
 Sweetcorn 
 Mushrooms 
 Carrots 
 Bananas 
 Pasta 
 Meat/fish 
 Dairy products 
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Appendix G 24 hour food record 
 
Participant No: Participant ID: Visit No: 
Food intake record 
Please write down everything you consumed during the 24 hours prior to your 2 hour fast. Please 
include details of all meals, snacks and beverages: 
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Appendix H Blueberry intervention palatability questionnaire 
 
Participant number:_______ Visit:________ Drink:______ Date: ____/____/___ 
 
Please answer the following questions by circling the appropriate number response on the scale. 
Please regard the ends of each scale as indicating the most extreme sensation you have ever felt. 
 
1.  How sweet did you find the drink? 
  
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
2.  How bland did you find the drink? 
  
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
3.  How tasty did you find the drink? 
 
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
4.  How pleasant did you find the drink? 
 
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
5.  How sour did you find the drink? 
 
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
6.  How satisfying did you find the drink? 
 
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
7.  How much more of this drink do you think you could consume? 
 
None at all1 2 3 4 5 6 7 8 9 A lot more 
 
8.  How easy did you find it to consume the drink? 
 
Not at all 1 2 3 4 5 6 7 8 9 Extremely 
 
9.  Any additional comments about the drink: 
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________ 
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Appendix I Immediate & delayed recall word lists 
 
1 2 3 4 5 6 7 
hose latch swamp inn cane dew scout 
tank fox fudge yacht spike prune pit 
seed branch sail worm owl knight shell 
bone brick gun soil pearl drain blade 
card tool board stew lung crown flag 
wood star pine film church nurse oil 
bin ball pot coin jar broom tray 
clock meat neck soap dog leaf brush 
salt spoon fruit men bag knee book 
prison metal penny doorway needle forest palace 
shepherd armour woodland sardine ferry dairy lily 
chapel measles arrow knuckle package cotton gravel 
jewel linen kitten valley bullet iron gravy 
hotel chicken rubber candy shoulder teacher wire 
toilet garden oven pocket picture paper building 
       
8 9 10 11 12 13 14 
lime fawn herd wick sword crane beast 
calf doll rake barn vest shrub crow 
oak duck rod dart cliff cone heel 
weed shore mud net deck pole shark 
van bush sweat thread frost stool chin 
blood land rug heart cloth beard throat 
school glove sock wheel stone corn sleeve 
rain ring soup hall seat plate lamp 
face tree plant room door box girl 
tack bowl sheet cheek pipe pig shield 
marble beehive camel ruby kennel cellar farmyard 
rifle barrel mansion slipper napkin daisy laundry 
tractor hammer soldier cherry lemon salad movie 
office motor piano dentist pepper brother uncle 
orange button ticket shower mirror bedroom pillow 
       
 212 
 
Appendix J Motivation & task difficulty questionnaire 
 
Participant No: Participant ID: Visit No: Session No: 
 
<Cognitive task name> 
How difficult did you find the <cognitive task name> task? 
 
1 2 3 4 5 6 7 8 9 
 
  Not at         Extremely 
  all 
 
 
How motivated were you to do well during the <cognitive task name> task? 
 
1 2 3 4 5 6 7 8 9 
 
  Not at         Extremely 
  all 
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Appendix K Fruit & vegetable consumption questionnaire 
To answer the next questions it is important that you understand what a portion of fruit is and 
also what a portion of vegetables is so below is a quick guide: 
 
Quick guide to fruit and vegetable portions 
FRUIT One portion of fruit is: 
Fresh Small-sized fruit - 2 satsumas, 2 kiwi fruits, 14 cherries, 2 handfuls of raspberries or 
blueberries 
 Medium-sized fruit - 1 medium fruit, e.g. 1 apple, banana, pear, orange or nectarine 
 Large fruit - 1 (5cm slice) of melon, 1 large slice of pineapple, 2 (5cm slices) of 
mango 
Dried  1 tablespoon of raisins, currants, sultanas, 3 apricots 
Juice A glass (150ml) of 100% juice (or smoothie) counts as 1 portion, but you can only 
count juice as 1 portion per day, however much you drink 
Tinned Roughly the same quantity of fruit that you would eat as a fresh portion: 2 pear or 
peach halves, 3 heaped tablespoons of fruit salad 
VEGETABLES One portions of vegetables is: 
Green  2 broccoli spears, 8 cauliflower florets 
Cooked  3 heaped tablespoons of cooked vegetables such as carrots, peas or sweetcorn  
Salad  3 sticks of celery, 1 medium tomato, 7 cherry tomatoes 
Tinned & 
frozen  
Roughly the same quantity as you would eat as a fresh portion 
Pulses & 
beans 
3 heaped tablespoons of baked beans, haricot beans, kidney beans, cannelloni 
beans, butter beans or chick peas. Remember that beans and pulses do count, but 
you can only count beans/pulses as 1 portion per day, however much you eat 
  
1. How many portions of fruit, of any sort, do you eat on a typical day?   ______ portions 
2. How many portions of vegetables, excluding potatoes, do you eat on a typical day?  _______ portions 
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Appendix L LMM results tables 
Table L.1 LMM results for Experiment 1.1 
Table L.1 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.1 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Cognition: 
         Immediate recall score 
(correct/15) 
 
1.1 716.50 
 
Visit 
 
F(2,54.00) 15.91 <0.001
    
Session 
 
F(1,69.62) 1.83 0.181 
     
Visit x 
Session 
 
F(2,82.13) 2.92 0.059 
          
  
1.2 704.10
 
Visit 
 
F(2,54.20) 16.82 <0.001
     
Session 
 
F(1,79.39) 0.02 0.881 
     
Visit x 
Session 
 
F(2,81.91) 4.36 0.016 
     
Motivation 
 
F(1,136.77) 13.56 <0.001 
          Immediate recall 
interference errors 
 
1.3 -14.71
 
Visit 
 
F(2,73.11) 0.07 0.934
    
Session 
 
F(1,61.39) 0.38 0.538 
     
Visit x 
Session 
 
F(2,71.07) 0.67 0.517 
          Delayed recall score 
(correct/15) 
 
1.1 798.11
 
Visit 
 
F(2,55.09) 2.87 0.065
    
Session 
 
F(1,72.68) 19.20 <0.001 
     
Visit x 
Session 
 
F(2,67.28) 2.03 0.140 
          
  
1.2 791.03
 
Visit 
 
F(2,53.22) 2.79 0.070
     
Session 
 
F(1,71.43) 17.08 <0.001 
     
Visit x 
Session 
 
F(2,65.15) 2.13 0.127 
     
Motivation 
 
F(1,127.22) 7.64 0.007 
          Delayed recall 
interference errors 
 
1.3 295.14
 
Visit 
 
F(2,54.91) 11.31 <.001
    
Session 
 
F(1,67.05) 44.29 <.001 
     
Visit x 
Session 
 
F(2,54.76) 9.16 <.001 
          Serial 3s score 
 
1.1 1188.55
 
Visit 
 
F(5,51.08) 72.00 <0.001
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Table L.1 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.1 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
(correct in 2 mins) 
    
Session 
 
F(1,74.78) 41.29 <0.001 
     
Visit x 
Session 
 
F(2,74.32) 4.39 0.016 
          
  
1.2 1186.78
 
Visit 
 
F(2,49.95) 70.48 <0.001
     
Session 
 
F(1,76.87) 42.98 <0.001 
     
Visit x 
Session 
 
F(2,76.20) 3.87 0.025 
     
Motivation 
 
F(1,155.27) 1.92 0.168 
        
  
Serial 3s RT (ms) 
 
1.1 2716.36
 
Visit 
 
F(2,53.86) 33.98 <0.001 
     
Session 
 
F(1,84.73) 16.13 <0.001 
     
Visit x 
Session 
 
F(2,47.79) 1.98 0.149 
          
  
1.2 2713.70
 
Visit 
 
F(2,53.89) 35.30 <0.001
     
Session 
 
F(1,86.05) 16.59 <0.001 
     
Visit x 
Session 
 
F(2,50.31) 1.45 0.243 
     
Motivation 
 
F(1,118.84) 2.85 0.094 
          Serial 3s errors 
(incorrect in 2 mins) 
 
1.1 725.55
 
Visit 
 
F(2,48.98) 0.11 0.893
    
Session 
 
F(1,68.38) 0.67 0.416 
     
Visit x 
Session 
 
F(2,80.10) 1.04 0.356 
          
  
1.2 724.30
 
Visit 
 
F(2,50.64) 0.07 0.930
     
Session 
 
F(1,66.62) 0.69 0.411 
     
Visit x 
Session 
 
F(2,79.75) 0.95 0.391 
     
Motivation 
 
F(1,40.60) 1.39 0.246 
          Serial 7s score 
(correct in 2 mins) 
 
1.1 1078.76
 
Visit 
 
F(2,48.54) 26.88 <0.001
    
Session 
 
F(1,57.88) 9.13 0.004 
     
Visit x 
Session 
 
F(2,67.26) 0.37 0.690 
          
 216 
 
Table L.1 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.1 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
  
1.2 1062.77 
 
Visit 
 
F(2,46.26) 32.86 <0.001 
     
Session 
 
F(1,69.02) 10.74 0.002 
     
Visit x 
Session 
 
F(2,71.52) 0.71 0.496 
     
Motivation 
 
F(1,135.85) 19.05 <0.001 
          Serial 7s RT (ms) 
 
1.1 2963.58
 
Visit 
 
F(2,66.09) 11.37 <0.001
     
Session 
 
F(1,67.10) 17.01 <0.001 
     
Visit x 
Session 
 
F(2,73.84) 4.39 0.016 
          
  
1.2 2963.53
 
Visit 
 
F(2,66.14) 11.43 <0.001
     
Session 
 
F(1,67.33) 17.04 <0.001 
     
Visit x 
Session 
 
F(2,73.47) 4.39 0.016 
     
Motivation 
 
F(1,124.54) 0.05 0.825 
          Serial 7s errors 
(incorrect in 2 mins) 
 
1.1 773.58
 
Visit 
 
F(2,53.59) 0.52 0.595
    
Session 
 
F(1,77.42) 0.52 0.474 
     
Visit x 
Session 
 
F(2,86.86) 0.51 0.600 
          
  
1.2 759.72
 
Visit 
 
F(2,49.04) 0.88 0.423
     
Session 
 
F(1,76.45) 0.36 0.548 
     
Visit x 
Session 
 
F(2,87.48) 0.67 0.513 
     
Motivation 
 
F(1,82.72) 16.49 <0.001 
          Sternberg accuracy 
(correct/96) 
 
1.1 963.90
 
Visit 
 
F(2,89.31) 1.51 0.226
    
Session 
 
F(1,95.03) 0.68 0.412 
     
Visit x 
Session 
 
F(2,79.32) 0.25 0.777 
          
  
1.2 926.88
 
Visit 
 
F(2,89.83) 1.84 0.165
     
Session 
 
F(1,86.21) 0.37 0.542 
     
Visit x 
Session 
 
F(2,81.68) 0.33 0.722 
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Table L.1 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.1 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Motivation 
 
F(1,131.06) 44.25 0.000 
          Sternberg scanning 
rate (ms/item) 
 
1.1 1466.11
 
Visit 
 
F(2,60.33) 7.08 0.002
    
Session 
 
F(1,58.80) 0.10 0.754 
     
Visit x 
Session 
 
F(2,70.08) 0.26 0.774 
          
  
1.2 1464.85
 
Visit 
 
F(2,60.89) 6.87 0.002
     
Session 
 
F(1,58.29) 0.07 0.789 
     
Visit x 
Session 
 
F(2,71.51) 0.25 0.777 
     
Motivation 
 
F(1,130.19) 1.37 0.243 
          Sternberg extrapolated 
RT (ms) 
 
1.1 2149.69
 
Visit 
 
F(2,60.81) 2.80 0.069
    
Session 
 
F(1,56.18) 8.80 0.004 
     
Visit x 
Session 
 
F(2,71.12) 1.13 0.328 
          
  
1.2 2146.33
 
Visit 
 
F(2,60.23) 2.82 0.067
     
Session 
 
F(1,55.60) 9.37 0.003 
     
Visit x 
Session 
 
F(2,71.45) 1.06 0.351 
     
Motivation 
 
F(1,128.73) 3.60 0.060 
          Stroop accuracy 
(correct/96) 
 
1.1 988.00
 
Visit 
 
F(2,72.10) 0.03 0.966
    
Session 
 
F(1,56.97) 0.04 0.835 
     
Visit x 
Session 
 
F(2,58.63) 1.18 0.316 
          
  
1.2 982.40
 
Visit 
 
F(2,66.97) 0.06 0.938
     
Session 
 
F(1,55.68) <0.01 0.949 
     
Visit x 
Session 
 
F(2,60.04) 1.20 
0.307 
     
Motivation 
 
F(1,102.34) 6.35 0.013 
        
  
Stroop incongruent RT 
(ms) 
 
1.1 1833.20
 
Visit 
 
F(2,52.04) 12.66 <0.001 
    
Session 
 
F(1,58.63) 23.75 <0.001 
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Table L.1 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.1 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Visit x 
Session 
 
F(2,74.99) 8.91 <0.001 
        
  
  
1.2 1830.40
 
Visit 
 
F(2,52.41) 13.62 <0.001 
     
Session 
 
F(1,57.19) 24.57 <0.001 
     
Visit x 
Session 
 
F(2,74.68) 8.70 <0.001 
     
Motivation 
 
F(1,140.55) 3.24 0.074 
          Stroop congruent RT 
(ms) 
 
1.1 1858.71
 
Visit 
 
F(2,48.90) 6.17 0.004
    
Session 
 
F(1,47.64) 44.81 <0.001 
     
Visit x 
Session 
 
F(2,83.96) 3.45 0.036 
          
  
1.2 1853.27
 
Visit 
 
F(2,43.04) 6.65 0.003
     
Session 
 
F(1,42.89) 50.08 <0.001 
     
Visit x 
Session 
 
F(2,83.05) 3.52 0.034 
     
Motivation 
 
F(1,140.24) 5.82 0.017 
          Stroop interference 
effect (ms) 
 
1.1 1753.17
 
Visit 
 
F(2,55.68) 0.32 0.729
    
Session 
 
F(1,58.75) 5.51 0.022 
     
Visit x 
Session 
 
F(2,84.38) 2.29 0.108 
          
  
1.2 1750.37
 
Visit 
 
F(2,55.57) 0.29 0.748
     
Session 
 
F(1,61.19) 6.50 0.013 
     
Visit x 
Session 
 
F(2,84.16) 2.40 0.097 
     
Motivation 
 
F(1,145.5) 3.19 0.076 
          Mood: 
         Mental fatigue 
(rating/9) 
 
1.1 657.59
 
Visit 
 
F(2,58.82) 5.18 0.008
    
Session 
 
F(1,69.09) 7.24 0.009 
     
Visit x 
Session 
 
F(2,83.19) 0.52 0.599 
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Table L.1 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.1 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Positive affect 
(score/50) 
 
1.1 1034.15 
 
Visit 
 
F(2,53.70) 5.18 0.009 
    
Session 
 
F(1,61.90) 13.24 0.001 
     
Visit x 
Session 
 
F(2,71.46) 3.13 0.050 
          Negative affect 
(score/50) 
 
1.1 789.83
 
Visit 
 
F(2,75.48) 0.31 0.737
    
Session 
 
F(1,58.12) 2.69 0.107 
     
Visit x 
Session 
 
F(2,54.22) 0.40 0.673 
          Perceived difficulty 
(rating/9) 
 
1.4 3597.07
 
Task 
 
F(5,186.29) 20.12 <0.001
    
Visit 
 
F(2,595.30) 7.38 <0.001 
     
Session 
 
F(1,602.72) <0.01 0.947 
     
Task x Visit 
 
F(10,595.30) 1.07 0.387 
     
Task x 
Session 
 
F(5,602.72) 7.22 <0.001 
     
Visit x 
Session 
 
F(2,544.08) 6.54 0.002 
     
Task x Visit x 
Session F(10,544.08) 1.87 0.047 
               
Motivation 
(rating/9) 
 
1.4 3287.93 
 
Task 
 
F(5,262.17) 10.42 <0.001 
    
Visit 
 
F(2,537.87) 8.03 <0.001 
     
Session 
 
F(1,481.32) 15.14 <0.001 
     
Task x Visit 
 
F(10,537.87) 0.80 0.632 
     
Task x 
Session 
 
F(5,481.32) 2.72 0.019 
     
Visit x 
Session 
 
F(2,547.79) 0.28 0.759 
     
Task x Visit 
x Session 
 
F(10,547.79) 0.61 0.803 
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Table L.2 LMM results for Experiment 1.2 
Table L.2 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Cognition: 
         Digit vigilance score 
(correct/45) 
 
1.1 1354.2 
 
Visit 
 
F(2,71.98) 2.31 0.106 
    
Session 
 
F(2,113.33) 8.35 <0.001 
     
Visit x 
Session 
 
F(4,86.69) 0.25 0.908 
          
  
1.2 1340.72 
 
Visit 
 
F(2,80.15) 1.87 0.160
     
Session 
 
F(2,117.55) 5.87 0.004 
     
Visit x 
Session 
 
F(4,85.72) 
0.32 0.867 
     
Motivation 
 
F(1,172.34) 6.54 0.011 
          Digit vigilance 
commission errors 
 
1.1 1035.88 
 
Visit 
 
F(2,90.77) 6.64 0.002
    
Session 
 
F(2,132.04) 0.52 0.598 
     
Visit x 
Session 
 
F(4,101.48) 0.74 0.568 
          
  
1.2 1020.55 
 
Visit 
 
F(2,93.92) 4.94 0.009
     
Session 
 
F(2,132.14) 0.09 0.917 
     
Visit x 
Session 
 
F(4,98.55) 
0.58 0.677 
     
Motivation 
 
F(1,224.24) 10.48 0.001 
        
  
Digit vigilance RT (ms) 
 
1.1 2636.74 
 
Visit 
 
F(2,63.25) 1.31 0.277 
     
Session 
 
F(2,125.79) 6.70 0.002 
     
Visit x 
Session 
 
F(4,88.65) 0.89 0.475 
          
  
1.2 2613.18 
 
Visit 
 
F(2,65.49) 0.78 0.463
     
Session 
 
F(2,127.82) 4.21 0.017 
     
Visit x 
Session 
 
F(4,88.14) 
0.75 0.560 
     
Motivation 
 
F(1,237.80) 8.14 0.005 
          RVIP score 
(correct/40) 
 
1.1 1701.31 
 
Visit 
 
F(2,73.09) 24.45 <0.001
    
Session 
 
F(2,138.86} 3.77 0.026 
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Table L.2 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Visit x 
Session 
 
F(4,98.89) 2.47 0.049 
          
  
1.2 1671.44 
 
Visit 
 
F(2,71.74) 26.88 <0.001
     
Session 
 
F(2,138.85) 5.51 0.005 
     
Visit x 
Session 
 
F(4,100.73) 
2.09 0.088 
     
Motivation 
 
F(1,243.60) 9.49 0.002 
        
  
RVIP commission 
errors 
 
1.1 2017.52 
 
Visit 
 
F(2,61.71) 0.47 0.627 
    
Session 
 
F(2,115.62) 3.13 0.048 
     
Visit x 
Session 
 
F(4,90.25) 3.01 0.022 
          
  
1.2 1979.62 
 
Visit 
 
F(2,64.14) 0.61 0.548
     
Session 
 
F(2,116.65) 3.06 0.050 
     
Visit x 
Session 
 
F(4,86.94) 
3.22 0.016 
     
Motivation 
 
F(1,206.91) 2.31 0.130 
          RVIP RT (ms) 
 
1.1 2763.36 
 
Visit 
 
F(2,82.07) 3.97 0.023
     
Session 
 
F(2,133.40) 4.44 0.014 
     
Visit x 
Session 
 
F(4,100.73) 0.91 0.464 
          
  
1.2 2725.26 
 
Visit 
 
F(2,82.56) 3.59 0.032
     
Session 
 
F(2,133.46) 5.38 0.006 
     
Visit x 
Session 
 
F(4,97.61) 0.86 0.490 
     
Motivation 
 
F(1,231.89) 1.68 0.196 
          Serial 3s score (correct 
in 2 mins) 
 
1.1 1959.48 
 
Visit 
 
F(2,39.61) 46.21 <0.001
    
Session 
 
F(2,104.14) 16.73 <0.001 
     
Visit x 
Session 
 
F(4,84.61) 2.81 0.031 
          
  
1.2 1943.22 
 
Visit 
 
F(2,35.86) 49.65 <.001
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Table L.2 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Session 
 
F(2,105.74) 22.49 <.001 
     
Visit x 
Session 
 
F(4,82.51) 
2.87 0.028 
     
Motivation 
 
F(1,197.14) 17.64 <.001 
          Serial 3s errors 
(incorrect in 2 mins) 
 
1.1 1257.89 
 
Visit 
 
F(2,78.14) 2.87 0.063
    
Session 
 
F(2,115.35) 0.37 0.691 
     
Visit x 
Session 
 
F(4,93.40) 1.45 0.223 
          
  
1.2 1255.26 
 
Visit 
 
F(2,77.23) 2.72 0.072
     
Session 
 
F(2,117.78) 0.18 0.832 
     
Visit x 
Session 
 
F(4,92.95) 
1.46 0.222 
     
Motivation 
 
F(1,158.75) 2.81 0.096 
          Serial 3s RT (ms) 
 
1.1 4402.4 
 
Visit 
 
F(2,64.08) 31.22 <0.001
     
Session 
 
F(2,104.49) 11.44 <0.001 
     
Visit x 
Session 
 
F(4,93.00) 1.56 0.192 
          
  
1.2 4400.72 
 
Visit 
 
F(2,64.06) 30.25 <.001
     
Session 
 
F(2,104.83) 12.12 <.001 
     
Visit x 
Session 
 
F(4,93.23) 
1.58 0.185 
     
Motivation 
 
F(1,165.433) 1.82 0.180 
          Serial 7s score (correct 
in 2 mins) 
 
1.1 1736.98 
 
Visit 
 
F(2,62.26) 28.94 <0.001
    
Session 
 
F(2,123.19) 13.49 <0.001 
     
Visit x 
Session 
 
F(4,94.21) 0.84 0.503 
          
  
1.2 1715.02 
 
Visit 
 
F(2,63.84) 32.34 <0.001
     
Session 
 
F(2,114.35) 16.54 <0.001 
     
Visit x 
Session 
 
F(4,92.52) 
1.11 0.355 
     
Motivation 
 
F(1,209.03) 11.28 0.001 
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Table L.2 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
          Serial 7s errors 
(incorrect in 2 mins) 
 
1.1 1110.51 
 
Visit 
 
F(2,78.98) 0.61 0.545
    
Session 
 
F(2,127.26) 7.94 0.001 
     
Visit x 
Session 
 
F(4,94.52) 0.91 0.462 
          
  
1.2 1086.54 
 
Visit 
 
F(2,73.78) 1.14 0.325
     
Session 
 
F(2,133.11) 8.63 <0.001 
     
Visit x 
Session 
 
F(4,98.18) 
1.39 0.244 
     
Motivation 
 
F(1,183.87) 2.72 0.101 
          Serial 7s RT (ms) 
 
1.1 4745.02 
 
Visit 
 
F(2,79.59) 42.14 <0.001
     
Session 
 
F(2,107.78) 25.42 <0.001 
     
Visit x 
Session 
 
F(4,89.87) 1.94 0.111 
          
  
1.2 4706.44 
 
Visit 
 
F(2,79.61) 44.95 <0.001
     
Session 
 
F(2,110.43) 28.16 <0.001 
     
Visit x 
Session 
 
F(4,87.32) 
2.34 0.061 
     
Motivation 
 
F(1,219.22) 4.45 0.036 
Mood: 
         Mental fatigue 
(rating/9) 
 
1.1 1132.14 
 
Visit 
 
F(2,76.15) 0.18 0.836
    
Session 
 
F(2,130.86) 2.00 0.139 
     
Visit x 
Session 
 
F(4,94.29) 
1.11 0.359 
          Positive affect 
(score/50) 
 
1.1 1729.76 
 
Visit 
 
F(2,73.67) 3.48 0.036
    
Session 
 
F(2,126.73) 8.93 <0.001 
     
Visit x 
Session 
 
F(4,88.15) 
0.28 0.888 
          Negative affect 
(score/50) 
 
1.1 1309.28 
 
Visit 
 
F(2,71.56) 1.28 0.286
    
Session 
 
F(2,136.12) 6.35 0.002 
     
Visit x 
Session 
 
F(4,98.66) 
0.64 0.635 
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Table L.2 continued 
     LMM fixed effects, interactions & covariates 
Experiment 1.2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
        
  
Perceived difficulty 
(rating/9) 
 
1.4 3873.52 
 
Task 
 
F(3,204.29) 142.51 <0.001 
    
Visit 
 
F(2,452.46) 22.98 <0.001 
     
Session 
 
F(2,586.29) 37.75 <0.001 
     
Task x Visit 
 
F(6,449.48) 2.72 0.013 
     
Task x 
Session 
 
F(6,585.91) 2.83 0.010 
     
Visit x 
Session 
 
F(4,447.35) 8.86 <0.001 
     
Task x Visit x 
Session F(447.30) 1.18 0.297 
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Table L.3 LMM results for Experiments 1.1 & 1.2 combined 
Table L.3 continued 
     LMM fixed effects, interactions & covariates 
Experiments 1.1 & 1.2 
combined 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Cognition: 
         Serial 3s score (correct 
in 2 mins) 
 
1.5 3161.68 
 
Time of 
day 
 
F(1,171.56) 0.02 0.891 
     
Visit 
 
F(2,95.87) 100.94 <0.001 
     
Session 
 
F(2,144.33) 35.24 <0.001 
     
ToD x Visit 
 
F(2,97.24) 2.23 0.113 
     
ToD x 
Session 
 
F(2,144.55) 1.07 0.345 
     
Visit x 
Session 
 
F(4,106.31) 4.00 0.005 
     
ToD x Visit 
x Session 
 
F(4,106.30) 0.91 0.463 
          
  
1.6 3141.77 
 
Time of 
day 
 
F(1,171.33) <0.01 0.999 
     
Visit 
 
F(2,95.38) 107.35 <0.001 
     
Session 
 
F(2,148.61) 41.71 <0.001 
     
ToD x Visit 
 
F(2,96.33) 2.72 0.071 
     
ToD x 
Session 
 
F(2,147.96) 0.75 0.475 
     
Visit x 
Session 
 
F(4,107.74) 3.65 0.008 
     
ToD x Visit 
x Session 
 
F(4,107.80) 0.70 0.596 
     
Motivation 
 
F(1,388.76) 21.02 <0.001 
          Serial 3s errors 
(incorrect in 2 mins) 
 
1.5 1983.35 
 
Time of 
day 
 
F(1,69.15) 5.34 0.024 
     
Visit 
 
F(2,117.59) 2.04 0.135 
     
Session 
 
F(2,144.40) 0.90 0.410 
     
ToD x Visit 
 
F(2,119.15) 0.73 0.485 
     
ToD x 
Session 
 
F(2,144.70) 0.77 0.467 
     
Visit x 
Session 
 
F(4,110.41) 1.64 0.168 
     
ToD x Visit 
 
F(4,110.55) 1.02 0.401 
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Table L.3 continued 
     LMM fixed effects, interactions & covariates 
Experiments 1.1 & 1.2 
combined 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
x Session 
          
  
1.6 1978.14 
 
Time of 
day 
 
F(1,71.49) 6.66 0.012 
     
Visit 
 
F(2,115.97) 1.79 0.172 
     
Session 
 
F(2,144.19) 0.62 0.540 
     
ToD x Visit 
 
F(2,117.31) 0.77 0.465 
     
ToD x 
Session 
 
F(2,143.69) 0.96 0.387 
     
Visit x 
Session 
 
F(4,110.69) 1.67 0.163 
     
ToD x Visit 
x Session 
 
F(4,110.83) 0.96 0.433 
     
Motivation 
 
F(1,194.51) 5.40 0.021 
          
Serial 3s RT (ms) 
 
1.5 7118.82 
 
Time of 
day 
 
F(1,146.48) 0.45 0.505 
     
Visit 
 
F(2,119.15) 63.75 <0.001 
     
Session 
 
F(2,205.13) 21.52 <0.001 
     
ToD x Visit 
 
F(2,121.59) 0.15 0.857 
     
ToD x 
Session 
 
F(2,204.88) 0.71 0.491 
     
Visit x 
Session 
 
F(4,146.74) 1.57 0.184 
     
ToD x Visit 
x Session 
 
F(4,147.48) 0.79 0.536 
          
  
1.6 7115.79 
 
Time of 
day 
 
F(1,144.47) 0.41 0.521 
     
Visit 
 
F(2,118.64) 62.76 <0.001 
     
Session 
 
F(2,206.34) 22.69 <0.001 
     
ToD x Visit 
 
F(2,120.63) 0.17 0.844 
     
ToD x 
Session 
 
F(2,205.55) 0.54 0.582 
     
Visit x 
Session 
 
F(4,145.76) 1.47 0.215 
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Table L.3 continued 
     LMM fixed effects, interactions & covariates 
Experiments 1.1 & 1.2 
combined 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
ToD x Visit 
x Session 
 
F(4,147.02) 0.86 0.487 
     
Motivation 
 
F(1,270.60) 3.16 0.077 
          Serial 7s score (correct 
in 2 mins) 
 
1.5 2812.56 
 
Time of 
day 
 
F(1,151.74) 1.87 0.174 
     
Visit 
 
F(2,111.21) 52.10 <0.001 
     
Session 
 
F(2,173.06) 17.45 <0.001 
     
ToD x Visit 
 
F(2,113.08) 6.44 0.002 
     
ToD x 
Session 
 
F(2,173.41) 0.82 0.441 
     
Visit x 
Session 
 
F(4,115.67) 0.99 0.414 
     
ToD x Visit 
x Session 
 
F(4,115.88) 0.80 0.531 
          
  
1.6 2776.99 
 
Time of 
day 
 
F(1,151.59) 0.87 0.353 
     
Visit 
 
F(2,110.47) 57.18 <0.001 
     
Session 
 
F(2,156.24) 22.27 <0.001 
     
ToD x Visit 
 
F(2,111.67) 5.80 0.004 
     
ToD x 
Session 
 
F(2,154.61) 1.20 0.304 
     
Visit x 
Session 
 
F(4,116.54) 1.14 0.342 
     
ToD x Visit 
x Session 
 
F(4,117.30) 1.21 0.311 
     
Motivation 
 
F(1,380.09) 27.13 <0.001 
          Serial 7s errors 
(incorrect in 2 mins) 
 
1.5 1915.13 
 
Time of 
day 
 
F(1,81.57) 0.06 0.805 
     
Visit 
 
F(2,107.19) 1.25 0.289 
     
Session 
 
F(2,163.85) 4.60 0.011 
     
ToD x Visit 
 
F(2,109.03) 0.12 0.890 
     
ToD x 
Session 
 
F(2,164.00) 0.25 0.782 
     
Visit x 
Session 
 
F(4,111.94) 0.19 0.942 
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Table L.3 continued 
     LMM fixed effects, interactions & covariates 
Experiments 1.1 & 1.2 
combined 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
ToD x Visit 
x Session 
 
F(4,112.33) 1.16 0.334 
          
  
1.6 1889.38 
 
Time of 
day 
 
F(1,82.59) 0.08 0.780 
     
Visit 
 
F(2,105.37) 1.91 0.153 
     
Session 
 
F(2,156.62) 3.85 0.023 
     
ToD x Visit 
 
F(2,106.15) 0.12 0.887 
     
ToD x 
Session 
 
F(2,155.14) 0.20 0.819 
     
Visit x 
Session 
 
F(4,107.47) 0.23 0.920 
     
ToD x Visit 
x Session 
 
F(4,108.27) 1.21 0.309 
     
Motivation 
 
F(1,326.80) 11.78 0.001 
          
Serial 7s RT (ms) 
 
1.5 7672.87 
 
Time of 
day 
 
F(1,161.61) 0.25 0.618 
     
Visit 
 
F(2,102.79) 42.23 <0.001 
     
Session 
 
F(2,152.25) 27.73 <0.001 
     
ToD x Visit 
 
F(2,103.56) 2.53 0.085 
     
ToD x 
Session 
 
F(2,152.36) 0.66 0.519 
     
Visit x 
Session 
 
F(4,106.37) 2.19 0.075 
     
ToD x Visit 
x Session 
 
F(4,106.64) 1.06 0.379 
          
  
1.6 7634.93 
 
Time of 
day 
 
F(1,164.69) 0.58 0.448 
     
Visit 
 
F(2,100.57) 42.40 <0.001 
     
Session 
 
F(2,154.15) 29.24 <0.001 
     
ToD x Visit 
 
F(2,100.65) 2.32 0.103 
     
ToD x 
Session 
 
F(2,152.83) 0.62 0.540 
     
Visit x 
Session 
 
F(4,107.45) 2.71 0.034 
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Table L.3 continued 
     LMM fixed effects, interactions & covariates 
Experiments 1.1 & 1.2 
combined 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
ToD x Visit 
x Session 
 
F(4,108.36) 1.05 0.383 
     
Motivation 
 
F(1,310.62) 2.20 0.139 
Mood: 
         Mental fatigue 
(rating/9) 
 
1.5 2779.06 
 
Time of 
day 
 
F(1,79.41) 0.91 0.343 
     
Visit 
 
F(2,115.12) 1.61 0.205 
     
Session 
 
F(2,158.09) 0.45 0.638 
     
ToD x Visit 
 
F(2,116.97) 0.66 0.521 
     
ToD x 
Session 
 
F(2,158.09) 1.74 0.179 
     
Visit x 
Session 
 
F(4,111.79) 0.40 0.808 
     
ToD x Visit 
x Session 
 
F(4,112.25) 0.16 0.960 
          Positive affect 
(score/50) 
 
1.5 2085.36 
 
Time of 
day 
 
F(1,129.26) 3.18 0.077 
     
Visit 
 
F(2,106.24) 6.44 0.002 
     
Session 
 
F(2,138.03) 15.91 <0.001 
     
ToD x Visit 
 
F(2,107.87) 4.32 0.016 
     
ToD x 
Session 
 
F(2,138.11) 0.38 0.683 
     
Visit x 
Session 
 
F(4,96.71) 1.51 0.205 
     
ToD x Visit 
x Session 
 
F(4,97.03) 1.42 0.235 
          Negative affect 
(score/50) 
 
1.5 1821.22 
 
Time of 
day 
 
F(1,97.94) 0.01 0.929 
     
Visit 
 
F(2,118.14) 1.49 0.229 
     
Session 
 
F(2,168.32) 6.57 0.002 
     
ToD x Visit 
 
F(2,119.59) 1.93 0.150 
     
ToD x 
Session 
 
F(2,168.34) 0.91 0.404 
     
Visit x 
Session 
 
F(4,114.36) 1.28 0.283 
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Table L.3 continued 
     LMM fixed effects, interactions & covariates 
Experiments 1.1 & 1.2 
combined 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
ToD x Visit 
x Session 
 
F(4,115.34) 0.05 0.995 
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Table L.4 LMM results for Experiment 2 
Table L.4 continued 
     LMM fixed effects, interactions & covariates 
Experiment 2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Cognition: 
         Immediate recall 
(score/15) 
 
2.1 2213.36 
 
Visit 
 
F(5,219.21) 1.88 0.098 
    
Session 
 
F(1,264.00) 30.95 <0.001 
     
Dose 
 
F(5,216.82) 0.36 0.875 
     
Session x Dose 
 
F(5,264) 1.23 0.293 
          Immediate recall 
interference errors 
 
2.2 -680.2 
 
Visit 
 
F(5,264.06) 1.07 0.379 
    
Session 
 
F(1,264.01) 11.24 0.001 
     
Dose 
 
F(5,263.30) 0.16 0.978 
     
Session x Dose 
 
F(5,264.01) 0.33 0.898 
          Delayed recall 
(score/15) 
 
2.1 2259.32 
 
Visit 
 
F(5,219.14) 2.98 0.013 
    
Session 
 
F(1,264.00) 100.36 <0.001 
     
Dose 
 
F(5,217.31) 0.76 0.583 
     
Session x Dose 
 
F(5,264.00) 1.40 0.225 
          Delayed recall 
interference errors 
 
2.2 199.64 
 
Visit 
 
F(5,264.04) 0.67 0.647 
    
Session 
 
F(1,263.06) 58.79 <0.001 
     
Dose 
 
F(5,263.17) 0.96 0.441 
     
Session x Dose 
 
F(5,263.06) 1.03 0.401 
          Seral 3s score 
(correct in 2 mins) 
 
2.1 3648.66 
 
Visit 
 
F(5,219.20) 80.02 <0.001 
    
Session 
 
F(1,263.94) 22.98 <0.001 
     
Dose 
 
F(5,218.38) 1.25 0.287 
     
Session x Dose 
 
F(5,263.94) 0.25 0.941 
          Serial 3s errors 
(incorrect in 2 mins) 
 
2.1 2152.71 
 
Visit 
 
F(5,213.88) 0.83 0.531 
    
Session 
 
F(1,254.27) 3.37 0.067 
     
Dose 
 
F(5,214.96) 0.61 0.695 
     
Session x Dose 
 
F(5,254.27) 0.25 0.942 
          Serial 3s RT (ms) 
 
2.1 7417.28 
 
Visit 
 
F(5,218.15) 109.92 <0.001 
     
Session 
 
F(1,261.91) 63.60 <0.001 
     
Dose 
 
F(5,212.89) 1.47 0.201 
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Table L.4 continued 
     LMM fixed effects, interactions & covariates 
Experiment 2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Session x Dose 
 
F(5,261.89) 0.57 0.727 
          Seral 7s score 
(correct in 2 mins) 
 
2.1 3191.56 
 
Visit 
 
F(5,218.11) 27.62 <0.001 
    
Session 
 
F(1,261.55) 16.52 <0.001 
     
Dose 
 
F(5,217.68) 0.57 0.721 
     
Session x Dose 
 
F(5,261.63) 1.16 0.328 
          Serial 7s errors 
(incorrect in 2 mins) 
 
2.1 2025.52 
 
Visit 
 
F(5,221.58) 0.75 0.585 
    
Session 
 
F(1,263.97) 1.64 0.201 
     
Dose 
 
F(5,221.65) 0.65 0.661 
     
Session x Dose 
 
F(5,263.97) 0.67 0.650 
          Serial 7s RT (ms) 
 
2.1 8481.82 
 
Visit 
 
F(5,192.26) 20.45 <0.001 
     
Session 
 
F(1,237.18) 14.59 <0.001 
     
Dose 
 
F(5,193.34) 0.32 0.898 
     
Session x Dose 
 
F(5,236.58) 1.51 0.189 
          Sternberg accuracy 
(correct/96) 
 
2.1 2747.04 
 
Visit 
 
F(5,206.40) 5.67 <0.001 
    
Session 
 
F(1,245.07) 0.45 0.501 
     
Dose 
 
F(5,206.75) 1.07 0.376 
     
Session x Dose 
 
F(5,245.25) 0.43 0.824 
          Sternberg scanning 
rate (ms/item) 
 
2.1 4211.07 
 
Visit 
 
F(5,219.80) 7.69 <0.001 
    
Session 
 
F(1,264.15) 1.77 0.185 
     
Dose 
 
F(5,219.15) 1.85 0.104 
     
Session x Dose 
 
F(5,264.13) 0.42 0.833 
          Sternberg 
extrapolated RT (ms) 
 
2.1 5991.01 
 
Visit 
 
F(5,219.23) 3.79 0.003 
    
Session 
 
F(1,264.00) 17.37 <0.001 
     
Dose 
 
F(5,219.24) 1.49 0.194 
     
Session x Dose 
 
F(5,264.00) 0.91 0.476 
          Stroop accuracy 
(correct/96) 
 
2.1 2444.58 
 
Visit 
 
F(5,218.39) 0.79 0.560 
    
Session 
 
F(1,260.78) 0.08 0.772 
     
Dose 
 
F(5,218.22) 1.09 0.367 
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Table L.4 continued 
     LMM fixed effects, interactions & covariates 
Experiment 2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Session x Dose 
 
F(5,260.71) 0.72 0.610 
          Stroop incongruent 
RT (ms) 
 
2.1 5601.64 
 
Visit 
 
F(5,218.94) 1.97 0.083 
    
Session 
 
F(1,264.00) 19.54 <0.001 
     
Dose 
 
F(5,218.95) 1.82 0.109 
     
Session x Dose 
 
F(5,264.00) 0.33 0.893 
          Stroop congruent RT 
(ms) 
 
2.1 5564.72 
 
Visit 
 
F(5,218.91) 0.61 0.691 
    
Session 
 
F(1,264.00) 21.99 <0.001 
     
Dose 
 
F(5,218.71) 2.12 0.064 
     
Session x Dose 
 
F(5,264.00) 0.49 0.785 
          Stroop interference 
effect (ms) 
 
2.1 5153.71 
 
Visit 
 
F(5,219.28) 4.24 0.001 
    
Session 
 
F(1,263.11) 0.11 0.741 
     
Dose 
 
F(5,219.96) 1.28 0.272 
     
Session x Dose 
 
F(5,263.10) 0.69 0.630 
Mood: 
         Mental fatigue 
(rating/9) 
 
2.1 2098.79 
 
Visit 
 
F(5,219.63) 3.40 0.006 
    
Session 
 
F(1,264.00) 10.51 0.001 
     
Dose 
 
F(5,219.58) 0.40 0.845 
     
Session x Dose 
 
F(5,264.00) 1.08 0.375 
          Positive affect 
(score/50) 
 
2.1 3368.94 
 
Visit 
 
F(5,219.44) 1.86 0.102 
    
Session 
 
F(1,264.00) 3.37 0.067 
     
Dose 
 
F(5,218.87) 0.41 0.838 
     
Session x Dose 
 
F(5,264.00) 0.66 0.654 
          Negative affect 
(score/50) 
 
2.1 2496.64 
 
Visit 
 
F(5,219.03) 0.39 0.852 
    
Session 
 
F(1,259.58) 4.55 0.034 
     
Dose 
 
F(5,219.06) 0.48 0.793 
     
Session x Dose 
 
F(5,259.65) 1.05 0.389 
Physiology: 
         Systolic BP (mmHg) 
 
2.1 3122.99 
 
Visit 
 
F(5,219.10) 2.80 0.018 
     
Session 
 
F(1,264.00) 153.18 <0.001 
     
Dose 
 
F(5,218.27) 1.46 0.205 
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Table L.4 continued 
     LMM fixed effects, interactions & covariates 
Experiment 2 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Session x Dose 
 
F(5,264.00) 0.21 0.957 
          Diastolic BP (mmHg) 
 
2.1 2843.16 
 
Visit 
 
F(5,217.05) 3.90 0.002 
     
Session 
 
F(1,259.02) 107.86 <0.001 
     
Dose 
 
F(5,216.67) 0.71 0.620 
     
Session x Dose 
 
F(5,259.87) 0.30 0.915 
          Heart rate (bpm) 
 
2.1 3322.48 
 
Visit 
 
F(5,219.50) 1.62 0.155 
     
Session 
 
F(1,263.40) 28.60 <0.001 
     
Dose 
 
F(5,210.58) 1.46 0.204 
     
Session x Dose 
 
F(5,263.39) 1.45 0.206 
Palatability: 
         ‘Sweet' rating 
(out of 9) 
 
2.3 987.07 
 
Dose 
 
F(5,44.23) 1.57 0.190 
         ‘Bland' rating 
(out of 9) 
 
2.3 978.25 
 
Dose 
 
F(5,44.52) 2.82 0.027 
         ‘Tasty' rating 
(out of 9) 
 
2.3 1049.05 
 
Dose 
 
F(5,44.54) 10.07 <0.001 
         ‘Pleasant' rating 
(out of 9) 
 
2.3 1046.32 
 
Dose 
 
F(5,44.36) 10.26 <0.001 
         ‘Sour' rating 
(out of 9) 
 
2.3 945.97 
 
Dose 
 
F(5,44.21) 3.97 0.005 
         ‘Satisfying' rating 
(out of 9) 
 
2.3 1053.19 
 
Dose 
 
F(5,44.29) 5.10 0.001 
         ‘How much more 
could you consume?’ 
rating (out of 9) 
 
2.3 1051.72 
 
Dose 
 
F(5,43.24) 6.82 <0.001 
         ‘How easy was it to 
consume?' rating 
(out of 9) 
  
 
2.3 1100.45 
 
Dose 
 
F(5,43.75) 10.61 <0.001 
                  
  
 235 
 
Table L.5 LMM results for Experiment 3 
    LMM fixed effects, interactions & covariates 
Experiment 3 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Physiology: 
         Blood glucose (mmol/l) 
 
3.1 1194.95 
 
Time 
 
F(7,84.00) 45.17 <0.001
     
Dose 
 
F(4,59.06) 15.12 <0.001 
     
Time x Dose 
 
F(28,84.00) 4.53 <0.001 
     
BMI 
 
F(1,15.99) 5.64 0.030 
          iAUC 
 
3.2 908.44 
 
Dose 
 
F(4,17.12) 14.02 <0.001
     
BMI 
 
F(1,17.88) 0.07 0.795 
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Table L.6 LMM results for Experiment 4  
Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Glucose: 
        
 
Blood glucose (mmol/l) 
 
4.0 1555.11 
 
Visit 
 
F(3,121.85) 2.02 0.115 
     
Time 
 
F(4,164.00) 215.62 <0.001 
     
Dose 
 
F(3,91.99) 4.93 0.003 
     
Time x 
Dose 
 
F(12,164.00) 3.36 <0.001 
          
  
4.1 1546.29 
 
Visit 
 
F(3,120.95) 2.03 0.113 
     
Time 
 
F(4,164.00) 215.62 <0.001 
     
Dose 
 
F(3,90.27) 4.81 0.004 
     
Time x 
Dose 
 
F(12,164.00) 3.36 <0.001 
     
BMI 
 
F(1,39.01) 9.96 0.003 
          
  
4.2 1535.77 
 
Visit 
 
F(3,121.01) 2.39 0.072 
     
Time 
 
F(4,164.00) 11.30 <0.001 
     
Dose 
 
F(3,91.02) 0.23 0.878 
     
Time x 
Dose 
 
F(12,164.00) 0.62 0.824 
     
BMI 
 
F(1,44.38) 8.48 0.006 
     
Time x 
BMI 
 
F(4,164.00) 0.84 0.504 
     
Dose x 
BMI 
 
F(3,91.12) 0.19 0.906 
     
Time x 
Dose x 
BMI 
 
F(12,164.00) 0.40 0.962 
          iAUC 
 
4.0 1646.42 
 
Visit 
 
F(3,39.99) 0.09 0.965 
     
Dose 
 
F(3,91.69) 2.11 0.104 
          
  
4.3 1646.1 
 
Visit 
 
F(3,40.03) 0.09 0.965 
     
Dose 
 
F(3,92.64) 2.15 0.100 
     
BMI 
 
F(1,39.86) 0.33 0.569 
          Cognition: 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
Digit vigilance score 
(correct/45) 
 
4.4 2078.6 
 
Visit 
 
F(3,113.74) 3.42 .020 
    
Session 
 
F(2,154.02) .48 .621 
     
Dose 
 
F(3,112.93) .29 .836 
     
Session 
x Dose 
 
F(6,154.00) 1.22 .297 
          
  
4.5 2078.58 
 
Visit 
 
F(3,113.98) 3.37 .021 
     
Session 
 
F(2,180.71) .42 .656 
     
Dose 
 
F(3,112.81) .29 .835 
     
Session 
x Dose 
 
F(6,153.77) 1.23 .295 
     
Glucose 
 
F(1,373.34) .02 .885 
          Digit vigilance commission 
errors 
 
4.4 1660.27 
 
Visit 
 
F(3,121.23) 2.83 .041 
    
Session 
 
F(2,157.54) 0.63 .535 
     
Dose 
 
F(3,121.48) 1.02 .388 
     
Session 
x Dose 
 
F(6,157.40) 1.20 .308 
          
  
4.5 1660.02 
 
Visit 
 
F(3,121.28) 2.74 .046 
     
Session 
 
F(2,179.16) 0.43 .649 
     
Dose 
 
F(3,121.36) 1.04 .379 
     
Session 
x Dose 
 
F(6,156.89) 1.20 .307 
     
Glucose 
 
F(1,413.42) 0.27 .607 
          Digit vigilance RT (ms) 
 
4.4 4512.43 
 
Visit 
 
F(3,123.55) 2.29 .082 
     
Session 
 
F(2,163.68) 7.59 .001 
     
Dose 
 
F(3,123.06) 0.65 .581 
     
Session 
x Dose 
 
F(6,163.67) 0.58 .748 
          
  
4.5 4512.42 
 
Visit 
 
F(3,124.03) 2.28 .083 
     
Session 
 
F(2,190.03) 7.28 .001 
     
Dose 
 
F(3,123.13) 0.66 .581 
     
Session 
x Dose 
 
F(6,164.07) 0.58 .746 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Glucose 
 
F(1,394.38) 0.01 .915 
          RVIP score (correct/40) 
 
4.4 2828.14 
 
Visit 
 
F(3,123.36) 0.31 .821 
     
Session 
 
F(2,163.61) 4.54 .012 
     
Dose 
 
F(122.70) 0.92 .434 
     
Session 
x Dose 
 
F(6,163.61) 0.68 .666 
          
  
4.5 2826.45 
 
Visit 
 
F(3,123.72) 0.26 .851 
     
Session 
 
F(2,192.98) 5.40 .005 
     
Dose 
 
F(3,122.63) 0.90 .442 
     
Session 
x Dose 
 
F(6,164.28) 0.63 .705 
     
Glucose 
 
F(1,342.04) 1.70 .193 
          RVIP commission errors 
 
4.4 2936.27 
 
Visit 
 
F(3,123.16) 1.55 .204 
     
Session 
 
F(2,160.78) 1.60 .206 
     
Dose 
 
F(3,122.98) 0.07 .977 
     
Session 
x Dose 
 
F(6,160.77) 1.03 .405 
          
  
4.5 2936.15 
 
Visit 
 
F(3,123.69) 1.51 .216 
     
Session 
 
F(2,187.78) 1.60 .204 
     
Dose 
 
F(3,123.09) 0.07 .977 
     
Session 
x Dose 
 
F(6,161.14) 1.03 .406 
     
Glucose 
 
F(1,323.17) 0.12 .726 
          RVIP RT (ms) 
 
4.4 4603.01 
 
Visit 
 
F(3,122.19) 2.86 .040 
     
Session 
 
F(2,163.51) .92 .400 
     
Dose 
 
F(3,123.36) 1.33 .269 
     
Session 
x Dose 
 
F(6,163.51) 1.54 .169 
          
  
4.5 4602.68 
 
Visit 
 
F(3,122.75) 2.86 .040 
     
Session 
 
F(2,190.19) .48 .622 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Dose 
 
F(3,123.32) 1.34 .263 
     
Session 
x Dose 
 
F(6,164.04) 1.58 .156 
     
Glucose 
 
F(1,416.08) .33 .567 
          Serial 3s score (correct in 2 
mins) 
 
4.4 3212.85 
 
Visit 
 
F(3,120.61) 97.76 <.001 
    
Session 
 
F(2,158.32) 18.62 <.001 
     
Dose 
 
F(3,120.71) 1.84 .143 
     
Session 
x Dose 
 
F(6,158.30) 0.66 .684 
          
  
4.5 3206.36 
 
Visit 
 
F(3,120.59) 96.90 <.001 
     
Session 
 
F(2,186.33) 21.80 <.001 
     
Dose 
 
F(3,120.33) 1.87 .138 
     
Session 
x Dose 
 
F(6,158.58) 0.66 .684 
     
Glucose 
 
F(1,345.39) 6.81 .009 
          
  
4.6 3174.72 
 
Visit 
 
F(3,117.04) 106.68 <0.001 
     
Session 
 
F(2,214.29) 3.62 0.028 
     
Dose 
 
F(3,308.69) 3.83 0.010 
     
Session 
x Dose 
 
F(6,237.09) 1.57 0.155 
     
Glucose 
 
F(1,405.87) 9.68 0.002 
     
Glucose 
x 
Session 
 
F(2,208.96) 5.16 0.006 
     
Glucose 
x Dose 
 
F(3,308.62) 4.81 0.003 
     
Glucose 
x 
Session 
x Dose 
 
F(6,241.69) 1.69 0.125 
          
         Serial 3s errors (incorrect in 
2 mins) 
 
4.4 1840.93 
 
Visit 
 
F(3,121.95) 2.19 .093 
    
Session 
 
F(2,161.68) 2.95 .055 
    
Dose 
 
F(3,117.66) 0.17 .916 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Session 
x Dose 
 
F(6,161.74) 0.82 .553 
          
  
4.5 1840.76 
 
Visit 
 
F(3,122.43) 2.21 .090 
     
Session 
 
F(2,184.03) 2.83 .061 
     
Dose 
 
F(3,117.61) 0.18 .911 
     
Session 
x Dose 
 
F(6,159.80) 0.83 .552 
     
Glucose 
 
F(1,397.38) 0.17 .678 
          Serial 3s RT (ms) 
 
4.4 7006.66 
 
Visit 
 
F(3,116.29) 31.53 <.001 
     
Session 
 
F(2,156.34) 31.24 <.001 
     
Dose 
 
F(3,106.34) 1.00 .394 
     
Session 
x Dose 
 
F(6,156.23) 1.44 .204 
          
  
4.5 7006.44 
 
Visit 
 
F(3,116.39) 31.60 <.001 
     
Session 
 
F(2,181.67) 28.98 <.001 
     
Dose 
 
F(3,106.57) 0.99 .399 
     
Session 
x Dose 
 
F(6,156.82) 1.41 .212 
     
Glucose 
 
F(1,305.07) 0.23 .632 
          Serial 7s score (correct in 2 
mins) 
 
4.4 2909.63 
 
Visit 
 
F(3,118.96) 35.01 <.001 
    
Session 
 
F(2,156.55) 11.62 <.001 
     
Dose 
 
F(3,118.73) 1.15 .330 
     
Session 
x Dose 
 
F(6,156.43) 0.93 .477 
          
  
4.5 2907.69 
 
Visit 
 
F(3,117.46) 36.54 <.001 
     
Session 
 
F(2,185.35) 12.37 <.001 
     
Dose 
 
F(3,117.11) 1.22 .305 
     
Session 
x Dose 
 
F(6,156.74) 0.81 .566 
     
Glucose 
 
F(1,366.22) 2.01 .157 
          Serial 7s errors (incorrect in 
 
4.4 1905.87 
 
Visit 
 
F(3,122.12) 1.77 .157 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
2 mins) 
    
Session 
 
F(2,163.04) 2.42 .092 
     
Dose 
 
F(3,120.87) 0.94 .423 
     
Session 
x Dose 
 
F(6,163.09) 1.06 .389 
          
  
4.5 1905.66 
 
Visit 
 
F(3,121.53) 1.81 .149 
     
Session 
 
F(2,185.23) 2.07 .129 
     
Dose 
 
F(3,119.52) 0.95 .419 
     
Session 
x Dose 
 
F(6,163.16) 1.03 .410 
     
Glucose 
 
F(1,432.31) 0.22 .642 
          Serial 7s RT (ms) 
 
4.4 7736.26 
 
Visit 
 
F(3,114.31) 24.56 <.001 
     
Session 
 
F(2,145.93) 10.99 <.001 
     
Dose 
 
F(3,115.09) 1.71 .168 
     
Session 
x Dose 
 
F(6,146.53) 0.89 .502 
          
  
4.5 
  
Visit 
 
F(3,114.47) 24.64 <.001 
   
7736.06 
 
Session 
 
F(2,170.14) 10.93 <.001 
     
Dose 
 
F(3,115.05) 1.72 .166 
     
Session 
x Dose 
 
F(6,148.88) 0.88 .509 
     
Glucose 
 
F(1,341.38) 0.20 .655 
Mood: 
         Mental fatigue (rating/9) 
 
4.4 1882.09 
 
Visit 
 
F(3,123.79) 0.34 0.799 
     
Session 
 
F(2,163.32) 3.45 0.034 
     
Dose 
 
F(3,123.45) 2.04 0.112 
     
Session 
x Dose 
 
F(6,163.30) 0.53 0.788 
          
  
4.5 1879.06 
 
Visit 
 
F(3,124.28) 0.32 0.813 
     
Session 
 
F(2,193.07) 4.77 0.009 
     
Dose 
 
F(3,123.30) 2.12 0.102 
     
Session 
x Dose 
 
F(6,163.37) 0.60 0.728 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Glucose 
 
F(1,364.76) 3.12 0.078 
          
  
4.6 1868.98 
 
Visit 
 
F(3,120.40) 0.27 0.844 
     
Session 
 
F(2,235.88) 1.09 0.338 
     
Dose 
 
F(3,321.80) 0.67 0.573 
     
Session 
x Dose 
 
F(6,239.18) 0.77 0.593 
     
Glucose 
 
F(1,434.37) 1.19 0.276 
     
Glucose 
x 
Session 
 
F(2,237.88) 1.79 0.169 
     
Glucose 
x Dose 
 
F(3,329.16) 0.37 0.772 
     
Glucose 
x 
Session 
x Dose 
 
F(6,246.05) 0.92 0.482 
          Positive affect (score/50) 
 
4.4 3042.2 
 
Visit 
 
F(3,121.50) 2.01 0.116 
     
Session 
 
F(2,161.97) 4.99 0.008 
     
Dose 
 
F(3,120.70) 1.31 0.275 
     
Session 
x Dose 
 
F(6,161.96) 1.07 0.384 
          
  
4.5 3027.96 
 
Visit 
 
F(3,122.47) 1.80 0.150 
     
Session 
 
F(2,189.76) 5.55 0.005 
     
Dose 
 
F(3,121.48) 1.13 0.338 
     
Session 
x Dose 
 
F(6,163.31) 0.95 0.461 
     
Glucose 
 
F(1,356.86) 1.36 0.244 
          Negative affect (score/50) 
 
4.4 2227.91 
 
Visit 
 
F(3,120.75) 0.40 0.751 
     
Session 
 
F(2,161.93) 4.63 0.011 
     
Dose 
 
F(3,111.87) 0.63 0.594 
     
Session 
x Dose 
 
F(6,162.81) 0.63 0.705 
          
  
4.5 2227.86 
 
Visit 
 
F(3,121.18) 0.40 0.750 
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Table L.6 continued 
     LMM fixed effects & covariates 
Experiment 4 
           
 
Model Fit (-2LL) 
 
Factor 
 
df F statistic p value 
     
Session 
 
F(2,193.08) 4.23 0.016 
     
Dose 
 
F(3,111.94) 0.63 0.597 
     
Session 
x Dose 
 
F(6,161.77) 0.63 0.708 
     
Glucose 
 
F(1,307.10) 0.04 0.834 
Palatability: 
         ‘Sweet' rating (out of 9) 
 
4.7 602.7 
 
Dose 
 
F(3,40.81) 15.76 <0.001 
          ‘Bland' rating (out of 9) 
 
4.7 633.65 
 
Dose 
 
F(3,40.94) 6.79 0.001 
          ‘Tasty' rating (out of 9) 
 
4.7 645.36 
 
Dose 
 
F(3,40.62) 2.11 0.114 
          ‘Pleasant' rating (out of 9) 
 
4.7 662.16 
 
Dose 
 
F(3,40.43) 2.13 0.112 
          ‘Sour' rating (out of 9) 
 
4.7 503.48 
 
Dose 
 
F(3,40.63) 8.82 <0.001 
          ‘Satisfying' rating (out of 9) 
 
4.7 650.21 
 
Dose 
 
F(3,40.59) 1.05 0.382 
          ‘How much more could you 
consume?’ rating (out of 9) 
 
4.7 664.4 
 
Dose 
 
F(3,40.62) 0.94 0.429 
         ‘How easy was it to 
consume?' rating (out of 9) 
  
 
4.7 682.43 
 
Dose 
 
F(3,40.56) 0.457 0.714 
                  
 
 
